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Abstract 
Purpose: This study aimed to evaluate the lowering of carbohydrates from 
conventionally recommended levels of ≥ 55% of energy intake as a valid and 
safe treatment option for managing obesity and related disease.  
Methods: The study was a qualitative systematic review of fourteen randomized 
controlled studies, each with at least one study arm that lowered intake of 
carbohydrates  to either ketogenic levels (≤50g/d) (Atkins type diet) or non-
ketogenic levels including Zone type diets (>50g/d to 40-45% of energy intake). 
Low-carbohydrate diets have generally implied increased protein intake to 
around 30% of energy intake. Outcomes evaluated included weight and fat loss; 
dyslipidemia; blood sugar  control; hypertension; nutritional adequacy; hunger 
and satiety; adherence and safety. A synthesis of process, results and 
implications was used towards generating a theoretical weight management 
framework. 
Results: In the short to medium term of up to six months both the ketogenic and 
non-ketogenic lowering of carbohydrates within the context of a calorie reduction 
of 300-750 kcal/day generated clinically meaningful weight loss results of 5-10%. 
Lower-carbohydrates diet plans generated similar or better results for most of the 
main outcomes examined as compared with conventional higher-
carbohydrate/low-fat diet alternatives. Longer-term studies were few in number 
but weight loss results were in the range of 2-6% with no significant diet 
difference noted. Potential impact of ketogenic diets on dyslipidemia, renal and 
bone health needs further evaluation. When lowering carbohydrates or calories, 
nutritional adequacy may require management with the use of supplementation. 
Conclusions & Implications: Lowering carbohydrates may provide an important 
and useful strategy to achieve a regular daily calorie deficit, generate clinically 
meaningful weight loss and improve related metabolic health markers. 
Recommended weight management protocols may be individualised based on a 
theoretical model that considers individual health risks and genetics, dietary 
preferences, carbohydrate sensitivity and is geared towards improved 
adherence.   
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CHAPTER 1- INTRODUCTION 
Obesity has been recognised by the World Health Organisation [WHO] as a 
world-wide epidemic and a major cause of various related metabolic disease co-
morbidities including cardiovascular disease (CVD), type 2 diabetes (T2D), 
dyslipidemia, hypertension, osteoporosis and cancer (Despres, Lemieux & 
Prud‟homme, 2001; James, 2008). Obesity has historically been an issue in 
affluent societies, in geographical areas and in periods of history where food is 
available in abundance to large sections of the population (Gordon, Goldberg & 
Chosy, 1963). Despite sustained efforts by individuals and governments, rates 
of obesity and overweight have remained on the increase.  McMillan-Price & 
Brand-Miller (2004) noted that more than 40% of adults were overweight or 
obese in the United States (US), Europe and Australia. More recently, the 
United Kingdom (UK) Department of Health [DOH] (2012) has acknowledged 
that as per the last Health Survey for England, in 2010, 62.8% of adults and 
30.3% of children were overweight or obese. Of these 26.1% of adults and 16% 
of children were obese. 
 
Macronutrient intakes, namely carbohydrates, proteins and fats and their role in 
the optimal health as well as the management of obesity and related disease, 
have been the subject of interest over centuries (American Medical Association 
[AMA], 1974). The relative macronutrient composition of the diet in traditional 
hunter-gatherer societies (38% proteins, 39% fat, 23% carbohydrate) varied 
considerably with the macronutrient make-up of traditional western diets (16% 
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protein, 34% fat, 49% carbohydrate) (Cordain, 2002).  Traditional diets have 
undergone significant changes with modernization. Higher-carbohydrate foods 
based on cereals, beans, dairy products and refined foods with sugar and 
cooking fat were not included in traditional diets (Bryngelsson & Asp, 2005).  
Some of these nutritional changes have been linked to resulting health problems 
particularly increased intake of saturated fat (Jew, AbuMweis & Jones, 2009) 
and the introduction of refined versions of sugar and flour (Westman et al., 
2007).  Western Government Health Authorities particularly in the US and the 
UK have since the 1960s and more emphatically since the 1980s, endorsed 
low-fat and higher carbohydrate eating plans to support cardiovascular health, 
optimal health and the management of obesity (Food Standards Agency [FSA] 
2006; La Berge, 2008).  
 
McMillan Price and Brand-Miller (2004) note that a low-fat / high-carbohydrate 
approach for obesity management is logical as carbohydrates have a relatively 
low energy density as compared with fat (4 kilocalories /gram (kcal/g) compared 
to 9 kcal/g for fat) thereby causing meals to be bulkier and more filling than high-
fat meals. Pirozzo, Summerbell, Cameron and Glasziou (2003) further highlight 
that high-fat foods are relatively less satiating and favour both passive and 
active over-consumption due to improved taste and palatability. Cheuvront 
(2003) notes that the dietary macronutrient composition of 55% carbohydrates, 
15% protein and 30% fat representing the current recommended protocol is 
supported by scientific research spanning twenty five years. However 
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challenges to the existing paradigm with differing macronutrient composition 
levels and/or caloric restriction have been made by several medical and nutrition 
professionals as well as lay people with personal experience by means of 
popular diet books (Skidmore, 2007). A small sample of low-carbohydrate 
bestsellers include „The Carbohydrate Addict‟s Diet‟ (Heller & Heller, 1991), „The 
Zone Diet‟ (Sears & Lawren, 1995), „Dr. Atkins New Diet Revolution‟ (Atkins, 
2002) and „The South Beach Diet (Agatston, 2003)‟. More recently The Dukan 
Diet (Dukan, 2010) first published in France in 2000 but republished in the UK in 
2010 has gained popularity.  Many of these approaches recommend a moderate 
to severe restriction of carbohydrate intake and are generally regarded and 
labelled as “Fad Diets” by the Medical Establishment (Saltzman, Thomason & 
Roberts, 2001). Nonetheless, some of these differing approaches are 
increasingly being included as the subject of scientific research and clinical trials 
(Dansinger, Gleason, Griffith, Lara-Castro & Garvey, 2004; Selker & Schaefer; 
2005, Shai et al., 2008). The research is often initiated and funded by the 
Foundations promoting these so called “Fad Diets”, to review and test popular 
belief and to arrive at clinical protocol in respect of diet and obesity 
management. 
  
Pirozzo et al. (2003) highlighted that after more than two decades of the 
recommended low-fat /high-carbohydrate dietary approach, obesity and CVD 
has stood at much higher levels than in the 1980‟s.  Astrup, Larsen and Harper 
(2004) noted that obesity has remained a significant worldwide issue despite a 
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substantial decrease in fat intake and pointed out that a compensatory increase 
in the intake of carbohydrates in the form of processed starchy foods and 
sugars was potentially responsible for this result. Gardner et al. (2007), following 
a study comparing low-carbohydrate diets with low-fat diets, support the idea 
that despite the higher levels of fat, particularly saturated fat, concerns about the 
adverse effects of low-carbohydrate diets on blood lipid and CVD risk are not 
substantiated.  
 
Hite et al. (2010) highlight that US dietary guidelines to increase carbohydrates 
intake, reduce fat, saturated fat, salt, cholesterol were first proposed in 1977 
and continue to be re-iterated (United States Department of Agriculture, [USDA], 
2010). However the incidence of overweight, obesity and diabetes have 
increased.  Hence potentially, the stigma attached to fat intake particularly 
saturated and polyunsaturated fats and the recommendation of higher 
carbohydrate intake based on the state of the science in the 1960s and 1970s 
may have to be re-evaluated in the light of more recent science (Hite, 2010; 
Taubes, 2011).  
 
Three previous studies have performed systematic reviews on the efficacy 
and/or safety of low-carbohydrate diets however their conclusions are 
conflicting. Bravata et al. (2003) found that weight loss using low-carbohydrate 
diets was associated more clearly with decreased caloric intake and increased 
diet duration, not reduced carbohydrate content. Nordmann et al. (2006) and 
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Hession, Rolland, Kulkarni, Wise and Broom (2008) concluded that low-
carbohydrate/high-protein diets were more effective than low-fat diets at 
reducing weight and cardiovascular risk at six months and were as effective if 
not more effective up to one year. Hence there remains a lack of clarity on the 
viability or effectiveness of low-carbohydrate diets for weight management 
purposes and the extent to which carbohydrates need to be lowered to promote 
effective weight management.   
 
As a health advisor and nutritional therapist, this researcher is particularly 
interested in the potential to manage obesity and related CVD risk factors via 
dietary advice and protocol that can be sustained over time. Differences in 
views persist between UK and US government sponsored dietary advice in 
favour of a low-fat/higher-carbohydrate approach (FSA, 2006; USDA, 2010) and 
the increasing popularity of the low-carbohydrate approach to weight 
management being promoted by some medical doctors and health professionals 
with experience of treating obesity and related disease.  Hence the rationale of 
this study is to assess the potential and validity of lower-carbohydrate diets and 
to consider a theoretical framework for the recommendation of restricting 
carbohydrate intake for the management of overweight, obesity and related 
disease.   
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CHAPTER 2 - LITERATURE REVIEW 
Definition and Aetiology of Overweight & Obesity 
Obesity is described as a condition where excessive fat accumulation in adipose 
tissue impairs health (DOH 2012; Goldberg, 2003). The UK DOH (1991, p. 52) 
Committee of Medical Aspects (COMA) of Food Policy in the UK confirmed that 
a body mass index (BMI) between 25 and 30 kilograms /meters squared (kg/m2) 
may be described as overweight and above 30 kg/ m2 as obese. A BMI of 35 kg/ 
m2 or over is regarded as morbid obesity. This is in line with the WHO criteria for 
defining overweight and obesity (Allender & Rayner, 2007). The underlying 
reasons for and causes of obesity are complex and multifactorial and would 
include genetic susceptibility, reduced physical activity, consumption of 
excessive quantities of highly palatable, energy rich, easily available, energy 
dense food and other social and economic factors (Bouchard, 1991; McMillan-
Price & Brand-Miller, 2004; Stein & Colditz, 2004).  
 
Metabolic Disease Risk Factors of Obesity 
Reaven (2005; 2006) describes insulin resistance as a defect in the ability of 
insulin to adequately perform the function of glucose disposal and is potentially 
responsible for a cluster of cardiovascular risk factors associated with obesity 
termed as metabolic syndrome (Fonseca, 2005; Reaven, 2006). The defining 
components of metabolic syndrome are three or more of the following criteria: 
central obesity as evident from an elevated waist circumference, elevated 
triglycerides (TAG), reduced high-density lipoprotein cholesterol (HDL-C), 
                                                                
7 
 
elevated blood pressure and elevated fasting blood glucose (Fonseca, 2005; 
Reaven, 2006). Lara-Castro & Garvey (2004) concur that insulin resistance is 
the key issue underlying the pathogenesis of metabolic syndrome and is 
associated with generalized obesity and the accumulation of body fat. Despres 
et al., (2001) highlight that abdominal obesity, particularly visceral adipose 
tissue has been associated with glucose intolerance and hyperinsulinaemia 
resulting from insulin resistance and results in increased risk of CVD (Fonseca, 
2005). Heller and Heller (1994) draw a significant link between chronic elevated 
circulating insulin, as seen in obese subjects, to atherosclerosis, hypertension, 
non-insulin dependent diabetes mellitus (NIDDM), CVD and some forms of 
cancer and stroke.  
 
Reaven (2005) suggests that low-fat/high carbohydrate diets do not rectify the 
basic defect of insulin resistance rather they increase the metabolic 
manifestations. Reaven (2005) further reiterated that the practice, since the 
1960‟s, of replacing saturated fats by carbohydrates is not supported by the 
available research. Reaven (2005) proposes that the treatment of insulin 
resistance requires weight loss and making dietary macronutrient changes that 
replace saturated fat with unsaturated fats and not with carbohydrates.  There is 
widespread belief and sufficient evidence that weight loss, even as low as 5-
10% favourably affects markers of metabolic disease (Despres et al., 2001; 
Lara-Castro & Garvey, 2004) and can improve insulin sensitivity (Reaven, 
2005). Hence pursuing weight loss of 5-10% is regarded as clinically meaningful 
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to the improvement of metabolic health and the reduction of carbohydrates in 
the diet has a potential significance for managing insulin resistance.  
 
Historical Context to Carbohydrate Restricted Diets for Weight Loss  
The first available account of a successful restricted-carbohydrate weight loss 
diet for an individual was by Banting (1869) which called for restriction of sweet 
and starchy foods to support weight loss while allowing ad libitum meat intake 
(Banting, 1869; American Medical Association [AMA], 1974). Pennington 
(1953a; 1953b) set out an alternate approach to the problem of obesity using a 
low-carbohydrate calorically unrestricted diet (AMA, 1974).  Gordon et al. (1963) 
undertook a clinical trial and demonstrated successful weight loss with calories 
restricted to 1320 calories and ratios from protein: fat: carbohydrates of 
30:55:15 but with an emphasis on unsaturated fats.   
 
The very low-carbohydrate diet in „Dr Atkins Diet Revolution, 1972 „(as cited by 
AMA, 1974) was heavily criticised by the AMA (1974) with concerns over levels 
of saturated fats and cholesterol rich foods permitted. Atkins (2002) published a 
revised edition of the „Atkins Diet Revolution‟, re-iterating recommendations of 
restricting carbohydrate intake to ≤ 20g for two weeks followed by an increase of 
5g per day for each week following up to a maximum of 50g of carbohydrate 
intake per day.   
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Other medical and nutrition professionals have developed alternative versions of 
the low-carbohydrate/high-protein diet claiming to address some of the shortfalls 
of the Atkins Diet (Kauffman, 2004). The Zone Diet (Sears & Lawren, 1995) 
recommended lowering carbohydrate intake from the conventional diet levels of 
≥55% to 40% of energy intake with 30% of energy emanating from dietary 
proteins and fats respectively. Hence lowering carbohydrates to manage obesity 
has a history that spans more than a century and potentially warrants closer 
consideration.  
 
Defining Low-Carbohydrate Diets 
There is no clear definition of a low-carbohydrate diet and diets that limit 
carbohydrate have been variously described as “low-carbohydrate”, “very-low-
carbohydrate”, “high-protein”, “high-fat” and “ketogenic” (Westman, 
Mavropoulos, Yancy & Volek, 2003).  Adam-Perrot, Clifton and Brouns (2006) 
suggest low-carbohydrate refers to less than 100g of carbohydrates per day. 
Boucher, Benson, Kovarik, Solem and VanWormer (2008) refer to low-
carbohydrate as <130g/day. Westman et al. (2007) note that diets with a 
carbohydrate intake of <20-50g/d are referred to as low-carbohydrate ketogenic 
(LCK) diets whilst carbohydrate intakes of 50-150g/d are unlikely to generate 
ketone bodies and could be referred to as low-carbohydrate non-ketogenic diets 
(LCNK). Additionally a nutritional intake of <200g of carbohydrate is sometimes 
called a low-carbohydrate diet but may not generate the associated and 
expected metabolic changes. (Westman et al., 2007).   
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Potential Mechanisms for the Effectiveness of Low-carbohydrate Diets 
Johnstone, Horgan, Murisin, Bremner and Lobley (2008), note that when 
carbohydrate intakes are very low (< 20 g /d), the reduced glucose availability 
causes a ketogenic state to occur and a generation of ketone bodies from fat 
reserves. Westman et al. (2003) suggest that when carbohydrates are severely 
restricted, energy is derived from ketones and fatty acids in place of glucose. 
Whilst a ketogenic state is not essential for improved satiety, less hunger and 
reduced caloric intake result. Additionally, voluntary intake of energy appears to 
be less when carbohydrate intake is <10% of energy as compared with higher 
levels of carbohydrate intake of 35-45% of energy intake (Johnstone et al., 
2008). Bryngelsson and Asp (2005) highlight that carbohydrates are a preferred 
source of energy and that fat burning is suppressed when glucose is available. 
Hence carbohydrates and sugars are regarded as fattening and excess 
carbohydrates encourage de novo lipogenesis (Bryngelsson & Asp, 2005).   
 
Leidy, Mattes and Cambell (2007) show that during weight loss, protein intake 
influences appetite, the hunger stimulating hormone – „ghrelin‟ and 
thermogenesis. Astrup et al. (2004) summarise some of the recognised 
mechanisms that may account for weight loss related to a low-carbohydrate 
diet. These include increased excretion of bound water caused by depletion of 
carbohydrate stores; the appetite suppressing effects of a ketogenic diet; the 
greater satiating effects of and the reduction in spontaneous food intake 
associated with the implied higher protein levels associated with a low-
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carbohydrate diet; a reduced energy intake due to limited food choices (Astrup 
et al., 2004; Bryngelsson & Asp, 2005). 
  
Davis et al. (2009) concur that carbohydrates are the primary source of glucose 
for metabolism and that reducing carbohydrate intake can reduce insulin levels, 
improve glycemic control, improve insulin sensitivity and reduce postprandial 
hyperglycemia.  Heller and Heller (1994) promote a theory that frequent daily 
intake of carbohydrates sustains chronic hyperinsulinemia and insulin resistance 
and reducing the frequency of carbohydrate intake is required to manage these 
conditions without necessarily reducing the recommended 55-60% of daily 
energy intake from carbohydrates.  
 
McMillan-Price and Brand-Miller (2004) have highlighted the high-glycemic 
effect of many of the carbohydrates included in a typical western diet including 
potatoes, breads, and low-fat cereal products. The intake of these foods result 
in a high-glycemic load and increased demand for insulin often causing the 
chronic hyperinsulinemia referred to above by Heller and Heller (1994). Hence 
there are apparent mechanisms that support the theory that a restriction of 
carbohydrate intake and/or the alteration of the quality of or frequency of 
carbohydrates intake may impact on insulin resistance, hunger indicators, 
satiety, appetite control and consequently body weight and obesity 
management. 
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Toxic Environment  
Horgen and Brownell, 2004 note that the root of the obesity epidemic crisis may 
be related to the „toxic environment‟ which surrounds people with inexpensive, 
heavily marketed, convenient foods high in fat and calories and promotes 
reduced physical activity. Schwartz and Brownell (2007) suggest that the key 
drivers of human over-consumption are flavour variety, large portions, visibility 
and proximity. Many of the un-healthful foods readily available contain refined 
and processed carbohydrates and sugars or high-fat fried foods. Hence 
lowering carbohydrates could aim to reduce consumption of junk and/or 
processed foods and sugars and consequently impact positively on obesity 
management.  
 
Psychological & Behavioural Factors 
Brownell and Wadden (1992) highlight that behaviour is significant both in the 
aetiology and treatment of obesity and that long-term weight-management 
ultimately depends on the ability of patients to alter their behaviour patterns with 
respect to diet and exercise. Self-monitoring, stimulus control, cognitive 
restructuring and reinforcement by reward are behavioural treatment techniques 
that have been researched and remain important tools to improve the success 
of weight management protocols in clinical and domestic settings (Brownell & 
Stunkard, 1978). Bond, Phelan, Leahey, O.Hill and Wing (2009) highlight the 
significance of  the loss of control over eating („disinhibition‟) and the degree of 
conscious control over eating („cognitive restraint‟) as behaviours significant to 
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weight management. Davis and Turner (2001) re-iterate that weight 
maintenance requires life-long behavioural changes combining exercise with 
dietary changes and social support.  
 
Patel and Hu (2008) suggest that short sleep duration appears to be 
independently associated with weight gain due to increased caloric intake and 
reduced energy expenditure that may potentially result from sleep deprivation. 
Spiegel et al. (2004) note that sleep plays a significant role in energy 
homeostasis and that the satiety hormone „leptin‟ levels are dependent on sleep 
duration. Healy and Schwartz (2010) highlight that chronic stress can lead to 
truncal obesity and insulin resistance. Hence in addition to dietary issues, 
consideration of psychological and behavioural influences on weight 
management are potentially relevant.  
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CHAPTER 3 - METHODOLOGY 
Research Questions  
The key research questions being raised are if and how obesity, abdominal 
obesity and related co-morbidities may be influenced by diet and macronutrient 
composition. In particular, can obesity and related heath markers be managed 
via lowering carbohydrate intake which usually implies increased protein intake? 
Are lower-carbohydrate diets beneficial for weight management both in absolute 
terms and in comparison to the more widely accepted conventional higher-
carbohydrate/low-fat or other low-calorie dietary approaches?  Are low-
carbohydrate diets safe and effective and may they be recommended in clinical 
practice? Furthermore if the lay press and some potentially informed medical 
professionals recommend lowering carbohydrates for obesity management via 
popular literature, why are these not generally prescribed by health authorities? 
 
Study Design 
The study design is that of a systematic review which aims to identify and 
provide an overview of all relevant literature on the given topic and is also 
referred to as a “systematic literature review” (Green, 2005).  Cook, Mulrow and 
Haynes (1997) discuss systematic reviews as being a process that synthesizes 
best evidence for clinical decisions. Like other types of research, systematic 
reviews are subject to bias, which requires management via rigorous methods 
and reproducible criteria to be included in the review (Cook et al., 1997). In 
contrast to the three other systematic reviews on the subject of low-
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carbohydrate diets (Bravata et al., 2003; Hession et al., 2008; Nordmann et al., 
2006), and to enable better focus on the theoretical issues, the results of the 
underlying studies have not been statistically combined.  Accordingly this study 
may be regarded as a qualitative systematic review (Cook et al., 1997; Jadad, 
1998, p. 83). In addition the study may be regarded as an evaluation as it uses 
scientific method and systematic collection of data to assess the effectiveness 
of interventions (Bowling, 2002, p.9) and involved exploring how existing 
knowledge may be used to inform and guide practical clinical guidelines (Jadad, 
1998, pp. 90-91).  
 
Data Searches 
Several searches were performed on the PubMed database using search 
strings such as “weight loss AND carbohydrate”; “diet AND obesity AND 
cardiovascular”, “proteins AND low carbohydrate AND weight”, “high protein 
AND weight loss”, “weight loss AND macronutrient”. The search strategy aimed 
to identify studies between 2000 and 2010; was limited to studies in English; 
and to the search terms “clinical trial”, and “randomized controlled trial”; with 
subjects that were adult of 19+ years. Titles and abstracts were reviewed to 
identify relevant studies and in addition reference lists of selected studies were 
scrutinised to identify additional studies that might be relevant. However the final 
selection was limited to studies for which full text articles were available. In 
addition a wide range of popular diet books relating to lowering carbohydrate 
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intake towards the management of obesity and related disease were reviewed 
for relevant concepts, empirical experience and supporting research articles. 
   
 Study Selection Criteria 
The available studies were diverse in design. The intention was to include 
randomized controlled trials (RCTs) regarded as “the gold standard” in terms of 
quality of evidence (Hart, 2003). Hence, most of the study designs considered 
and/or selected had participants randomized to receive one or more low to 
moderate carbohydrate diets compared with alternative diets that were generally 
low-fat or low-calorie in content.  All studies that involved lowering carbohydrate 
intake as part of the study design were considered for inclusion irrespective of 
the title of the study or description of the diet.  Specifically, studies that referred 
to high-protein (HP) diets were considered for inclusion if the HP diet design 
implied a low carbohydrate diet content.  Only studies conducted in an 
outpatient setting were included to represent the researcher‟s interest in a 
clinical setting. Target end-points or clinical end-points were identified and 
studies were excluded if they did not report data for at least one of the obesity 
body composition outcomes and one of the co-morbidity related clinical 
outcomes and in particular dyslipidemia markers.  Fourteen studies were finally 
selected for inclusion in the review. 
 
 
 
                                                                
17 
 
Data Collection 
The data collection codes and categories were obesity represented by weight, 
body mass index (BMI) and body fat measures including abdominal obesity 
represented by waist circumference (WC). In addition relevant metabolic 
disease and CVD related end points considered were blood glucose, insulin 
resistance and/or insulin sensitivity; dyslipidemia indicators including total 
cholesterol (TC);  triglycerides (TAG), high density lipoprotein cholesterol (HDL-
C) and low density lipoprotein cholesterol (LDL-C) particularly LDL-C particle 
size (Despres et al., 2001); and hypertension indicators. Other information 
collected included hunger and satiety indicators, dietary adherence, adverse 
effects, exercise and activity levels and supervision and monitoring undertaken.  
 
Data Evaluation 
The selected trials were evaluated against a series of criteria based on selected 
references as listed in Appendix A1. The criteria were expanded to develop a 
research analysis tool and instrument for data collection (Kumar 1999, p. 125) 
that would cover the key elements of dietary studies for the purpose of 
management of obesity and related disease.  The criteria aimed to evaluate the 
relevance of the study, the methodology, results and their interpretation to the 
research question being considered. In addition the criteria aimed to assess the 
external validity of the studies to the researcher as a nutritional therapist in 
ascertaining a sustainable protocol for overweight and obesity and related co-
morbidities in clinical practice.  
                                                                
18 
 
  
Results from the application of the research tool for each of the fourteen studies 
included in the review are attached as appendices A2-A15.  The complexity of 
the dietary studies in terms of the number of variables and variety of 
measurement methodologies adopted made analysing each of the studies to 
address the questions raised by the research tool excessively time consuming. 
Hence as a time-saving method, the research enquiry tools were completed 
where relevant, with direct extracts from the papers and broadly referenced as 
such in the Appendices A2 to A15. The length and detail included in the 
research tool was designed to provide adequate original comment from the 
studies to enable the synthesized conclusions to be corroborated in any 
subsequent review.  
 
The data collection sheets (Appendices A2-A15) highlight the various influences 
on the outcomes of a typical weight loss study namely duration, caloric 
restriction, macronutrient composition, saturated and other fat levels, fibre 
levels, activity and exercise levels, supervision and monitoring. Tables 1, 2 and 
3 with a related key for abbreviations and Appendix B1 derived from the data 
collection sheets summarise the diversity of dietary design and protocol for the 
low and moderate carbohydrate diets included in this review and the 
comparative diets. 
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CHAPTER 4 - RESULTS 
Identified Studies & Study Characteristics 
Based on the search on Pubmed, fourteen studies were identified to be included 
in the review. The dietary studies selected included a range of diets with 
differing recommended macronutrient ratios particularly manipulating 
carbohydrate levels as described in Appendix B1 and shown in Tables 1, 2 and 
3. The low and moderate carbohydrate studies were collated within two main 
categories. Low-carbohydrate ketogenic (LCK) Atkins type diets (Table 1) and 
low-carbohydrate non-ketogenic (LCNK) diets including the moderate 
carbohydrate Zone type diets which are also non-ketogenic but recommend a 
diet protocol of carbohydrates: protein: fat of 40:30:30 (Table 2). Sacks et al. 
(2008) included two diets which had 40% fat and either 35% or 45% of energy 
from carbohydrate with the balance of 25% and 15% respectively from protein 
intake. Both these diets were regarded as a closer to the Zone type diets and 
have been categorised as such.  
 
In total the review considered twelve Atkins type diets (Table 1), fifteen low-
carbohydrate non-ketogenic diets (Table 2), of which twelve were moderate-
carbohydrate Zone type diets (Table 2), giving data on twenty seven low to 
moderate carbohydrate interventions. These were assessed against twenty low-
fat diets (Table3) with a fat intake ranging from 10-30% and carbohydrate intake 
generally higher than 55% and 2 low-calorie dietary interventions. Hence this 
review permits a study of low and moderate carbohydrate diets, makes a 
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comparison between ketogenic and non-ketogenic low-carbohydrate diets and 
enables both low and moderate carbohydrate diets to be assessed against the 
generally recommended low-fat/higher-carbohydrate conventional diets. 
 
 
Table 1. Low-Carbohydrate Ketogenic Diets (LCK) / Atkins Diets (A) (Alphabetical Order) 
 
 
Study 
Study Arms 
 
Year  Duration Protein 
% 
Carbohydrate  % Fat %  Calories (kcal) 
/ Diet Detail 
Dansinger : A  
A:Z:L:W 
 
2005 1 yr 
/52w  
  NS < 20g increased up to 50g per 
day 
     NS  NCR. MCR=138 
1921 kcal p/d actual  
Foster: A  
A:L 
 
2003 3m/13 w 
6m/26 w 
1 yr 
/52w 
   NS Atkins diet rules      NS  NCR 
Johnston: A 
A:Z 
2006 6 w 30% 5% increased by 5g p/w in 
weeks 3-6 to between 20g – 
40g /day 
 
60% 
SF-30% 
 1500 kcal isocaloric 
McAuley :A 
A:Z:L 
2004 8 w ; 
16w & 
24w 
  NS- 20g p/d for 2 weeks. 5g 
increase per week till 50g of C 
by week 8 
 NS  NCR required. 
Resulting deficit in 
kcal- 519  kcal (8w); 
384 (16w) ; 381 (24w) 
 
 Samaha :A 
A:L 
 
2003 6 m 
/26w  
   NS <30g per day   NS  NCR 
Shai : A 
A:L:M 
 
2008 2 yr / 
104w 
   NS <20g of C per day for 2months 
gradual increase to 120g p/d. 
 
 
  NS  NCR  
Stern :A 
A:L 
 
 
2004 1 yr /  
52 w 
    NS <30g per day 
 
   NS     NCR 
Yancy : A  
A:L 
 
2004 24m / 
104 w   
    NS 5g per day raised weekly 
 
AC=29±11.1g – 8% of daily 
intake 
 
   NS  NCR  required 
Average intake for 
Atkins group 1461 kcal 
 
 
 
KEY : A=Atkins ; AC=actual consumption;  C= carbohydrates; g=grams; kcal= kilocalories; L=low fat/high 
carbohydrate; LCK=low carbohydrate ketogenic; m=months; M= Mediterranean diet;  MCR= Mean Caloric Restriction; 
NCR= No calorie restriction; NS = not specified; p/d= per day; p/w=per week; SF= saturated fat; w =weeks;  
W= Weight Watchers; yr = year; Z=Zone. 
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Table 2- Low-Carbohydrate Nonketogenic Diets  (N) Including Zone  (Z) Type Diets 
 
Lower Carbohydrate Non Ketogenic  diets (N) – >50-120g /d of carbohydrate  
Study 
Study Arms 
Year  Duration Protein 
% 
Carbohydrate  % Fat %  Calories (kcal)/Diet 
Detail 
Luscombe-
Marsh LF/HP 
N:N 
2005 12 w 
 
40% 30% (110g/d) 
Fibre :21g/d 
30% 
SF≤10
% 
 ER: 1500kcal (30%) 
ER  1434 kcal, C=30%  
Luscombe-
Marsh HF/SP 
N:N 
2005 12 w 20% 30% (110g/d) 
Fibre 27g /d 
50%  ER: 1500kcal (30%) 
1434 kcal  
C=30% 
Meckling  N 
N:L 
2004 10 w   - Reducing  C from 100g to 50-
70g by day 5 
Achieved reduction 228 g/d 
     -  Wm:1205-1605 kcal 
Mn: 1402-2200 kcal 
Deficit: 763 kcal (33%) 
 
Lower/Moderate Carbohydrate Zone type diets (Z) - Protein (30%)/Carbohydrate (40%)/ Fat (30%) 
Study 
Study Arms 
 
Year  Duration Protein 
% 
Carbohydrate  % Fat %  Calories (kcal)/Diet 
Detail 
Dansinger Z 
A:Z:L:W 
 
2005 1 year  30% 40% 30%   NCR; MCR=251 
1808 kcal/d actual  
 
 
Frisch Z 
Z:L  
2009 6m &1yr 25% <40% >35%  Required  deficit :500 
kcal  
Actual ER : 400 kcal 
 
Johnston  Z  
A :Z 
2006 6 w 30% 40% 30% -  
SF 30% 
 1500kcal isocaloric 
Layman 
Z(HP)  
Layman  
Z+EX (HP) 
 
Z:Z+EX:L 
2005 16 w 30%  
1.6g/kg
/day 
Actual: 
107g/d 
40% 
C:P Ratio<1.5 
AC: C:P = 1.24 (30%) 
fibre of 17g 
 
30% 
57g of 
fat 
Actual 
32% 
 1700 isocaloric diets   
McAuley Z 
(HP)   
 
A:Z:L 
2004  8 w; 
16w & 
24w  
30% 40% 30% 
(mainly 
MUFA) 
 5 meals < 5hrs apart 
NCR required; 
Resulting deficit of 
kcal- 522(8w); 
346(16w); 403(24w) 
 
Parker Z  
 
Z:L 
 
2002 8 w ER  
4w EB 
28% 42% 28% 
SF-8%, 
MUFA-
12% 
PUFA – 
5%  
 ER =1600 
Sacks Z (HF)  
Z:Z:L:L 
 
2008  24 m 25% 
15% 
35% 
45% 
Fibre: 20g 
40% 
40% 
SF≤8% 
 
 750 kcal deficit 
 
KEY : A=Atkins ; AC=actual consumption;  C= carbohydrates; EB= Energy Balance; ER= energy restriction;  EX= 
Exercise; g=grams; g/d=grams per day; g/kg/d= grams per kilogram per day; HF= high fat; hrs= hours; HP= high 
protein; kcal= kilocalories; L=low fat/high carbohydrate; LF= lower fat; m=months; MCR= Mean Caloric Restriction; 
Mn=men; MUFA=monounsaturated fatty acids; N= low-carbohydrate non-ketogenic; NCR= No calorie restriction; 
P=Protein; PUFA= polyunsaturated fatty acids; SF= saturated fat; SP= standard protein; w =weeks; W= Weight 
Watchers; Wm= women; Yr=year; Z=Zone. 
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Table 3: Comparative Diets Included In Study -  Low-Fat/Higher Carbohydrate (L); Low-Fat – Ornish Diet (O); 
Low-Calorie (LCAL )-Mediterranean Diet (M),  Weight Watchers Diet (W)  
 
Low-Fat / Higher Carbohydrate Conventional Diets (L) 
Study 
Study Arms 
Year  Duration Protein 
% 
Carbohydrate  % Fat %  Calories (kcal)/Diet 
Detail 
Dansinger 
(L):O  
A:Z:L:W 
2005 1 yr / 
52w  
NS NS 10%  MCR=192 
Foster  L 
A:L 
2003 1 yr/52w 15% 60% 25%  Wm: 12-1500 
Mn: 1500-1800 
Frisch L 
Z:L 
2009 6m / 26 
w & 1yr 
/52 w 
15% 55% <30% 
 
 RD= 500 kcal ; AD= 
400 kcal deficit  for 6m; 
Below baseline at 12m 
Layman L 
Z:Z+EX: 
L:L+EX 
2004 16 w 15%;  
0.8g/ 
kg/d 
AC:18
% 
52.5-55%.  Fibre 17g 
C:P >3.5 
AC: 198g/d (61%) 
30%. 57 
g of fat 
AC: 
25.5% 
 1700 isocaloric diets 
Free-living Actual: 
1300-1400kcal 
(ER=33%) 
McAuley  L 
A:Z:L 
2004 8w, 
16w; 
24w 
15% >55% <30%  NCR required; 
Resulting deficit of 
kcal- 439 (8w); 343 
(16w); 350 (24w) 
Meckling  L 
 
N:L 
2004 10 w NS AC=Increase of 13g/d from 
start level of 100g/d. 
NS  Wm:1205-1605kcal 
M : 1402-2200 
Deficit: 607 kcal (29%) 
Parker  L(LP) 
 
Z:L 
2002 8 w 16% 55% 26% 
SF-8%, 
MUFA-
12% 
PUFA – 
5% 
 ER-1600kcal 
Sacks L (HC)  
Z:Z:L:L 
2008 24 m / 
104 w 
15% 
20% 
Fibre:20g  
65% 
55% 
SF≤8% 
20% 
20% 
 750 kcal deficit 
Shai – L 
A:L:M 
2008 2 yr/ 
104w 
NS  NS 30%  W: 1500 kcal 
M: 1800 
Samaha L 
A:L  
2003 6m/26w NS NS ≤30%  500 kcal deficit 
Stern L 
A:L 
2004 1 yr/ 
52w 
NS NS ≤30%  500 kcal deficit 
Yancy  L  
 
A:L 
2004 24 w  AC= 
197.6±
34.2g 
– 52% 
of daily 
intake 
NS <30%   500-1000 kcal 
reduction.  
 
Average energy intake 
1502 kcal 
Other Low Calorie Diets (LCAL) 
Dansinger  W 
A:Z:L:W 
2005 1 yr / 
52w 
NS NS NS  ER: 1200-1600 kcal 
MCR=244 
Shai – M 
A:M:L 
2008 2 yr / 
104 w 
NS NS NS  W: 1500 kcal 
M: 1800 kcal 
KEY : A=Atkins ; AC=actual consumption;  AD= actual deficit; C= carbohydrates; EB= Energy Balance; ER= energy 
restriction;  EX= Exercise; g=grams; g/kg/d= grams per kilogram per day; g/d= grams per day; HC= high carbohydrate; 
kcal= kilocalories; L=low fat/high carbohydrate; LCAL= low-calorie diet m=months; LP= low protein; M= Mediterranean 
diet;  MCR= Mean Caloric Restriction; Mn=men; MUFA=monounsaturated fatty acids; N= low-carbohydrate non-
ketogenic; NCR= No calorie restriction; NS= not specified; P=Protein; PUFA= polyunsaturated fatty acids; 
RD=required deficit;  SF= saturated fat; w =weeks; W= Weight Watchers; Wm= women; yr= year; Z=Zone. 
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The results of the individual studies can be synthesised under some broad 
headings. The primary outcomes identified by this study are the effects of 
carbohydrate restriction on weight loss both in the short term of up to six 
months; weight loss over the longer term of twelve to twenty four months; and 
fat loss and/or waist circumference results. Furthermore, the mechanisms 
underlying and influences on weight loss and fat loss potentially as a result of 
carbohydrate restriction are assessed including energy restriction; impact of 
protein intake; cultural and gender effects and the effects of exercise. 
Additionally the impact of carbohydrate restriction is considered in relation to 
lipid control; insulin and glycemic control; hypertension; hunger and satiety 
indicators; attrition and adherence to dietary protocol; quality of nutrient intake 
and nutritional adequacy; and safety and side effects. The results from the 
selected studies are expressed both in absolute terms and in relation to low-fat 
higher carbohydrate alternatives where relevant.  
 
 Weight Management Results 
Where data was available, reported mean weight loss and percentage mean 
weight loss from baseline was tabulated by reference to intervention duration of 
the weight loss phase of the study and information on caloric restriction 
(prescribed or resulting) to permit analysis of the impact of both duration and 
caloric restriction on weight loss results (Tables 4, 5 & 6; Appendices B1 & B2). 
Figure 1 shows the mean weight loss and percentage of mean weight loss from 
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baseline results for the low and moderate carbohydrate diets included and 
summarised in Appendix B1 and Tables 4 and 6.  
Table 4 : Low and Moderate Carbohydrate Interventions (Up to 6 months Duration) -   
               Mean & Percentage Weight Loss and Mean Energy Deficit / Day 
Study / Duration Mean Weight 
loss in kg 
% Weight Loss Mean Energy Deficit /day 
(E=estimated deficit from 
2000 kcal) 
Atkins Type Diet 
Foster et al. (2003)  
3 months 
6 months 
 
6.7 kg  
6.9 kg 
 
6.8% at 13 w   
7.0%  at 26 w 
No calorie restriction  
(NCR) but reduced 
calories consumed 
 
Johnston et al. (2006) 
6 weeks   
 
6.3 kg 
 
6.6% at 6 w  
 
500 kcal (E) 
 
McAuley et al. (2004)  
8 weeks 
16 weeks  
24 weeks 
 
6.6 kg 
6.9 kg 
7.1 kg 
 
6.9% at 8 w   
7.1% at 16 w 
7.3% at 24 w  
 
519 kcal 
384 kcal 
381 kcal 
 
Samaha et al. (2003) 
6 months  
5.8 kg 4.4% at 26 w   NCR but less than low-fat ( 
LF) comparative  
 
Yancy et al. (2004) 
24 weeks 
 
12.0 kg 
 
12.9% at 24 w  
1461±325 kcal. – Deficit 
500 (E) 
 
Non-Ketogenic low-carbohydrate Diets 
Luscombe-Marsh et al.(2005) 
N (HF/SP) 
N (LF/HP) 
 
10.2 kg  
9.2 kg 
 
10.2%  
9.5%  
 
 
500 (E) kcal 
 
Meckling et al. (2004)  
10 weeks  
  
7.0 kg 7.6% at 10 w  400-800 (E) kcal 
Non-Ketogenic  low-carbohydrate Zone Type Diets 
Frisch et al. (2009) 
6 months   
 
7.2 kg  
 
7.1% at 26 w   
 
400 kcal 
 
Johnston et al. (2006) 
6 weeks  
 
7.2 kg 
 
7.2% at 6 w    
 
500 (E) 
 
Layman et al. (2004) – 16 weeks   
              Z  
             Z+EX  
Average (Z &Z+EX)  
 
8.7 kg  
9.8 kg 
9.3 kg  
 
9.5% at 16 w  
11.3% at 16 w    
 
300 (E) -1700 kcal/day 
McAuley et al. (2004) 
8 weeks 
16 weeks 
24 weeks  
 
5.4 kg 
7.0 kg 
6.9 kg 
 
5.8% at 8 w  
7.3% at 16 w 
7.4% at 24 w  
 
522 kcal 
346 kcal 
403 kcal 
 
Parker et al. (2002) – 8 weeks 4.5kg 4.6 % at 8 w  400 (E) – 1600 kcal/d  
 
Sacks et al. (2008) 
6 months  
 
6.0 kg 
 
6.5 % at 26 w   
 
750 kcal 
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As the studies included were RCTs, the control groups were assigned 
alternative diets which in the main were higher-carbohydrate/low-fat, 
conventional diets (Tables 5 & 6) representing the existing paradigm and the 
diet that most health government health authorities in the UK and the US 
continue to support. Figure 2 shows the relative mean percentage weight loss 
for the various diet arms included in each study to permit a comparative 
analysis. Both figures 1 and 2 are shown in order of intervention duration to 
assess trends related to the length of the intervention on weight loss achieved.    
Table 5 : Low-Fat/High Carbohydrate Interventions (Up to 6 Months Duration) -                                        
Mean & Percentage Weight Loss and Mean Energy Deficit /Day 
Study /Duration Mean Weight 
loss in kg 
% Weight Loss Mean Energy Deficit /day 
(E=estimated) in kcal/day 
 
Low- Fat Diets (L) 
Foster et al. (2003)  
3 months 
6 months 
 
2.6 kg 
3.1 kg 
 
2.7 % at 13 w  
3.2 % at 26 w  
 
Women (Wm):(E) 650 
kcal/d; Men (Mn) : (E) 350 
kcal/d 
 
Frisch et al. (2009)  
6 months 
 
6.2 kg 
 
6.3 % at 26 w 
 
400 kcal /d 
 
Layman et al. (2004)  
            L 
            L + Exercise (EX)                                                 
 
7.8 kg  
6.7 kg
 
8.3 % at 16 w 
8.4% at 16 w   
  
 
300 (E) -1700 kcal/d 
McAuley et al. (2004)  
8 weeks 
16 weeks  
24 weeks 
 
4.3 kg 
4.4 kg 
4.7 kg 
 
4.4 % at 8 w 
4.5 % at 16 w 
4.8 % at 24 w 
 
439 kcal/d 
343kcal/d 
350kcal/d 
 
Meckling et al. (2004)  
10 weeks   
 
6.8 kg 
 
7.4% at 10 w 
 
607 kcal (29%) 
Parker et al. (2002) 
8 weeks  
 
4.5 kg  
 
4.9 % at 8 w  
 
 
400 kcal/d (E)  
Sacks et al. (2008)  
 6 months                    
 
6.0kg 
 
6.5% at 26 w 
 
750 kcal kcal/d 
 
Samaha et al. (2003) 
6 months  
 
1.9 kg  
 
1.4% at 26 w  
 
500 kcal /d  
 
Yancy et al. (2004) 
24 weeks 
 
6.5 kg 
 
6.7 % at 24 w  
500-1000 kcal /d reduction 
expected.  
Average intake 1502 kcal 
500 kcal/day (E) 
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Weight Loss Achieved (Up to Six Months) – Absolute and Percentage 
For interventions spanning 6 weeks to 6 months with varying levels of caloric 
restriction of 300 to 750 kcal per day as shown in Table 4, most of the 
carbohydrate restricted diets included showed a mean weight loss of between 5 
and 10 kilograms of body weight from baseline as shown in Table 4 and Figure 
1. Percentage weight loss from baseline mirrored mean weight loss as shown in 
Figure 1 and similarly was between 5 and 10% for most of the low and 
moderate carbohydrate interventions that extended up to six months. These 
included Atkins type diets, non-ketogenic low-carbohydrate diets and Zone type 
diets.  The similarity between weight loss in kilograms and percentage weight 
loss may be explained as baseline weight was generally in the region of 90-
100kg.  
 
A few exceptions were noted where weight loss was outside the range noted 
above. In Parker, Noakes, Luscombe and Clifton (2002), the Zone type 
intervention generated a mean weight loss of 4.6% at eight weeks with a calorie 
intake restricted to 1600 kcal. The percentage weight loss was marginally lower 
than the results for the other Zone type diets included in this review though after 
an additional four weeks of energy balance the weight loss percentage for the 
zone diet group was 5.3% suggesting an independent effect of diet composition. 
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Figure 1: Mean Weight Loss in Kilograms (kg) and Percentage of Mean Weight Loss From Baseline 
For Low And Moderate Carbohydrate Diets Included In the Study – In Order of Intervention 
Duration.  
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Figure 2: Percentage of Mean Weight Loss from Baseline for Low-Carbohydrate & Comparative 
Diets Included In Study – In Order of Intervention Duration  
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In Yancy, Olsen, Guyton, Bakst and Westman (2004), at 24 weeks, weight loss 
results shown are the expected mean weight loss data based on a linear mixed 
effects model. The expected mean weight loss was an average of 12.0 kg 
(12.9%) in the low-carbohydrate Atkins group is considerably higher than that 
demonstrated by the other studies that included an Atkins type protocol in the 
design.  It is plausible that the linear mixed effects model used is not 
comparable with the method of assessing weight loss differential in the other 
studies and that the weight loss recorded may be overstated.   
 
The Atkins diets in Samaha et al. (2003) generated a weight loss marginally 
below 5% of 4.4% at six months. As the participant group in Samaha et al. 
(2003) and in the follow-up study Stern et al. (2004) at twelve months included 
morbidly obese individuals with baseline weight of 130-132 kg as compared to 
90-100kg for the other studies, a lower percentage weight loss may be 
expected. Hence apart from a few exceptions, most of the studies suggest that 
in the short to medium term of up to six months lowering carbohydrate intake 
may enable clinically meaningful weight loss of 5-10%, though in the case of 
morbid obesity, these levels of weight loss are small (Samaha et al. 2003). 
 
Figure 2 and tables 4, 5 & 6, show that in all the selected studies other than 
Dansinger et al. (2005), Parker et al. (2002) and Sacks et al. (2008), the 
percentage weight loss results for the restricted-carbohydrate diets were better 
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than those for the low-fat comparative diets though in many cases the 
differences within the studies were not regarded as statistically significant. 
 
Longer Term Weight Loss & Weight Loss Maintenance (12 to 24 months) 
Mean and percentage weight loss from baseline data for longer-term, low-
carbohydrate and comparative low-fat and low-calorie interventions included in 
the study is shown in Table 6 and represented in Figures 1 & 2. For studies 
exceeding six months weight loss results were less favourable than for studies 
with durations of up to six months. Weight loss for the interventions exceeding 
12 months and up to 2 years (Table 6) was generally in the range of 2-6% rather 
than 5-10% for shorter term interventions of up to six months across all the 
dietary arms.  Attrition rates were higher, adherence rates were poorer and 
weight regain was higher for the longer-term interventions.  
 
In Frisch et al. (2009), sustaining a 400-500 kcal deficit beyond six months was 
noted to be challenging leading to the possibility of weight regain. Dansinger et 
al. (2005) noted that at one year, there was poor sustainability and adherence 
rates for all the diets studied and that adherence level rather than diet type was 
the key determinant of clinical benefits. In Stern et al. (2004), participants on the 
one year low-carbohydrate diet maintained most of their 6 month weight loss 
whereas those on the conventional diet continued to lose weight throughout the 
year. The final year 1 weight change was -5 ± 8.7 kg in the low-carbohydrate 
group and -3.1 ± 8.4 kg in the conventional diet group.  
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 Table 6. Low- Carbohydrate & Comparative Diets  (Interventions between 12 and 24 months)   –  
Mean & Percentage Weight Loss and Energy Deficit / Day 
 Mean Weight 
Loss in kg 
% Weight Loss Energy Deficit Per Day 
(ED)  
E= estimated  (Appendix 
B2) 
Atkins Type Diets 
Dansinger et al. (2005) – 12 
months 
 
2.1 kg 
 
2.1% at 52 w  
Mean Calorie Reduction 
(MCR)   138 kcal 
 
Foster et al. (2003) 
12 months 
 
4.3 kg 
 
4.4% at 52 w  
 
kcal < than baseline 
 
Shai et al. (2008) 
24  months  
 
5.5 kg 
 
5.1% at 52 w   
  
No kcal Restriction  
(NCR) 
 
Stern et al. (2004) 
12 months 
 
5.0 kg 
 
3.8% at 52 w  
 
kcal < LF diet  
 
Non-Ketogenic Zone Type Diets 
Dansinger et al. (2005) -12 
months 
 
3.2 kg 
 
3.2% at 52 w   
 
251 kcal 
 
Frisch et al. (2009) 
12 months  
 
5.8 kg 
 
5.8% at 52 w  
 
kcal < baseline 
 
Sacks et al. (2008) 
24 months   
 
3.3 kg 
 
3.5 % at 104 w 
 
750 kcal  
 
Low-Fat/High-Carbohydrate Diets 
Dansinger et al.(2005) -  
Ornish (O) 
12 months  
 
 
3.3 kg 
 
 
3.4% at 52 w  
 
 
192 kcal 
 
Frisch et al. (2009) 
1 year  
 
4.3 kg 
 
4.4% at 52 w 
 
400 kcal 
 
Foster et al. (2003) 12 
months  
 
2.5 kg  
 
2.5% at 52 w  
Women (Wm): 650 (E)  
kcal; Men (Mn):  350 kcal 
(E) 
 
Sacks et al. (2008) LF/AP 
LF/HP                           
 
3 .0 kg 
3.6  kg 
 
3.2 % at 104 w 
3.9 % at 104 w 
 
 
750 kcal 
Shai et al. (2008) 
2 Year  
 
2.9 kg 
 
3.2 % at 104 w  
 
 
Wm: 500 (E); Mn: 200 (E) 
Stern et al. (2004) 
1 Year   
 
3.1 kg 
 
2.4 % at 52 w 
 
500 kcal/d 
 
Low Calorie Diets 
Dansinger et al. (2005) – 
Weight Watchers  
 
3.0 kg  3.1% at 52 w 244 kcal/d 
Shai et al. (2008)- 
Mediterranean (M) 
4.4 kg 4.8% at 104 w Wm: 500 (E) kcal/d 
Mn: 200 (E) kcal/d 
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The difference between the two diet groups was not significant. Persons on the 
low-carbohydrate diet who dropped out lost less weight than those who 
completed the study. In contrast weight loss was not significantly different for 
those on the conventional diet who dropped out (Stern et al., 2004). 
 
Over a one-year duration, Frisch et al. (2008) found the low-carbohydrate Zone 
type diet to be as effective as a low-fat/higher-carbohydrate alternative if not 
more effective for clinically meaningful weight loss. In Sacks et al. (2008), the 
average weight loss among the 80% of the participants who completed the two 
year trial was 4kg. However, 14-15% of the participants had a reduction of at 
least 10% of their initial weight suggesting the significance of individual 
responses.  After 12 months participants generally began to regain weight and 
by 24 months the weight loss recorded in all the four diet groups namely the two 
moderate-carbohydrate Zone type diets and the two low-fat/higher-carbohydrate 
diets was similar (Sacks et al., 2008).  
 
In Shai et al. (2008) for 272 of the participants who completed the 24 month 
study of the 322 participants who joined the trial, the mean weight loss was 5.5 
± 7.0 kg in the low carbohydrate Atkins group, 4.6 ± 6.0 kg in the Mediterranean 
diet group and 3.3 ± 4.1kg in the low fat group. The weight loss differential was 
considered significant for the comparison between the low-carbohydrate and 
low-fat groups at 24 months (P=0.03) (Shai et al., 2008).  
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In Foster et al. (2003) and Stern et al. (2004) at 12 months, the differences 
between low-carbohydrate diets and low-fat alternatives were not found to be 
significant even though the weight loss results at three and six months favoured 
low-carbohydrate diets. Hence it is evident that that weight loss differentials 
between a low-carbohydrate approach and a conventional diet evident at six 
months may diminish over a period of one year and a low-carbohydrate diet 
may potentially be less sustainable over a longer term than a conventional diet. 
 
Fat Loss & Abdominal fat as represented by Waist Circumference 
The data from the selected studies on fat loss and the impact of the diets on 
waist circumference is summarized in Appendix C.  Of the fourteen studies, 
three did not measure, comment or report on fat loss data or waist 
circumference changes (Foster et al., 2003; Samaha et al., 2003; Stern et al., 
2004). In all the studies where fat loss and waist circumference changes were 
measured, a positive association between weight loss and fat loss and/or waist 
circumference reduction was noted. In seven of the fourteen studies (Dansinger 
et al., 2005; Johnston et al., 2006; Luscombe-Marsh et al. 2005;  Meckling, 
O‟Sullivan & Saari, 2004; Sacks et al., 2008; Shai et al., 2008; Yancy et al., 
2004), the differences in fat loss and/or waist circumference results between the 
different diet arms were not significant.  
 
A few of the studies (Frisch et al., 2009; McAuley et al., 2004; Layman et al., 
2005) suggested that lowering carbohydrates may give better fat loss and/or 
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reduction in waist circumference results than conventional low-fat diets. Layman 
et al. (2005) noted that fat loss and waist circumference reduction was greatest 
in the low-carbohydrate group with the higher protein intake and higher intensity 
and duration of exercise. Meckling et al. (2004) found however that the 
decrease in lean mass was significant only in the low-carbohydrate group 
suggesting that a low-fat diet with sufficient protein may better preserve lean 
mass (Meckling et al., 2004). Hence, from the studies selected, fat loss and a 
reduction in waist circumference are positively correlated irrespective of diet 
type; fat loss and preservation of lean mass is enhanced by increased intake of 
protein and higher levels of exercise. Furthermore, low-carbohydrate diets may 
generate similar if not greater fat loss and reductions in waist circumference as 
compared with conventional low-fat diets.   
 
 Energy Restriction – Prescribed & Voluntary 
Energy restriction both prescribed and voluntary is noted to be a key influence 
on weight loss achieved. Where no caloric restriction was stipulated at the 
outset, energy deficit achieved was estimated based on a notional baseline 
energy level of 2000 kcal per day representing an average energy intake 
(Appendix B2). All the weight loss diets included irrespective of diet type as 
shown in tables 4, 5 and 6 suggest that prescribed or resulting, regular and 
ongoing, energy restriction of 300-750 kcal/d accompanies and potentially 
underlies weight loss results.   
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Where diet arms were isocaloric, there was little difference in the weight loss 
and fat loss results between Atkins and Zone type diets in Johnston et al. (2006) 
and between two carbohydrate-restricted non-ketogenic diets in Luscombe-
Marsh et al. (2005). Moreover, all the weight loss occurred in the twelve week 
energy restriction phase with no further weight loss occurring during the 4 week 
energy balance phase highlighting the significance of energy restriction in the 
weight loss process (Luscombe-Marsh et al., 2005).   
 
In McAuley et al. (2004), even though none of the diets were formally restricted 
for calories, after eight weeks, the resulting caloric reduction was approximately 
450-500 kcal per day for each of the diets. The theory suggested by McAuley et 
al. (2004) is that with an ad libitum dietary protocol, based on the Atkins diet or a 
Zone type diet, clinically meaningful weight loss may be achieved due to the 
daily calorie deficit that results from following the protocol. Hence, low-
carbohydrate dietary protocols can provide valid weight management options in 
an ad libitum feeding scenario or free-living conditions or where calorie 
restriction cannot be imposed or complied with. Furthermore, in an ad libitum 
feeding scenario, low-carbohydrate diets particularly the low-carbohydrate 
Atkins protocol may achieve clinically significant weight loss and often better 
weight loss than a higher-carbohydrate/low-fat conventional diet over a short to 
medium term.  
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Ketogenic versus Non-Ketogenic low–carbohydrate diets 
Three studies included in this review permitted a direct comparison between 
ketogenic and non-ketogenic methods of achieving carbohydrate restriction for 
purposes of weight management.  Where the diet design was isocaloric as in 
Johnston et al. (2006), the weight loss of 6.3 ± 0.6 kg (6.6% of baseline weight) 
or fat loss of 3.4 kg for ketogenic Atkins group did not differ significantly by week 
six from the Zone type group which had weight loss of 7.2 ± 0.8 kg (7.2% of 
baseline weight) and fat loss of 5.5kg. In McAuley et al. (2004) following an 
eight week weight loss phase, the weight loss for the Atkins group of 6.9% was 
similar to that in the Zone Group of 5.8%. Mean fat mass reduction at eight 
weeks in the Atkins Group was 4.4 kg and 3.1 kg in the Zone Group. Dansinger 
et al. (2005) included both the Atkins and Zone dietary approaches and noted 
that the weight loss results at one year were modest but the differences were 
not statistically significant. Hence the need to severely restrict carbohydrate 
intake for weight loss purposes may be questioned and a more moderate 
reduction of carbohydrate may be as effective.  
 
For Atkins type diets whilst caloric prescriptions were not made, there were 
resulting daily calorie deficits noted. Possible explanations for the lower calorie 
intake could suggest that subjects may have experienced greater satiety with 
the permitted liberal portions of protein and fat and/or increased adherence due 
to the relative simplicity, monotony or novelty of the diet (Foster et al., 2003; 
Samaha et al., 2003), or ketosis and water loss in the initial phase (Yancy et al., 
                                                                
37 
 
2004). Foster et al. (2003) suggested that ketosis was not a likely explanation 
for the increased weight loss with the Atkins low-carbohydrate diet group as 
compared with the low-fat group as ketones were not present for most subjects 
after the first six months. Hence the Atkins approach may provide a viable 
option for weight management if appropriate to an individual‟s preferences and 
health profile. 
 
Gender, Ethnic & Cultural Differences 
In Parker et al. (2002), whilst overall weight loss of 5.2 ± 1.8 kg was achieved 
for both diet groups, this study showed a significant potentially gender related 
effect  as women lost more weight on the Zone type diet as compared with the 
higher carbohydrate diet (6.0 kg vs. 4.2kg). Similar outcomes were noted for 
women for fat mass (5.3 vs. 2.8 kg) and abdominal fat (1.3 vs. 0.7kg). Men in 
the study lost more weight (5.8 kg vs. 4.7kg), fat mass (5.1kg vs. 3.8kg) and 
abdominal fat (1.7 vs1.4 kg) on the higher-carbohydrate plan (Parker et al., 
2002).  This study finds that a higher-protein Zone type diet may have appealed 
to the women dieters included in the study more than the men (Parker et al., 
2002). In Samaha et al. (2003), white subjects lost more weight than black 
subjects (mean 13 ± 19 kg vs. 5±12kg, (P=0.009) suggesting that weight loss 
diets and results both in terms of adherence and appeal may have gender 
related, cultural, ethnic and / or genetic influences.  
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Impact of Higher Protein Levels implicit in Low-carbohydrate Diets 
Lower-carbohydrate diets have generally implied higher protein intake (up to 
30% of energy intake) as compared with higher-carbohydrate conventional diets 
where the protein intake is approximately 15% of energy intake. In Luscombe-
Marsh et al. (2005), for two groups with carbohydrate intake restricted to 30% of 
energy, the subjects‟ satiety levels were higher for the group with higher protein 
intake of 40% as compared with group with protein intake of 20% (P=0.02). 
Luscombe-Marsh et al. (2005) highlight that higher levels of protein intake may 
improve satiety levels and reduce the amount of food desired at the next meal. 
 
 Results from Layman et al. (2005) suggest that with a daily caloric restriction of 
20-30%, reduced carbohydrate intake and exercise of sufficient intensity, both 
weight loss and fat loss can be enhanced by consuming higher protein levels of 
up to 1.6g per kilogram of body weight per day (Layman et al., 2005). Hence 
carbohydrate restriction together with adequate intake of protein and 
appropriate exercise would appear to support weight management and fat loss. 
 
Quality of Carbohydrates and Related Food Choices – Nutritional Value; 
Level of Refining and Processing; Glycemic Index and Load; Dietary Fibre 
Levels.    
A few of the studies included in this review considered the impact of the quality 
of macronutrient and food choices on weight loss, caloric values, hunger, satiety 
and cravings. In Meckling et al. (2004) both the low-carbohydrate and the low-
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fat groups were advised to eliminate fried foods, high fat and high sugar foods, 
limit intake of breads, pastas, rice and desserts; eliminate intake of candy, dried 
fruit, sweetened soft drinks and sugar and encouraged to increase intake of 
vegetables, lean meats, eggs and nuts. Sacks et al. (2008) re-iterated that 
recommending inclusion of foods with a low-glycemic index may influence 
weight loss.  
 
In Luscombe-Marsh et al. (2005), saturated fat was restricted to 10% of energy 
and fibre for both low-carbohydrate non-ketogenic diets were 21 and 27 grams 
per day respectively. Sacks et al. (2008) corroborate that prescribing a minimum 
intake of dietary fibre and a limit to the intake of saturated fat and cholesterol 
may support the weight loss process (Sacks et al., 2008). In Meckling et al. 
(2004), the low-fat/ high-carbohydrate group did not meet targets for 
carbohydrate and fibre intake whilst the Zone group were closer to achieving the 
fibre targets set for the high-carbohydrate group and achieved relatively better 
weight loss results. The authors conclude that the high-carbohydrate group may 
have had better results if they had better instruction with regard to the type of 
fruit, vegetables and wholegrain cereal included in their diet. Hence weight loss 
may be influenced by both the quality and quantity of macronutrient intake – 
carbohydrates, protein and fat; the level of saturated fat intake; the level of fibre 
intake; the glycemic index of foods and the glycemic load of meals and 
specifically the limiting of high-sugar and high-fat foods.  
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Low-carbohydrate Diets and Nutritional Adequacy 
A few of the studies included, evaluated the nutritional adequacy of the diets. In 
Johnston et al. (2006), the Zone type diet was found to have ≥ 67% of the US 
Recommended Daily Amounts (RDA) for the micronutrients whilst for the Atkins 
type diet fibre, vitamin E, folate, iron, magnesium and potassium were <67% of 
RDA. Hence a daily multivitamin and mineral was included in the protocol.  
 
Meckling et al. (2004) who studied a more moderate reduction in carbohydrates 
as compared with the Atkins type protocol, shows that subject to the overall 
attainment of sufficient energy reduction, the exclusion of fruits, whole-grain 
breads and pastas nutrient rich with their vitamin, mineral and antioxidant 
content as required by some of the very low-carbohydrate dietary protocols may 
not be essential to achieve statistically meaningful weight loss.  This study 
highlighted some significant differences between the diet groups related to 
nutritional adequacy despite similar levels of energy restriction. The low-
carbohydrate regime caused deficiencies in calcium, magnesium, iron, vitamin 
D, folate and Vitamin B6 whilst the low-fat diet caused deficiencies in calcium 
and vitamin E requirements.  
 
In Meckling et al., 2004, as highlighted by the authors, short-term nutritional 
shortfalls in the interest of weight management may be tolerated but for the 
longer-term, nutritional adequacy must be catered for by means of adequate 
nutrient supplementation. The highlighted studies confirm that with energy 
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restriction and/or macronutrient manipulation to achieve energy restriction, 
nutritional inadequacies must be assessed and insured against either via dietary 
adjustment and/or nutritional supplementation.  Furthermore, the inclusion of a 
daily multivitamin supplement which is usually prescribed by the Atkins diet 
protocol may be both necessary and prudent during the restricted carbohydrate 
weight management protocol.  
 
Low-carbohydrate Diets and Exercise 
Duration and intensity of exercise and activity levels are likely to impact on the 
creation of a sufficient energy deficit on a daily basis relevant for weight loss. 
Hence, in weight loss studies, inadequate measurement and reporting of 
exercise and/or activity levels could be a confounding factor whilst assessing 
results. This was the case for three of the fourteen studies included in the 
review. For the remaining eleven studies, other than for Layman et al. (2004), 
activity levels either remained constant during the trial and/or did not differ 
significantly between the diet groups.  
 
Layman et al. (2004) compared Zone type diets with and without the inclusion of 
exercise to a low-fat/higher-carbohydrate conventional diet protocol with and 
without exercise. Exercise in the control groups averaged <100min per week 
against the recommendation of 30 minutes of walking 5 days a week. The 
„Exercise‟ groups were also recommended 30 minutes of walking 5 days a week 
plus 30 minutes of resistance training and stretching 2 days/week. The higher 
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exercise group‟s compliance was supervised and averaged more than 200 
minutes per week. The low-carbohydrate group with higher exercise levels 
achieved the largest relative weight loss at 11.2%. The low-carbohydrate control 
group with less exercise had weight loss of 9.5%. The higher-carbohydrate 
group with higher exercise levels had weight loss of 8.4% whilst the high-
carbohydrate control group with less exercise achieved weight loss of 8.3%.  
Taking the two higher exercise groups together the average reduction in fat 
mass was 7.2±0.7kg whereas the lower non-supervised exercise groups 
reduced body fat by 5.5±0.5 kg (P<0.05).   
 
Higher protein intake, lower carbohydrate intake and supervised exercise 
produced a 21.4% reduction in absolute body fat whilst the higher carbohydrate 
group without supervised exercise had a 12.8% reduction in body fat. A similar 
pattern was evident for changes in abdominal or trunk fat.  Layman et al. (2004) 
highlights the additive effects of the low-carbohydrate / high-protein diet and 
exercise on body composition with significant main effects of diet (P<0.01) and 
exercise (P<0.001). Hence with moderate restriction of carbohydrate and 
appropriate levels of protein intake, exercise may enhance weight loss and fat 
loss in the short to medium term. 
 
Hunger, Satiety & Well Being 
Five of the fourteen studies included in this review assessed or commented on 
hunger, satiety or well being indicators.  For Atkins type diets, McAuley et al. 
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(2004) highlight that enhanced satiety and reduced appetite may be due to the 
ketonuria associated with carbohydrate restriction. Samaha et al. (2003) note 
that higher satiety for Atkins type diet may be associated with increased intake 
of protein and fat. Sacks et al. (2008) used questionnaires to ascertain satiety, 
hunger, diet satisfaction at specific points in time but found similar results for the 
two zone type and two low-fat diet groups.  
 
In Luscombe-Marsh et al. (2005), for two non-ketogenic low-carbohydrate diet 
groups, the higher protein group had more favourable hunger responses and 
more favourable maintenance of the thermic effect of food (TEF), potentially 
highlighting the greater satiating effect of protein. Subjects in the higher protein 
group did desire to eat less at both week 0 and week 16 (main effect of diet, 
P=0.02). There was significant reduction in the 3-hour hunger response 
(P=0.018); and a trend after sixteen weeks, for a reduced desire to eat (P=0.06) 
and a reduced amount desired to be eaten (P=0.07) (Luscombe-Marsh et al., 
2005).  
 
Johnston et al. (2006) noted improved hunger ratings from “no particular 
feelings” to “satisfied” (P=0.078) for both the Atkins type diet and the Zone type 
diet included in the study. The hunger indicators did not differ between the two 
groups suggesting that it may be the protein level in the diet rather than the 
extent of carbohydrate restriction that potentially affects hunger levels. Based on 
a “profile of mood states” (POMS) questionnaire used to assess six distinct 
                                                                
44 
 
mood states, feelings of „vigour-activity‟ were greater for the Zone type diet as 
compared with the Atkins diet (P=0.025) at week 5. The other mood indicators 
such as „fatigue-inertia‟, „depression-dejection‟, and „anger-hostility‟ did not differ 
between the diet groups. This suggests that within the context of a higher-
protein intake, lower-carbohydrate intake levels may potentially affect the desire 
to be physically active, a behavioural response that may affect obesity states in 
the long run. Hence the implied higher protein levels implicit in lower-
carbohydrate diets may be significant for longer-term adherence to the diet plan 
by promoting satiety, and deflecting feelings of hunger. Additionally it may be 
appropriate to monitor the effects of lowering carbohydrates on energy levels as 
part of a weight management plan.  
 
Attrition & Adherence, Support & Supervision 
Most of the studies included in the review other than Layman et al. (2005) 
included data on withdrawals and dropouts. However for many of the studies, 
withdrawals, attrition and adherence were not found to be diet related. 
Dansinger et al. (2005) observed a strong curvilinear association between self-
reported dietary adherence and weight loss (r=0.6; P<0.001) and that 
participants in the top tertile of adherence lost 7% of weight. Higher 
discontinuation rates were noted for both the Atkins and the Ornish low-fat 
groups as these may too extreme relative to the Zone and Weight Watchers 
group. In addition Dansinger et al. (2005) noted that self-reports of dietary 
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adherence decreased in relation to time and to a similar extent in each of the 
diet groups studied.  
 
Sacks et al. (2008) noted that diminished adherence occurred between six 
months and 2 years as is typical in weight loss trials. They further highlight that 
regular attendance at counselling sessions helps with weight loss and 
prevention of weight regain. Frisch et al. (2009) showed that continuous contact 
with participants reduced drop-out rates and improved compliance. Samaha et 
al. (2003) found that subjects in the low-carbohydrate Atkins group attended 
more dietary counselling meetings than the low-fat group and that the 
differences in attrition were statistically significant at three months (P=0.03) in 
favour of the low-carbohydrate approach but not at six months.  
 
In Foster et al. (2003), the percentage of dropouts at 3, 6 and 12 months was 
higher for the conventional low-fat group (30, 40 and 43% respectively) than in 
the low-carbohydrate Atkins group (15, 27 and 39%) but these differences were 
not significant. Whilst there are mixed results as to whether the adherence rate 
was higher for the low-carbohydrate diet or the low-fat approach, overall based 
on the studies included in this review, dietary adherence and regular counselling 
influences the extent of weight loss and the prevention of weight regain.  
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Adverse Effects & Safety 
Relevant results from the included studies are collated in Appendix D. Yancy et 
al. (2004), over 2 weeks,  reported a greater level of adverse effects in the low-
carbohydrate Atkins diet group as compared with the low-fat diet group as 
shown in Table 7.   
Table 7- Adverse Effects: Yancy et al. (2004) 
Adverse Effect Low –CHO Group Low-fat Group Significant 
Constipation 68% 35% YES-P<0.001 
Headache 60% 40% YES-P=0.03 
Halitosis 38% 8% YES-P<0.001 
Muscle Cramps 35% 7% YES- P<0.001 
Diarrhoea 23% 7% YES – P=0.006 
 
The authors suggest that such symptomatic adverse effects that occur at the 
start of low-carbohydrate diets are short-lived and may be reduced and 
managed by an increase in fluid intake, dietary inclusion of low-starch 
vegetables, bouillon and a daily multivitamin and mineral supplement (Yancy et 
al., 2004). Layman et al. (2005) for the Zone Diet, Luscombe-Marsh et al. (2005) 
and Meckling et al. (2004) for low-carbohydrate non-ketogenic diets, reported no 
adverse effects or events.  
 
The impact of low-carbohydrate diets particularly the Atkins type diet on renal 
health and bone-turnover and inflammatory markers were not consistently 
assessed across the studies reviewed. Dansinger et al. (2005) who included 
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both an Atkins diet and a Zone type diet in their study design reported no 
evidence of clinically significant adverse renal effects. Johnston et al. (2006) 
found that the arachadonic acid: eicosapentanoic acid ratio (AA: EPA) was 
nearly 90% higher in the Atkins group as compared with the Zone group 
(P=0.038) associated with increased inflammation, a factor that could be 
monitored in future when the Atkins diet is the preferred dietary option. 
 
Hence the studies included in this review have not shown any significant 
adverse side-effects or safety issues related to non-ketogenic low-carbohydrate 
diets including the Zone type diets. Atkins type diets may generate short-term 
adverse effects that can managed with appropriate actions or precautions. 
Effects of lowering carbohydrates, particularly with respect to the Atkins type 
diet on, bone turnover, renal health and inflammatory markers are potentially 
significant end-points that have been omitted from most of the studies included.   
 
Lipid Control Results 
Most of the studies selected reported or commented on the impact of the dietary 
protocols on the main cholesterol markers - TC, LDL-C, HDL-C and TAG as 
shown in Appendix E. The results from the studies, including percentage or 
actual levels of lipid marker change where identified, are summarised at a high 
level between the low-carbohydrate ketogenic and non-ketogenic diets in Table 
8 and the higher-carbohydrate/low-fat comparative and /or control diets in Table 
9.  
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TABLE 8: CHANGES IN BLOOD LIPID LEVELS WITH LOW-CARBOHYDRATE DIETS 
 
Study Year  Durat-
ion 
TC LDL -C HDL-C  TAG 
 
 
LOW- CARBOHYDRATE KETOGENIC (LCK)- ATKINS (A)  
 
Dansinger  A 2005 1 year  ND ↓ NSS ↑ ↔  
Foster  A 2003 1 year ND ↔ ↑ ↓> LF 
 
 
Johnston  A 2006 6 w ND ↑ 5 dieters 
↓4 dieters 
↓9% ND  
McAuley  A 2004 8 w  ND ↓ < HP & HC  ↑ ↓  
Samaha  A 2003 6 m ↔ ↔ ↔ ↓  20±42% 
 
 
Shai   A 2008 2 year TC:HDL 
↓20% 
 
↔ ↑0.22 mmol /l. ↓-0.27 mmol/l 
 
 
Stern  A  2004 1 year ↔ ↔ ↓ ↓ > LF 
 
 
Yancy  A  2004 24 w  ND ↑0.04 mmol/l ↑0.14 mmol/L ↓- 
0.84mmol/L 
 
 
LOW CARBOHYDRATE NONKETOGENIC (N)– 50-100g C 
 
Meckling  N 2004 10 w  ↔ ↔ ↑ +0.14mmol/L ↓ -0.4 
 
 
Luscombe- Marsh 
(LF/HP)  N 
2005 12 w 
 
↓6.6±1.4% ↓3.4±1.9% ↑6.8±2% ↓ 
23.1±3.6% 
 
 
Luscombe-Marsh 
(HF/SP) N 
2005 12 w ↓6.6±1.4% ↓3.4±1.9% ↑6.8±2% ↓ 
23.1±3.6% 
 
 
LOW- CARBOHYDRATE ZONE (Z) TYPE DIETS 
 
Dansinger  Z 2005 1 yr  ND ↓ ↑ ↔  
Frisch Z 2009 6m& 
1yr 
↔ ↔ 
↔ 
↔ ↓ 14% 
↓ 7% 
 
 
Johnston  Z 2006 6 w  ↑2 dieters 
↓8 dieters 
 
↓9% ND  
Layman  (HP ) Z 
Layman (HP)  Z+EX 
2005 16 w ↓ 3.7% ↓ 1.7% ↑ 0.01± 0.03 
mmol 
 
↓ 20.2%  
McAuley  Z 2004  8 w  ND 
 
↓ ↑ ↓  
Parker Zone  Z 2002 8 w 
ER  
 
↓ ↓ ↔ ↓  
Sacks  (LC/HF) Z 2008  24 m ↓1% ND ↑9% ↓ 12-17% 
 
 
 
KEY : ↓=reduced; ↑= increased;  ↔= No significant change, A= Atkins; C= carbohydrates; HC= high 
carbohydrate; ER= energy restriction; EX=exercise; HDL-C= high density lipoprotein; HF= high fat; HP= high 
protein;  cholesterol; kcal= kilocalories; L= low-fat/high carbohydrate; LC= Low-carbohydrate; LDL-C=low 
density lipoprotein cholesterol; M= Mediterranean diet;  m=months;  mmol/l= millimoles per litre; Mn=Men; 
N= low carbohydrate nonketogenic; NCR= No Calorie Restriction;  ND=No Data; NSS= Not statistically 
significant; TAG = triglycerides; TC= total cholesterol; w =weeks; Wm= Women; W= Weight Watchers diet; 
yr=year; Z= Zone 
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TABLE 9: CHANGES IN BLOOD LIPID LEVELS WITH LOW-FAT / HIGH CARBOHYDRATE DIETS 
 
LOW- FAT CONVENTIONAL DIETS (L) 
 
Study Year  Durat-
ion 
TC LDL  HDL  TAG 
 
 
Dansinger O 2005 1 year ND ↓ ↔ ↔ 
 
 
Foster L 2003 1 year ND ↔ ↑ ↓ 
 
 
Frisch L 2009 6m, 
1y 
 
↑  
↔ 
↔ 
 
↓ 
↑ 
↔ 
↔ 
 
Layman L 
Layman L +EX 
2004 16 w ↓ 9.2% ↓ 10.4% ↓0.08± 
0.03 mmol 
 
↓5.2%  
McAuley  HC 2004 8 w ND ↓< HP ↑<HF/HP ↓ <HF/HP 
 
 
Meckling  L 2004 10 w ↓-1.6mm ↓ -1.3mm ↓-0.3 ↓ -0.4 
 
 
Parker  L /LP 2002 8 w ↓ < HP ↓<HP ↔ ↓ 
 
 
Sacks L/HC  2008 24 m ↓ 5% ND ↑6% ↓12-17% 
 
 
Samaha L  2003 6m ↔ ↔ ↔ ↓2±28%  
 
 
Shai  L 2008 2 year TC:HDL 
↓12% 
 
↔ ↑+0.16 mmol/l ↓0.03 mmol/l 
 
 
Stern L 2004 1 year ↔ ↔ ↓> LC ↓ 
 
 
Yancy  L  2004 24 w  ND ↓  0.19 
mmol/L 
 
↑-0.04 mmol/L ↓-0.31mmol/L  
OTHER MODERATE CARBOHYDRATE /LOW CALORIE DIETS 
 
Dansinger  W 2005 1 year ND ↓ ↑ ↔ 
 
 
Shai  M 2008 2 year  ND ↔ ↑  ND 
 
 
COLOUR KEY:    Negative Neutral  Positive 
 
  
KEY : ↓=reduced; ↑= increased;  ↔= No significant change, >=greater than; <=lesser than; A= Atkins; HC= 
high carbohydrate; ER= energy restriction; EX=exercise; HDL-C= high density lipoprotein; HF= high fat; HP= 
high protein;  cholesterol; kcal= kilocalories; L= low-fat/high carbohydrate; LC= Low-carbohydrate; LDL-
C=low density lipoprotein cholesterol; M= Mediterranean diet;  m=months;  mmol/l= millimoles per litre; 
Mn=Men; N= low carbohydrate nonketogenic; NCR= No Calorie Restriction;  ND=No Data; NSS= Not 
statistically significant; O= low-fat Ornish diet; TAG = triglycerides; TC= total cholesterol; w =weeks; Wm= 
Women; W= Weight Watchers diet; yr=year; Z= Zone. 
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The results are colour coded green to show a positive result, pink to show an 
adverse change, blue where no significant change was found and white to show 
areas for which no data (ND) was available.  In addition Tables 8 and 9 highlight 
if lipid markers increased (↑), decreased (↓) or showed no significant change 
(↔). 
 
LDL Cholesterol (LDL-C) 
The studies included in this review show mixed results with respect to the 
potential effects of lowering carbohydrates on LDL-C as indicated in Tables 8 
and 9. Of the eight studies that included Atkins type diets,  four showed no 
significant change, one showed an increase in LDL-C whilst Johnson et al. 
(2006) showed a split result where LDL-C levels increased for five participants 
and reduced for four participants. For the three low-carbohydrate non-ketogenic 
diet arms, LDL-C reduced for two and did not change significantly for one. For 
the seven studies that included Zone type diets, LDL-C reduced for four, did not 
change for one whilst for one study no data was available. Johnston et al. 
(2006) showed a split result where LDL-C reduced for eight participants and 
increased for two participants.  
 
Johnston et al. (2006) found that over the six weeks of the trial, LDL-C was 
directly correlated to β-hydroxybutyrate concentrations (r=0.297, P=0.025) and 
that the mean β-hydroxybutyrate levels, related to ketone bodies, was 3.6 times 
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in the Atkins participants as compared with that in the Zone diet participants at 
week 2 (P=0.018) but did not differ at week 6.  
 
Parker et al. (2002) observed a significant time by diet effect in the reduction of 
LDL-cholesterol (P=0.009) with a greater reduction for the Zone diet as 
compared with the higher carbohydrate comparative diet. McAuley et al. (2005) 
noted that LDL-C results decreased for individuals on the Zone type diet and the 
conventional higher-carbohydrate diet but were not consistently lower for the 
Atkins group. A small number of Atkins dieters had a marked increase in LDL-C. 
Similarly in Yancy et al. (2004), LDL-C increased by more than 10% in 30% of 
individuals who completed the study. Hence the mixed results with respect to 
LDL-C suggests that caution needs to be applied when suggesting the Atkins 
type diet with potentially higher levels of saturated fat when LDL-C levels are of 
concern. Similar caution may not be necessary with a more moderate Zone type 
diet. 
 
HDL Cholesterol (HDL-C) 
Most of the studies (nine of the fourteen studies selected) as shown in Tables 8 
and 9 indicated an improvement or an increase in HDL-C levels with weight loss 
following a low or moderate carbohydrate plan - the Atkins diet plan as well as 
the non-ketogenic diets including the Zone type diets. In three of the studies 
(Frisch et al., 2009; Parker et al., 2002; Samaha et al., 2003) the HDL-C result 
was unchanged.  In Johnston et al. (2006) an adverse 9 % reduction in HDL-C 
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is reported for both the Atkins and Zone arms of the trial but no data was 
available to explain this further. Stern et al. (2004) found that with a one-year 
Atkins weight loss plan, HDL-C had reduced however the reduction of HDL-C on 
the comparative higher-carbohydrate conventional diet was greater.  
 
Of the 12 studies that included a low-fat/higher-carbohydrate conventional diet, 
HDL-C decreased for three, remained unchanged for three and increased for 
six. Hence lowering calories via reduced carbohydrate intake and/or the 
resulting weight loss may help in improving HDL cholesterol levels.  Similar 
results may be obtained with a conventional low- fat diet though an increase in 
HDL-C was more consistent with a low-carbohydrate diet protocol. 
 
Triglycerides (TAG) 
A majority of the studies selected showed that weight loss was accompanied by 
reduced TAG levels for the low-carbohydrate diets – ketogenic and non-
ketogenic as well as the higher- carbohydrate /low-fat diets. Foster et al. (2003), 
McAuley et al. (2004) and Stern et al. (2004) show that fasting TAG reduced  for 
all three diets types - the Atkins, Zone and low-fat/high-carbohydrate groups but 
reduced to a significantly greater extent with the Zone and Atkins diets as 
compared with the high-carbohydrate diet. Frisch et al. (2009) over six months 
and one year, found no significant change in TAG levels from baseline values 
for the low-fat diet group but found a 14% and 7% reduction in TAG in the low-
carbohydrate Zone diet group over six months and one year respectively. 
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Dansinger et al. (2005) noted no significant change for TAG across the Atkins, 
low-fat and low-calorie Weight Watchers (WW) dietary designs. These results 
would indicate reduced TAG may be associated with weight loss and/or calorie 
reduction irrespective of diet type but could also potentially result from lowering 
carbohydrate intake. 
 
Endocrine and Hormonal Results- Insulin and Blood Sugar Effects 
The hormonal and endocrine results derived from the studies including 
outcomes relating to blood glucose, glycosylated haemoglobin (HbA1c), insulin 
levels, insulin sensitivity and insulin resistance measures are summarised in 
Appendix F. Twelve of the fourteen studies selected have included blood sugar 
and insulin indicators as outcome measures. All twelve of the studies selected 
noted that lowering carbohydrate intake diets showed improved glycemic and 
/or insulin markers.   
 
In five of the twelve studies (Meckling et al., 2004; Sacks et al., 2008; Samaha 
et al., 2003; Shai et al., 2008; Stern at al., 2004), improvements in glucose and 
/or insulin markers were better for the lower-carbohydrate diets relative to low-
fat and low-calorie dietary designs. The other studies selected have shown that 
improvements in glycemic and/or insulin results with low-carbohydrate diets are 
similar to the comparative low-fat or low-calorie diets potentially suggesting that 
these insulin and blood sugar effects may relate to energy restriction or to the 
weight loss rather than the macronutrient content of the diet.   
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Shai et al. (2008) showed that among the diabetic group, a decreased level of  
HbA1c at 24 months in each of the three low-carbohydrate, low-fat and the 
Mediterranean diet groups but found that the changes were significant (P<0.05) 
only in the low-carbohydrate Atkins type diet group. The direct effect of an 
Atkins type low-carbohydrate diet on glycemic control for diabetics particularly 
the effect on HbA1c was further corroborated in Samaha et al. (2003) and Stern 
et al. (2004). As HbA1c remains a significant risk factor for diabetes, a dietary 
consideration in favour of a very low-carbohydrate approach may be relevant.  
 
Dansinger et al. (2005) compared four diet types namely the low-carbohydrate 
Atkins and Zone diets, the low calorie Weight Watchers and the low-fat Ornish 
diet. They noted improvements in blood glucose and insulin levels for all four 
diets at two months, six months and twelve months. Furthermore, the lower 
carbohydrate Atkins and Zone diets were more likely to reduce insulin in the 
short-term (up to two months ) though the Atkins diet failed to significantly 
reduce mean fasting insulin levels at one year (Dansinger et al., 2005). 
 
Luscombe-Marsh et al. (2005) studied two non-ketogenic diets with 
carbohydrate intake restricted to 30% of energy.  Results after sixteen weeks 
showed a decrease in fasting serum insulin by 25 ± 4.2% (P<0.001) for both diet 
groups, with the main effect of time and a reduced insulin resistance index 
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(HOMA) of 34± 8.8% (P<0.001). Johnston et al. (2006) found that insulin 
sensitivity was significantly improved with both the Atkins and Zone type diets.  
 
Several studies as shown in Appendix F (Dansinger et al., 2005; Foster et al., 
2003; Frisch et al., 2009, McAuley et al., 2004; Parker et al., 2002; Shai et al., 
2008) show that glycemic control and/or insulin levels decreased significantly in 
all the diet groups with no significant differences between the groups, potentially 
connecting improved insulin levels to reduction in calories consumed and/or 
weight loss.   
 
Hence, lowering carbohydrate in the diet may support favourable changes for 
one or more of the following - blood glucose, HbA1c, insulin levels, insulin 
sensitivity and insulin resistance. The Atkins very low-carbohydrate protocol has 
shown to be particularly beneficial for glycemic control for diabetics. Additionally, 
as compared with low-fat diets, lowering carbohydrates may be at least as 
beneficial if not more favourable for achieving improved blood glucose and 
insulin sensitivity.   
 
Hypertension 
Hypertension is one of the outcomes relevant to metabolic syndrome and 
potentially affected by obesity and diet. Ten of the twelve studies as shown in 
Appendix G found that both the lower-carbohydrate diet as well as the higher-
carbohydrate alternative show favourable blood pressure (BP) results. The diets 
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caused a reduction from baseline in both the systolic blood pressure (SBP) 
and/or diastolic blood pressure (DBP) with no significant differential effect 
between the diets indicating a potential link between energy restriction and/or 
weight loss and BP. 
 
Frisch et al. (2009) found that SBP at twelve months was significantly higher in 
the low-fat group as compared with the low-carbohydrate group. Hence whilst 
improvements in blood pressure markers may be a result of calorie restriction 
and/or weight loss achieved, lowering carbohydrates and related weight loss 
achieved does appear to support the improvement in hypertension markers. 
  
                                                                
57 
 
CHAPTER 5- DISCUSSION 
This study focused on dietary protocol that lowered carbohydrate intake levels 
from the recommended carbohydrate levels of 55-60% in a conventional or low-
fat/higher-carbohydrate diet. The study has included very low-carbohydrate 
ketogenic Atkins type diets with carbohydrate intake of 20-50 g/d and 
interventions with more moderate restriction of carbohydrates including the 
Zone type diet where carbohydrates are limited to 40% of daily energy intake 
were also included.  
 
This review confirms that in the short-term, for periods from six weeks to six 
months, with a prescribed or resultant calorie deficit per day of 300-750 kcal or  
30% of baseline energy intake, clinically meaningful weight loss of between 5-10 
kilograms or between 5-10% of initial weight may be achieved with low-
carbohydrate diet plans. Longer-term studies included in this review show that 
weight loss slows down considerably and is in the range of 2-5 kilograms  
(2-6 %) over twelve to twenty four months.  
 
The review also shows that lowering carbohydrates via the Atkins and Zone 
type diets, together with the resulting calorie reduction, compare favourably with 
low-fat/higher carbohydrate diets, generating better if not similar results for 
weight loss, fat loss, lipid markers, blood sugar and insulin markers and 
hypertension. A reservation was noted was in relation to the Atkins type diet and 
LDL-C for which, results were mixed and potentially adverse relative to the 
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conventional low-fat diet. Additionally, the results show that other influences 
may work in concert with lowering carbohydrate intake to generate favourable 
weight loss changes and improved metabolic health. These include sufficient 
levels of protein intake; adequate intake of good fats; avoidance of refined 
sugars and processed foods; appropriate behavioural changes including 
adequate activity levels.  
 
The results of this review suggest that lowering carbohydrates may provide 
nutritional advisors with a valid short-term obesity management tool subject to 
individual preferences and health profile. More caution is required for longer-
term use of low-carbohydrate Atkins type diet plans with greater monitoring and 
management of inflammatory markers, bone health, renal health, impact on 
LDL-C and nutritional adequacy.  Consequently Public Policy on recommending 
low-carbohydrate diets as a treatment plan for obesity management may not be 
justified until additional research is undertaken on the longer-term implications 
of a low-carbohydrate dietary protocol. 
 
The weight loss results shown by this study are in line with that expected in 
standard behavioural weight loss programs of up to six months as noted by 
Wing and Phelan (2005) who suggest that such participants lose 7-10kg  
(7-10%).  Despres et al. (2001) suggest that a 5-10% weight loss is regarded as 
clinically significant in reducing the risk of diabetes and CVD however this level 
of weight loss may not be sufficient for an obese and particularly a morbidly 
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obese individual as suggested in Samaha et al. (2003). Pharmacological and 
particularly surgical options may be more effective options for morbid obesity. 
Bond et al. (2009) note that for severely obese individuals (BMI ≥ 40kg/m2 or 
>100pounds overweight), bariatric surgery is the most effective long-term weight 
loss strategy with average expected weight loss of 25%. By comparison, 
behavioural weight loss treatments including dietary therapy may typically 
generate weight loss of 10% (Bond et al., 2009). The UK National Health 
Service [NHS], National Institute for Heath and Clinical Excellence [NICE] 
(2006), Clinical Guidelines 43 for Obesity (NICE, 2006) recommends bariatric 
surgery to treat morbid obesity.    
 
As with previous systematic reviews defining a „low-carbohydrate‟ diet together 
with determining inclusion criteria was challenging and remains subject to 
debate (Adam-Perrot et al., 2006; Boucher et al. 2008; Westman et al., 2003; 
Westman et al., 2007). In the systematic reviews undertaken by Hession et al. 
(2008) and Nordmann et al. (2006) high-protein, ketogenic diets with 
carbohydrate content of less than 20-50g/d and low-carbohydrate diets with 
carbohydrate content of ≤ 60g /d were included in the review.  Bravata et al. 
(2003) included 107 studies with 94 interventions reporting data for 3268 
participants. Of these, 663 participants received diets with a carbohydrate 
content of ≤ 60g/d of whom only 71 received ≤ 20 g/d of carbohydrates. The 
lack of a clear definition of a low-carbohydrate/ higher protein diet has meant 
that study designs are not consistent nor are sufficiently robust. Hence 
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conclusions from systematic reviews and their scope to influence public policy 
on the effectiveness of carbohydrate restriction remain inconsistent (Hession et 
al., 2008). 
 
RCTs on the subject of lower-carbohydrate diets have focused on the low-
carbohydrate Atkins type ketogenic diets or more moderate carbohydrate 
restricted Zone type non-ketogenic diets which supports why such diets have 
been considered in this review. The Atkins and Zone type diets are both popular 
methods of lowering of carbohydrate intake for weight management purposes, 
and have and continue to challenge the existing low-fat/higher carbohydrate 
paradigm.  Although these approaches are regarded as “fad diets” (Saltzman et 
al., 2001), they are supported by popular diet books which provide definition, 
supporting information, methodology, recipes and testimonials of experience 
and success of such dietary protocols and have both enabled and persuaded 
the scientific community to test these protocols more rigorously using RCTs.  
Hence reviewing the scientific evidence for effectiveness of the popular Atkins 
and Zone type protocols in the context of a weight management protocol is 
relevant for clinical practice of a nutritional therapist and lends to both internal 
and external validity of this study.  
 
This review found that lowering carbohydrates supported favourable changes 
for hormonal and endocrine markers (blood glucose, HbA1c, insulin levels, 
insulin sensitivity and insulin resistance) and lipid control (HDL-C, TAG). The 
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Atkins diet was noted to be particularly beneficial for the glycemic control for 
diabetics, however showed mixed results for LDL-C, potentially due to higher 
levels of saturated fat intake. Hence caution was indicated when an Atkins type 
diet is considered for individuals with raised LDL-C. Other studies noted similar 
results for the Atkins type weight loss diet. Hession et al. (2008) and Nordmann 
et al. (2006) cover thirteen very low-carbohydrate, Atkins type interventions and 
support the view that low-carbohydrate diets are at least as effective if not better 
than comparative low-fat diets both over six months and over a year for 
management of obesity and related CVD risk.   
 
Volek et al. (2009), compared two hypocaloric ( ̴ 1500kcal) diets - an Atkins type 
low-carbohydrate diet (% carbohydrate: fat: protein=12:59:28) with a low-fat diet 
(LFD) (56:24:20) in 40 subjects with atherogenic dyslipidemia. Whilst both 
interventions improved several metabolic results, the low-carbohydrate subjects 
had consistently reduced glucose (-12%); insulin concentrations; (-50%); weight 
loss (-10%); reduced adiposity (-14%); more favourable TAG (-51%); HDL-C 
(13%); postprandial lipemia (-47%) and improved LDL particle distribution.  
Gardner et al. (2007), in a twelve month randomized trial noted that 
premenopausal women following the Atkins diet lost more weight and had more 
improved metabolic factors than women assigned to the Zone diet, and low-
fat/higher-carbohydrate Ornish or Learn diets.  
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Sharman, Gomez, Kraemer and Volek (2004), during a 2 consecutive six-week 
energy restricted diet, noted that a low-fat diet was more effective at lowering 
LDL-C but the low-carbohydrate Atkins type diet was more effective at 
improving several other outcomes of metabolic syndrome including the 
decrease in fasting serum TAG, the TAG/HDL ratio, postprandial lipemia, serum 
glucose and greater weight loss (Sharman et al., 2004).  Similarly Nordmann et 
al. (2006) indicated that LDL-C decreased more for participants randomized to 
low-fat diets but HDL-C and TAG results were better for individuals following a 
low-carbohydrate Atkins type diet. It should be recognized that the trials 
incorporating an Atkins type diet are small in number and often undertaken by 
and/or sponsored by the Atkins Foundation and individuals connected with the 
foundation hence creating a potential for bias. However these connections are 
declared and open to scrutiny and review.  
  
 The results from this study specifically endorse the validity of the Atkins type 
diet as a potential weight management option for individuals who are unable to 
count and/or control caloric intake or those who may prefer an ad libitum dietary 
protocol. In an ad libitum scenario, ketogenic low-carbohydrate diets may cause 
improved satiety and reduced voluntary food intake.  Johnstone et al. (2008) in 
a four week trial found that in the short term, ad libitum food intakes were lower 
with a very low carbohydrate (4% carbohydrate) as compared with a moderate 
carbohydrate (35% carbohydrate diet).  
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Although the Atkins diet appears to promote weight loss without hunger in the 
short term, potential short-term adverse effects were noted namely constipation, 
headaches, halitosis, muscle cramps and diarrhoea that were significantly 
higher than the comparative low-fat diets. It was held that these may be 
managed with adequate fluid intake, nutritional supplementation and increased 
vegetable fibre intake (Yancy et al., 2004). The long-term effects of the Atkins 
type diet on health and disease prevention however are still unknown (Astrup et 
al., 2004; Gardner et al., 2007) and the sustainability of such a low-carbohydrate 
diet over a longer term is questionable. Crowe (2005) corroborates that the 
Atkins type low-carbohydrate diet is not likely to be harmful in the short-term and 
possibly for up to six months, the benefits may outweigh risks. However, the 
longer term impact of severe carbohydrate restriction particularly on nutritional 
adequacy, dyslipidemia markers, renal and bone health requires further 
research.  Hence, in addition to the favourable effects of an Atkins type diet on 
satiety and appetite, the potential impact of a ketogenic Atkins type diet on lipid 
markers particularly LDL-C, bone health, kidney function, nutritional adequacy 
and adverse side-effects would need to be independently assessed prior to 
recommending such a weight loss plan (Adam-Perrot et al. 2006) .   
 
In addition to low-carbohydrate Atkins type diets, the results of this study also 
endorse the consideration of more moderate restriction of carbohydrates as 
required by Zone type diets. Three of the fourteen studies included in the review 
(Dansinger et al., 2005; Johnston et al., 2006; McAuley et al.; 2004), show that, 
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as compared with an Atkins type diet plan, similar or better weight loss results 
may be achieved with a moderate-carbohydrate diet.  A further seven studies 
indicate than non-ketogenic low-carbohydrate diets and/or Zone type diets 
compare favourably with low-fat diets. Johnston, Tjonn and Swan (2004) in a six 
week study show that with fat intake held at 30% of energy, a more moderate 
zone type protocol may be significantly better than a low-fat/higher-carbohydrate 
conventional diet plan with weight loss of 6% (P<0.05) and loss of fat mass of   
9 – 11% (P<0.05).  
 
Other studies have had similar results with respect to Zone type diets and 
obesity management. Skov, Toubro, Renn, Holm and Astrup (1999) in a study 
over six months showed that a Zone type diet resulted in weight loss of 8.9kg 
(10%) and fat loss of 7.6 kg, significantly higher than that for the low-fat/higher 
carbohydrate group. In addition fasting plasma triglycerides and free fatty acids 
had decreased significantly from baseline and as compared with a low-fat diet. 
Farnsworth et al. (2003) in a study of 12 weeks of energy restriction found that a 
Zone type diet generated weight loss of 7.9 ± 0.5 kg and fat loss of 6.9 ± 0.4 kg, 
results that were similar to a group on a higher-carbohydrate conventional diet. 
Additionally, after weight loss, for the Zone type diet group, the glycemic 
response and serum TAG decreased significantly more than for the low-fat 
group (P<0.05).  
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Brinkworth, Noakes, Parker, Foster and Clifton (2004) corroborate the reduction 
in weight loss results over the longer term and concur with the overall 
favourable comparison of a carbohydrate restricted diet (CRD) with conventional 
low-fat/higher carbohydrate diets. They undertook a one-year follow -up of a 
randomised trial comparing two hypocaloric ( ̴ 1600kcal) diets – a Zone type 
CRD with a conventional low-fat/higher carbohydrate diet. Brinkworth et al. 
(2004) found that at week 64, weight loss for the CRD was 3.7±1.0 kg (3.8%) 
while that for the conventional diet was 2.2±1.1kg (2.4%) and suggested that the 
CRD may in the long-term have a better CVD profile than the conventional diet. 
The results from the review of Zone type diets suggest that there may be no 
need to reduce carbohydrate levels as drastically as in ketogenic Atkins type 
diets in order to achieve clinically meaningful weight loss and more moderate 
carbohydrate restriction as in Zone type diets may be appropriate if they induce 
and sustain an on-going and regular caloric deficit. As noted for studies on the 
Atkins type diets, individuals connected with the Foundation supporting the 
Zone diet may have been involved with trials on the Zone diet but the 
connections are properly disclosed and open to scrutiny.  
 
Hence this study has shown that for studies under six months as well as for 
longer-term studies of 12 to 24 months, lowering carbohydrates may provide as 
good an option if not a better option for weight loss and improvement of CVD 
risk factors as compared with the conventional low-fat/higher carbohydrate diet. 
Bravata et al. (2003), conversely, found insufficient evidence to recommend low-
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carbohydrate diets for participants older than age 50, for use longer than 90 
days or for Atkins type diets with carbohydrate intake of 20g/d or less. The large 
number and heterogeneity of the studies included in Bravata et al. (2003) may 
explain the difficulty in arriving at clear conclusions. Bravata et al. (2003) also 
concluded that weight loss was associated with decreased calorie intake and 
increased diet duration but not reduced carbohydrate content. This review 
concurs with the significance of regular daily calorie deficits underlying weight 
loss and the relevance of diet duration, but focuses on the result that an energy 
deficit and lowering carbohydrate content are not mutually exclusive and in fact 
the lowering of carbohydrate intake may successfully result in creating a 
sustainable energy deficit and provide a valid weight management option.  
 
The reduction of mean weight loss for diet studies exceeding six months noted 
by this review suggests the occurrence of weight loss plateaux and potential 
weight regain after a certain time period or weight loss level also recognised by 
Hession et al. (2008).  Roberts, Barnard and Croymans (2008) question why 
participants in weight loss trials regain weight between 6 and 24 months despite 
a reported calorie deficit of 300-600 calories. Whilst a possible explanation 
considered was errors in recording and reporting food intake, a further 
explanation may involve difficulty and or inability to sustain the calorie deficit for 
sustained periods of time. Klem, Wing, McGuire, Seagle and O Hill (1997) and 
Wing and O Hill (2001) in descriptive studies of successful long-term weight loss 
maintenance from individuals on the National Weight Control Registry (NWCR) 
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in the US stress the significance of a diet low in fat, regular physical activity, self 
monitoring, coping skills that enable individuals to respond to cravings and 
stressful situations in way that maintain dietary restraint. Despite the popularity 
of low-carbohydrate diets, the NWCR results do not as yet endorse 
carbohydrate restricted diets (CRD) for successful long-term weight 
management, a result that potentially warrants further research.  
 
Results from this study indicate the significance of protein intake in conjunction 
with lowering carbohydrates for favourable weight loss results. The low-
carbohydrate studies included in this review have incorporated protein intake of 
between 25-30% of energy intake for the non-ketogenic low-carbohydrate diets 
and Zone type diets and whilst not specified, the Atkins type diets have 
generally implied protein intake in the range of at 30% of energy. By contrast for 
the low-fat/ higher carbohydrate diets, protein levels were generally close to 15-
20%.  Two of the studies included (Layman et al., 2005; Luscombe-Marsh et al., 
2005) highlight the favourable impact of higher protein levels implicit in 
restricted-carbohydrate diets on satiety, appetite, weight loss and fat loss. Leidy, 
Carnell, Mattes and Campbell (2007) corroborate the significance of protein 
intake and show that a with a 750 kcal/day energy deficit diet for twelve weeks, 
a higher-protein group consuming 30% protein experiences greater perceptions 
of satiety and pleasure during energy restriction and lower losses of lean body 
mass as compared with a group consuming 15% protein of total energy intake 
although had comparable weight loss.   
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Clifton, Keogh and Noakes (2008) show that in a 12 week intensive weight loss 
programme followed by a 52 week follow-up, protein intake was linked to weight 
change (P=0.003) and that higher protein intake confers some weight loss 
benefit (Clifton et al., 2008). Hence higher protein intake generally implicit in a 
low-carbohydrate dietary design would appear to be significant in promoting 
satiety and preserving lean body mass during diet induced weight loss and may 
be significant for longer term adherence to a low-carbohydrate weight loss plan.  
 
The results suggest that in addition to the quantity of macronutrient intake, the 
quality and nature of macronutrients may influence obesity management results. 
Three of the studies included in this review provide perspectives on the nature 
of carbohydrates and fats permissible in the diet plans for weight loss. In 
summary these studies recommend the exclusion of high sugar and high fat 
foods, prescribing minimum intake of dietary fibre, limiting saturated fats and 
cholesterol, inclusion of low-glycemic carbohydrates and lean protein. Meckling 
et al. (2004) noted that the Zone type low-carbohydrate diet group who were 
able to include fruit, vegetable and wholegrain cereals in their diet were better 
able to achieve the fibre targets set for the high-carbohydrate group and 
achieved better weight loss results.  
 
Maki, Rains, Kaden, Raneri and Davidson (2007) in a twelve week RCT found 
that a reduced glycemic load ad libitum diet group lost significantly more weight 
and had better improvement in HDL-C as compared with a low-fat portion 
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controlled diet group. Conversely Liese et al. (2005) in a two-year study found 
no association between glycemic index and insulin sensitivity, BMI or waist 
circumference but found a positive association of fibre intake with the same 
markers. Howard and Wylie-Rosett (2002) corroborate that a diet high in 
sucrose of >20% of energy is linked with increased TAG due to increased 
hepatic secretion as well as impaired clearance of very-low-density lipoprotein. 
Hence, weight management results are potentially impacted by the quality of 
carbohydrate and fats included in the dietary protocol. Crowe (2005) concurs 
that advice to those following a low-carbohydrate diet should promote the 
reduction of refined „nutritionally deplete‟ carbohydrate foods but encourage the 
inclusion of fruit and high-fibre carbohydrate sources and replace saturated fat 
intake with mono-unsaturated fats (MUFA) and polyunsaturated fats (PUFA). 
 
The results suggest that lowering carbohydrates particularly to levels required 
by the Atkins type diet and/or the related prescribed or resulting caloric deficit 
may potentially cause nutritional shortfalls. These shortfalls may need to be 
managed and corrected by the use of appropriate supplements. Adam-Perrot et 
al. (2006) corroborate that low-carbohydrate diets that restrict food choices and 
recommend generally low intake of fruits vegetables and whole grain products 
as is required during the early phases of the Atkins diet potentially causes 
shortfalls in intake of dietary fibre, vitamins, calcium, potassium, magnesium 
and iron. Whilst short-term nutritional shortfalls may be tolerated, correction of 
longer-term shortfalls associated with carbohydrate and/or caloric restriction 
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should be addressed with appropriate nutritional supplements. Crowe (2005) 
corroborates that when recommending a low-carbohydrate diet, taking a daily 
multivitamin supplement would be sensible to protect against micronutrient 
deficiencies.   
  
The studies selected mainly compare lowering carbohydrates with a higher-
carbohydrate low-fat design. These reflect the nature of the studies available as 
RCTs. The studies selected show that low-fat, calorie-restricted, conventional 
diet may also generate favourable weight loss and favourable lipid change 
results however lowering fats has potentially has led to a situation where good 
and essential fats have been removed from the diet while high sugar or high 
sugar substitute foods have been substituted with consequential effects on 
health. Essential fats are often ignored in low-fat dietary recommendations as is 
evident from the studies selected. Minimum intake of these essential fats is 
rarely stipulated in the design of the diets studied. 
 
Research has for some years provided evidence on the benefits of MUFA, the 
need for some saturated fat and the requirement for dietary intake of essential 
fats in the form of omega 3 and omega 6 fatty acids (Lichtenstein & Van Horn, 
1998). Siri-Tarino, Sun, Hu and Krauss (2010) suggest that the benefits of 
reducing saturated fats must be evaluated in the context of the replacement 
macronutrient included. Whilst replacement of saturated fats with PUFA or 
MUFA may lower CVD risk (Lichtenstein & Van Horn, 1998), there are few 
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epidemiological or clinical trials that support the replacement of saturated fats by 
carbohydrates to support CVD makers favourably. Recent dietary guidelines by 
the USDA (2010) recommend that most of the 20-35% of fat intake 
recommended should constitute PUFA and MUFA. Hence, when recommending 
lowering carbohydrates in a weight loss protocol, the quantity and quality of fats 
to be included is relevant and important. 
 
Siri-Tarino et al. (2010) further re-iterate that a higher intake of carbohydrates 
particularly refined carbohydrates can exacerbate atherogenic dyslipidemia as a 
result of raised insulin levels. Whilst the FSA (2006) and USDA (2010) 
guidelines promote wholegrains over refined carbohydrates, a question remains 
as to whether the level of carbohydrates recommended (≥ 55% of energy) is 
appropriate (Hite et al., 2010) and potentially whether carbohydrate intake levels 
should be determined based on individual profile and „carbohydrate sensitivity‟ 
(Heller & Heller, 1994).  
  
This systematic review selected RCTs that lowered carbohydrate intake to 
assess if lowering carbohydrates supports the management of obesity and 
related disease. RCTs are the “gold standard” for quality of evidence (Hart, 
2003). The included studies, however, were heterogeneous in nature which was 
also noted in previous systematic reviews of dietary studies (Bravata et al., 
2003; Hession et al., 2008).  Determining recommended dietary protocol for 
health and/or weight loss from reviews of a range of diverse research studies 
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designed as RCTs is highly likely to be challenging (Bravata et al., 2003) 
because of the number of variables and potential confounding factors in the 
design and application of diets.  However by using the data extraction analytical 
tool as per Appendices A2-A15, some uniformity of analysis was possible and 
an attempt has been made to draw from this relatively small selection of studies 
included, sufficient data and concepts towards a theoretical framework. 
 
Furthermore, the dietary studies could not be blinded and the controls were 
usually an alternative eating plan as opposed to a placebo in a drug trial. Hence, 
the three-item, five point scale (Jadad et al., 1996) used to assess the quality of 
RCTs was not appropriate for the dietary studies selected as these were not 
blinded (Nordmann et al., 2006).  The lack of blinding potentially diminishes the 
quality and validity of the individual trials (Nordmann et al., 2006). It would 
appear that pharmaceutical options have a greater chance of being approved as 
weight loss and cardiovascular risk management treatment options as these 
lend themselves better to double blind RCTs. This is corroborated by the UK 
NHS obesity guidelines (NICE, 2006) that offers obese patients pharmaceutical 
options to enable weight loss where behavioural programmes have not 
succeeded.  
 
RCTs are more easily able to deal with quantitative and tangible variables that 
can be measured at defined points in time. Apart from dietary and activity 
variables, obesity, hunger and satiety are potentially affected by variables that 
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may not lend themselves to convenient measurement within the structure of a 
dietary RCT. These include daily and regular levels of stress, quality and 
quantity of sleep, daily and hourly levels of the hormones insulin, glucagon, 
leptin, ghrelin, growth hormone and cortisol (Healey & Schwartz, 2010; Spiegal 
et al. 2004). Dietary RCTs are not able to effectively assess the impact of these 
variables though in some of the studies selected, periodic qualitative and 
quantitative measures have been used to estimate the effect of some of these 
variables. These are more easily incorporated in an individualised case study 
approach where obesity can be managed on a personalised programme. Hence 
inherent limitations in the applicability of RCTs to dietary and behavioural 
obesity studies and the complexity of the variables impacting on obesity states 
affects the completeness of the conclusions derived.  
 
This review has highlighted the additive effects of lowering carbohydrate intake, 
adequate protein and exercise on weight loss and fat loss. Giannopoulou et al. 
(2004) noted a modest weight loss of 5% over fourteen weeks with a 
hypocaloric (600 kcal deficit), reduced carbohydrate (40%), and high 
monounsaturated fat (40%), moderate protein (20%) diet group. Similar weight 
loss results were noted for a group with the same diet together with an exercise 
programme of walking for 50 minutes three times per week. However, visceral 
adipose tissue loss, generally associated with improvements in insulin sensitivity 
and glycemic control, was only evident for the exercise group (Giannopoulou et 
al., 2004).    
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Slentz et al. (2009) in an RCT evaluating the effects of exercise duration and 
intensity on visceral fat found that while sedentary controls gained visceral fat, 
participants who undertook the equivalent of 11 miles of moderate exercise like 
walking per week prevented accumulation of visceral fat. In addition higher 
intensity exercise like jogging for 20 miles per week resulted in decreased 
visceral abdominal fat. Hence the evaluation of the amount and intensity of 
exercise for the decrease of and/or the prevention of gain of abdominal fat is 
significant for any weight loss effort and should be considered in conjunction 
with dietary changes.  
 
This review has highlighted that the sustainability of weight loss diets is likely to 
be influenced by a variety of outcomes which may include satiety, hunger and 
well being, adherence and attrition, side effects and safety and supervision and 
monitoring required. These outcomes have been measured and evaluated 
inconsistently across the studies selected. Their omission undervalues the 
quality of the results obtained. The relatively higher protein intake implicit in both 
the low-carbohydrate Atkins and Zone type diets would appear to increase 
satiety and reduce hunger whilst sustaining a caloric deficit. The Zone type diet 
generated a more favourable mood profile and feelings of high energy 
(Johnston et al., 2006). Bravata et al. (2003) also identified the need for studies 
of isocaloric diets with differing carbohydrate content to be assessed for 
symptoms of hunger and tolerability of the diet. Hession et al. (2008) 
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recommends the use of questionnaires within dietary weight loss studies to 
assess appetite, mood, and impact on lifestyle.   
 
From the results of this study, adherence rates were generally linked to weight 
loss success. It was noted that attrition and drop-out rates were high as is 
common in dietary studies with a RCT design but were not generally diet 
related. It was further noted that ongoing continuous monitoring improved 
compliance and reduced drop-out rates (Frisch et al., 2009, Shai et al., 2008).  
Hession et al. (2008) have also recommended the use of continuous 
improvement methodology to better manage attrition rates when using RCTs for 
diet and lifestyle interventions.  
 
This study finds that a higher-protein Zone type diet may suit or be preferred by 
women dieters as compared with men (Parker et al., 2002) and the Atkins type 
diet may work better for white subjects more than black subjects (Samaha et al., 
2003). This suggests that a weight loss strategy both in terms of choice, 
adherence and appropriateness may have gender, cultural, ethnic and / or 
genetic influences. Recently popularised genetic profile tests (MyGenomics, 
2012) are also able to corroborate if fat restriction or carbohydrate restriction is 
more appropriate for an individual. NICE (2006) supports the need for cultural 
and ethnic sensitivity when suggesting weight loss protocol. 
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As noted previously, where total cholesterol and or LDL-C levels are high, a 
high-saturated fat Atkins type diet may not be appropriate whilst a more 
moderate carbohydrate Zone type diet or a low-fat conventional diet do not 
indicate adverse results. Additionally, vegetarians and vegans would find it 
difficult to use the Atkins protocol due the high animal protein content. Lowering 
carbohydrates may also have particular significance for individuals with an 
impaired carbohydrate mechanism leading to “carbohydrate sensitivity” or 
“carbohydrate addiction” and/or “sugar addiction” (Heller & Heller, 1994).   In 
such a scenario, lowering the absolute intake of carbohydrates or the frequency 
of intake as described by Heller and Heller (1994) may provide an appropriate 
weight loss and management strategy to manage the resultant chronic 
hyperinsulinemia. Hence, weight loss plans should be individualised and tailored 
to address an individual‟s health risk profile, genetic susceptibilities, cultural and 
dietary preferences. 
 
This review is subject to several limitations many of which are in common with 
similar reviews of dietary studies. The sample size of selected studies is 
relatively small. The study searches were limited to the PubMed database for 
English language studies from 2000 to 2010, involving clinical trials for which full 
text articles were available together with reference lists of articles selected. This 
process may have introduced some selection bias and /or publication bias 
(Bravata et al., 2003; Nordmann et al., 2006).  
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A majority of the studies available for inclusion as well as those selected were of 
a relatively short duration of up to six months with few studies extending the 
intervention duration to 12 and 24. There was insufficient follow-up of the short 
term study results also noted by Bravata et al. (2003) and Hession et al. (2008).  
This reflects the overall population of clinical trials available on the subject of 
lowering carbohydrates. It is recognized that studies of such short duration may 
not adequately reflect a longer-term lifestyle change expected in obesity 
management.  
 
Any limitations of the individual studies in process, inclusion, structure or results 
would implicitly be carried forward into the results and observations from this 
systematic review that aims to combine the process and results of the 
underlying studies included. All the studies selected required recording and 
declaration of food intake. Such records of food intake via food diaries are 
generally subject to error and inaccuracies which may affect the integrity of the 
results of this study. Assessing behavioural interventions including dietary 
studies is difficult due to potential inaccuracies in recording food consumption 
and activity levels. Roberts et al. (2008) note that food frequency questionnaires 
may not always provide accurate information on energy and macronutrient 
intake but are better at indicating general dietary patterns. Lichtman et al. (1992) 
and Goris, Westererp-Plantenga and Westerterp (2000) further highlight that 
self-reported calorie intake is often under-reported in dietary studies.  
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Not all the studies consider nutritional adequacy or provide sufficient detail on 
the quality of carbohydrates and other foods permissible on the diet plan 
significant because the primary culprit in weight gain may not necessarily be the 
relative quantity of macronutrients but the quality thereof. Not all the studies 
included in this review incorporate or isolate the effects of exercise on weight 
loss. Exercise may in many studies be regarded as a confounding factor. Either 
insufficient detail was provided of the nature and intensity of activity undertaken 
in order to assess impact on the energy balance equation or studies stated that 
participants were encouraged to maintain baseline levels of exercise and 
activity, also noted by Bravata et al. (2003).  Most of the studies included in this 
review report on body composition but the primary focus is weight loss rather 
than fat loss. Some studies did not provide results on fat loss, waist 
circumference and preservation of lean mass following caloric restriction thereby 
diminishing their usefulness in assessing impact on metabolic disease.  
 
The studies selected potentially gave insufficient emphasis to hunger, satiety, 
well being and/or slowing of metabolism responses caused by food restriction. 
Whilst these outcomes were included in a few studies, it is plausible that they 
are key outcomes for any weight management study, contribute to continued 
adherence to the diets involved and hence should be essential outcome 
measures. Bravata et al. (2003) concur with the need for additional studies of 
isocaloric diets where participants are assessed for hunger responses and on 
the tolerability of the diet.  
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The assessment of LDL particle size by the inclusion of small low-density 
lipoproteins as an outcome measure was largely omitted by most of the studies 
selected. Small low-density lipoproteins are now recognised as a key CVD risk 
indicator along with triglycerides level and HDL-C markers (Despres et al., 
2001). Hession et al. (2008) also highlighted that the studies included in their 
review failed to investigate changes in the LDL particle size and Sharman et al. 
(2002) indicate that on a low-carbohydrate/high protein diet, LDL particle size 
changes from small to large therefore resulting in a less atherogenic profile.  
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CHAPTER 6 – FUTURE IMPLICATIONS 
Future implications from this review relate to potential improvements in the 
design, data range and scope of future dietary research studies for weight 
management including those that restrict carbohydrate intake; exploring and 
establishing methods of sustaining weight loss over a longer term and weight 
loss maintenance and evaluating the importance of Public Policy on obesity 
management.   
 
Future weight management studies including those that lower carbohydrate 
intake should measure changes in body fat, waist circumference and abdominal 
obesity more clearly, as these have been significantly linked to insulin 
resistance, metabolic syndrome and chronic heart disease; evaluate the 
sustainability of a caloric deficit over the longer term; provide improved reporting 
on hunger, satiety and well-being outcomes as these strongly influence 
adherence and attrition; explore other reasons for attrition and adherence to 
assess if reasons for dropping out may be avoided or reduced by better 
management. In this context, methods to prevent a physiological response of 
slowing down metabolism in response to sustained caloric deficit or severe 
carbohydrate restriction should be studied further. Possible methods could 
involve the concept of calorie cycling and/or cycling of carbohydrate intake 
levels to break monotony or to prevent weight loss stagnation. Studies that 
included higher protein levels or very low-carbohydrate levels should measure 
renal health and bone turnover due to potential health risks identified.  
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In addition more focused long-term studies should be undertaken to identify 
critical success factors to achieve sustained weight reduction to healthy BMI 
levels. Analysis of successful weight management protocol should be 
undertaken by critically continually reviewing cases from the National Weight 
Control Registry [NWCR] in the US (as cited in Wing & Phelan, 2005), 
successful case studies from medical practice, popular diet literature as any 
successful experience may have the potential to be replicated in a clinical 
setting.  
 
Although dietary guidelines recommend the lowering of refined and processed 
foods, greater controls and monitoring should be undertaken with respect to the 
manufacturing and marketing of high sugar/high fat foods. Stronger public 
information messages should be made to persuade all individuals, particularly 
overweight and obese individuals to limit the level of carbohydrate intake 
including starches to good quality, low glycemic carbohydrates based on their 
tolerance levels.  
 
Dietary management of obesity and overweight is a field of scientific study 
where unpublished grey literature and popular diet books have and may 
continue to push the boundaries of scientific understanding and identify areas 
which have the potential for more rigorous research. This is evident from the 
iterative development of the theory from researchers, clinicians and lay people 
via diet and weight loss books. Considerable insights have been obtained by 
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these individuals from a synthesis of research studies on feeding, hunger, 
appetite, digestion and metabolism. Government health agencies should 
sponsor research by means of RCTs on successful or popular protocol and 
provide public guidance on dietary changes required to combat obesity. In this 
context, Crowe (2005) suggests that some of the new “commercial incarnations” 
of low-carbohydrate diets that incorporate such sensible dietary changes should 
be promoted by doctors, nutritionists and public health messages (Crowe, 
2005). 
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CHAPTER 7: A PROPOSED THEORETICAL WEIGHT MANAGEMENT 
MODEL   
Based on a synthesis of findings from this review and consideration of the 
limitations it may be postulated that weight management should be a tailored, 
individualised programme that requires the assessment of several key 
elements. Figure 3 diagrammatically represents a suggested theoretical basis 
for designing a weight management protocol that may be appropriate for clinical 
practice.  
 
Weight Management  may be regarded as a function of several influences that 
include energy restriction; carbohydrate Intake – good quantity in keeping with 
individual carbohydrate sensitivity; protein intake- good quality and sufficient;  
fats– sufficient MUFA, PUFA , low saturated and trans fats; dis-allowance of 
refined sugars, processed food, and “junk food”; reduced glycemic load of meals 
and increased fibre; sufficient diet duration; improved adherence; regular 
monitoring and supervision; exercise & activity – suitable type, intensity and 
frequency; adequate sleep and stress management. Desired outcomes are 
weight loss achieved – absolute and percentage; increased fat Loss ; waist 
circumference reduction; hunger management; higher satiety levels ; lean mass 
preservation; TAG reduction; HDL-C increase; Small LDL-C particle reduction; 
Improved glycemic control and insulin sensitivity; nutritional adequacy; safety 
and reduced side effects; flexibility in choosing a diet; clear dietary protocol and 
support ; and adequate diet maintenance plans.  
                                                                
84 
 
INFLUENCES DESIRED PROCESS 
PROCESS 
DESIRED OUTCOMES 
 
FIGURE 3.  A PROPOSED THEORETICAL WEIGHT MANAGEMENT MODEL 
Energy Restriction – 
Regular Daily 
Calorie Deficit 
Carbohydrate Intake 
– Good Quality in 
keeping with 
Carbohydrate 
Sensitivity 
 
 
Protein Intake – Good 
Quality & Sufficient 
Fat Intake – Sufficient 
MUFA, PUFA, Low 
Saturated Fat 
Disallowance of refined 
sugars; processed 
foods & junk food 
Diet Duration 
Improved Adherence 
Regular Monitoring & 
Supervision 
Exercise & Activity: 
Suitable Type, Intensity 
& Frequency 
Adequate Sleep/Rest & 
Stress Management 
Weight Loss – Absolute 
(kg) & Percentage (%) 
Fat Loss – Absolute (kg) 
& Percentage (%) 
 
Waist Circumference 
Reduction 
Lean Mass Preservation 
Good Satiety Levels, 
Improved Hunger 
Management, Reduced 
food cravings, Well-
being 
Lipid Control –  
Increased (↑) HDL-C 
Reduced (↓) LDL-C 
Reduced (↓) TC 
Increased (↑) LDL-C 
particle size 
 
Glycemic Control    
Insulin Resistance ↓   
Insulin Sensitivity  ↑ 
           
Reduced Glycemic 
Load of Meals & 
Increased Fibre 
Nutritional Adequacy 
Ensured 
Safety & Reduced Side 
Effects 
PROPOSED  
WEIGHT 
MANAGEMENT 
PROTOCOL 
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loss 
programmes to 
suit individual 
tastes, cultural 
preferences & 
genetic profile 
Clear Diet 
Guidelines 
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Weight Loss 
Maintenance 
Guidelines 
Flexibility & 
Adaptive 
Capacity 
Adequate 
Nutritional 
Supplementation 
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The studies selected in this review have measured and commented on many of 
if not all of the above outcomes. As suggested by the model the tailoring of a 
weight management strategy in a clinical setting may consider lowering 
carbohydrates if suitable or preferred by an individual but would need to done in 
concert with appropriate recommendations on the other influences on weight 
management identified and management of any related risks. Glenny, O‟Meara, 
Melville, Sheldon and Wilson (1997) in a comprehensive systematic review on 
the treatment and prevention of obesity support the use of multi-component 
strategies for the management of obesity and recommend that interventions that 
indicate success should be replicated.  
 
The most recent obesity related guidelines for the UK (NICE 2006) and the US 
dietary guidelines (USDA, 2010) also recommend multi-component 
interventions that include improved eating behaviour, increased physical activity 
and reduced energy intake. However they continue to support a low-fat/ higher 
carbohydrate approach to obesity management with a recent increased 
emphasis on PUFA and MUFA. Little or insufficient recognition is given to the 
potential need to reduce carbohydrate intake in keeping with individual 
carbohydrate tolerance levels; the significance of the glycemic load of meals; or 
the significance of the level of protein intake.  
 
  
                                                                
86 
 
CHAPTER 8 – CONCLUSIONS 
This study endorses a strategy of lowering carbohydrates in the management of 
mild to moderate overweight and related metabolic disease if appropriate the to 
the preferences and health risk profile of an individual. In the short term of six 
weeks to six months, „clinically meaningful‟ weight loss of 5-10% and an 
improvement in metabolic risk factors may be expected. Longer-term weight 
loss with a carbohydrate restricted diet reduces to 2-6 % for periods from 12 to 
24 months suggesting that sustaining such weight loss and preventing weight 
gain may be challenging.  A daily caloric deficit in the range of 300-750 kcal/day 
or 30% of baseline energy, prescribed or resulting from the low-carbohydrate 
dietary protocol was significant to the weight loss results achieved. Current 
dietary guidance for obesity management in the UK and the US supports a low-
fat/higher carbohydrate approach to obesity management with an emphasis on 
energy restriction and lowering saturated fat intake. They do not currently 
support low-carbohydrate diets for health potentially due to uncertainties about 
long-term suitability of low-carbohydrate diets.  
  
Whilst this theoretical and philosophical review of lowering carbohydrate intakes 
for the management of obesity and related metabolic disease does not suggest  
that low-carbohydrate dietary therapy is the best or only way forward, it does 
question the existing paradigm and status of the conventional low-fat/higher 
carbohydrate diet as being the most appropriate or most effective option for all 
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individuals including overweight and obese individuals as is currently being 
proposed by health advisors in the UK and US.  
 
As a nutritional therapist, there is a case for tailoring weight loss dietary advice 
based on the format of a theoretical model suggested in this review to suit 
individual preferences, genetics and medical profile. Sustainability of the diet 
design and potential for longer term adherence is more significant when 
recommending a relevant weight loss plan.  Some individuals are more easily 
able to restrict fat intake whilst others are more easily able to restrict 
carbohydrate intake. Such preferences should be taken into account when 
designing an appropriate diet plan.  
 
Lowering carbohydrate intake may provide a viable method of calorie restriction 
particularly for the short to medium term and should be an available choice to 
individuals for weight management, if appropriate and subject to the 
management of related risks. More research is required to support the longer-
term use of ketogenic Atkins type diets for obesity management but a more 
moderate reduction of carbohydrates as suggested by Zone type diets may be 
compatible with recent dietary guidelines issued by health authorities in the US 
and the UK.   
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(Compiled by reference to 1) Crombie, 1996; 2) Jadad et al., 1996; 3) Downs and Black, 1998; 
4) Kumar, 1999, p. 125; 5) Bowling 2002, p.137) 
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Criteria Reference  
Aims and objectives of the studies and  reasons for undertaking the study and perceived general importance clear. 1,2,3,5 
Hypothesis and research questions clearly stated 5 
Dependent and independent variables identified 5 
Study design and interventions clearly described, Appropriateness of the intervention   2,3,5 
Study described as randomised  and double blind 1,2,3 
Characteristics of patients included clearly described? 3 
At least one control or comparison group 2 
Statistical power to detect type I and II errors discussed. Sample size justified? 1,2,3,5 
Relevance to the research question being explored. Relevance to researcher. 1 
Internal and External validity and reliability discussed   3,4,5 
The study settings, study populations, subject inclusion and exclusion criteria 2,5 
Selection, funding and information bias 1,3, 4,5 
Ethical considerations, Conflict of interest discussed 5 
Analysis- treatment groups comparable at baseline, basic data adequately described  1 
Confounding factors described 3,5 
Methodology and statistical methods described 1,5 
Baseline, process and outcome measures 1, 2 
Outcomes, endpoints clinically relevant and clearly described? 1,3 
Description of withdrawals and drop outs? All subjects accounted for? 1,2,3 
Adverse Effects and safety discussed? 1,2,3 
Statistics appropriate and adequate? 2,3,5 
Results clear and adequately reported 1,5 
Conclusions clearly stated? 5 
Generalizability and practical consequences of results? 3,5 
Limitations of research and design presented 5 
Future Implications discussed 5 
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Author Dansinger, Gleason,Griffith,Selker & Schaefer(2005) 
 
Title  Comparison of the Atkins, Ornish, Weight Watchers and Zone Diets for Weight Loss and Heart Disease Reduction 
 
Journal  Journal of the American Medical Association 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. Reputable Key Author. Dansinger is an MD but promotes himself as a low-carb doctor- hence potential 
author bias. Dansinger and Schaefer are MDs and affiliated to the Division of Endocrinology, Diabetes and Metabolism and Drs 
Griffith and Selker are affiliated to the Institute for clinical research and health policy studies. Dr Schaefer and Ms Gleason affiliated 
to the Jean Mayer US Department of Agriculture Human Nutrition Centre on Aging at Tufts University. 
 
General Aim Clear Evaluation of four named diets for weight loss and heart disease reduction. Aim to determine their relative realistic clinical 
effectiveness and sustainability for weight loss and cardiac risk factor reduction. 
 
Specific Study objectives stated To assess adherence rates and effectiveness of 4 popular diets for weight loss and cardiac risk factor reduction.  
 
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and cardiovascular disease (CVD) risk management.  
 
Two of the four diet intervention arms lowered carbohydrates. The four diets studied were a low-carbohydrate Atkins Diet, a 
moderate carbohydrate Zone Diet, a low-calorie Weight Watchers diet and a very low-fat Ornish Diet.  
Internal Validity - methods and 
actual results in the light of study 
objectives 
Not Controlled. Comparative Intervention 
Study described as randomised Yes. 160 participants were randomly assigned to either Atkins(carbohydrate (CHO) restriction), n=40; Zone (macronutrient  balance, 
n=40;  Weight Watchers (calorie restriction, n=40; Ornish (fat restriction, n=40) 
 
Study described as double blind No.  
 
Description of withdrawals and 
dropouts present 
Yes. Completers were: Atkins: 53% (21 of 40); Zone: 65% (26 of 40; Weight Watchers: 26 of 40 (65%); Ornish: 50% (20 of 40). 
Participants who did not complete the study at months 2, 6, and 12 were 34 (21%), 61(38%) and 67 (42%). 
Reasons of dropouts and non completion provided. These included “disliked diet”, “Unable to adhere”, and “moved away”.  
 
Randomisation / blinding 
appropriate 
Randomisation was relevant. Blinding for participants would not be possible as these are popular diets that participants would 
most likely be aware of. 
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Randomisation / blinding 
appropriate contd.  
Study personnel were blinded to dietary assignment to avoid the possibility of biased recruiting according to diet type or biased 
dietary assessment. 
 
Target Population Adults of any age who were overweight or obese with BMI between 27 and 42 
 
Why was study done? What was 
perceived general importance? 
To address the scarcity of data addressing the health effects of popular diets especially as some of these are departing 
substantially from mainstream medical advice. 
 
Is there a clear hypothesis and 
objectives? 
Null Hypothesis – No change from baseline  
What specific question is being 
addressed? 
Are these diets effective for weight loss and for reducing cardio-metabolic risk and what is the level of adherence 
 
 
The study setting- where did study 
take place? 
At a single-centre academic medical centre in Boston Massachusetts, USA. 
The study population - Intended 
group to whom results should 
apply  vs. group actually studied 
Overweight or obese adults with evidence of elements of cardio- metabolic disease. 
Group actually studied  160 participants from the Boston Massachusetts area recruited from 247 individuals who agreed to be screened. 
 
The social, cultural, economic, 
ethnic background 
Individuals able to respond to newspaper advertisements, television publicity for local news coverage. Ethnic background was not 
disclosed but authors suggest that recruitment strategy was designed to meet race and sex criteria consistent with US federal 
guidelines. Demographics information is available for each group in terms of % of women, and % of white race individuals 
 
Study Approval Study conducted at Tufts University Academic Medical Centre. The protocol was approved by the local institutional board. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out? contd. 
Clear inclusion criteria. Adults of any age who were overweight or obese with a BMI between 27 and 42 kg/m2 and having at least 
one of following metabolic cardiac risk factors: Fasting glucose of at least 110mg/dL (≥6.1mmol/L; total cholesterol (TC) of at least 
200mg/dL (≥5.2mmol), low density lipoprotein (LDL) cholesterol of at least 130mg/dL (≥3.4mmol/L); high density lipoprotein (HDL) of 
40mg/dl or less (≤1.0 mmol/L); triglycerides of at least 150mg/dL; systolic blood pressure of at least ; 145mm Hg; diastolic blood 
pressure of at least 90 mm Hg or current use of oral medication to treat hypertension, type 2 diabetes or dyslipidemia 
Exclusion criteria-included unstable chronic illness, insulin therapy, urinary microalbumin of more than of more than 2 times 
normal; serum creatinine of at least 1.4 mg/dL (≥123.8 µmol/L, clinically significant abnormalities of liver or thyroid test results; 
weight loss medication or pregnancy 
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Is there a power calculation to 
determine sample size? 
Yes. Using t tests and 2-sided type 1 error of 5%- estimate that 40 participants needed in each group to achieve 80% power to 
detect a weight change of 2% from base line or 3% between diets. 
 
Was there selection bias? None evident. Participants recruited using newspaper advertisements and television publicity. 247 individuals screened and 160 
finally selected.  
 
Was there funding bias? None evident. The study was supported by grants related to the National Institutes of Health (NIH). 
 
Confounding Factors Study only evaluated dietary components. Did not consider other specific components that may affect results. 
Effects of Medication cannot be quantified and separated from the effects of the dietary change. Hence the changes in metabolic 
markers are not purely due to dietary adjustments. 
Missing data analysis 
 
How does the study group relate to 
researchers interest groups / 
patients? 
The researcher’s interest groups would potentially include overweight and/or obese adults with one or several of the named 
metabolic disorders and potentially on one or more of the related medications.  
What was the intervention and how 
was it carried out? 
4 groups were given four 1 hour sessions during first 2 months by team of a dietician and a physician. 1
st
 meeting group given diet, 
rationale, written materials and official cook book. Subsequent meetings aimed to maximize adherence by reinforcing positive 
dietary changes and addressing barriers to adherence. 
Atkins Group: aimed for less than 20g of CHO daily with a gradual increase towards 50 g daily 
Zone Group: aimed for 40:30:30 balance of percentage calories from CHO, fat and protein respectively 
Weight Watchers group aimed to keep total daily “points” in range determined by current weight.  Each point was roughly 50 
calories and most participants aimed for 24 to 32 points 
The Ornish group aimed for a vegetarian diet with 10% of calories from fat. 
Standardised recommendations relating to supplements, exercise and external support. All participants encouraged to take a 
multivitamin daily and obtain 60 minutes of exercise weekly 
To approximate realistic sustainability, participants asked to follow assigned diet strictly for 2 months following which they were 
encouraged to follow assigned diet according to self determined interest level 
 
What was measured and how was it 
measured? 
Dietary Adherence: Measured via participant completed 3-day food records at baseline, 1,2,6 and 12 months which were analysed 
via a computerized diet analysis program and a 10 point score to reflect the degree to which the group achieved the specified 
dietary target. Also telephoned participants monthly to rate adherence during previous 30 days. 
 
Were baseline measures used? 
 
 
Age, sex, race, smoker- more than 1 cigarette per week, hyperglycaemia – fasting blood glucose of 110mg/dL; exercise – greater 
than mild; mean and SD of BMI, Body weight (kg), waist size (cm); BP-systolic and diastolic in mm Hg; Glucose, Insulin,cholesterol-
total, LDL, HDL, Total/HDL ratio, LDL/ HDL, triglycerides, C-reactive protein, total protein, nitrogen, creatinine levels  
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Were baseline measures used? 
Contd. 
Mean total energy intake was 2059 calories with 46.4%, 34.5% and 17.6% calories derived from CHO, Fat and protein respectively. 
No significant caloric and macronutrient differences between groups at baseline. 
 
Were process measures used? 
 
 
 
 
 
 
 
Were process measures used? 
contd. 
Statistical Analysis: Analysis of variance used to assess differences in baseline variables between diet groups; independent t tests 
were used to compare baseline variables between study participants who discontinued study with those who remained. 
1 sample t test for normally distributed variables ( absolute changes for weight loss and cardiac risk variables) and Wilcoxon rank 
sum test for skewed variables  (dietary variables) 
Missing data replaced by baseline data for a primary intent to treat analysis or excluded for a secondary completers analysis 
 
Pearson correlation coefficient used to compare adherence data from diet records and self reports – using a single analysis that 
paired the 2 mean scores for each diet across 5 time points 
Linear regression used to assess the relationship between changes in weight, dietary adherence variables and cardiac risk factors 
and to assess the independent effects of potentially confounding variables including baseline characteristics and changes in 
exercise  and medication use 
P values were 2 – sided and P≤.05 was considered statistically significant.  
 
Were outcome measures 
identified? Are there clear validated 
outcomes? 
Yes  
Are the methods quantitative or 
qualitative? 
Quantitative and Qualitative 
Safety Results No evidence of clinically significant renal impairment in any diet group. This would be a concern for the low CHO groups. 
 
Endpoint/ Biomarker Tested Primary end point: mean absolute change from baseline weight at 1 year within each group and relative between groups. 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b as a significant risk factor for CVD disease along with HDL and triglycerides would have been relevant and 
important. 
Are the endpoints relevant to actual 
practice 
Yes. 
Dietary Intake and Adherence 
Results 
For each group dietary adherence according to self-reports decreased progressively with time and to a similar extent in each diet 
group.  
25% of participants in each diet group sustained a mean adherence of at least 6 of 10 regarded as a clinically meaningful adherence 
level. 
At 1 year, the mean caloric reduction from baseline were 138 for Atkins, 251 for Zone, 244 for Weight Watchers and 192 for Ornish 
groups (P<0.05, P=0.7 between diets) 
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Weight loss and cardio-protective 
mechanisms identified  
 
Adherence to diet. Caloric deficit. 
Weight Loss / Body Composition 
results 
All 4 diets resulted in modest statistically significant weight loss at 1 year with no statistically significant differences between diets. 
In each diet group approximately 25% of the initial participants sustained a 1 year weight loss of more than 5% and approximately 
10% lost more than 10% of body weight. Weight loss was highly associated with waist size reductions for all diets (Pearson r=0.86 
at one year; P<0.001) with no significant difference between diets. In women mean (SD) body weight decreased by 2.4 (5.1) kg (2.5% 
change from baseline) and waist size by 2.3 (4.5) cm. For the men body weight decreased by 3.3 (6.4) kg (3.1 % change from 
baseline) and waist size  by 3.1 (5.8) cm at 1 year (P=0.30 for sex differences) 
No significant association between diet type and weight loss (r=0.07; P=0.4) 
Strong curvilinear association between self reported dietary adherence and weight loss (r=0.60; P<.001). Participants in the top 
tertile of adherence lost 7%  
 
Ketonuria Results None noted 
 
Cardiac Risk Factor Results 
 
 
 
 
 
Cardiac Risk Factor Results contd. 
All 4 diets achieved modest though statistically significant improvements in several cardiac risk factors at 1 year. 
All diets reduced mean LDL cholesterol levels at 1 year though for Atkins Group the reduction was not statistically significant 
(P=0.07). All diets significantly increased mean HDL cholesterol except for Ornish Group (P=0.6). The LDL/HDL ratio decreased 
approximately 10% for each group (P<0.05). 
No diet programme significantly altered triglycerides, blood pressure and fasting glucose at 1 year. 
The lower CHO diets (Atkins and Zone) reduced triglycerides , diastolic BP and insulin in the short term though Atkins failed to 
significantly reduce mean fasting insulin levels at year 1 (P=.26). All diets reduced 1 year C-reactive protein levels by approximately 
15-20% though reduction was not significant for the Zone Diet (P=.09). 
Secondary analysis which excluded missing data demonstrated larger but similar changes. 
Amount of weight loss predicted amount of improvement in several cardiac risk factors. For each diet weight loss was significantly 
associated with changes in total/HDL cholesterol ratio (r=  -0.36), C-reactive protein (r= -0.37); and insulin levels (r= -0.39), 
regardless of diet type (P=.48, P=.57, P=.31) 
 
No diet significantly worsened any cardiac risk factor in association with weight loss or dietary adherence at 1 year.   
 
Endocrine markers and Hormonal 
Effects 
Improvements in blood Glucose and Insulin levels for all four diets at 2m, 6m and 12m.  The lower-carbohydrate diets Atkins and 
Zone more likely to reduce insulin in the short term (2m) though Atkins failed to significantly reduce mean fasting insulin levels at 
one year. 
All the diets reduced 1-year C-reactive protein levels by approximately 15% to 20% though not significant for the Zone diet.  
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Exercise and Medication use Exercise levels according to participant reports were modestly increased from baseline throughout the trial (all P<0.05) and to a 
similar extent for each diet group (P=0.7 between diets). 
At 1 year the numbers of participants with increased and decreased exercise levels from baseline were 11 and 2 for Atkins, 10 and 7 
for Zone, 14 and 3 for weight watchers and 8 and 3 for Ornish Groups. 
The amount of weight loss was positively associated with changes in exercise level (r=0.27, P=.001) with no significant differences 
between diets (P=0.7) 
After accounting for dietary adherence, there was no significant association between change in exercise and change in body 
weight or any cardiac risk factor.  
When individuals who initiated cholesterol lowering medication were excluded from the intent to treat analysis, the reductions in 
LDL/HDL ratios observed with each diet remained statistically significant and associations between weight loss and lipid changes 
were unchanged or slightly stronger. 
 
What effect may bias have on the 
result? 
None evident  
The Author's conclusions - are 
these justified? 
 
The Author's conclusions - are 
these justified? contd. 
A variety of popular diets can reduce weight and CVD risk factors but only for minority who can sustain dietary adherence level. 
Lower adherence for Atkins and Ornish group suggest diets may be too extreme.  Practical techniques required to increase dietary 
adherence.  
Adherence rates and clinical improvements would have been better if participants had been able to freely select from 4 diet 
options.  
Findings challenge idea that one type of diet is best for everybody and that alternative diets can be disregarded.  
Also findings do not support notion that very low-carbohydrate diets are better than standard diets. 
 
Poor sustainability and adherence rates resulted in modest weight loss and cardiac risk factor reduction for each diet group as a 
whole. 
Cardiac risk factor reduction was associated with weight loss regardless of diet type 
Adherence level rather than diet type was key determinant of clinical benefits 
CVD outcome studies appropriate to assess potential health effects of these diets 
More research needed to identify practical techniques to increase dietary adherence and to match individuals’ food preferences, 
lifestyle and medical conditions.  
 
Findings suggest that the degree to which a patient exhibits features of the metabolic syndrome might guide the degree of 
carbohydrate restriction.  
 
Generalizability- the extent to 
which the results might apply 
outside the study 
The baseline characteristics in each of the 4 diet groups were well matched and representative of the overweight population of the 
US. However these may be reasonably representative of South-Asian obesity and of a treatment group relevant to the researcher. 
Women were well represented and included a higher percentage of non-whites which may be relevant to South-Asian interest 
group. 
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Discussion points Higher discontinuation rates for the Atkins and Ornish Groups suggest these may have been found to be extreme. 
Practical techniques are needed to manage a national obesity epidemic- dietary adherence may improve if a broad spectrum of diet 
options are used to suit individual patient food preferences, lifestyles and CVD risk profiles. Adherence may have improved if 
participants had freely chosen their diets 
Findings challenge the concept that 1 type of diet is best for all or that very low CHO diets are better than standard diets  
Results support growing body of research that restriction of CHO and saturated fat have different effects on CVD profile- low CHO 
diets increase HDL cholesterol and more effective for short- term reduction of serum triglycerides, glucose and /or insulin; low 
saturated fat diets decrease LDL cholesterol. Hence clinicians can tailor level of CHO restriction.  
High- CHO/low- fat reduce or fail to increase HDL cholesterol – the significance of which in terms of CVD is unclear. Increase in 
HDL with low CHO/high fat diets still unclear due to lack of relevant intervention trials.  
Study design limited support beyond 2 months to reflect real-world conditions. Drawback of approach for highly adherent 
individuals   
 
Were study limitations discussed? A much larger sample size would be required to “a best diet” 
High rate of attrition confounds the results potentially 
The assumption that participants who discontinued the study were unchanged from the baseline is reasonable but imprecise but 
authors feel validity supported by 3 observations 
 
Study limited in ability to exclude long-term safety risks or occasional dangerous adverse effects resulting from diets though no 
short-term safety risks were found. 
 
Measurement of dietary intake and adherence relied on self-reporting and therefore subjective.  
 
Other limitations  
Software used to analyse diet also subject to errors 
After 2 months participants encouraged to follow their diet according to their own self determined interest level. Hence this could 
be a confounding factor.   
Whilst this approach was useful to estimate the real world effectiveness and sustainability of diets but downside was that it was 
poorly suited to determine the effects of each diet in highly adherent individuals.  
 
Future Implications discussed Individualised diet plans appropriate.  More research needed to identify practical techniques to increase dietary adherence 
including one to match individual food preferences, lifestyles and medical conditions.  
Further CVD outcome studies required to determine clinical effects of carbohydrates and saturated fats on HDL cholesterol  
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Author Foster et al. (2003) 
 
Title  A Randomized trial of a Low-Carbohydrate Diet for Obesity 
 
Journal  The New England Journal of Medicine 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. 5 out of 10 authors are MDs and 3 PhDs 
General Aim Clear To evaluate the efficacy of the low-carbohydrate (LC), high protein (Atkins diet).  
 
Specific Study objectives stated To evaluate the efficacy of the LC high-protein (Atkins diet) for weight loss and managing risk factors for coronary heart disease 
in obese persons.  
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet and particularly carbohydrate (CHO) 
restriction is significant to weight management and CVD risk management 
 
A low-carbohydrate Atkins type diet compared with a low-fat conventional diet over 3m, 6m and 12m. 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized Controlled Trial. Comparative Intervention. One year multicentre trial.  
Study described as randomised Yes. Subjects randomly assigned at each site with the use of a random-number generator to follow one the 2 diets.  
 
Study described as double blind No 
 
Description of withdrawals and 
dropouts present 
 63 persons (43 women and 20 men) participated in the study. 
 
49 subjects completed 3 months of the study (28 on the low CHO diet and 21 on the conventional diet; 42 completed 6 months (24 
on the low CHO diet and 18 on the conventional diet); 37 subjects completed 12 months (20 on the low CHO diet and 17 and the 
conventional diet) 
 
The percentage of dropouts at 3, 6, and 12 months was higher for the conventional diet group (30, 40, and 43% respectively) than 
in the low CHO diet (15, 27 and 39%) but these differences were not statistically significant. 
 
Overall 59 % of subjects completed the study; 88% of those who completed the six month assessment completed the study. 
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Randomisation / blinding 
appropriate 
Subjects were randomly assigned at each site with use of a random number generator to follow either the low-carbohydrate high 
protein Atkins diet or a high-carbohydrate, low- fat, conventional diet. 
 
Target Population Obese Adults 
 
Why was study done? What was 
perceived general importance? 
To evaluate the effectiveness of the low-carbohydrate high protein, high fat Atkins diet on weight loss and CVD risk factors 
Is there a clear hypothesis and 
objectives? 
Not clearly stated but adequately implied.  
What specific question is being 
addressed? 
 
Is the low-carbohydrate Atkins diet effective and safe?   
The study setting- where did study 
take place? 
Multicenter study at the Schools of Medicine at the Universities of Pennsylvania,  Colorado, Washington, St Louis & Thomas 
Jefferson University, Philadelphia.  
 
Group actually studied  A total of 63 persons (43 women and 20 men) randomly assigned to follow either a low CHO, high protein, high fat Atkins diet or a 
high CHO, low-fat, energy deficit conventional diet.  
 
The social, cultural, economic, 
ethnic background 
20 men and 43 women, 76% white, 19% black 4% Hispanic, Average age 44. Average BMI 33.5 
 
 
Study Approval Protocol approved by the relevant institutional review boards of the participating institutions. All subjects provided written 
informed consent.  
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
 
Potential subjects excluded if they had clinically significant illnesses including type 2 diabetes, were taking lipid lowering 
medications, were pregnant or lactating or were on medication that may affect body weight.  
Is there a power calculation to 
determine sample size? 
Not evident. 
Was there selection bias? Unable to ascertain. None evident.  
 
Was there funding bias? Grants from NIH – No funding bias evident. 
 
Confounding Factors Daily multivitamin supplement. Did this impact on weight loss? Activity levels not measured or accounted for. 
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How does the study group relate to 
researchers interest groups / 
patients? 
 
Researcher’s interest matches study group   
 
What was the intervention and how 
was it carried out? 
Professional Contact was minimal to approximate the approach used by most dieters. 
All subjects completed a comprehensive medical examination and routine blood tests. 
Subjects in both groups instructed to take a daily multivitamin supplement and met with a registered dietician for 15 to 30 minutes 
at 3, 6, and 12 months to review dietary issues. 
33 low- CHO subjects met with a registered dietician to review the Atkins type diet which involved limiting CHO intake without 
restricting fat and protein. For the first 2 weeks CHO intake is limited to 20g per day and is then gradually increased till a stable 
desired weight is achieved.  
Each subject given a copy of Dr Atkins New Diet Revolution and instructed to read the book and follow the diet as described.  
The 30 subjects assigned to the conventional diet reviewed with a dietician the high-CHO, low-fat, low-calorie (1200 to 1500 kcal 
per day for women and 1500 to 1800 kcal per day for men with 60% of calories from CHO; 25% from fat and 15% from protein. 
They had to receive instruction about calorie counting. 
Subjects were given a copy of the Learn Program for Weight Management which provides 16 lessons on weight control.  
 
What was measured and how was it 
measured? 
Body weight using calibrated scales with subjects wearing light clothing and no shoes was measured at baseline, and at weeks 2, 
4, 8,12,16,20,26,34,42 and 52. 
Blood pressure and urinary ketones were also assessed at baseline and at weeks 2,4,8,12,16,20,26, 34,42 & 52  
Blood samples obtained after subjects fasted overnight at baseline, 3, 6 and 12 months to determine serum lipoproteins 
concentrations 
An oral glucose tolerance test performed at baseline and at 3, 6, and 12 months. After overnight fasting, blood samples were 
obtained or measurement of plasma glucose and insulin concentrations were measured before and 30, 60, 90 and 120minutes 
after oral administration of a 75g glucose load. 
Insulin sensitivity assessed using the quantitative insulin-sensitivity check index 
 
Were baseline measures used? Baseline characteristics shown in table in Paper. The 2 experimental groups were comparable with no significant differences in 
terms of sex distribution, age, weight, BMI, CVD and hormonal markers. 
Were process measures used? 
 
 
 
 
 
 
LDL cholesterol concentration was calculated according to the Friedwald formula. TC, HDL and triglyceride levels were measured 
according to procedures recommended by the Centres for Disease Control and Prevention. 
Plasma insulin was measured by radioimmunoassay and plasma glucose by a glucose oxidase autoanalyser. 
Urinary ketone concentrations were measured with dipsticks.  
 
Data on all subjects at all sites were analysed together. 
A t-test for independent samples was used to assess differences in baseline variables between the groups.  
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Were process measures used? 
contd. 
Two sets of analyses were conducted. The primary analysis was a repeated measures ANOVA in which baseline values were 
carried forward in the case of missing data.  
In a secondary analysis an analysis of covariance, in which initial weights were covariates was used to examine changes in 
weight from baseline to the end of the study for those who completed the study. 
A chi-square analysis was performed to determine differences between groups in categorical variables and correlations with 
categorical variables were assessed   with Spearman’s rho coefficient.  
Triglyceride values were not normally distributed so log –transformed values were analysed.  
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Weight, Attrition, Urinary Ketones, BP, Oral Glucose tolerance test, Serum Lipoproteins. 
Are the methods quantitative or 
qualitative? 
Both quantitative and qualitative 
Safety Results Urinary Ketones 
The % of patients who tested positive for urinary ketones was significantly greater in the low CHO group in relation to the 
conventional diet group but there were no significant differences after 3 months.  
 
No significant relation between weight loss and ketosis at any time during the study 
 
The data suggests that ketosis was unlikely to be responsible for the increased weight loss with the low- CHO diet because the 
researchers did not find any relation between presence of urinary ketones and weight loss. Furthermore urinary ketones were not 
present in most subjects on either diet after first six months. 
 
Endpoint/ Biomarker Tested Body weight, BP, urinary ketones, serum lipoprotein concentrations, glucose tolerance, plasma glucose and insulin 
concentrations before and 30, 60, 90, 120 minutes after oral administration of 75g glucose load  
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b  
The study was focused on weight and specific risk factors for CHD. It did not evaluate effects on other important clinical end 
points such as renal function, bone health and exercise tolerance.  
 
Are the endpoints relevant to actual 
practice 
 
Yes and consistent with other studies 
Dietary Intake and Adherence 
Results 
 
 
Adherence and Attrition 
49 subjects completed 3 months of the study (28 on the low CHO diet and 21 on the conventional diet; 42 completed 6 months (24 
on the low CHO diet and 18 on the conventional diet); 37 subjects completed 12 months (20 on the low CHO diet and 17 and the 
conventional diet) 
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Dietary Intake and Adherence 
Results. contd. 
The percentage of dropouts at 3, 6, and 12 months was higher for the conventional diet group (30, 40, and 43% respectively) than 
in the low CHO diet (15, 27 and 39%) but these differences were not statistically significant. 
Overall 59 % of subjects completed the study; 88% of those who completed the six month assessment completed the study. 
 
Weight loss and cardioprotective 
mechanisms identified 
 
 
 
 
 
 
The difference in weight loss between the two groups in the first six months demonstrates an overall greater energy deficit in the 
low-carbohydrate group, despite unrestricted protein and fat intake in this group and instructions to restrict energy intake in the 
conventional-diet group.  
 
The mechanism responsible for the decreased energy intake induced by a low-carbohydrate diet with unrestricted protein and fat 
intake is not known but may be related to the monotony or simplicity of the diet, alterations in plasma or central satiety factors, or 
other factors that affect appetite and dietary adherence.  
Data suggests that ketosis was unlikely to be responsible for the increased weight loss with the low-carbohydrate diet, since we 
did not find any relation between the presence of urinary ketones and weight loss. Furthermore, urinary ketones were not present 
in most subjects on either diet after the first six months. 
 
Weight Loss / Body Composition 
results 
In the analysis in which missing values were carried forward, the group on the low-CHO diet lost significantly more weight than 
the conventional diet group at 3months (P=0.001) and at 6 months (P=0.02) but the difference was not statistically significant at 12 
months (P=0.26). 
 
Subjects on the low-carbohydrate diet had lost more weight than subjects on the conventional diet at 3 months (mean [SD], -
6.85.0 vs. -2.73.7 percent of body weight; P=0.001) and 6 months (-7.06.5 vs.-3.25.6 percent of body weight, P=0.02), but the 
difference at 12 months was not significant (-4.46.7 vs.-2.56.3 percent of bodyweight, P=0.26).   
 
Cardiac Risk Factor Results Systolic BP did not change significantly in either group. Diastolic BP decreased in both groups but there were no significant 
differences between the groups.  
No significant differences between the groups in the total or LDL cholesterol concentration except at month 3 when values were 
lower in the conventional diet group. 
The relative increase in HDL cholesterol and relative decrease in triglyceride concentrations was greater in the group on the low 
CHO diet than in the conventional diet throughout the study. 
 
 The results of the analyses that included data on subjects who completed the study and data obtained at the time of the 
last follow-up visit for those who did not complete the study (Table 3 in paper ) were nearly identical to the analyses in which 
base-line values were carried forward in the case of missing data (Table 2 in paper ) with respect to blood pressure, insulin 
sensitivity, and serum lipoproteins. 
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Endocrine markers and Hormonal 
Effects 
Oral glucose-tolerance test-   The area under the glucose curve did not change significantly in either group throughout the study. 
The area under the insulin curve decreased in both groups, but there were no significant differences between groups (Tables 2 
and 3). There were no significant differences between groups in insulin sensitivity (assessed by the quantitative insulin-sensitivity 
check index). 
Both groups had significant increases in insulin sensitivity at six months, but the values were not significantly different from base 
line at one year (Tables 2 and 3 in the paper). 
 
Although subjects with diabetes were excluded from our study, many — if not most — of our subjects, because of their obesity, 
were probably insulin- resistant with respect to glucose metabolism. 
 
Treatment with either diet was associated with an improvement in insulin sensitivity as determined by an oral glucose-tolerance 
test; progressively less insulin was secreted to maintain the same blood glucose concentrations.  
 
Exercise and Medication use Patients were excluded if they had any clinically significant illnesses or were taking any lipid lowering or weight related 
medications. 
 
Daily Multivitamin supplement for both groups. 
 
What effect may bias have on the 
result? 
None Evident. 
The Author's conclusions - are 
these justified? 
 
 
 
 
 
 
 
 
 
 
 
 
The results of this multicenter, randomized, controlled trial demonstrate that the low-carbohydrate, high-protein, high-fat Atkins 
diet produces greater weight loss (an absolute difference of approximately 4 percent) than a conventional high-carbohydrate, low-
fat diet for up to six months, but that the differences do not persist at one year. The magnitude of weight loss at six months in the 
low-carbohydrate group approximates that achieved by standard behavioral and pharmacologic treatments. These weight losses 
are particularly noteworthy because the diet was implemented in a self-help format and subjects had little contact with health 
professionals. 
 
The lack of a statistically significant difference between the groups at one year is most likely due to greater weight regain in the 
low-carbohydrate group and the small sample size. These data suggest that long-term adherence to the low-carbohydrate Atkins 
diet may be difficult. 
 
The overall effect of the low-carbohydrate diet in comparison with a conventional diet on the risk of CHD is uncertain.  
At the present time there is not enough information to determine whether benefits of an Atkins type diet outweigh its potential 
adverse effects on the risk of CHD in obese persons. 
 
When the energy content of an energy-deficit diet is stable, macronutrient composition does not influence weight loss. 
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Generalizability- the extent to which 
the results might apply outside the 
study 
A long term view of the Atkins diet for generally well overweight and obese individuals and consequences is relevant to its 
application outside the study.  Should not be generalised to overweight or obese subjects with serious obesity related diseases 
such as diabetes and hypercholesterolemia as these were excluded.  
 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The low CHO diet produced a greater weight loss (approximately 4%) that a conventional diet for up to six months but the 
differences do not persist at one year.  
 
The magnitude of the weight loss on the low- CHO diet approximates that achieved by other behavioural and pharmacologic 
treatments.  Significant as the diet was on a self help format. 
 
The lack of a statistically significant difference at one year is likely due to greater weight gain in the low CHO group and small 
sample size. 
Long term adherence to the low CHO may be difficult. 
 
Difference of weight loss in the first 6 months demonstrates an overall greater energy deficit despite unrestricted protein and fat 
in the low CHO group and instruction to restrict energy intake in the conventional diet group. 
When the energy content of an energy deficit diet is stable, the macronutrient composition does not influence weight loss.  
The mechanism for decreased energy intake by a low CHO diet with unrestricted protein and fat is not known but may be related 
to monotony or simplicity of the diet, alterations in plasma or central satiety factors or other factors that affect appetite and 
dietary adherence. 
 
The data suggests that ketosis was unlikely to be responsible for the increased weight loss with the low CHO diet because the 
researchers did not find any relation between presence of urinary ketones and weight loss. Furthermore urinary ketones were not 
present in most subjects on either diet after first six months. 
 
Although subjects with diabetes were excluded, most of the subjects were probably insulin resistant. Treatment with either diet 
improved insulin sensitivity. The data does not demonstrate an effect of macronutrient composition independent of weight loss 
on insulin sensitivity in obese subjects without diabetes.  
However results of metabolic studies should be interpreted with caution given the study’s small sample size and one year 
duration. Additional studies with more precise measures of insulin sensitivity are needed to evaluate this issue better. 
Health concern of consuming unrestricted saturated fat with potential to increase LDL cholesterol – established risk factor for 
coronary heart disease (CHD).  At 3 months LDL cholesterol increased for low-CHO group but decreased in subjects on 
conventional diet group so difference significant. Over the longer term LDL levels closer to baseline values and not significantly 
different between groups. 
Increased weight loss associated with the low CHO diet may offset the adverse effect of saturated fat intake on serum LDL. 
Weight loss associated with decreases in LDL cholesterol usually observed with moderate weight loss.  
Low CHO associated with greater decreases in serum triglycerides and increases in HDL than the conventional diet which are 
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Discussion points – contd.  also important risk factors for CHD. The magnitude of these changes approximate that obtained with pharmacologic treatments 
such fibric acid derivatives and niacin.  
Changes are greater than that expected from a moderate weight loss therefore it is likely that the macronutrient composition 
contributed to the improvement in the HDL-triglyceride axis.  
Overall effects of a low-CHO diet versus conventional diet on CHD is uncertain. The low CHO diet improved some indicators (HDL 
and triglycerides) but not others (BP, Insulin sensitivity and serum LDL). 
 
Were study limitations discussed? Self- help nature of treatment which is consistent with way in which the low-CHO diet is typically used, contributed to attrition rate 
of 41%.  
High attrition rate underscores the difficulty of long term compliance with either diet when given without supervision.  
More comprehensive behavioural treatment would probably have decreased attrition, increased adherence and improved 
comparison with clinic-based treatments for obesity. 
The study was focused on weight and specific risk factors for CHD. It did not evaluate effects on other important clinical end 
points such as renal function, bone health, cardiovascular function and exercise tolerance.  
Also the findings should not be generalized to overweight subjects or obese subjects with serious obesity related diseases such 
as diabetes and hypercholesterolemia.  
 
Future Implications discussed Additional long-term studies are needed to determine whether increased HDL and decreased triglycerides have the same effect on 
CVD outcomes when one is consuming a diet high in saturated fat.  
Also possible that diet with high saturated fat, low fruits and vegetables and fibre with low CHO diet can independently increase 
CHD risk. 
Additional studies needed to evaluate safety and efficacy of low-CHO, high-protein, high-fat diets 
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Author Frisch et al. (2009) 
Title  A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically 
guided weight loss program 
 
Journal  Cardiovascular Diabetology 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal  
General Aim Clear The authors investigated whether macronutrient composition of energy-restricted diets influences the efficacy of a telemedically 
guided weight loss program. 
 
Specific Study objectives stated To establish whether or not a carbohydrate-restricted telemedically  guided weight loss program results in a more pronounced 
weight loss and influences metabolic risk markers more beneficial than a fat-restricted diet does. 
 
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and cardiovascular disease (CVD) risk management. 
 
One moderate-carbohydrate Zone type diet compared with a low-fat diet 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized, comparative intervention 
Study described as randomised Yes. Participants (n = 200) were randomly assigned by computer- generated random number lists in two equal groups: the LOGI 
group was assigned to a low-carbohydrate diet developed by Ludwig et al. [9] and modified by Worm[19]; the DGE group received a 
conventional low-fat diet according to recommendations issued by the Deutsche Gesellschaft  für Ernährung [20]. 
 
Study described as double blind No  
 
Description of withdrawals and 
dropouts present 
Of a total number of 298 persons who were initially interested in attending the study 76 persons refused to participate after a first 
phone screening. Additional 16 persons did not meet the inclusion criteria. For the same reason six other persons were excluded at 
the baseline investigation at our clinic. In total, 200 persons were thus included in our study. 
 
Of the 200 participants, 35 subjects were lost during follow-up- due to non-compliance with the weight reduction program (n = 23), 
personal reasons (n = 7), diagnosis of Guillain-Barré syndrome (n = 1), diagnosis of a malignancy requiring chemo preventive 
therapy (n = 1), and pregnancy (n = 3). The number of drop-outs did not differ between study groups (P > 0.05). 
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Randomisation / blinding 
appropriate 
Randomisation between the two diets was appropriate. Blinding was not relevant as the participants were aware of the diets they 
were assigned. 
 
Target Population Overweight subjects attending a telemedically guided weight loss programme 
 
Why was study done? What was 
perceived general importance? 
To assess if a carbohydrate–restricted diet results in more pronounced weight loss  
Is there a clear hypothesis and 
objectives? 
To assess whether macronutrient composition of energy- restricted diets influences the efficacy of a telemedically guided weight 
loss programme.  
 
What specific question is being 
addressed? 
Is a carbohydrate-restricted weight loss programme more effective than a low-fat diet with respect to weight loss and 
cardiovascular risk factors? 
 
The study setting- where did study 
take place? 
This study was conducted between December 2005 and November 2006 at the Heart Centre North Rhine-Westphalia, Institute for 
Applied Telemedicine, Bad Oeynhausen, Germany. Recruitment began in November 2005 by advertisements in local newspapers 
and by providing information sheets at different local health insurance offices.  
 
Group actually studied  200 overweight subjects 
 
The social, cultural, economic, 
ethnic background 
German residents, 18-70 year old and a BMI > 27kg/m2 with no history of CVD, ischemia, diabetes. Pregnancy, lactation and 
vegetarianism were exclusion criteria.  
 
Study Approval All participants gave written informed consent to the study procedures, which were approved by the Ethics Committee of the Ruhr-
University Bochum, Faculty of Medicine, Germany. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
The criteria for eligibility were an age of 18 to 70 years and a BMI (calculated as weight in kilograms divided by height in meters 
squared) > 27 kg/m2. We excluded patients with a history of any cardiovascular symptomatology. Moreover, we excluded patients 
with cholelithiasis, urolithiasis, insulin dependent diabetes mellitus, and pacemaker implantation. In addition, pregnancy, lactation, 
and vegetarianism were exclusion criteria. Further exclusion criteria were the participation in another weight loss program and 
medical treatment for weight reduction. 
 
Is there a power calculation to 
determine sample size? 
None evident 
Was there selection bias? None evident  
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Was there funding bias? This study was funded by different German health insurances and the 'Institute for Applied Telemedicine', Heart Centre NRW, Ruhr 
University Bochum, Bad Oeynhausen, Germany. 
 
Discussion point re telemedicine influencing low attrition rates may involve a funding bias. 
 
Confounding Factors None identified 
 
How does the study group relate to 
researchers interest groups / 
patients? 
Overweight subjects are within researcher’s interest group. The exclusion of vegetarians does not support the researcher’s 
interests. 
What was the intervention and how 
was it carried out? 
The target macronutrient composition in the LOGI group was less than 40% of total energy intake (% energy) from carbohydrates, 
more than 35% energy from fat, and 25% energy from protein [21]. 
 
The target macronutrient composition in the DGE group was more than 55% energy from carbohydrates, less than 30% energy from 
fat, and 15% energy from protein. 
 
We instructed all participants in an ambulatory training session and delivered diet books to all participants about their respective 
diets [19, 22, and 23]. All participants were advised to reduce their daily energy intake by at least 500 kcal. 
 
At study entry, each participant received an electronic scale (TC-100, I.E.M., Stolberg, Germany, mean deviation ± 0.2 kg with 
standard deviation of 0.06 kg) with added Bluetooth® technology. Weekly, the actual body weight data had to be sent to the 
Institute of Applied Telemedicine using a mobile phone. 
 
The weight reduction program consisted of weekly nutrition education and dietary counselling by phone with a nutritionist during 
the first six months. This regular weekly support was stopped during the second half-year. The study subjects were responsible for 
buying and preparing foods by themselves. 
 
At baseline, after six months, and after twelve months, each subject attended an outpatient medical visit where body weight and 
height were measured in underwear on a calibrated electronic clinical scale (model 920, SECA GmbH & co. kg., Hamburg, Germany; 
tolerance ± 0.2 kg). Moreover, waist circumference was assessed by standard procedures using a 150-cm anthropometric 
measuring tape, and body composition by bioelectrical impedance analysis (Multifrequency Analyzer Nutrigard M, Data Input 
GmbH, Darmstadt, Germany). 
 
What was measured and how was it 
measured? 
 
We defined the presence of a metabolic syndrome after determination of waist circumference, blood levels of triglycerides, high 
density lipoprotein (HDL)-cholesterol, and fasting plasma glucose, blood pressure, and respective medical treatment according to 
current guidelines [24]. 
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What was measured and how was it 
measured? contd. 
Blood pressure was manually determined using a cuff and stethoscope.  
 
Blood samples were drawn from the antecubital vein after a 12-h overnight fast. 
 
Medical history and medical treatment were assessed using hospital documents. 
 
At baseline and after 1, 3, 6, and 12 months, we assessed energy and nutrient intake (diet compliance) by the use of a 3-day 
validated food record [25] and the amount of daily physical activity by using a standardized, validated questionnaire [26]. 
 
We measured serum levels of total cholesterol, high-density lipoprotein (HDL)-cholesterol, low density lipoprotein 
(LDL)-cholesterol, triglycerides, glucose, and fructosamine using the Architect autoanalyzer (Abbott, Wiesbaden, Germany), and 
glycated haemoglobin (HbA1c) using the autoanalyzer HA-8160 (Menarini Diagnostics, Berlin, Germany). We used enzyme-linked 
immuno assay kits to assess proinsulin (IBL, Hamburg, Germany) and adiponectin (R&D Systems GmbH, Wiesbaden- 
Nordenstadt, Germany). All intra- and interassay coefficients of variation were below 10.0%. 
Were baseline measures used? Characteristics at study entry were comparable between groups, with the exception of sex distribution and fat-free mass (Table 1).  
(Figure 1). Medication use was similar between groups at baseline (Table 1) and did not change during the study period (data not 
shown). 
 
Energy and macronutrient intake and energy expenditure are shown in Table 2. At baseline, energy intake, energy expenditure and 
macronutrient composition were similar in both groups. 
 
Were process measures used? We expressed categorical variables as percentage rates and continuous variables as mean ± standard deviation or standard error 
of the mean, when appropriate. Because several variables such as fat-free mass, diastolic and systolic blood pressure, glucose, 
HbA1c, proinsulin, triglycerides, HDL-cholesterol, and adiponectin were not normally distributed as tested by the Kolmogorov-
Smirnov test, these data were normalized using logarithmic transformation. We used the unpaired t-test to compare continuous 
values of the study groups at baseline. For comparative evaluations of categorical variables, we used the Chi Square test. Results 
of anthropometric, clinical, and biochemical parameters at the 6-month and 12-month examinations are presented as change from 
baseline. The unpaired t-test and the paired t-test were used to specify those time points with significant differences between 
groups or within groups, when appropriate. 
 A 2-factor analysis of covariance was used to compare anthropometric, clinical, and biochemical parameters between the LOGI 
and DGE groups with its respective baseline value and with fat-free mass and sex distribution as covariates. 
Data were evaluated following the intention-to-treat and the per-protocol method. Missing data were replaced with baseline data in 
the intention-to-treat analysis. P values <0.05 were considered statistically significant. P values between 0.05 and 0.10 were 
considered borderline significant. Considering a standard deviation of 3.5 kg, the statistical power (α = 0.05; β = 0.80) was sufficient 
to detect a difference in body weight of 1.3 kg between the two study groups. We used SPSS, version 14.0 (SPSS Inc., Chicago, IL), 
to perform the statistical analyses. 
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Are the methods quantitative or 
qualitative? 
Quantitative and qualitative. 
Safety Results None reported. 
 
Endpoint/ Biomarker Tested Weight loss and loss of fat mass were primary endpoints. Metabolic and cardiovascular risk markers such as waist circumference, 
blood pressure, blood lipids, and parameters of glucose metabolism were considered secondary endpoints. 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b 
Are the endpoints relevant to actual 
practice 
 
Yes relevant to actual practice. 
Dietary Intake and Adherence 
Results 
 
 
 
 
During the first six months energy intake decreased by approximately 400 kcal/d compared to baseline in both groups. At month 
12, mean energy intake had slightly increased again in both groups but remained below baseline values. Metabolic rate increased 
in both groups. Mean macronutrient composition differed significantly between both groups from month 1 to month 12. 
During the study period, carbohydrate intake was between 11% and 7% higher in the DGE group compared with the LOGI group. In 
addition, the LOGI group had a 4% to 8% higher fat intake and a 2% to 3% higher protein intake than the DGE group, whereas 
alcohol intake did not differ between groups (data not shown). Especially the DGE group did not achieve the target for carbohydrate 
intake (> 55%). 
 
The use of telemedicine permits continuous contact to participants, individual support, and control of weight loss. Moreover, use of 
this technique resulted in a low drop-out rate of only 17% in our study participants. 
 
Weight loss and cardio-protective 
and other mechanisms identified  
 
 
 
 
 
 
 
 
 
 
It has been assumed that the better 1-year efficacy of carbohydrate- restricted diets on weight loss compared to fat-restricted diets 
can be explained by a greater energy deficit in subjects on a low-carbohydrate intake. 
Since mean energy intake and energy expenditure did not differ between the two groups, the differences in the aforementioned 
parameters are most likely due to differences in macronutrient relations. 
However, despite similar energy intake at month 12, weight loss tended to be greater at month 12 in the LOGI group compared with 
the DGE group of our study. 
 
Note that differences in macronutrient composition of the diet may influence resting or postprandial energy expenditure. 
 
Since protein intake increases diet-induced thermogenesis, it can well be that the slightly higher protein intake in the LOGI group 
compared with the DGE group during the entire study period could also have resulted in a slightly higher metabolic rate, and thus 
in a slightly higher weight loss. 
 
 
 
 
 
APPENDIX A4: Data Collection Sheets – Frisch et al. (2009)          
(Text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and Numerical 
references included in brackets refer to the original article).   
 
119 
 
Weight loss and cardio-protective 
and other mechanisms identified – 
contd.  
Our results are in line with a very recently published trial by Sacks et al. [30]. They investigated four diets with different 
macronutrient relations and showed that weight loss is related to adherence and attendance to instructional sessions. 
 
Despite the favourable effects of both diets on weight loss in our study, the carbohydrate-reduced diet was more beneficial with 
respect to some cardiovascular risk markers such as waist circumference, triglycerides, HDL-cholesterol, and systolic blood 
pressure compared to the fat reduced diet. Our data show into the same direction than earlier study results [12-14, 29, 31, 32] but 
were less pronounced. This may at least in part be due to two factors: the comparably higher weight loss by carbohydrate-
restricted diets in these earlier studies [12, 13, 29, 30], and/ or a more pronounced carbohydrate restriction in the low-carbohydrate 
diets used [12-14, 29, 31]. 
 
Low-carbohydrate diets may diminish triglyceride production in the liver in response to decreased carbohydrate delivery [14]. 
 
The greater preservation of HDL-cholesterol on a low-carbohydrate diet may be the result of down-regulation by dietary fats of 
those hepatic receptors, which bind HDL-cholesterol [33]. However, it remains unclear why HDL-cholesterol and triglycerides 
differed only at the 6-month visit between the two groups of our study. It may well be that the transient effects on triglycerides and 
HDL cholesterol are related to differences in macronutrient composition in our study groups which became smaller over time 
(Table 3). 
 
Obviously, other variables like waist circumference and systolic blood pressure were only influenced by the degree of weight loss 
in the two groups and not by macronutrient composition (Table 3). 
It should also be mentioned that the similar loss in body weight in both groups of our study was associated with a similar 
improvement in several metabolic risk markers such as fat mass, diastolic blood pressure, and glucose, fructosamine, proinsulin, 
and adiponectin blood concentrations (Table 3). 
 
Decreasing insulin resistance and increasing adiponectin levels reduces atherosclerotic and inflammatory processes and 
endothelial dysfunction [35- 37] and may thus have decreased the cardiovascular risk in both study groups. 
 
Weight Loss / Body Composition 
results 
 
 
 
 
 
 
 
 
Both diets resulted in similar weight loss (Figures 2 and 3). In detail, weight loss was 7.2 ± 5.4 kg in the LOGI group and 6.2 ± 4.8 kg 
in the DGE group at month 6.  
 
In the second half-year, mean weight regain was 1.6 kg in the LOGI group and 1.9 kg in DGE group. Thus, at the end of the study 
weight loss was 5.8 ± 6.1 kg in the LOGI group and 4.3 ± 5.1 kg in the DGE group at month 12, a difference that reached borderline 
significance (p = 0.065).  
 
In both groups, approximately 76% of weight reduction was due to a loss of fat mass. 
 
Waist circumference decreased in both study groups (Table 3). At month 6, values did not differ between groups. At month 12, 
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Weight Loss / Body Composition 
results contd. 
however, the decrease in waist circumference was more pronounced in the LOGI group compared with the DGE group even when 
adjustments were made for fat-free mass, and sex distribution. 
 
Ketonuria Results Not applicable 
 
Cardiac Risk Factor Results Triglyceride levels did not change from baseline to month 6 and month 12 in the DGE group, but declined in the LOGI by 14% at 
month 6, and 7% at month 12 compared to baseline values. 
 
HDL-cholesterol decreased in the DGE group until month 6, but rose again in the second half year, whereas this parameter 
remained unchanged in the LOGI group. 
 
Changes from baseline in triglyceride and HDL-cholesterol levels differed significantly between the LOGI and DGE groups at month 
6. However, these differences disappeared later on in the study. 
 
Total-cholesterol was not affected in the LOGI-group but increased in the DGE group between month 6 and 12. Nevertheless, total 
cholesterol did not differ significantly between groups at any time point. 
 
Diastolic blood pressure decreased in both groups, whereas systolic blood pressure was significantly higher at month 12 in the 
DGE group compared with the LOGI group. 
 
The differences in systolic blood pressure at month 12 remained significant after adjustments were made for fat free mass and sex 
distribution. 
 
Endocrine markers and Hormonal 
Effects 
Changes in parameters of glucose metabolism were similar between groups For the low-carb group Glucose reduced by -0.26± 0.76  
mmol/l at 6 months and by 0.25 ± 0.75 at 12months and for the high-carb group by 0.28± 0.14 at 6 m and 0.14 ± 0.46 at 12months. 
HbA1c reduced by 0.2 % ± 0.2 for both groups at 6m and 12m. 
 
Exercise and Medication use Energy expenditure between the two groups was similar at baseline and reasonably similar at 1 m, 3 m, 6m and 12months. 
Medication use at baseline provided. 
 
What effect may bias have on the 
result? 
None evident 
The Author's conclusions - are 
these justified? 
 
 
Despite the favourable effects of both diets on weight loss, the carbohydrate-reduced diet was more beneficial with respect to 
major cardiovascular risk factors such as central obesity, triglycerides, HDL-cholesterol, and systolic blood pressure compared to 
the fat-reduced diet. Nevertheless, compliance with a weight loss program appears to be even a more important factor for success 
in prevention and treatment of obesity than the composition of the diet. 
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The Author's conclusions - are 
these justified? Contd. 
Despite some additional beneficial effects of energy-restricted low-carbohydrate diets on cardiovascular risk markers it appears 
that poor long-term adherence to such diets limits its success in clinical practice [34]. Note reference 34 is Dansinger et al. (2005) 
included in this review and it is significant that supervision ceased after 2 months which could explain the lower levels of 
adherence.  
 
Generalizability- the extent to 
which the results might apply 
outside the study 
The results of a telemedically monitored protocol providing continuous contact with participants , individual support and control of 
weight loss provides  an interesting technique to promote adherence and enable a lower drop-out rate.  
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this telemedically guided weight reduction program both, an energy-restricted high-carbohydrate diet (DGE group) and an 
energy-restricted low-carbohydrate diet (LOGI group) resulted in a satisfactory weight loss and an improvement of several 
metabolic parameters over a period of 12 months. 
 
However, weight loss tended to be greater, and the decline in waist circumference and systolic blood pressure was more 
pronounced in the LOGI group than in the DGE group. 
 
With respect to HDL-cholesterol and triglycerides, beneficial effects in the LOGI group compared to the DGE group were only seen 
at the 6-month follow-up visit. 
 
 
Since mean energy intake and energy expenditure did not differ between the two groups, the differences in the aforementioned 
parameters are most likely due to differences in macronutrient relations. 
 
The mean body weight loss of 7.2 kg at month 6 and 5.8 kg at month 12 in the LOGI group (Figure 3) was similar compared to 
literature reports about efficacy of carbohydrate- restricted diets [12-15,29]. In these earlier reports, results of carbohydrate-
restricted diets were also compared with fat-restricted diets. 
 
 Mean weight loss of the fat restricted diets was only 1.6 kg – 3.9 kg at month 6 [12- 15,29] and 2.2 kg – 3.1 kg at month 12 [12,14,29] 
and thus lower than the mean weight loss in the energy restricted fat-reduced group (DGE group) in our study (6.2 kg at month 6 
and 4.3 kg at month 12, respectively). 
 
It has been assumed that the better 1-year efficacy of carbohydrate- restricted diets on weight loss compared to fat-restricted diets 
can be explained by a greater energy deficit in subjects on a low-carbohydrate intake. 
 
Since in our study energy intake and body weight loss were similar in both groups within the first 6 month, our results are in line 
with the aforementioned hypothesis. 
 
However, despite similar energy intake at month 12, weight loss tended to be greater at month 12 in the LOGI group compared with 
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Discussion points – contd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the DGE group of our study. 
 
Note that differences in macronutrient composition of the diet may influence resting or postprandial energy expenditure [15]. 
 
Since protein intake increases diet-induced thermogenesis, it can well be that the slightly higher protein intake in the LOGI group 
compared with the DGE group during the entire study period could also have resulted in a slightly higher metabolic rate, and thus 
in a slightly higher weight loss. 
 
Nevertheless, our data also demonstrate that even with an energy-restricted high-carbohydrate diet a weight loss similar to an 
energy-restricted carbohydrate-reduced diet can be achieved. 
 
Importantly, the regain of weight after 12 months confirms earlier assumptions [17, 18] that continuous intensive care and control 
is a more important factor for participants' compliance and, thus, for the success of a weight loss program than minor alterations in 
macronutrient composition in the diet. 
 
Our results are in line with a very recently published trial by Sacks et al. (2009) [30]. They investigated four diets with different in 
Sacks et al. macronutrient relations and showed that weight loss is related to adherence and attendance to instructional sessions. 
All the diets in Sacks et al. (2009) were equally successful in promoting weight loss and maintaining weight. 
 
Despite the favourable effects of both diets on weight loss in our study, the carbohydrate-reduced diet was more beneficial with 
respect to some cardiovascular risk markers such as waist circumference, triglycerides, HDL-cholesterol, and systolic blood 
pressure compared to the fat reduced diet. Our data show into the same direction than earlier study results [12-14, 29, 31, 32] but 
were less pronounced. This may at least in part be due to two factors: the comparably higher weight loss by carbohydrate-
restricted diets in these earlier studies [12, 13, 29, 30], and/ or a more pronounced carbohydrate restriction in the low-carbohydrate 
diets used [12-14, 29, 31]. 
 
Low-carbohydrate diets may diminish triglyceride production in the liver in response to decreased carbohydrate delivery [14]. 
 
The greater preservation of HDL-cholesterol on a low-carbohydrate diet may be the result of down-regulation by dietary fats of 
those hepatic receptors, which bind HDL-cholesterol [33]. However, it remains unclear why HDL-cholesterol and triglycerides 
differed only at the 6-month visit between the two groups of our study. It may well be that the transient effects on triglycerides and 
HDLcholesterol are related to differences in macronutrient composition in our study groups which became smaller over time (Table 
3). 
 
Obviously, other variables like waist circumference and systolic blood pressure were only influenced by the degree of weight loss 
in the two groups and not by macronutrient composition (Table 3). 
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Discussion points contd.  Our results also demonstrate the general problem of adherence to a diet with extreme nutrition relations. 
 
The use of telemedicine permits continuous contact to participants, individual support, and control of weight loss. 
Moreover, use of this technique resulted in a low drop-out rate of only 17% in our study participants. 
 
Note that earlier investigations have already reported relatively high attrition-rates of 30–50% in studies using very low-
carbohydrate diets [12, 34]. 
 
It should also be mentioned that the similar loss in body weight in both groups of our study was associated with a 
similar improvement in several metabolic risk markers such as fat mass, diastolic blood pressure, and glucose, fructosamine, 
proinsulin, and adiponectin blood concentrations (Table 3). 
 
Decreasing insulin resistance and increasing adiponectin levels reduces atherosclerotic and inflammatory processes and 
endothelial dysfunction [35- 37] and may thus have decreased the cardiovascular risk in both study groups. 
 
Were study limitations discussed? It was not possible to achieve the target macronutrient relations in the two study groups in the long run. The target of carbohydrate 
content in the LOGI group (< 40% energy) was only reached within the first 3 months and the target of carbohydrate content in the 
DGE group (>55% energy) was not reached at any time. 
 
Future Implications discussed The use of telemedicine and /or continuous contact via the internet to monitor patients is relevant for future investigation 
Refer to the Dukan online support process.  
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Author Johnston et al. (2006)  
 
Title  Ketogenic low-carbohydrate diets have no metabolic advantage over nonketgenic low-carbohydrate diets 
 
Journal  American Journal of Clinical Nutrition.  
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. Two of the authors were connected with the Zone Diet which was similar to the non ketogenic low 
carbohydrate diets in the study. Barry Sears is the author of the Zone diet and on the Board of Zone Labs Inc. and Heather 
Hutchins is an employee of Zone Labs Inc. 
 
General Aim Clear To assess the significance of a ketogenic low-carbohydrate weight loss diet with a less restrictive non ketogenic weight loss diet. 
 
Specific Study objectives stated To compare weight loss and biomarker change in adults on a ketogenic low-carbohydrate (KLC) or a non ketogenic low 
carbohydrate (NLC) diet.  
  
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet and particularly CHO restriction is 
significant to weight management and CVD risk management. Particularly relevant in assessing effects of the level of CHO 
consumed. 
Two low-carbohydrate diet arms compared. An Atkins type diet and a Zone type diet. 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized Controlled Trial. 6 week study. 
Study described as randomised Yes. Subjects were stratified by age, sex and BMI and randomly assigned to one of two diets. 
 
Study described as double blind No 
 
Description of withdrawals and 
dropouts present 
One participant in the KLC developed heart arrhythmia during the first week and was dropped from study.  
Randomisation / blinding 
appropriate 
Blinding not appropriate. Subjects were stratified by age, sex and BMI and randomly assigned to one of two diets. 
Target Population Generally well, overweight sedentary Adults between 20-60 years, screened for diagnosed disease and prescription medication. 
 
Why was study done? What was 
perceived general importance? 
In the context of low-carbohydrate diets for weight loss the significance of how much carbohydrate restriction is necessary to 
attain effective results is the key question. 
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Is there a clear hypothesis and 
objectives? 
To compare a ketogenic vs. a non-ketogenic diet in the context of an energy restricted diet. 
What specific question is being 
addressed? 
Does a low-carbohydrate diet have to be ketogenic to be effective for weight loss? 
The study setting- where did study 
take place? 
Department of Nutrition , University of Arizona 
The study population - Intended 
group to whom results should apply  
vs. group actually studied 
20 sedentary, overweight men and women, aged 20-60y; body mass index >25. 
The social, cultural, economic, 
ethnic background 
Not much known about the social cultural or ethnic background of the subjects. 
Study Approval Study protocol approved by the Institutional Review Board of Arizona State University. All participants gave written informed 
consent. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Sedentary, overweight men and women [aged 20–60 y; body mass index (BMI; in kg/m2) _ 25] were screened for diagnosed disease 
and use of prescription medications. 
 
One participant (KLC diet group) developed heart arrhythmias during the first week and was dropped from the study. 
 
Is there a power calculation to 
determine sample size? 
Although the study was limited by the small sample size, power calculations did indicate a 70% power to detect a change of 
0.6mmol/L in LDL cholesterol. 
Pearson’s correlation was used to identify relations between variables.  
 
Was there selection bias? Not evident 
 
Was there funding bias? Barry Sears, a key author is a stockholder and serves on the boards of directors of Zone Labs Inc and other Zone companies 
supporting non-ketogenic diets. 
 
Confounding Factors None noted 
 
How does the study group relate to 
researchers interest groups / 
patients? 
Overweight subjects who may not be obese are within the clinical interest area of the researcher. 
What was the intervention and how 
was it carried out? 
 
Study compared weight loss and metabolic effects of a ketogenic LC diet (beginning with <20g carbohydrates) and a non 
ketogenic diet (40% energy as carbohydrate). 
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What was the intervention and how 
was it carried out? Contd. 
All food and drink were provided to subjects and energy intake was strictly controlled to participants who remained sedentary. 
All food and drink was prepared and served to participants. Hot lunches prepared and served to participants- Monday through 
Friday. Breakfast, dinner and weekend meals prepared and packaged for participants to take home.  
 
After the 6 week trial participants were instructed to continue with their allocated diet on their own for 4 weeks. 
 
A registered dietician discussed diet details and meal plans with each participant for these 4 weeks. 
 
The protein content of the 2 diets was comparable (30% of energy) but the KLC diet was high in fat (60% of energy with saturated 
fat 21% of energy) and very low in carbohydrates (beginning with approx 5% of energy) whereas the NLC diet was low in fat (30% 
of energy with saturated fat of 9%) and carbohydrates (approx 40% of energy). The carbohydrate content of the KLC was increased 
by 5g/wk in weeks 3-6 and this group was asked to consume 40g of CHO during the self-monitored phase of the trial.  
 
The NLC had ≥67% of recommended dietary intakes (RDA) for the micronutrients; the KLC was less nutritious : fibre, Vitamin E , 
folate, iron, magnesium and potassium were <67% of RDA.re provided a daily multivitamin and mineral tablet beginning at the end 
of week 2v of the 6 week trial.  
 
Diets were developed by a registered dietician using FOOD PROCESSOR for WINDOWS nutrition analysis software.  
 
A 14-day rotating menu was devised for each diet plan.  Foods were prepared using scales and liquid measures. 
 
Participants within diet groups had similar meal plans but daily energy intakes were individually adjusted by altering portion size 
to provide approximately 70% of that needed for weight maintenance.  
 
What was measured and how was it 
measured? 
On day 1 of each week of 6 week trial, body weight and fat mass were recorded using a Tanita Body Composition analyser. 
 
A 7 point Likert scale was used to assess hunger and how they felt generally over the past week. 
 
A Profile of Mood States (POMS) questionnaire that assessed 6 mood states was completed. 
 
Body weight and fat mass were also recorded at week 10. 
 
Before start of trial and at weeks 2 and 6 participants provided a 24-hr urine sample; Resting Energy Expenditure (REE) was 
measured after a 12 hour fast a 24 hour avoidance of light to heavy activity.  
 
A fasting blood sample was collected at weeks 0, 2 and 6. 
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Were baseline measures used? Baseline indices did not vary by group. 
 
Were process measures used? 
 
 
 
REE was estimated from a mean of 20 minutes of continuous gas sampling via indirect calorimetry by using a prescribed formula 
and adjusting for body mass.  
 
Serum concentrations of glucose, creatinine; total, HDL and LDL cholesterol and triacylglycerols were measured at Sonora Quest 
Laboratories.  
 
Plasma Insulin was measured using radioimmunoassay and insulin sensitivity was assessed using the homeostasis model 
assessment (HOMA) index for insulin resistance (mmol fasting glucose/L) X µU fasting insulin /mL/22.5. 
 
Urinary creatinine was measured using colorimetric procedures. 
 
Plasma uric acid, C-reactive protein, liver enzymes and urinary calcium were also measured. 
 
Blood β-hydroxybutyrate was measured  enzymatically by using an autoanalyser 
. 
Fatty acid composition of isolated serum phospholipids reported as the ratio of arachidonic acid to eicosapentoenoic acid was 
analysed by gas chromatography. 
 
Statistical Analyses were performed using SPSS for windows software. The repeated measures analysis of variance with main 
effects of time and group time interaction was used to assess differences in metabolic data. 
 
To assess change in body mass at week 6 by group or to ascertain whether a significant group X time interaction was observed for 
metabolic parameters, an unpaired Student’s t test was performed.  
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Body Weight , Fat mass, fat free mass, hunger ratings, feelings of vigour-activity, 6 distinct mood states (tension-anxiety, 
depression-dejection, anger-hostility, vigour-activity, fatigue-inertia and confusion-bewilderment), cholesterol, triacylglycerol, LDL 
cholesterol, HDL cholesterol, β-hydroxybutyrate concentrations ; serum AA:EPA, insulin, C-reactive protein, 24-hr urinary calcium 
concentrations  
 
Are the methods quantitative or 
qualitative? 
Quantitative and qualitative methods 
Safety Results 
 
 
Creatinine Clearance Values 
These did not exceed baseline values at week 6 but at 2 weeks for the KLC they were 20% above baseline. A higher creatinine 
clearance rate may be a normal physiologic response but in persons with a compromised renal function complications may occur. 
 
 
 
 
 
APPENDIX A5: Data Collection Sheets – Johnston et al. (2006)         
(Text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and Numerical 
references included in brackets refer to the original article). 
   
128 
 
Safety Results contd. Hence persons at risk of kidney disease should carefully consider KLC diets.  
 
AA: EPA was 90% higher after week 6 on the KLC. As inflammation is associated with faster rates of kidney function loss and 
elevated ratios of fatty acids is associated with increased inflammation and tumouregenesis in rat models.  
 
Plasma uric acid and urinary calcium typically higher with high-protein diets were not significantly higher at trial week 6 than at 
baseline.  
Endpoint/ Biomarker Tested Body Weight , Fat mass, fat free mass, hunger ratings, feelings of vigour-activity, 6 distinct mood states (tension-anxiety, 
depression-dejection, anger-hostility, vigour-activity, fatigue-inertia and confusion-bewilderment), cholesterol, triacylglycerol, LDL 
cholesterol, HDL cholesterol, β-hydroxybutyrate concentrations ; serum AA:EPA, insulin, C-reactive protein, 24-hr urinary calcium 
concentrations 
Are there end points other than 
those reported that might be 
relevant and important 
Apo Lipoprotein a and b.  
Are the endpoints relevant to actual 
practice 
Yes 
Dietary Intake and Adherence 
Results 
Dietary intake as prescribed. No specific report on adherence. 
Weight loss and cardio-protective 
mechanisms identified,  
Reduced Hunger likely to result from protein intake level. 
Weight Loss / Body Composition 
results 
At the end of the 6 week trial the total weight loss did not differ significantly between the diet groups (6.3±0.6 and 7.2±0.8 for KLC 
and NLC dieters respectively; P=0.324). 
 
The mean change in total weight during the self-monitored adherence phase (weeks 7-10) was also not significantly affected by 
diet (-1.4 kg and 0.1 for NLC and KLC respectively; P=0.114) 
 
The reduction in fat mass over the 6 week trial was also was not significantly affected by diet (5.5 and 3.4kg for NLC and KLC 
respectively; P=0.114).  
 
Fat- free mass did not change significantly during the 6 week trial but BMI was significantly lower after 6 weeks in both diet groups.  
 
Hunger ratings improved over the 6 week trial in both diet groups from “no particular feeling” to “satisfied”- P=0.078) and did not 
differ significantly between the two groups. 
 
Feelings of vigour activity as measured by the POMS questionnaire was greater for the NLC compared with the KLC during the 
trial; P=0.025. 
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Cardiac Risk Factor Results 
 
Compared with baseline, the 6 week LDL concentrations increased for 5 KLC dieters and decreased in the remaining 4 KLC dieters. 
In comparison LDL cholesterol was raised in 2 NLC dieters and decreased in the remaining 8 NLC dieters. 
HDL cholesterol concentrations fell 9% during the 6 week trial in both diet groups. 
 
Hepatic function as indicated by serum ϒ- glutamyltransferase concentration was favourably affected by the dietary treatments 
which were also directly related to impaired glucose tolerance. 
 
 
Hormonal and Endocrine results Insulin sensitivity was significantly improved by both LC diets 
 
Exercise and Medication use Not Reported 
 
What effect may bias have on the 
result? 
Lead Authors connection with Zone Diets may have created bias in favour of the non ketogenic diet 
The Author's conclusions - are 
these justified? 
Differentiating between ketogenic and non ketogenic LC diets is important for clinical practice because ketogenic diets have been 
associated with adverse metabolic events included elevated LDL and cardiac complications 
 
In this study the KLC did not offer any metabolic advantage over the NLC. 
 
Both diets were effective at reducing total body mass and insulin resistance.  
 
The KLC diet was associated with elevated blood ketones directly related to LDL cholesterol concentrations and inflammatory risk.  
 
Hence severe restrictions in dietary carbohydrate are not warranted. 
 
The NLC was associated with feelings of high energy and a favourable mood profile.  
Authors recommend that low-fat meats and vegetables, 8-9 daily servings of fruit and vegetables are included and a dietary 
carbohydrate limit near 100-125 g/d. 
 
Patients should be advised that there is no metabolic advantage associated with ketosis during dieting. 
 
Generalizability- the extent to which 
the results might apply outside the 
study 
 
 
Results are relevant for individualisation of diet plans 
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Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
Under isocaloric conditions total weight loss and fat loss did not differ significantly by diet treatment. 
 
According to weight loss averages during the self -monitored follow-up period dietary compliance may be more easily achieved 
with NLC than KLC. 
 
Reductions in total and LDL cholesterol did not differ significantly by group but 9% of variation in LDL cholesterol was directly 
related to blood ketone concentrations and several KLC dieters had marked increases in LDL cholesterol. 
Hence blood lipid concentrations should be monitored in persons who are following ketogenic diets. 
 
As in other weight loss trials, insulin resistance (HOMA index units) decreased in both diet groups (30%; P<0.05) and body mass 
explained nearly 20% of the variance. 
 
The greater success of LC diets than the conventional low-fat HC diet with respect to weight loss has been attributed to the 
maintenance of previous REE during active weight loss and to reduced hunger but it is unclear whether these factors are related 
dietary carbohydrate restriction or to increased dietary protein. Weight adjusted REE increased in both diet groups increased over 
the 6 week trial but  blood β-hydroxybutyrate concentrations were not correlated with REE (r= -0.014, P=0.921) which indicates that 
the protein content of the diet rather than the severity of the carbohydrate restriction contributed to the increased REE.  
 
These data support the contention that calorie-reduced diets high in protein facilitate weight loss by partly preserving the 
metabolic rate. Fat-free mass – the major determinant of REE was not correlated with REE in this trial and cannot explain the 
observed increases in metabolism. 
  
Exercise and activity levels remained constant during the trial. It is possible that the high-protein diet increased body protein 
turnover and peptide bond synthesis and hydrolysis – processes that require ATP and utilise energy. 
 
Weekly ratings of perceived hunger did not differ by diet which suggests that is the protein content of the diet and not the amount 
of dietary restriction of carbohydrates that affects perceived hunger.  
 
The data suggests that in the context of high-protein diets small differences in dietary carbohydrate (as little as 50-60g /day) may 
affect emotion, mood state and potentially the desire to be physically active.     
 
Were study limitations discussed? Study was limited by the small sample size. Nonetheless the data offer important insights about metabolic consequences of low-
carbohydrate dieting.  
Future Implications discussed The relevance of ketogenic diets in favour of a non ketogenic diet is questioned. A more balanced approach to low-carbohydrate 
diets is recommended with the inclusion of low-fat meats and dairy products, 8-9 daily servings of fruit and vegetables and dietary 
carbohydrate near 100-125 g/d 
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Author Layman, Evans, Baum, Seyler, Erickson & Boileau (2004) 
 
Title  Dietary Protein and Exercise have additive effects on Body Composition during Weight Loss in Adult Women 
 
Journal  Journal of Nutrition of the American Society for Nutritional Sciences 
 
Quality of Journal and competence 
of Researchers 
Peer reviewed journal.  Donald Layman- Professor Emeritus of Nutrition. Department of Food Science and Human Nutrition. 
Richard A. Boileau . Professor Emeritus of Kinesiology Department of Kinesiology and Community Health Applied Health Sciences. 
 
General Aim Clear To evaluate interactions of diet composition and exercise on body composition changes and blood lipids during weight loss  
 
Specific Study objectives stated To compare 2 isocaloric diets – a high-protein / low-carbohydrate (HP/LC) with a low-protein/high carbohydrate (LP/HC) diet with 
and with no exercise on body composition. 
  
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and CVD risk management 
 
A moderate-carbohydrate Zone type diet with and without the inclusion of exercise compared to a higher-carbohydrate 
conventional diet protocol with and without exercise. 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Not controlled – Comparative intervention 
Study described as randomised Yes. Randomised 4 month weight loss trial using a 2X2 block design (Design X Exercise). The 4 groups were the protein and 
exercise (PRO+EX), carbohydrate and exercise (CHO+EX), a protein group (PRO) and a carbohydrate group (CHO).  
 
Study described as double blind No  
 
Description of withdrawals and 
dropouts present 
No 
Randomisation / blinding 
appropriate 
Due to resource shortage , the first 24 women were randomly assigned to either the PRO+EX or the CHO+EX groups (n=12 
each)and the next 24 were randomly assigned to either the PRO or CHO groups (n = 12 each). 
 
Target Population Adult women 
Why was study done? What was 
perceived general importance? 
To assess the ideal balance of macronutrients necessary to optimize the combined effects of exercise and energy restriction 
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Is there a clear hypothesis and 
objectives? 
The hypothesis was that a diet with increased protein and reduced CHO combined with an exercise program of aerobic activity and 
resistance training produce an additive effect on loss of body fat and maintenance of fat free mass (FFM). 
The aim of the study was also to measure the effects of diet treatments and exercise on changes in blood lipids and various 
indicators of metabolic change during weight loss including blood concentrations of leptin, adiponectin, ghrelin and insulin. 
 
What specific question is being 
addressed? 
There are few studies that provide direct evidence about the combined merits and interactions of specific diet and exercise 
choices. Furthermore, the ideal balance of macronutrients (carbohydrates, lipids, and protein) necessary to optimize the combined 
effects of exercise and energy restriction is unknown. 
 
The study setting- where did study 
take place? 
University of Illinois 
The study population - Intended 
group to whom results should 
apply  vs. group actually studied 
Overweight and obese Adults 
Group actually studied  Women (n = 48) aged 40–56 y were recruited to participate in a weight loss study. Exclusion criteria were BMI < 26 kg/m2, body 
weight > 140 kg (due to DXA scanning bed constraints), smoking, any existing medical conditions requiring medications that would 
affect primary or secondary outcomes of the study, use of oral steroids or use of anti-depression medication. 
 
The social, cultural, economic, 
ethnic background 
Not provided. Recruitment process not explained. 
Due to resource shortage , the first 24 women were randomly assigned to either the PRO+EX or the CHO+EX groups (n=12 
each)and the next 24 were randomly assigned to either the 
PRO or CHO groups (n = 12 each). 
 
Study Approval Study approved by the Institutional Review Board at the University of Illinois at Urbana-Champaign 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Women aged 40-56 y were recruited 
 
Exclusion criteria were BMI <26 kg/m2; body weight >140kg; smoking; any existing medical conditions requiring medications that 
would affect primary or secondary outcomes of the study; use of oral steroids or anti-depression medication.  
No explanation of study dropout if any. 
 
Is there a power calculation to 
determine sample size? 
None Available 
Was there selection bias? Potentially possible. Recruitment process not explained.  
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Was there funding bias? None evident. Authors interest in promoting high-protein weight loss plans was supported by the National Cattlemen’s Beef 
Association, The Beef Board and Kraft Foods 
 
Confounding Factors None evident 
 
How does the study group relate to 
researchers interest groups / 
patients? 
The researcher’s interest groups would potentially include overweight women with a desire to lose weight or improve metabolic 
markers and understanding the impact of exercise with diet.  
 
What was the intervention and how 
was it carried out? 
 
 
 
 
What was the intervention and how 
was it carried out? Contd. 
The CHO diet provided dietary protein at 0.8g/Kg/d (15% of energy intake) with a CHO: PRO ratio >3.5 and dietary lipids at approx 
30% of energy intake. The PRO diet provided dietary protein at 1.6 g/kg/d (30% of energy intake with a CHO: PRO ratio <1.5 and 
dietary fats at 30%. Hence the PRO Diet resembles a Zone type diet. 
Institute of Medicine minimum RDA for CHO =130g/d, PRO=0.8 g/kg and with upper limits for CHO <65% ad protein <35% of total 
energy intake resembling a conventional low-fat/high carbohydrate diet. 
The two diets were designed to be equal in energy 1700kcals , total fat intake 57g and fibre 17g 
Both diets emphasized use of high quality proteins including meat dairy eggs and included 5 servings/day of vegetables and 2-3 
servings of fruit. 
 
Exercise treatments  
Control Group: NIH Guidelines for weight Management including 30 min of walking 5d/wk undertaken voluntarily. Exercise 
monitored daily via activity logs on 3d/month. Subjects wore accelerometers. Control group averaged 100min/wk of added exercise. 
The EX Group required walking 5d/wk for 30min/d plus a resistance training programme 2 d/wk consisting of 30 min stretching and 
resistance using 7 nautilus weight machines. EX subjects were required to complete a minimum of one 12 repetition set on each 
machine with resistance weight selected to elicit fatigue by the final repetition. 
 
What was measured and how was it 
measured? 
Protocol: All subjects participated in a baseline evaluation period that included a 24 h food recall, a 24 h food recall, instructions for 
weighing and recording of foods, two 3-d weighed foods records and measurement of bodyweight, height and blood lipids.  
 
Were baseline measures used? Age, height (cm), Weight (Kg), BMI (kg/m2). Baseline characteristics did not differ among subjects in each of the treatment groups. 
Baseline characteristics did not differ among the different treatment groups. Subjects had a mean age of 46.6 y weight of 87.7kg 
BMI of 32.9 and relative body fat of 44.1%. Due to wave recruitment there was a difference in BMI (P=0.047) largely associated with 
the difference between the CHO and CHO+EX groups. 
 
Were process measures used? 
 
 
 
Body weight measured using an electronic Scale – Tanita Model BWB-627A.  Whole body composition and trunk fat determined by 
DEXA scans by the same technician using standard manufacturer guidelines. 
 
Plasma leptin, adiponectin, ghrelin and insulin were determined by commercial RIA kits with all samples for a given sample 
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Were process measures used? 
contd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
analysed in a batch.  
 
Serum total cholesterol (TC), HDL-C and TAG were determined by standardized methods by the Washington University School of 
Medicine Core Laboratory for Clinical Studies. LDL cholesterol was calculated using the Friedwald equation.  
 
Diet: Subjects were provided electronic food scales and instructed to weigh all food servings at all meals. 
They were required to report a 3-d weighed food record for each week throughout the study. Nutrient intakes were evaluated as 
mean daily intakes from 3-d weighed records using nutritionist Pro software (First DataBank). After baseline data collection, 
subjects received instruction from a research dietician about their specific diet and walk-in programme. During the 16 wk weight 
loss programme subjects were required to attend a 1 hr meeting each week at the research facility.  
 
Each week subjects were weighed in light clothing without shoes and turned in the 3-d weighed food records and daily activity 
logs. 
 
Statistics: All data analyses conducted using SPSS version 12.0.  Differences at baseline were evaluated using one-way ANOVA 
with further evaluation using Fisher’s least significant test.  Pre-test vs. post test values within a group were evaluated by a 
Student’s t- test.  
The primary analysis to evaluate the relative effect of the diet and exercise treatments used a 2-way ANOVA (Diet X Exercise) and 
the change over time as the dependent variable. 
To evaluate treatment effects on hormones, controlling for changes in body composition, an analysis of covariance (ANCOVA) was 
used where indicated. 
Were outcome measures 
identified? Are there clear validated 
outcomes? 
Yes 
Are the methods quantitative or 
qualitative? 
Quantitative and Qualitative 
Safety Results None discussed.  
 
Endpoint/ Biomarker Tested Body Weight markers: body weight, fat mass, trunk fat, lean mass 
Endocrine markers of obesity: Plasma concentrations of leptin, insulin, ghrelin and adiponectin. 
Blood lipids: TC, LDL-C, HDL-C and TAG. 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b as a significant risk factor for CVD disease along with HDL and triglycerides would have been relevant and 
important. 
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Are the endpoints relevant to actual 
practice 
Yes 
Dietary Intake and Adherence 
Results 
Daily energy intakes at baseline from 3-d weighed food records were 2138 kcal/d for all subjects.  
Daily menus were designed to provide 1700kcal/d but subjects were free-living and ultimately determined final daily energy intake.  
Reductions in energy intake from weekly 3-d weighed food records did not differ among groups shown by non-significant Diet and 
Exercise main effects and interactions. 
Subjects in the PRO groups maintained protein intakes of 107g/d and approx 30% of energy intake. The ratio of CHO: PRO was 
1.24. Total dietary lipid intake decreased to 49g/day (32% of dietary energy) and SFA decreased to 19.1 g/d (12.4% of energy) 
Subjects in the CHO groups maintained CHO intake at 198g/d (61% of energy) and reduced lipid intake to 37g/d (25.5 of energy) and 
SFA to 11g/d (7.5 % of energy). Protein intake was 57g/d (18% of energy intake) and the ratio of CHO:PRO was approx 3.5 
 
Weight loss and cardio-protective 
mechanisms identified,  
Protein sparing effects of increased protein on lean body mass 
Increased loss of body fat associated with lower insulin response to the reduced CHO diet 
Reduced metabolic efficiency produced by increased dietary ratio of protein to CHO  
 
Weight Loss / Body Composition 
results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All groups lost significant body weight during the 16 week treatment period. 
Body weight changes were larger (P<0.05) in the groups consuming higher protein and reduced CHO.  
The PRO and PRO+EX groups had a weight loss of 9.3±0.8 kg after 16 weeks while the CHO and CHO+EX groups reduced body 
weight by 7.3±0.5 kg (P<0.05). 
The PRO+EX group had the largest relative weight loss at 11.2% and the CHO group had the smallest relative weight loss at 8.4%. 
Changes in body composition indicated that weight loss was predominantly fat mass and there were increased fat losses 
associated with the higher protein diet and the exercise program. 
Subjects in the PRO +EX and the CHO +EX groups reduced body fat by 7.2±0.7kg whereas subjects not in the supervised exercise 
program reduced body fat by 5.5±0.5kg (P<0.05). 
The PRO and EX effects were independent and additive. 
Specifically the combined effects of the PRO diet and the EX program produced a 21.4 % decrease in absolute body fat. 
Subjects in the CHO group without exercise had a 12.8% reduction in absolute body fat. 
Changes in absolute trunk fat were similar to changes in total fat mass with reduction in trunk fat for the PRO groups greater than 
the CHO groups. 
Change in trunk fat relative to change in whole body fat reduced significantly in all treatment groups with the PRO+EX group 
having the greatest ratio reduction of -0.028±0.007(P=0.001) and the CHO group experiencing the least change -0.015 ±0.005 
(P=0.009) however there was no significant main effect for diet (P=0.32) or exercise (P=0.12). 
 
Changes in lean mass reflected a significant positive effect of the exercise program (P<0.001) and a trend for a beneficial effect of 
the PRO diet (P=0.10). 
The PRO+EX group had no significant change in lean mass whereas the CHO had the largest decrease in lean mass. 
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Weight Loss / Body Composition 
results-  Contd. 
The additive effects of the PRO+EX on body composition were apparent with significant main effect of Diet (P<0.01) and exercise 
(P<0.001). 
Subjects in the PRO and PRO+EX groups reduced body fatness by 4.3% whereas subjects in the CHO and CHO+EX groups reduced 
relative body fatness by 2.9%.  
The subjects in the PRO +EX and CHO+EX groups reduced relative body fat by 4.7% where non-exercising subjects reduced body 
fatness by 2.5% 
 
Ketonuria Results None noted. CHO at 30% of energy intake. 
 
Cardiac Risk Factor Results Initial serum lipid concentrations did not differ among all groups. After 16 wk of weight loss, changes in TC, LDL were greater in the 
CHO and the CHO+EX than in the PRO Groups 
 
Serum TC in the CHO and CHO+EX groups decreased by 0.51 ±0.09mmol/L (9.2%) and LDL-C decreased by 0.38±0.08mmol/L 
(10.4%) from baseline values. 
 
In the PRO and PRO+EX groups these decreased by 0.21 ±0.12mmol/L (3.7%) and 0.08±0.11 mmol/L (1.7%).  
 
Changes in TAG were highest in the PRO groups by 0.32 ±0.06mmol/L (20.2%).  In the CHO and CHO+EX groups TAG concentration 
decreased by 0.1±0.07 mmol/L(5.2%). 
 
HDL-C concentrations changed in opposite directions for the 2 diet treatments. The PRO groups had a net increase of 
0.01±0.03mmol/L in HDL-C and the CHO groups decreased by 0.08±0.03mmol/L. 
 
Ratios of TAG/HDL were more responsive to the PRO diet than the CHO diet  
 
No significant effects of EX were apparent for any lipid outcomes. 
 
Endocrine markers and Hormonal 
Effects 
Each of the 4 hormones responded to weight loss.  
Plasma concentration of leptin and insulin decreased and adiponectin and ghrelin increased. 
Only adiponectin showed treatment specific changes 
Blood concentrations of adiponectin doubled in the EX groups (P<0.05). After controlling for change in fat mass, the main effect of 
EX remained significant (P=0.02) 
 
Exercise and Medication use 
 
 
Exercise was a significant part of the treatment protocol. 
 
Exercise treatments  
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Exercise and Medication use contd. Control Group: NIH Guidelines for Weight Management including 30 min of walking 5d/wk undertaken voluntarily. Exercise 
monitored daily via activity logs on 3d/month. Subjects wore accelerometers. Control group averaged 100min/wk of added exercise. 
The EX Group required walking 5d/wk for 30min/d plus a resistance training programme 2 d/wk consisting of 30 min stretching and 
resistance using 7 nautilus weight machines. EX subjects were required to complete a minimum of one 12 repetition set on each 
machine with resistance weight selected to elicit fatigue by the final repetition. 
 
What effect may bias have on the 
result? 
None evident 
The Author's conclusions - are 
these justified? 
Subjects in both diet treatments were successful in reducing daily energy intake, achieving macronutrient goals and reducing body 
weight and body fat mass. 
Subjects consuming a PRO diet with CHO:PRO ratio <1.5 lost more total weight and body fat and less lean mass compared with 
CHO diet group with a CHO:PRO ratio >3.5. 
Exercise increased loss of body fat and preserved lean mass.  
This study adds to body of evidence supporting protein-sparing effects from higher protein intakes during energy restriction. 
 
Generalizability- the extent to 
which the results might apply 
outside the study 
The question of dietary and macronutrient management with or without exercise and the level of exercise relevant to weight loss 
remains an important issue relevant to obesity studies and the general client base of the researcher. 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The study demonstrates interactions between the macronutrient content of diet and exercise during weight loss. 
Subjects consuming more protein and less carbohydrates lost more weight and fat mass and tended to lose less lean mass (P=0.1) 
than groups consuming more carbohydrates. 
 
Exercise increased the loss of body fat and preserved lean mass. 
 
The combined effect of diet and exercise was found to be additive for correcting body composition. 
 
The PRO +EX group exhibited the greatest loss of body fat  -8.8kg with minimal change in lean mass -0.4kg whereas the CHO group 
had the least change in body fat -5.0kg and the greatest loss of lean mass -2.7kg. 
 
Daily energy deficits were comparable across all treatment groups. 
 
This study is consistent with other short term weight loss studies that show that diets with reduced CHO and increased protein 
result in increased weight loss and increased loss of body fat and reduced loss of lean body mass. 
Similarly confirms other study results that supplemental exercise tends to increase weight loss but has greater effects on body 
composition through preserving lean body mass whilst increasing fat loss. 
There was a main effect of diet on total weight loss with no added effect of exercise. 
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Discussion points- Contd. There was an absence of a main effect of exercise on weight loss consistent with other studies that weight loss by exercise 
requires >30 min/d and increases in lean tissue may reduce changes in total body weight.  
For fat loss there were main effects of both diet and exercise indicating that the effects of HP, RC (reduced Carbohydrate) and 
Exercise had a main effect of reducing loss of lean tissue 
 
Hormone changes reflect decreases in body fat mass. Plasma lepton decreased with weight loss, ghrelin increased and 
adiponectin showed exercise specific changes.  
 
Low plasma adiponectin positively associated with metabolic syndrome X – increased BMI, body fat percentage and blood TAG and 
reduced HDL-C. Weight reduction by energy restriction increases plasma adiponectin.  
Exercise of short duration does not alter body weight or body fat or adiponectin levels. 
 
Blood lipids are influenced more by diet than exercise. 
CHO groups had larger reductions in TC and HDL-C while PRO groups had greater reductions in TAG and maintained higher 
circulating levels of HDL-C. These results are consistent with previous studies. 
Blood lipids respond to both changes in body weight and dietary macronutrient content.  
This study raises the question about the relative merits of expressing dietary intakes of macronutrients as a percentage of energy 
or absolute amounts. The study design provided protein at 0.8 and 1.6g/kg/d based on specific requirements for leucine.  
 
At the baseline the CHO group had mean protein off 78.0g/day or 0.89g/kg/d. Energy restriction decrease in protein to 57g/d or 0.71 
g/kg/d. Although this is 17% of reduced energy intake it is below minimum RDA value of 0.8g/kg/day. This may explain part of the 
loss of lean mass.  
Similar concern about percentage of energy vs. Absolute amounts for dietary lipids. Subjects in the PRO groups reduced dietary 
intake of lipids by 30.1g/day and SFA by 7.5g/day. Total lipids were 31.9% and SFA for 12.4% of total energy which are higher than 
current guidelines.  
  
Were study limitations discussed? None discussed. 
Lack of proper details about the recruitment process, no details of the drop-out rates or non completers, the wave and block 
randomisation which may have introduced bias, the short term of the study and the small sample studied are all potential 
limitations of the study. 
 
Future Implications discussed Differential effects of the diet and exercise treatments suggests that specific treatments may be more beneficial for specific 
individuals e.g. an individual with familial hypercholesterolemia may benefit from a low fat CHO diet likely to produce changes in 
TC and LDL while an individual with high triglycerides and low HDL,T2D may benefit from the PRO diet. 
Further research required for individualisation of dietary macronutrients based on phenotypes can improve long term treatment of 
obesity and associated health risks.  
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Author Luscombe-Marsh et al. (2005) 
 
Title  Carbohydrate-restricted diets high in either monounsaturated fat or protein are equally effective at promoting fat loss and 
improving blood lipids.  
 
Journal  The American Journal of Clinical Nutrition.  
 
Quality of Journal and competence 
of Researchers 
Peer reviewed Journal. Luscombe- Marsh PhD from Adelaide University, post-doctoral position at the University of Maastricht, The 
Netherlands.  Manny Noakes and Peter M Clifton both PhDs 
 
General Aim Clear This study explores a pertinent question arising from previous studies that whether, in the context of carbohydrate-restricted diets, 
the high-protein or the high-fat modification is potentially better at promoting fat loss and improving cardiovascular and diabetes 
risk. 
 
Specific Study objectives stated The objective of the present study was to compare the short-term effects of 2 isocaloric, energy restricted, carbohydrate-matched 
diets that were either low-fat, high-protein (LF-HP) or high-fat, standard-protein (HF-SP; monounsaturated-fat enriched) on weight 
loss, body composition, energy expenditure, appetite, glucose, insulin, and lipid metabolism in subjects with insulin 
concentrations >12 mU/L.  
 
The short-term effects of the 2 moderate-carbohydrate dietary prescriptions on markers of bone turnover, inflammation, and renal 
function were also examined. 
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet and particularly carbohydrate (CHO) 
restriction is significant to weight management and CVD risk management. Particularly relevant in assessing effects of the level of 
CHO that may be recommended.  
2 carbohydrate restricted diets included in design with carbohydrates restricted to 30% of energy with differing levels of protein 
and fat. These were classified as low-carbohydrate non-ketogenic diets. 
 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Parallel randomized study.  
Study described as randomised The 73 subjects accepted for participation in the study were sorted into pairs matched for fasting serum insulin, BMI, age, and sex. 
The resulting matched groups were randomly assigned to either the low-fat, high-protein (LF-HP) 30% Fat and 40% Protein diet or 
the high-fat, standard-protein (HF-SP) diet with 50% Fat and 20% protein.  
 
Study described as double blind No 
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Description of withdrawals and 
dropouts present 
Yes. Seventy-three obese men and women were recruited through public advertisement. 36 (13 men and 23 women) assigned to 
the LF-HP group and 37 (13 men and 24 women) assigned to the HF-SP group. 5 dropouts prior to start of intervention – 1 LF and 2 
LF could not be contacted; 1 HF due to work commitments; 1LF for family reasons leaving 34 in each group (13 men and 21 
women).  11 dropouts before end of intervention – 7 in LF group and 4 in HF group. Reasons given. Leaving 30 in the HF-SP group 
and 27 in the LF-HP group. 
 
Randomisation / blinding 
appropriate 
73 subjects accepted were sorted into pairs matched for fasting serum insulin, BMI, age and sex. The resulting matched groups 
were randomly assigned to either the low-fat, high-protein (LF-HP) or high-fat, standard protein (HF-SP).  
 
Target Population Obese Adults who were generally in good health. 
 
Why was study done? What was 
perceived general importance? 
In the context of carbohydrate restricted diets is the high-protein or the high-fat modification potentially better at improving 
cardiovascular and diabetes risk. 
 
Is there a clear hypothesis and 
objectives? 
To compare the short-term effects of 2 isocaloric (1500kcal per day) energy-restricted , moderate but matched (30%) carbohydrate 
diets, that were either low-fat, high-protein (LF-HP) or high-fat, standard protein (HF-SP). 
 
What specific question is being 
addressed? 
Together with moderate carbohydrate, is lowering fat or lowering protein more effective for improving CVD and diabetes risk 
The study setting- where did study 
take place? 
University of Adelaide 
The study population - Intended 
group to whom results should apply  
vs. group actually studied 
73 Obese men and women (26 men and 47 women) with BMI between 27 and 40; Aged between 20 and 65y.  
The social, cultural, economic, 
ethnic background 
Not much known about the social cultural or ethnic background of the subjects. 
Study Approval All experimental procedures followed the ethical standards of and were approved by the Human Ethics Committees of the 
Commonwealth Scientific Industrial Research Organisation (CSIRO) and the Royal Adelaide Hospital. All participants gave written 
informed consent. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
A screening session was conducted, and subjects were included if they were aged between 20 and 65 y, were nondiabetic, had a 
fasting serum insulin concentration >12 mU/L, and a body mass index (in kg/m2) between 27 and 40. 
 
Is there a power calculation to 
determine sample size? 
The study had 80% power (α= 0.05) to detect differences between dietary groups of 3.6 kg in body weight, 0.9 kg in lean and fat 
mass, 3 mU/L in fasting insulin, 0.2 mmol/L in LDL cholesterol, and 7% in REE. 
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Was there selection bias? None evident 
 
Was there funding bias? Supported in part by the National Health and Medical Research Council of Australia. No bias evident.  
 
Confounding Factors None noted 
 
How does the study group relate to 
researchers interest groups / 
patients? 
 
Obese and overweight are within the clinical interest area of the researcher. 
What was the intervention and how 
was it carried out? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The protocol and potential risks and benefits of the study were fully explained to each subject before he or she provided written 
informed consent.  
 
The 16-wk intervention was divided into a 12-wk period of energy restriction followed by 4 wk of energy balance.  
 
At weeks 0, 2, 4, 6, 8, 10, 12, 14, and 16, measurements of body weight were made and diet counselling was given.  
 
At weeks 0, 4, 8, 12, and 16, measurements of blood pressure were made and venous blood was collected.  
 
In addition, at weeks 0 and 16, 24-h urine samples were collected. 
 
Subjects taking antihypertensive or lipid lowering medication were asked to maintain all medications and supplements at pre-
study doses. 
 
Most subjects were sedentary at baseline and were asked to continue their usual physical activity levels and to refrain from 
drinking >2 standard glasses of alcohol per week throughout the study. 
 
The prescribed diets were:   
1) a LF-HP diet containing 30% of energy as fat (46 g/d) and 40% of energy as protein (136 g/d), and 
2) a HF-SP diet containing 50% of energy as fat (76 g/d) and 20% of energy as protein (67 g/d).  
For each diet, the percentages of energy derived from carbohydrate and saturated fat were matched; carbohydrate was restricted 
to 30% of energy (approximately 110 g/d), and saturated fat was restricted to <10% of energy. The fibre content of each diet was 
similar (21 g/d in the LF-HP diet and 27 g/d in the HF-SP diet). 
To achieve the composition of the prescribed diets, the subjects followed fixed-menu plans and were supplied with key foods that 
made up 60% of their energy intake. 
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What was the intervention and how 
was it carried out? – Contd. 
Foods were provided at 2 weekly intervals when the subjects visited the research unit for dietary counselling. 
 
The subjects were counselled by a dietician on the dietary protocol and on how to keep daily dietary intake checklists for all foods 
eaten. 
 
The subjects’ body weights and dietary intake checklists were monitored every 2 wk, and dietary adjustments were made if the 
food specified was too little or too much. 
 
Three consecutive days (1 weekend day and 2 weekdays) of the checklists from each 2-wk period were analyzed with the use of 
DIET/1 NUTRIENT CALCULATION software (1998; Xyris Software, Highgate Hill, Australia), a computerized database of Australian 
foods. 
 
The study was conducted on an outpatient basis over 16 wk. 
 
Both dietary groups underwent 12 wk of energy restriction (approximately 6000 kJ/d, or 1433 kcal/day or30% restriction of total 
energy) followed by 4wk in energy balance with the same macronutrient composition. If an individual was not achieving the 
desired weight loss of 0.5–1 kg/wk during the energy-restricted phase, or if during the energy balance phase he or she did not 
maintain a stable weight, minor adjustments in food intake were made at the fortnightly diet counselling sessions. 
 
 
The test meals were  LF-HP (2636 kJ, 37% of energy as protein, 30% fat, 32% carbohydrate) and HF-SP (2586 kJ, 18% of energy as 
protein, 49% fat, 32% carbohydrate) 
 
What was measured and how was it 
measured? 
 
 
 
 
 
 
 
 
 
 
 
On 2 consecutive days at weeks 0, 4, 8, 12, and 16, body weight, blood pressure, and venous blood samples were taken in the 
morning after the subjects had fasted overnight for measurement of blood glucose, insulin, and lipid concentrations.  
 
At weeks 0 and 16, a single venous blood sample was taken for the determination of serum creatinine, and a 24-h urine sample was 
collected for the assessment of the ratio of urea to creatinine to determine dietary compliance. 
 
Calcium and sodium excretion, as well as ratios of deoxypyridinoline to creatinine and of pyridinoline to creatinine (biomarkers of 
bone turnover) were assessed from the 24-h urine sample at weeks 0 and 16. 
 
Also at weeks 0 and 16, measurements of body composition and total energy expenditure and a 3-h meal tolerance test using 
meals that were representative of the diet to which the subjects were assigned were performed. 
 
Venous blood samples for the determination of glucose, insulin, and free fatty acid concentrations were taken before the subjects 
 
 
 
 
 
APPENDIX A7: Data Collection Sheets – Luscombe-Marsh et al. 2005          
(Text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and Numerical 
references included in brackets refer to the original article).  
  
143 
 
What was measured and how was it 
measured? – contd. 
had their test meals as well as 30, 60, 120, and 180 min after the meal. 
 
Resting energy expenditure (REE), the thermic effect of feeding (TEF), respiratory quotient (RQ), and appetite sensations (hunger, 
satiety, fullness, and desire to eat) were also measured before and after the meal at these time points. 
 
Body weight (model AMZ14 digital scale; A&D Mercury, Kinomoto, Japan) was recorded while the subjects were wearing light 
clothing without shoes. Total fat mass and total lean mass were assessed by whole-body dual-energy X-ray absorptiometry 
(densitometer XR36; Norland Medical Systems 
 
Thirty subjects (6 men and 8 women from the LF-HP group and 6 men and 10 women from the HF-SP group) were recruited to 
participate in the energy expenditure measurements performed at weeks 0 and 16. 
 
The subjects were asked to refrain from participating in planned exercise, drinking alcohol, and smoking for ≥12 h before the 
measurement of resting energy expenditure. 
 
 
Appetite responses 
Hunger, fullness, satiety, desire to eat, and the amount of food desired to eat were assessed by using a 100-mm visual analogue 
scale before and 30, 60, 120, and 180 min after the test meal.  
 
The subjects were asked to make a single vertical mark on each scale somewhere between the 0- and 100-mm extremes (e.g., 
hungry to not hungry) to indicate their feelings at that time point. The subjects did not discuss their ratings with each other and 
could not refer to their previous ratings when marking the scale. 
 
Were baseline measures used? No significant differences existed in subject characteristics between treatment groups at baseline. 
 
For body weight, there was a main effect of sex such that the men were heavier than the women (P< 0.001). 
There was also a diet-by sex interaction (P=0.04) such that the men in the HF-SP group weighed more than did the men in the LF-
HP group (P = 0.03). 
 
Fasting plasma glucose was higher in the men than in the women (main effect of sex, P = 0.018). 
 
Were process measures used? 
 
 
 
Biochemical analyses 
Fasting blood samples were collected in tubes containing either serum clotting activator for the measurement of insulin, lipids, 
fatty acids, and creatinine or sodium fluoride-EDTA for the measurement of glucose. 
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Were process measures used? – 
contd. 
Total cholesterol, HDL cholesterol, triacylglycerols, fatty acids, glucose, and creatinine were measured on a Hitachi centrifugal 
analyzer (Roche, Indianapolis, IN) with the use of standard enzymatic kits. 
 
Assays were performed for insulin, HDL cholesterol, and LDL cholesterol. 
 
All biochemical assays were performed in a single run at the end of the 16-wk study. 
 
Homeostatic model assessment (HOMA) was used as a surrogate measure of insulin sensitivity and was calculated as fasting 
serum insulin (mU/L) X fasting plasma glucose (mmol/L)/22.5. 
 
Twenty-four– hour urine samples were collected, the volume was recorded, and aliquots were frozen until analyzed (in one run at 
the end of the study) for the measurement of urea and creatinine concentrations with the urease enzymatic assay. 
 
Urinary pyridinium and deoxypyridinium cross-links (markers of bone turnover) were measured by using HPLC. 
 
Creatinine clearance was computed from plasma and 24-h urine creatinine excretion as follows: creatinine clearance = [(urine 
creatinine concentration in mmol/L) X (urine volume in mL/1140 min)/ (plasma creatinine concentration in (µmol/L) · 1000 mL
-1
 · 
min
-1
)] X 0.7. 
Two subjects were excluded from the lipid analysis because they ceased taking lipid-lowering medications 3 subjects were unable 
to have a dual-energy X-ray absorptiometry scan completed at week 16. 
 
Statistical analysis was performed by using SPSS for WINDOWS 10.0 software (SPSS Inc, Chicago, IL). 
 
Baseline measurements were assessed by using two-factor analysis of variance (ANOVA) with diet and sex as the fixed factors. 
The effect of the diet intervention was assessed by using repeated-measures ANOVA; for each dependent variable, the 
measurements at weeks 0, 4, 8, 12, and 16 are the within-subject factor (i.e., time) and diet and sex are the between-subject factors. 
 
In specific analyses, baseline weight, cholesterol, total fat mass and total lean mass were included as covariates. 
 
Week 0 and 16 response curves after the test meals were compared by using repeated-measures ANOVA with week and blood 
sampling time as the within-subject factors and diet and sex as the between subject factors. 
 
When significant interactions of time-by-diet or time-by-diet-by-sex were found, paired t tests were used to find where the 
differences lay. 
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Were outcome measures identified? 
Are there clear validated outcomes? 
Body weight and body composition, Resting energy expenditure, the thermic effect of feeding and respiratory quotient, Appetite 
responses, Biochemical analyses for measuring insulin, lipids, glucose  
 
Are the methods quantitative or 
qualitative? 
Quantitative and qualitative methods 
Safety Results Both diets were well tolerated, with no adverse events or effects reported. 
 
Endpoint/ Biomarker Tested Body weight and body composition, Resting energy expenditure, the thermic effect of feeding and respiratory quotient, Appetite 
responses, Biochemical analyses for measuring insulin, lipids, glucose, bone turnover, inflammation and renal function 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo Lipoprotein a and b 
Are the endpoints relevant to actual 
practice 
Yes 
Dietary Intake and Adherence 
Results 
 
 
 
 
Dietary Intake and Adherence 
Results – Contd. 
The energy and macronutrient contents derived from the subjects’ daily weighed-food checklists did not differ from those of the 
prescribed diets. 
 
The percentage of energy derived from the macronutrients of both diets was not significantly different during the energy-balance 
compared with the energy-restricted phase. 
 
Appetite 
The subjects did desire less to eat after the LF-HP meal than after the HF-SP meal at both week 0 and week 16 (main effect of diet, 
P=0.02. There was a significant reduction in the 3-h hunger response from week 0 to week 16 (main effect of time, P= 0.018). In 
addition, there was a trend for desire to eat (P = 0.06) and the amount desired to eat (P=0.07) to be reduced after 16 wk. 
 
Weight loss and cardio-protective 
mechanisms identified 
Increased protein at the expense of carbohydrates has a positive effect on insulin resistance and lipid metabolism.  
 
Data from an ad libitum feeding study (Skov 1999) suggest that the satiating effects of protein-rich foods, such as lean meat and 
low-fat dairy products, are responsible for the reduced energy intake (by approximately 20%) that leads to greater weight loss (by 
3.3 kg) after 6 mo of a LF-HP diet (30% fat, 25% protein) than after a LF-SP diet (30% fat, 12% protein). In the present study, the 
amount of food desired to eat over the 3-h period after the test meal was less after the LF-HP meal than after the isocaloric HF-SP 
meal, which is consistent with a greater satiating effect of protein. 
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Weight Loss / Body Composition 
results 
After 12 wk of energy restriction and 4 wk of energy balance, weight loss did not differ between subjects in the LF-HP and 
HF-SP groups. The amounts of fat and lean mass that were lost also did not differ. 
 
The reduction in body weight after 16 wk was 9.5±0.9%, or 9.2±0.7 kg (main effect of time, P< 0.001; 10.2± 1.4 kg for the HF-SP diet, 
9.7 ± 1.1 kg for the LF-HP diet). 
 
All the weight loss occurred during the energy-restricted phase of the diet (from week 0 to week 12); no further weight loss 
occurred during the energy balance phase. 
 
The men lost 2% more of their body weight than did the women (time-by-sex interaction, P = 0.03). 
 
From week 0 to week 16, the reduction in fat mass was 13.9 ± 1.5% and the decrease in abdominal fat mass was 17.1 ± 2.0% 
(main effects of time, P < 0.001). 
 
Lean mass was reduced by 6.0 ± 0.6% (main effect of time, P< 0.001). 
 
Cardiac Risk Factor Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Improvements in fasting serum lipid concentrations did not differ significantly between the LF-HP and HF-SP groups, and there 
were no time-by-diet or time-by-diet- by-sex interactions for any of these variables. 
 
Total cholesterol was reduced by 6.6 ± 1.4% at week 12 compared with week 0, and it remained reduced by 2.9± 1.4% at week 16 
(main effect of time, P < 0.001). 
 
LDL cholesterol was reduced by 3.4±1.9% at week 12 and by 0.7±2.3% at week 16 (P = 0.005). 
HDL cholesterol was increased by 6.8± 2.0% at week 12, and at the end of week 16 it remained 10.1 ± 2.1% above baseline  
(P < 0.001). 
 
The serum triacylglycerol concentration was reduced by 23.1 ± 3.6% by week 12 and by 15.9 ± 4.3% at week 16 (main effect of time, 
P< 0.001). 
 
The reduction in REE (regardless of whether it was expressed as an absolute value or was adjusted for body composition) did not 
differ significantly between the LF-HP and the HF-SP group, and there were no time-by-diet or time-by-diet-by-sex interactions for 
REE.  
 
There was no effect of diet composition on urinary calcium or sodium excretion, concentrations of bone-turnover markers, 
C - reactive protein (CRP) or blood pressure. 
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Cardiac Risk Factor Results – 
Contd. 
 
 
Urinary calcium and sodium excretion remained unchanged from week 0 to week 16 (3.5 ± 0.4 and 4.1± 0.4 mmol/24 h for week 0 
and week 16 calcium values, respectively, and 181 ± 31 and 158 ± 11 mmol/24 h for week 0 and week 16 sodium values), as did 
concentrations of the bone-turnover markers (94 ± 5.1 and 102 ± 5.2 nmol/mmol for week 0 and week 16 pyridinoline: creatinine 
values, respectively, and 26±1.3 and 28±1.4 nmol/ mmol for deoxypyridinoline: creatinine values). 
 
CRP fell by 24.0±20.2% (from 3.9±0.4 mg/L at week 0 to 3.1±0.4 mg/L by week 12; main effect of time, P=0.001), but by week 16 the 
reduction from baseline (6.7±15.0%) was not significant (week 16 CRP: 3.4 ± 0.37 mg/L). 
 
Systolic blood pressure decreased from 130±1.89 mm Hg at week 0 to 123±1.5 mm Hg at week 16 (main effect of time, P<0.001), but 
diastolic blood pressure remained unchanged (72 ± 1.3 mm Hg at week 0 and 71 ± 1.0 mm Hg at week 16). 
 
For serum creatinine, there was no main effect of time or diet. 
For men, the concentration decreased from 91.5±2.9 to 85.6±3.3_mol/L in the SP group (P=0.005) but remained unchanged in the 
HP group (85.3±2.3 and 85.7±3.0 µmol/L). 
 
Creatinine clearance did not change with time in either diet group (117 ± 13 and 124 ± 15 mL/min at weeks 0 and 16, respectively, in 
the HF-SP group, and 121 ± 10 and 141 ± 12 mL/min at weeks 0 and 16, respectively, in the LF-HP group). 
 
Hormonal and Endocrine results 
 
 
 
 
 
 
 
 
 
 
 
Fasting concentrations of plasma glucose remained unchanged throughout the 16 wk in both the LF-HP and HF-SP Groups. 
 
Improvements in fasting serum insulin, the HOMA index of insulin resistance, and in fasting serum free fatty acids were also not 
significantly different in the LF-HP and HF-SP groups. 
 
After 16 wk, the decrease in fasting serum insulin was 25 ± 4.2% (main effect of time, P < 0.001) and the HOMA insulin resistance 
index was reduced by 34±8.8% (P<0.001). 
 
There was a main effect of time on fasting serum FFA concentrations (P<0.001); the effect was due to a 26.7±7.3% increase from 
week 0 to week 12 (P= 0.009), but by week 16 the concentration had fallen and was not significantly different from that at week 0 (P 
= 0.34). 
At week 16, the increase in plasma glucose in response to the test meals was less than that at week 0. There was no significant 
effect of diet or any time-by-diet or time-by-diet-by sex interactions on plasma glucose responses. 
The glucose and insulin responses did not differ significantly after the LF-HP and HF-SP meals at both weeks 0 and 16. 
 
Exercise and Medication use The subjects were asked to refrain from participating in planned exercise. 
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What effect may bias have on the 
result? 
None noted 
The Author's conclusions - are 
these justified? 
In summary, in obese subjects with moderately elevated insulin concentrations, after 12 wk of energy restriction and 4 wk of 
energy balance, the magnitude of weight loss and the improvements in insulin resistance and lipid metabolism that were achieved 
with carbohydrate-restricted diets that contained either moderately increased amounts of protein or monounsaturated fat were not 
significantly different. 
 
The higher-protein meals however had the advantage of blunting the decrease in the (thermic effect of feeding) TEF observed after 
weight loss, and they also reduced the amount of food desired at the next meal. 
 
The implication of these findings is that protein from meat, poultry, and dairy foods or fat from food sources rich in 
monounsaturated fatty acids are both suitable options to replace some dietary carbohydrate, at least in the short term, and the 
choice of weight-loss diet can be tailored to individual preferences. 
 
Generalizability- the extent to which 
the results might apply outside the 
study 
 
Results would be relevant  for individualisation of diet plans  
Discussion points  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recent short-term studies (lasting 4–6 mo), including this study  have shown positive effects of diets in which protein is increased 
at the expense of carbohydrate on weight loss and markers of cardiovascular disease risk, such as insulin resistance and lipid 
metabolism. 
 
None of these studies, however, were designed to determine whether the beneficial effects, particularly on markers of 
cardiovascular disease risk, resulted from the reduced carbohydrate or the increased protein content of the diets. 
 
The present study therefore matched the carbohydrate content of 2 isocaloric, energy-restricted diets and manipulated the protein-
to-fat ratio. 
 
The main finding of the present study was that the LF-HP diet (which was based on lean meat, poultry, and low-fat dairy foods) and 
the HF-SP diet (which was based on lean meat, poultry, higher-fat milk, and oil and nuts high in monounsaturated fat) were both 
well accepted, as evident from the similar dropout rates in the 2 diet groups and compliance with the dietary prescriptions. 
 
The experimental diets had no deleterious effects on renal function, blood pressure, or markers of bone turnover and were equally 
effective at reducing body weight, improving insulin resistance, and improving cardiovascular disease risk factors. 
 
This finding contrasts with the results of 2 of the researchers previous studies of subjects with moderately elevated insulin 
 
 
 
 
 
APPENDIX A7: Data Collection Sheets – Luscombe-Marsh et al. 2005          
(Text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and Numerical 
references included in brackets refer to the original article).  
  
149 
 
Discussion points – Contd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
concentrations and type 2 diabetes, which showed statistically greater improvements in postprandial glucose responses, fasting 
lipid concentrations, and fat loss and lean mass preservation in women after 16 wk of a low-fat, moderate-carbohydrate, high-
protein diet than after an isocaloric low-fat, high-carbohydrate, standard-protein diet 
 
The  findings  also differs from those of Layman et al (2003) and Piatti et al (1994), who both showed that the fat-to–lean mass loss 
ratio (an indicator of fat utilization and preservation of lean mass) is greater for women after a high protein, moderate-carbohydrate 
diet. 
 
Thus, it appears that restriction of carbohydrate in a low-fat, moderate-carbohydrate, high-protein diet may be beneficial in 
improving body composition compared with a low-fat, high-carbohydrate, standard-protein diet, perhaps by reducing insulin and 
enhancing lipolysis of stored fat. 
 
However, an analysis of 94 weight-loss interventions found that total weight loss or changes in fasting plasma glucose and serum 
lipid concentrations were not independently associated with the reduced carbohydrate intake (Bravata et al. 2003), although body 
composition was examined in few of these interventions. Most studies have shown that energy intake and not macronutrient 
composition is the key determinant of total weight loss. There is concern that replacing carbohydrate with fat may adversely affect 
insulin resistance and plasma lipids, although unsaturated fat probably does not have this adverse effect. 
 
In the present study, the increased fat content of the HF-SP diet did not have any detrimental effect on insulin resistance or the 
lipid profile of the subjects, who showed weight-loss-related improvements. This finding is consistent with those of others who 
showed improvements in the lipid profile of subjects who were hypercholesterolemic (52) or had type 1 diabetes (53) after they 
were placed on high-monounsaturated-fat diets. 
 
In the present study, CRP was reduced significantly during active weight loss by 24%; during the weight maintenance phase, 
however, CRP rose and the final reduction of 14% was not statistically significant. 
 
An effect of energy intake on CRP has not been noted before, although weight loss has been shown to reduce CRP. 
 
In both of these low-carbohydrate diets, fasting free fatty acids were modestly elevated during the active weight-loss phase, 
consistent with greater use of fat as an energy source and enhanced mobilization of fat during energy restriction. 
 
This study and various others have consistently shown that a high-protein compared with a standard-protein meal increases the 
thermic effect of food (TEF) and may also reduce the decrease in the TEF after weight loss. Similarly, in the present study, we 
observed that the decrease in the TEF after weight loss was approximately 3.3% smaller in the LF-HP diet group than in the HF-SP 
group. Even though over the short-term, the TEF does not appear to enhance weight loss, it may have some effect, albeit minimal, 
on weight maintenance. 
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Discussion points – Contd. In this study, REE was reduced after weight loss but the reduction was not affected by the protein-to-fat ratio of the diet, a finding 
that is consistent with our previous results.  
 
In the present study, the amount of food desired to eat over the 3-h period after the test meal was less after the LF-HP meal than 
after the isocaloric HF-SP meal, which is consistent with a greater satiating effect of protein. 
 
Data from an ad libitum feeding study (Skov 1999) suggest that the satiating effects of protein-rich foods, such as lean meat and 
low-fat dairy products, are responsible for the reduced energy intake (by approximately 20%) that leads to greater weight loss (by 
3.3 kg) after 6 mo of a LF-HP diet (30% fat, 25% protein) than after a LF-SP diet (30% fat, 12% protein). 
 
Were study limitations discussed? Not discussed.  
 
Future Implications discussed Whether these mechanisms lead to differential weight loss under ad libitum conditions needs to be explored over the long term.  
The implication of these findings is that protein from meat, poultry, and dairy foods or fat from food sources rich in 
monounsaturated fatty acids are both suitable options to replace some dietary carbohydrate, at least in the short term, and the 
choice of weight-loss diet can be tailored to individual preferences. 
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Author McAuley et al. (2004) 
 
Title  Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women  
 
Journal  Diabetologia 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal.  
General Aim Clear To compare low-carbohydrate diets with a conventional diet in overweight women. 
 
Specific Study objectives stated To assess how popular low-carbohydrate diets namely the Atkins and Zone diet approaches compare with a high-carbohydrate 
conventional diet in Adult Women at risk of T2D due to being overweight and insulin resistant. 
 
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and cardiovascular disease (CVD) risk management. 
 
Two lower-carbohydrate diets included in the study. An Atkins type diet, Zone type diet and a low-fat/high-carbohydrate made up 
the three arms of the study.    
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized, comparative intervention 
Study described as randomised Ninety-six normoglycaemic, insulin-resistant women (BMI >27 kg/m2) were randomised to one of three dietary interventions: a high-
carbohydrate, high-fibre (HC) diet, the high-fat (HF) 
Atkins Diet or the high-protein (HP) Zone Diet. 
 
Study described as double blind No 
Description of withdrawals and 
dropouts present 
Of the 96 eligible participants, 12 withdrew from the study. Three withdrew after baseline measurements had been made, before the 
start of the dietary intervention, and were not included in the analysis. 
 
Randomisation / blinding 
appropriate 
A random allocation sequence was generated in blocks of nine. Sequentially numbered envelopes were used to assign participants 
to each group. There was no stratification. 
 
It was not possible to blind researchers or participants; however, the groups were designated by codes rather than actual names to 
minimize cross-contamination between the groups. 
Target Population Generally healthy overweight women  
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Why was study done? What was 
perceived general importance? 
The experimental approach was designed to mimic what might be achieved in clinical practice: the recommendations involved 
advice concerning food choices and were not prescriptive in terms of total energy. 
 
Is there a clear hypothesis and 
objectives? 
To question if the conventional diet recommendation low in saturated fatty acids, rich in wholegrains, vegetables and fruit is 
appropriate in order to reduce the risk of obesity, CVD and do the Atkins (high-fat) and Zone (high –protein) provide suitable 
alternatives 
 
What specific question is being 
addressed? 
Is a carbohydrate-restricted weight loss programme more effective than a low-fat diet with respect to weight loss and 
cardiovascular risk factors? 
 
The study setting- where did study 
take place? 
Edgar National Centre for Diabetes Research, Medical and Surgical Sciences, University of Otago, Dunedin , New Zealand 
Group actually studied  Ninety-six participants of European descent were eligible for randomisation to one of three groups by virtue of normal glucose 
tolerance,  total cholesterol <7 mmol/l, creatinine <130 μmol/l, normal liver function tests and reduced predicted insulin sensitivity 
(insulin sensitivity score ≤6.3 G mIU−1 l−1) 
 
The social, cultural, economic, 
ethnic background 
Participants of European descent.  
Study Approval The study was approved by the Otago Ethics Committee.  Written consent was obtained from participants. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Overweight women aged 30–70 years who were not pregnant or planning pregnancy, did not have a major medical condition, and 
were not currently undertaking a formal weight loss programme or following a strict vegetarian diet.  
 Five hundred women responded to local advertisements regarding this study.  A 75-g Overnight Glucose Tolerance Test (OGTT) 
was performed for 251 of the 314 potentially eligible individuals who were found to have a BMI >27 kg/m2 during a screening visit. 
 
Is there a power calculation to 
determine sample size? 
An earlier study indicated that the root mean square error (an estimate of SD) for weight loss, adjusted for baseline values, was 4.5 
kg. This is equivalent to an effect size of 0.66 or 0.70. Two samples of 32 subjects have the potential to detect this difference with 
80% power using the 5% level of significance. 
 
Was there selection bias? None evident. 
 
Was there funding bias? Study funded by the Health Research Council of New Zealand. 
 
Confounding Factors None identified 
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How does the study group relate to 
researchers interest groups / 
patients? 
The researcher’s interest groups would potentially include overweight and/or obese adults. The ad libitum dietary approach is of 
particular interest. 
What was the intervention and how 
was it carried out? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were supervised weight loss and weight maintenance phases (8 weeks each), but there was no contact between the research 
team and the participants during the final 8 weeks of the study. 
Although ad libitum consumption was advised regardless of group allocation, the first 8 weeks of the study were intended to be a 
weight loss phase, with dietary advice reinforced during weekly reviews. 
Similar supervision continued during the weight maintenance phase (weeks 8 to 16). From week 16 to week 24, participants were 
asked to continue to follow their dietary programme, but there was no contact with the research team. 
 
None of the diets were formally energy restricted during any phase. 
 
Demographic details and medical history were recorded, and a blood sample drawn for fasting glucose, insulin, lipid profile, serum 
creatinine and liver function tests.  
High-fat diet (Atkins Diet) -This dietary programme was based on the guidelines described in by Atkins. There were no specific 
macronutrient targets except for carbohydrates. During the first 2 weeks of the 8-week weight loss phase of the intervention, 
participants were instructed to limit certain foods in order to consume less than 20 g of carbohydrate daily.  
 
Participants were provided with tables indicating acceptable foods, separating restricted and free foods, and foods which had to be 
excluded. 
 
During weeks 3 to 8 of the weight loss phase, carbohydrate was reintroduced by the addition of 5 g/day each week, so that a 
maximum of 50 g of carbohydrate per day was consumed by week 8. 
 
During weeks 8 to 16 (the supervised weight maintenance phase of the intervention) the principle of increasing carbohydrate intake 
from the specific food lists by 5 g/day each week was continued until each participant found the maximum level of carbohydrate 
consumption without weight gain.  
 
During the unsupervised follow-up phase of the intervention, participants were encouraged to consume the amount of 
carbohydrate that would help to avoid weight gain. 
 
High-protein diet (Zone Diet): The Zone Diet recommends that of the total energy provided by each meal and snack, 40% should be 
from low glycaemic index carbohydrate, 30% from protein and 30% from fat (predominantly monounsaturated). 
 
Participants were advised to eat five times daily, with no more than 5 h between meals. The programme was presented to 
participants as a series of tables listing food types and serving sizes. Participants were advised to consume an appreciable amount 
of food from the protein table, to fill up with foods from the fruit and vegetable table, and to consume small amounts of items from 
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What was the intervention and how 
was it carried out?- contd.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the fats and oils table. A further table listed food items to be restricted to one serving per day. 
 
During the supervised weight maintenance phase, subjects were instructed to consume slightly larger portions of foods in 
the evening to maintain their body weight. During the unsupervised follow-up phase, participants were encouraged to continue 
consuming appropriate foods in quantities that facilitated weight maintenance. 
 
High-carbohydrate, high-fibre diet (control group): The nutrient composition of this diet was based on that recommended by 
Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). 
 
These guidelines focus on the consumption of specific food groups in specified daily amounts and consist of the following: (1) at 
least six servings of breads and cereals (preferably wholegrains); (2) at least three servings of vegetables and two of fruit, with 
emphasis on those rich in soluble fibre; (3) at least two servings of low fat milk or milk products; and (4) at least one serving of 
lean meat, chicken, seafood, eggs, cooked dried beans, peas or lentils (with legumes rich in soluble fibre especially encouraged). 
Advice to reduce dietary fat, salt and sugar intakes was also given. 
 
Each guideline was followed by a table containing serving sizes, healthy choices for that food group, and foods to be restricted as 
much as possible. During the supervised weight maintenance phase of the intervention, participants were instructed to consume 
slightly larger portions for their evening meal to maintain body weight. Similar advice was given for the unsupervised follow-up 
phase. 
 
What was measured and how was it 
measured? 
All three groups had diets of similar macronutrient composition at baseline. 
 
All measurements were made at baseline and during the final week of each of the three experimental periods. 
 
Height, weight and waist circumference (at the midpoint between the anterior superior iliac crest and the lowest rib) were 
measured, and BMI was calculated. Blood pressure was recorded after 5 min of rest using random-zero sphygmomanometers, and 
a 75-g OGTT was performed, with fasting and 2-h measurements of glucose and insulin assessed.  
 
Were baseline measures used? Fasting samples were also obtained for lipid measurements and for assessment of high-sensitivity C-reactive protein (CRP) using a 
kit from Roche Diagnostics (Indianapolis, IN, USA). 
 
A measure of body fat was obtained using an IMP5 Bioimpedance Analyser (Impedimed, Eight Mile Plains, QLD, Australia), with 
subjects in a fasted state after emptying their bladders and having refrained from alcohol and exercise for the previous 24 h.  
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Were process measures used? Participants were given scales to weigh food and asked to complete a 3-day dietary record. 
 
A difference in weight loss of 3 kg between the HC diet and either of the other two diets was considered to be of clinical 
importance. 
 
The data were analysed according to intention to treat. 
 
Mixed models were used to analyse the data. The models included a random effect for each person and assumed an underlying 
variance–covariance structure because of the multiple measures for each person. These provided appropriate standard errors for 
the statistical tests. Baseline measures were included to adjust for any baseline imbalance. The models examine relative change by 
setting the groups equal on the first occasion, and are the recommended way of overcoming problems associated with regression 
to the mean.  
 
Although the tests between the two alternative diets and the conventional diet were planned a priori, an overall test for all three 
diets was also carried out to compare the alternative diets. The value of the test statistic was compared with chi square distribution 
with appropriate degrees of freedom. The results are not reported in detail if the overall test was not statistically significant. 
 
Are the methods quantitative or 
qualitative? 
Quantitative and qualitative 
 
Safety Results Observed increases in LDL cholesterol with the Atkins high- fat diet were less than expected. The LDL levels with the Atkins diet 
were significantly higher in the HF Atkins group than in the HP Zone group. The HF Atkins group produced a marked increase in 
LDL cholesterol in a small number of participants suggesting that some individuals may be particularly sensitive to substantial 
increases in fat intake.  
 
Endpoint/ Biomarker Tested Weight, waist circumference, BMI, blood lipids, blood pressure, glucose and insulin, C-reactive protein. 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b, renal and bone health as one arm of the study was following the HF Atkins Diet.  
Are the endpoints relevant to actual 
practice 
Yes relevant to actual practice. 
 
 
Dietary Intake and Adherence 
Results 
 
 
The reported energy intake did not differ between the three groups at any stage of the 6-month study. 
The high-fat Atkins (HF) group met the week 8 carbohydrate target. Those on the high-protein Zone (HP) diet did not meet the target 
protein and carbohydrate levels, as more energy was derived from total fat than intended. 
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Dietary Intake and Adherence 
Results contd. 
Those on the high-carbohydrate, high-fibre (HC) diet met the targets for total fat, but did not meet the targets for saturated fat, 
carbohydrates or fibre. 
 
Compared with the HC diet, the HF diet was much lower in carbohydrate (−94 g, 95% CI −112 to −75) and fibre (−8 g, 95% CI −10 to 
−6), and much higher in total fat (+40 g, 95% CI 29–52) and saturated fat (+17 g, 95% CI 12–22). The protein intake of the HP group 
was 20 g (95% CI 11–30) higher than that of the HC group. The HP diet was also higher in total fat, the increase due to higher 
intakes of both saturated and monounsaturated fatty acids in the HP group. The HP and HC groups had similar fibre intakes. 
 
Although there were some differences in micronutrient intake between the three groups (data not shown in report), these 
differences were small, and average intakes were above or close to recommended levels. 
 
Weight loss and cardio-protective 
and other mechanisms identified,  
Reduced energy consumption due to novelty of a new diet, monotony due to restriction of accessible foods, enhanced satiety, and 
reduced appetite due to ketonuria associated with carbohydrate restriction. 
 
Weight Loss / Body Composition 
results 
 
 
 
 
Weight Loss / Body Composition 
results – Contd. 
Body weight, waist circumference and triglycerides levels decreased with all three diets and the reductions were significantly 
greater in the HF and HP groups than in the HC group. 
 
Compared with the control (HC) group, those on the HF and the HP diets lost a significantly greater amount of weight. 
 
Similar between-group differences were observed for waist circumference and fat mass. 
 Weight showed a significant time interaction.  
 
When compared with the HC group, body weight and BMI were reduced to a greater extent in the HF group than in the HP group at 
week 8. At week 16 the Atkins and Zone groups showed similar reductions.  By week 24 the HP Zone group showed greater 
reductions than the HF Atkins group.  
 
 When compared with the HC diet, the HF and HP diets were shown to produce significantly greater reductions in several 
parameters, including weight loss (Zone: -2.71, Atkins -2.82); , waist circumference  (Zone: -2.66; Atkins -3.48) and fat mass  
(Zone: -1.64; Atkins: -1.64). 
 
Ketonuria Results Not reported 
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Cardiac Risk Factor Results When compared with the HC diet, the HF and HP diets were shown to produce significantly greater reductions in several 
parameters, including triglycerides (HF −0.30 mmol/l, HF −0.22 mmol/l). LDL cholesterol decreased in individuals on the HC and HP 
diets, but tended to fluctuate in those on the HF diet to the extent that overall levels were significantly lower in the HP group than in 
the HF group (−0.28 mmol/l, 95% CI 0.04–0.52, p=0.02). Of those on the HF diet, 25% showed a >10% increase in LDL cholesterol, 
whereas this occurred in only 13% of subjects on the HC diet and 3% of those on the HP diet. 
 
Fasting triglycerides, although reduced by all three diets, fell to a significantly greater extent with the HP and HF diets than with the 
HC diet. 
 
In accordance with a previous Study (Foster et al. 2003), the HF Atkins diet produced a small increase in HDL cholesterol which 
was similar to that observed for the HP Zone diet, but greater than that produced by the HC conventional diet. 
 
Overall, LDL cholesterol was lower in the HP group than in the HC group. Levels of LDL cholesterol were increased by >10% 
in eight individuals (25%) in the HF Atkins group, four (13%) in the HC group and one (3%) in the HP Zone group. 
 
Systolic and diastolic blood pressures were modestly reduced. 
 
Blood glucose levels (0 and 2 h), creatinine, liver enzymes, CRP and the albumin/creatinine ratio did not change throughout the 
observation period. 
 
Diastolic blood pressure was significantly lower in the HF group than in the HC group (−3 mm Hg, 95% CI −6 to 0, p=0.03). 
 
No significant differences were observed between the dietary groups with respect to systolic blood pressure, fasting and 2-h 
glucose, fasting insulin and CRP 
Endocrine markers and Hormonal 
Effects 
 
 
 
 
 
 
 
 
 
 
 
Insulin levels decreased with all three diets. This study suggests that the popular diets reduced insulin resistance to a greater 
extent than the standard dietary advice did. During the first 8 weeks of the study all three diets produced a decrease in fasting 
insulin levels that was maintained throughout the study period. The observed improvement in key indicators of insulin resistance 
(central adiposity, hyperinsulinaemia and hypertriglyceridaemia) confirms that insulin sensitivity was improved by all three dietary 
regimens. 
The greater reductions in waist circumference and triglycerides observed in the HF and HP groups indicate that insulin sensitivity 
may have been improved to a greater extent by the alternative diets than by the HC diet. 
 
Furthermore, only when HC diets are derived from intact vegetables and fruit and wholegrain cereals is the full potential benefit 
observed in terms of lipid profile and glycaemic control. 
 
In the present study, participants on the HC diet achieved only a modest increase in fibre density, and thus did not receive the 
maximum benefit of such a dietary regimen. 
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Exercise and Medication use Not reported 
 
What effect may bias have on the 
result? 
None evident 
The Author's conclusions - are 
these justified? 
The HF Atkins Diet is a successful short-term approach for weight loss; however, LDL levels should be monitored, and those who 
show a significant increase should be advised to discontinue the diet. 
 
The potential deleterious effects of the diet in the long-term remain a concern. 
 
In conclusion, in the context of this study the HP Zone Diet appears to be the most appropriate overall approach to reducing the 
risk of cardiovascular disease and type 2 diabetes. In routine practice a reduced-carbohydrate, higher protein diet may be the most 
appropriate overall approach to reducing the risk of cardiovascular disease and type 2 diabetes. 
 
Generalizability- the extent to 
which the results might apply 
outside the study 
The use of restricted– carbohydrate diets for weight loss and the comparison to low-fat conventional diets is relevant outside the 
study. 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compared with the HC diet, the HF Atkins and HP Zone diets produced greater reductions in weight. Although subjects on the two 
alternative diets lost a similar amount of weight, the initial weight loss appeared greater in the HF Atkins group, whereas later in the 
study the difference was reversed.  This may be explained by the early fluid loss that occurs on a low-carbohydrate diet. 
 
Other studies comparing a single popular diet with the conventional approach have also reported that greater weight loss is 
achieved with HF and HP diets than with HC diets and there is much speculation regarding the mechanisms responsible for these 
findings.  The majority of earlier studies in which macronutrient composition was altered against a background of constant energy 
intake reported no difference in weight change when HP or HF diets were compared with HC diets. Only when the diets were 
consumed ad libitum was a difference in weight loss apparent. 
 
It seems likely that greater weight losses observed when HF or HP alternatives are compared with HC diets (consumed without 
energy prescription) are the result of reduced energy consumption rather than the use of alternative fuel sources due to the altered 
macronutrient composition of the diets. 
 
Reduced energy intake on such diets may result from the novelty of a new diet, monotony due to restriction of accessible foods, or 
enhanced satiety or a reduced appetite due to the ketonuria that is associated with carbohydrate restriction. 
 
Although energy intake seemed to be restricted to a similar extent by all three diets in the present study, the results suggest that 
under-reporting took place.  
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Discussion points – Contd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three day diet records are not sensitive enough to detect small differences in energy intakes (of approximately 500 kJ/ day) which, 
over a period of months, could account for the observed differences in weight loss (about 3 kg) between the groups. 
 
Concern has been expressed regarding the long-term safety of HF diets, particularly the potential for such diets to elevate total and 
LDL cholesterol.  In this study, the observed increases in these parameters were less than expected, probably due to the 
concomitant reduction in energy intake and weight loss. 
 
Although LDL levels were not markedly increased by the HF Atkins diet, levels were significantly higher in the HF Atkins group than 
in the HP Zone group, despite the fact that the two groups lost a similar amount of weight. 
 
Furthermore, the HF regimen produced a marked increase in LDL cholesterol in a small number of participants, suggesting that 
some individuals may be particularly sensitive to substantial increases in fat intake 
 
Fasting triglycerides were reduced by all three diets, but more so by the two popular diets. Fasting triglycerides decrease with 
weight loss, and carbohydrate-reduced diets have been reported to produce greater reductions than HC diets. 
 
The results of energy-controlled studies suggest that carbohydrate restriction may in itself result in lower triglyceride levels, 
however, these studies were of short duration, and did not allow for adaptation to a HC diet. 
 
 
During the first 8 weeks of the study all three diets produced a decrease in fasting insulin levels that was maintained throughout 
the study period. The observed improvement in key indicators of insulin resistance (central adiposity, hyperinsulinaemia and 
hypertriglyceridaemia) confirms that insulin sensitivity was improved by all three dietary regimens. 
 
The greater reductions in waist circumference and triglycerides observed in the HF and HP groups indicate that insulin sensitivity 
may have been improved to a greater extent by the alternative diets than by the HC diet. 
 
However, given that the aim in insulin resistant individuals is to reduce the cardiovascular risk as well as to reduce the risk of 
developing diabetes, the observed effect of the HF Atkins approach on LDL levels suggests that the HP diet offers a distinct 
advantage. 
 
Furthermore, a HF diet has been linked to other potentially deleterious effects not measured in the present study, including 
increased risk of thrombosis and cardiovascular disease associated with insufficient intake of wholegrain cereals. 
The data in this study does not indicate that any of the observed benefits afforded by the HF Atkins and HP Zone diets are a 
consequence of macronutrient composition; rather, they seem more likely to be secondary to the greater weight loss produced by 
these diets. 
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Discussion points – contd. The beneficial effects of the HP diet were achieved without full compliance. Protein and carbohydrate intakes in the HP group were 
lower than intended and fat intake was rather higher. 
Many participants did not achieve the required meal frequency. Thus, it would seem that the most frequent criticism of the Zone 
Diet—its rigid adherence to meal timing, is not an essential prerequisite to successful implementation. 
 
Those on the HC diet did not meet the targets for carbohydrate and fibre intakes, and saturated fatty acid intake remained higher 
than intended. 
 
It is probably necessary to be more directional with regard to fruit, vegetables and wholegrain cereals, which must be consumed in 
order to achieve targets. Given the high level of motivation of the volunteers, it seems likely that the guidelines employed to 
implement the HC recommendations were insufficiently specific.  
 
A diet that achieves the target carbohydrate and fibre levels (by increasing quantities of wholegrains, intact vegetables and fruits) 
would probably provide a benefit similar to that afforded by the HP approach. 
 
Were study limitations discussed? The HF Atkins diet has been linked to increased risk of thrombosis and CVD associated with insufficient intake of wholegrain 
cereals. These risks were not measured. 
The targets for carbohydrate and fibre intake were not met by the Conventional diet group and saturated fatty acid intake was 
higher than intended. Guidelines to high carbohydrate group were insufficiently specific  
 
Future Implications discussed Need to explore the potentially deleterious effects of the HF Atkins diet and the potential of the Zone diet for reducing CVD and 
diabetes.  
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Author Meckling, O’Sullivan & Saari (2004) 
 
Title  Comparison of a Low-fat Diet to a Low-Carbohydrate Diet on Weight Loss, Body Composition and Risk Factors for Diabetes and 
Cardiovascular Disease in Free-Living, Overweight Men and Women.  
 
Journal  The Journal of Clinical Endocrinology & Metabolism 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. The Principal author is a PhD associated with the Department of Human Biology and Nutritional Sciences, 
University of Guelph, Ontario, Canada. 
 
General Aim Clear  To evaluate an energy restricted low-carbohydrate diet with an isocaloric conventional low-fat diet. 
 
Specific Study objectives stated The authors had previously shown that in adult overweight women, a low-carbohydrate (LC) hypocaloric diet can promote efficient 
weight loss and improvements in body composition and lipid profile while maintaining glucose tolerance. 
 
The study was initiated to extend earlier observations made by the research team by directly comparing a conventional energy-
restricted, low-fat (LF) diet to an equivalent energy-restricted LC diet in an overweight group of men and women. 
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet particularly carbohydrate restriction 
is significant to weight management and CVD risk management 
 
One non-ketogenic low-carbohydrate compared with a low-fat diet.  
Internal Validity - methods and 
actual results in the light of study 
objectives 
Comparative Intervention. 
Study described as randomised Before initiation of the study, subjects were randomly assigned, on entry, to consume an energy-restricted, low-fat (LF) diet 
(control) or energy-restricted, LC diet for 10 weeks. There were no differences in the age, sex, weight, or BMI distribution between 
the two groups at randomization. 
 
Study described as double blind No 
 
Description of withdrawals and 
dropouts present 
Over the course of the study, four subjects dropped out of the LF group and five dropped out of the LC group (all female). 
Reasons for leaving the study included scheduling conflicts with blood collection, vacation plans, or noncompliance as 
evidenced at weekly counseling sessions and/or review of diet records. 
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Randomisation / blinding 
appropriate 
To maintain objectivity, data concerning biochemical parameters were not un-blinded to identify subjects until after all samples 
had been analyzed. Blinding of the subjects to diet choice was not considered relevant.  
 
Target Population Overweight healthy Adults 
 
Why was study done? What was 
perceived general importance? 
To evaluate the effectiveness of a restricted-carbohydrate non-ketogenic diet where carbohydrates intake was at 50-70g /day.  
Is there a clear hypothesis and 
objectives? 
Not clearly stated but implied. 
What specific question is being 
addressed? 
Is a restricted carbohydrate diet at 50-70g/day as effective as an isocaloric low- fat conventional diet?    
The study setting- where did study 
take place? 
University of Guelph, Ontario Canada.  
Group actually studied  Forty overweight, healthy adult volunteers (10 males and 30 females) were recruited from the Guelph community in Ontario, 
Canada via poster and newspaper advertisements between December 2000 and April 2001.  There were initially 20 subjects 
enrolled in each experimental group; LF, 16 females, 4 males; LC, 15 females, 5 males. 
 
The social, cultural, economic, 
ethnic background 
Average age 42 years.  No further details identified. 
Study Approval Approval for this study was granted by the Human Subjects Committee of the University of Guelph, and all subjects gave their 
informed, written consent to participate. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Criteria for admission included a BMI of more than 25 with the potential for weight loss of 9 kg or more without becoming 
underweight (BMI < 20), sufficient energy intake as based on habitual diet (>4000 kJ/d), and strong personal motivation. 
Two subjects had BMIs close to the cutoff; however, both of these subjects had high body fat (>30%) as measured by bioelectrical 
impedance analysis (BIA) and thus were considered suitable weight loss subjects. 
Subjects were ineligible if they were on medications known to affect blood glucose, blood lipids, or blood pressure. Individuals 
with obesity secondary to clinically diagnosed endocrine disease were also excluded. 
 
Is there a power calculation to 
determine sample size? 
Not evident 
Was there selection bias? None evident 
 
Was there funding bias? Supported in part by the Natural Sciences Engineering Research Council of Canada 
 
Confounding Factors None Evident  
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How does the study group relate to 
researchers interest groups / 
patients? 
Study group of overweight individuals within researcher’s interest area. 
What was the intervention and how 
was it carried out? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participants recorded at least 7 days of diet records before commencing the study diets. All study subjects were provided with 
journals, recipe ideas, information on how to keep accurate food records, and detailed food composition lists to assist with 
compliance.  
 
Subjects met weekly with one of the study coordinators for weight measurements and diet consultation. 
 
The goal of the LC diet was to restrict carbohydrates to 50–70 g/d. This was achieved by gradually restricting carbohydrate intake 
from 100 g on d 0 to 50–70 g by d 5. The restriction in carbohydrates resulted in concomitant energy restriction such that females 
achieved daily intakes of 5020–6690 kJ/d (1205-1605 kcal) and males 5860–9200 kJ/d (1406-2207 kcal).  
 
Subjects on the control diet (LF) were energy-restricted to achieve the same average energy restriction as the LC group. 
 
Subjects maintained detailed food diaries and exercise logs through the entire 10-wk period. Participants were instructed not to 
change their activity/exercise programs for the duration of the study. 
 
Food records were collected periodically, without prior announcement, throughout the 10-wk period to monitor compliance and 
ensure that energy intakes were similar between the two diet groups. Food records were analyzed using FoodWorks 3 (The 
Nutrition Company, Long Valley, NJ). 
When necessary, the intakes of LF subjects were adjusted through nutritional counseling to achieve matching energy intakes for 
the two experimental groups. 
 
Recommendations for food choices for the LC group included limiting intake of breads, pastas, rice, and desserts, eliminating 
intake of deep-fried foods, dried fruit, candy, sweetened soft drinks, and sugar and increased consumption of vegetables, lean 
meats, eggs, and nuts. 
 
Subjects on the LF regimen were instructed to eliminate high-fat dairy products and substitute with no-fat or LF alternatives, to 
increase intake of fruits, vegetables, whole-grain breads, and pastas and to eliminate fried foods, cream sauces, and high fat/sugar 
cakes, pastries, chocolate, and candy. They were also asked to reduce use of oil products in cooking. 
As with LC subjects, LF subjects were encouraged to consume lean meats as alternatives to high-fat meat products. 
Weekly counseling sessions were held to instruct subjects in both groups on appropriate dietary choices to meet the energy and 
fat or carbohydrate restriction. 
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What was measured and how was it 
measured? 
Weight was measured weekly, in similar clothing without shoes, to the nearest quarter kilogram using an electronic scale and tape 
measure to estimate the subjects’ weight (kilograms) and height (centimeters) respectively. 
 
Blood pressure was measured while the subject was sitting in a chair after a 5-min rest period, using a digital, self-inflating cuff. 
Measurements were taken in duplicate and averaged. Hypertension was defined as systolic blood pressure more than 140 mm Hg 
and/or diastolic pressure 90 mm Hg or more. 
 
Body composition was estimated at baseline, wk 6, and wk 10 by BIA (Bodystat 1500; Bodystat, Inc., Tampa, FL). 
 
To decrease dehydration, which could complicate the BIA measures, subjects were instructed to refrain from consumption of 
alcohol and caffeine and to avoid exhaustive exercise 24 h before the measurements were to take place. 
Subjects were encouraged to take in as much water as possible in the 2 d leading up to the measurements, and all subjects 
attempted to void immediately before the BIA. 
 
Total cholesterol, HDL cholesterol, triglycerides were also measured. 
Glucose was analyzed. 
Plasma insulin was measured at baseline and 10 wk. 
PAI-1 functional enzyme activity was measured by bioimmunoassay. 
D(-)3-hydroxybutyrate, the assay of Ketones were assessed.  
 
Were baseline measures used? Baseline characteristics of the two experimental groups were comparable in terms of sex distribution, age, weight, height, and 
BMI. 
 
Were process measures used? The average intake over at least a 7-d consecutive period was used for each subject at two time points during the 10-wk study, in 
addition to habitual intake before study entry. 
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Weight, BP, body composition, lipids, Glucose, Insulin, β-Hydroxybutyrate  
 
 
Are the methods quantitative or 
qualitative? 
Both quantitative and qualitative 
Safety Results No subjects reported significant side effects in either treatment group. 
 
Endpoint/ Biomarker Tested Weight, BP, body composition-BMI , lipids, Glucose, Insulin, B-Hydroxybutyrate, Micronutrients 
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Are there other end points other 
than those reported that might be 
relevant and important 
Apo lipoprotein a and b. 
 
Are the endpoints relevant to actual 
practice 
Yes and consistent with other studies. 
Dietary Intake and Adherence 
Results 
The average energy restriction over the 10-wk protocol was 2540 kJ (606 kcal) for the LF group and 3195 kJ (763 kcal) for the LC 
group. 
 
Although total protein intake (grams) did not change for subjects on the LC diet, because total energy decreased there was a net 
increase in the proportion of energy coming from protein in this group. 
Changes in protein intake were not significant for the LF group, and the LF group did not differ from the LC group at either 
baseline or after the 10-wk intervention period. 
 
Total fat intake did not change for subjects on the LC group but for LF subjects decreased by approximately 50 g/d producing a 
decrease in the percentage of energy from a habitual diet of 36.4% to an average of 17.8%. LF subjects consumed lower levels of 
all three classes of fatty acids and cholesterol compared with their habitual diets. The LC group consumed similar levels of fatty 
acids to their habitual diets but also consumed 250 mg of additional cholesterol not seen in their habitual diets. 
 
The largest dietary change for the LC group was a substantial decrease in carbohydrate intake by 228 g/d. This decrease included 
both complex carbohydrates as well as simple sugars. In contrast, there was a significant increase in carbohydrate consumption 
by the LF group (+13 g/d). 
 
The decrease in carbohydrate-rich foods was associated with a 50% decrease in fiber intake on the LC diet. 
 
Micronutrient Status 
Common changes in intake between the LF and LC protocols included a decrease in daily calcium (LF, -147 mg/d; LC, -139 mg/d), 
decrease in daily sodium (LF, -728 mg/d; LC, -1095 mg/d), and decrease in daily riboflavin (LF, -0.4 mg/d; LC, -0.9 mg/d) intake. 
Changes unique to the LF diet were a decrease in vitamin E (-2.2 mg/d) and an increase in vitamin C (+38 mg/d). 
Habitual folate intakes were higher in the LC group than the LF group, which resulted in a significant decrease in folate intake for 
the LC group on the intervention diet 
 
Other dietary intake changes unique to the LC diet included: lower potassium (-1050 mg/d), lower iron (-7 mg/d), lower magnesium 
(-77 mg/d), lower vitamin C (-82 mg/d), lower vitamin D (-64 mg/d), lower thiamin (-0.9 mg/d), lower vitamin B6 (-1.0 mg/d), and an 
approximate doubling of vitamin K intake (+-41 µg/d). 
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Weight loss and cardioprotective 
mechanisms identified  
For both the LC and the LF diets, there was an energy deficiency in relation to habitual intake 
 
LC Approach showed significant decrease in circulating insulin that translated to a significant decrease in insulin to glucose ratio, 
a possible indicator of insulin sensitivity.  
 
PAI-1 levels decreased in both groups which correlated with circulating triglycerides suggesting a reduction of CVD risk.  
 
Weight Loss / Body Composition 
results 
BMI decreased by approximately 2 kg/m2 with both control (LF) and test (LC) diet interventions. 
 
Total body weight decreased by 6.8 kg in the LF group and by 7.0 kg in the LC group over the 10-wk period.  
 
There was no difference in the pattern of weight loss over time between the two groups. 
 
Significant losses in fat weight were observed in both groups (LF, -5.4 kg; LC, -4.1 kg), but a significant decrease in lean mass  
(-1.9 kg) was observed only in subjects on the LC diet. 
 
Cardiac Risk Factor Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Twelve of 31 subjects completing all 10wkof the study had some form of abnormal blood pressure at baseline. The group results 
indicated that both diets were equally effective in reducing systolic blood pressure by about 10 mm Hg and diastolic blood 
pressure by 5 mm Hg. 
 
PAI-1 bioactivity, as a risk factor for cardiovascular disease was similar in both groups of subjects at baseline and significant 
improvements were observed for both groups after 10 wk of diet intervention. 
 
The magnitude of the decrease in PAI-1 appeared larger for the LF group, but this was not statistically different from the change 
observed in the LC group. 
 
Total cholesterol values at baseline indicated that six subjects in each diet category had hypercholesterolemia (>6.2 mm) and six 
more had borderline hypercholesterolemia (5.2–6.2 mm). After 10 wk, significant improvements in total cholesterol values were 
only observed in the LF group. 
 
Group results indicated that total and LDL cholesterol levels were unchanged from baseline in LC subjects, whereas total 
cholesterol decreased by 1.6 mm. LDL cholesterol decreased by 1.3 mm in LF subjects.  
 
LF subjects also showed a significant decrease (-0.3 mm) in HDL cholesterol. LC subjects showed a significant increase (+0.14) in 
HDL cholesterol. 
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Cardiac Risk Factor Results – 
Contd. 
Group results indicated that both LC and LF groups saw a decrease of 0.4 mm in total triglyceride values over the intervention 
period. 
 
 
There was an increase is circulating β hydroxybutyrate at the 2- and 4-wk time points in the LC group that remained numerically 
higher for the remainder of the study but not statistically different from the high at 2–4 wk or baseline. 
 
There were no statistical differences between the LC and LF subjects after wk 4. 
 
There was no change in β-hydroxybutyrate concentration over time in the LF group.  
 
Endocrine markers and Hormonal 
Effects 
Although individual results suggested some improvements in glucose control, group results indicated that there was no 
significant decrease in fasting serum glucose or either LF or LC interventions. 
 
However, fasting insulin levels were significantly lower after 10 wk of the LC diet, but not the LF diet. 
 
Nine subjects (seven in the LC group and two in the LF group), by definition, had impaired fasting glucose (>6.1 mm) at baseline 
and at least one other time point in the study. In fact, five of these individuals would be diagnosed as type II diabetic (>7.0mm) 
using fasting plasma glucose as the lone indicator. This resulted in a significant decrease in the insulin to glucose ratio for the LC 
group after diet intervention. 
 
There was no change in fasting glucose or insulin to glucose ratio for the LF subjects. 
 
Exercise and Medication use Participants were instructed not to change their activity /exercise programs for the duration of the study and Subjects maintained 
detailed exercise logs through the entire ten week period.  
 
What effect may bias have on the 
result? 
None evident 
The Author's conclusions - are 
these justified? 
Hypoenergetic diets of widely differing macronutrient concentration are feasible strategies for promoting short-term weight loss 
and improvements in chronic disease risk markers in overweight and obese men and women. 
 
A LF regimen may be preferred when reduction of blood cholesterol is a primary goal, whereas the LC regimen may be more 
appropriate when improvement in insulin sensitivity is the target. 
Either strategy promotes loss of fat weight and improvements of similar magnitude in blood pressure, and triglycerides, both of 
which can be seen as additional benefits to chronic disease risk reduction in addition to weight loss itself. 
 
 
 
 
 
 
APPENDIX A9: Data Collection Sheets – Meckling et al. (2004)          
(Text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and Numerical 
references included in brackets refer to the original article).   
 
168 
 
Generalizability- the extent to which 
the results might apply outside the 
study 
These results may be applied outside the study and remains relevant for short- term weight loss and improvement of CVD risk 
factors.  
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The outcomes in our study population suggest that either a LF or a LC energy-restricted diet is an effective means for short-term 
weight loss in overweight adults. 
 
Dietary compliance was assessed by interview and diet records and for the LC correlated well with early rises in blood β-
hydroxybutyrate. 
Energy restriction alone predicted a weight loss of 5.5. and 6.9 kg, respectively, in the LF and LC groups, which was close to the 
observed values of 6.8 and 7 kg for the same groups. 
 
Slight differences, particularly for LF subjects might be explained by underreporting of habitual diets, as the subjects became 
better able to estimate their intakes and keep better food records as the trial proceeded. 
 
BMI was improved in both groups of subjects and this was largely attributed to a decrease in fat mass. 
 
Although both groups also experienced losses in lean mass, this was only significant in the LC group, suggesting that a LF diet 
regimen with sufficient protein may better preserve lean mass. 
 
The study suggests that changes in LDL cholesterol may be transient. The LF diet used was less than 18% fat energy, which is 
considerably lower than the LF diets reported by others where increases in triglycerides were sometimes reported. The very LF 
level may also be responsible for the decrease in HDL cholesterol seen in this study and similar to the results of other LF diet 
intervention studies. 
 
This suggests that despite a slight decrease in HDL cholesterol in this group, the ratios of total cholesterol and LDL cholesterol to 
HDL cholesterol were all improved in both diet groups as was the ratio of triglyceride to HDL cholesterol, all indicators of 
cardiovascular disease risk reduction. 
 
Factors other than macronutrient composition must dominate in determining circulating triglyceride levels because the LC and LF 
differed so extremely in macronutrient content and yet resulted in identical triglyceride changes. 
 
In addition to being energy deficient relative to habitual diets, both the LF and LC diet restrictions resulted in major changes in 
micronutrient intake.  
In the short term, decreases in sodium intake may contribute to the improvements in blood pressure observed in both diet groups. 
If either of these diet patterns were to be pursued in the longer term, issues of calcium and vitamin E nutrition could become 
important in the LF regimen and calcium, magnesium, iron, vitamin D, folate, and B6 intakes relevant to those consuming a very 
LC diet. 
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Discussion points – Contd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dietary inadequacy can be tolerated in the short term to achieve weight loss goals, but maintenance diets must include the right 
balance of micronutrients to promote optimal health. 
 
Thus, the long-term impacts of these diet strategies on biochemical parameters and markers of disease risk need to be evaluated. 
 
With respect to glucose control, there were no significant changes in the LF group; however, on an individual basis, there were a 
number of subjects whose fasting glucose values improved over the study period. Mean insulin values were in the normal range 
for both diet groups at baseline and after 10 wk of intervention. Only the LC group showed a significant decrease in circulating 
insulin that translated into a significant decrease in insulin to glucose ratio, a possible indicator of insulin sensitivity. 
The more severe the insulin resistance (high insulin and high glucose), the more likely the subjects are to benefit from weight 
loss. 
 
The PAI-1 levels decreased in both diet groups, which would predict a reduction cardiovascular disease risk. 
 
The only blood marker that correlated with PAI-1 in the current study (regardless of diet group) was circulating triglyceride levels 
consistent with what other researchers have found. 
 
Were study limitations discussed? Data for waist circumference was not taken hence estimates for metabolic syndrome and those at high risk are underestimates of 
the real frequency in this population. Thus despite subjects’ belief that they were overweight/obese but otherwise healthy- this 
was inaccurate.  
 
Future Implications discussed Better screening of Adults to prevent diabetes type II, CVD and the metabolic syndrome and to promote early dietary and physical 
activity interventions is needed.  
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Author Parker, Luscombe, Noakes & Clifton (2002) 
 
Title  Effect of a High-Protein, High- Monounsaturated Fat Weight Loss Diet on Glycemic Control and Lipid Levels in Type 2 Diabetes  
 
Journal  Diabetes Care 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. Two authors are Phds and two are BScs.   
General Aim Clear Assessing   the effects of a high protein (HP) weight loss diet compared with a lower protein (LP) on fat and lean tissue and fasting 
and postprandial glucose and insulin concentrations. 
Replacing dietary protein for carbohydrate (CHO) during energy restriction and weight loss has been effective in sparing lean mass 
and improving insulin sensitivity in obese subjects but has not been tested in subjects with type 2 diabetes. 
 
Specific Study objectives stated To compare a HP diet – 28% Protein, 42% CHO, 28% Fat with 8% Saturated Fat, 12% monounsaturated FA and 5% PUFA with a LP 
Diet – 16% Protein, 55% CHO, 26% Fat with 8% saturated fat, 11% MUFA, 5% PUFA in 54 obese men and women with T2D during 8 
weeks of energy restriction (1600 kcals) and 4 weeks of energy balance .  
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and CVD risk management. 
 
A moderate-carbohydrate Zone type Diet compared with a higher-carbohydrate conventional diet. 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Comparison of 2 diets – effect on body composition measured via DEXA at weeks 0 and 12.  
Study described as randomised No but subjects were randomly assigned to the two diets. 
 
Study described as double blind No  
 
Description of withdrawals and 
dropouts present 
Yes. Of 66 subjects recruited, 54 completed the study. 2 subjects withdrew before commencement. A further 10 subjects, 5 from 
each group withdrew throughout the study. 
 
Randomisation / blinding 
appropriate 
Randomisation appropriate. 
Target Population Type 2 Diabetics 
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Author Sacks et al. (2009) 
 
Title  Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates 
 
Journal  The New England Journal of Medicine  
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. 17 Authors listed – 5 of whom are MDs and 6 are PhDs. 
FM Sacks is a member of the Department of Nutrition. Harvard School of Public Health  
 
General Aim Clear To assess the significance of the macronutrients on weight loss over one year. The crucial question is whether overweight people 
have a better response in the long term to diets that emphasize a specific macronutrient composition. 
 
Specific Study objectives stated To compare the effects of three principal dietary macronutrients over two years, recognizing that weight loss typically is greatest 6-
12 months after initiation of the diet with steady regain of weight subsequently.  
 
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and cardiovascular disease (CVD) risk management. 
 
Two lower-carbohydrate diet plans where carbohydrate was 35% and 45 % of energy similar to the Zone type diet compared with 2 
diets with a low-fat/higher carbohydrate design.  
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized , comparative intervention 
Study described as randomised Yes 811 overweight adults randomly assigned to one of 4 diets. The targeted percentages of energy from fat, protein and 
carbohydrates (CHO) in the four diets.  
 
Study described as double blind No 
 
Description of withdrawals and 
dropouts present 
 
 
 
 
 
Of 1638 participants who were screened, 811 (50%) were randomly assigned to a diet, and 645 (80% of those assigned) completed 
the study (i.e., provided a body-weight measurement at 2 years) 
 
Detailed description of dropouts and participants are available in the supplementary index.  Of 201 allocated to HF/HP 
(40%F:25%P:35%Carb),  168 completed; 6 withdrew, 27 lost to follow up of which 19 did not respond to repeated contact, 2 missed 
scheduled appointment, 1 moved away. 
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Description of withdrawals and 
dropouts present contd. 
Of 204 allocated to HF/AP (40% Fat, 15% Protein, 45% Carb), 151 completed, 12 withdrew, 41 lost to follow up. 
 
Of 202 allocated to LF/HP (20%F:25%P:55% C), 157 completed, 11 withdrew and 34 lost to follow up 
 
Of 204 allocated to LF/AP (20%Fat:15%P:65%C) 169 completed, 7 withdrew and 28 were lost to follow up of which 2 moved away, 20 
did not respond and 6 did not meet scheduled appointment. 
 
Randomisation / blinding 
appropriate 
Blinding was maintained by use of similar foods for each diet.  
 
Staff and participants were advised that each diet adhered to principles of a healthful diet and recommended for long term weight 
loss thereby establishing equipoise. Staff who measured outcomes were unaware of the diet assignment of the participants.  
 
Target Population Overweight and obese 30-70 year old Adult Subjects 
 
Why was study done? What was 
perceived general importance? 
To conduct a large trial designed to overcome limitations of previous trials comparing the effects of the three macronutrients. 
Limitations noted were small samples, underrepresentation of men, limited generalizability, a lack of blinded ascertainment of the 
outcome, a lack of data on adherence to assigned diets and a large loss to follow up.   
Weight loss studied over course of 2 years to evaluate the weight loss, weight regain and plateaux phases. 
 
Is there a clear hypothesis and 
objectives? 
Not clearly stated but implied hypothesis relates to the importance of macronutrient levels for weight management.  
What specific question is being 
addressed? 
Whether macronutrient composition affects weight management. 
The study setting- where did study 
take place? 
Trial conducted at 2 sites: The Harvard School of Public Health and Brigham and Women’s Hospital Boston; and the Pennington 
Biomedical Research Centre of the Louisiana State University  
 
Group actually studied Overweight and obese generally healthy adults ensuring the inclusion of adequate number of male subjects 
 
The social, cultural, economic, 
ethnic background 
Overweight and obese subjects of which 40% would be men.  
 
Study Approval The study was approved by the National Heart Lung and Blood Institute.  
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Inclusion criteria: Participants had to be 30-70 years of age and have a body mass index of 25-40. 
Exclusion Criteria: presence of Diabetes treated with oral medications or insulin or unstable CVD; use of medication that affects 
body weight and insufficient motivation as assessed by interview and questionnaire. 
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Is there a power calculation to 
determine sample size? 
The study was powered to detect a 1.67-kg weight loss as an effect of the level of protein or fat in the diet over the 2-year period, 
assuming a withdrawal rate of 40%. 
 
Was there selection bias? Not evident.  
 
Was there funding bias? None evident. The study was supported by grants from the National, Heart, Lung and Blood Institute. 
 
Confounding Factors None noted. 
 
How does the study group relate to 
researchers interest groups / 
patients? 
The researcher’s interest groups would potentially include overweight and/or obese adults 
What was the intervention and how 
was it carried out? 
The nutrient goals for the 4 diet groups. 20% fat, 15% protein and 65% carbohydrates (CHO) the low-fat average-protein plan(LFAP); 
20% fat, 25% protein and 55% CHO  the low fat, high protein plan (LFHP); 40% fat, 15% protein and 45% CHO- the high fat, average 
protein plan (HFAP); and the 40% fat, 25% protein and 35% CHO- the high fat, high-protein plan (HFHP).  
Design: 2 by 2 factorial design and allowed a dose response test of CHO intake that ranged from 35 to 65% of energy. 
 
Other goals for all groups were that diets should include 8% or less of saturated fat, at least 20g of dietary fibre and 150mg or less 
of cholesterol per 1000kcal.  Carbohydrate rich foods with a low glycemic index were recommended in each diet.  
 
Each person had a caloric prescription of a 750 kcal deficit per day from baseline as calculated from the participant’s resting 
energy expenditure and activity level. No initial diet had less than 1200kcal/d. 
 
Group sessions were held once a week, 3 of every 4 weeks during the first six months and 2 of every 4 weeks from 6 months to 2 
years. Individual sessions were held every 8 weeks for entire two years.  
 
Daily meal plans in 2-week blocks were provided. 
 
Participants were instructed to record their food and beverage intake in a daily food diary in a web based self-monitoring tool 
Behavioural counselling was integrated to promote adherence to the assigned diets. 
 
Contact among the groups was avoided.  
 
The goal for physical activity was 90 minutes per week. 
 
Participation in exercise was monitored by questionnaire and by an online self-monitoring tool.  
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What was measured and how was it 
measured? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Body weight and waist circumference were measured in the morning before breakfast on 2 days at baseline, 6 months, and 2 years, 
and on a single day at 12 and 18 months. 
 
Dietary intake was assessed in a random sample of 50% of the participants, by a review of the 5-day diet record at baseline and by 
24-hour recall during a telephone interview on 3 non-consecutive days at 6 months and at 2 years. 
 
Questionnaires that asked for information on satiety, food craving, eating behaviour, and satisfaction with the diet were 
administered at baseline (except for diet satisfaction) and at 6 months and 2 years. 
Fasting blood samples, 24-hour urine samples, and measurement of resting metabolic rate were obtained on 1 day, and blood-
pressure measurement on 2 days, at baseline, 6 months, and 2 years. 
Levels of serum lipids, glucose, insulin, and glycated haemoglobin were measured at the clinical laboratory at the Pennington 
Biomedical Research Centre. 
 
Blood pressure was measured with the use of an automated device (HEM-907XL, Omron). The participants were evaluated for the 
presence of the metabolic syndrome, which was defined by the presence of at least three of the following five criteria: waist 
circumference of more than 102 cm in men or more than 88 cm in women, a triglyceride level of 150 mg per decilitre (1.69 mmol per 
litre) or more, a high density lipoprotein (HDL) cholesterol level of less than 40 mg per deciliter (1.03 mmol per litre) in men or less 
than 50 mg per deciliter (1.29 mmol per litre) in women, a blood pressure of 130/85 mm Hg or more, and a fasting glucose level of 
110 mg per deciliter (6.1 mmol per litre) or more. 
 
Were baseline measures used? Baseline characteristics were similar among participants assigned to the four diets and between those who were assigned to a diet 
and those who completed the study. 
 
Were process measures used? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical Analysis 
Data were pooled from the diets for the two factorial comparisons: low fat versus high fat and average protein versus high protein. 
The analysis also included a comparison of two of the four diets, the diet with the lowest carbohydrate content and the diet with the 
highest carbohydrate content, and included a test for trend across the four levels of carbohydrates. 
 
The effects of protein, fat, and carbohydrate levels were evaluated independently with the use of two-sample t-tests at a two-sided 
significance level of 0.05. 
 
Exploratory post hoc analyses were performed with threshold amounts of weight loss as outcomes, with Bonferroni’s adjustment 
for multiple comparisons. 
 
Associations between adherence to the fat and protein goals and weight loss were also explored in post hoc analyses. 
 
An intention-to-treat analysis was performed in which long-term weight loss for persons who withdrew from the study early (after at 
 
 
 
 
 
APPENDIX A11: Data Collection Sheets – Sacks et al. (2009)         
(Text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and Numerical 
references included in brackets refer to the original article).   
 
182 
 
Were process measures used? 
contd. 
least 6 months of participation) was imputed on the basis of a rate of 0.3 kg per month of regained weight and a rate of 0.3 cm per 
month of regained waist circumference after withdrawal. 
 
Risk factors for cardiovascular disease and diabetes were also analyzed according to the intention-to-treat principle, with zero 
change from baseline imputed for missing data. 
 
Were outcome measures 
identified? Are there clear validated 
outcomes? 
Yes 
Are the methods quantitative or 
qualitative? 
Both quantitative and qualitative 
Safety Results 
 
 
 
 
 
 
Adverse events were reported by 57 participants (7%); there were no significant differences in the rates among diets.  
 
The ratio of urinary microalbumin to creatinine was more than 30 in five participants in the average-protein group and in five 
participants in the high-protein group at 6 months and in seven participants, all in the average protein groups, at 2 years. 
 
There was a larger decrease in urinary nitrogen excretion from baseline in the average-protein group than in the high protein group 
(a difference in the change of 1.6 g at 6 months and 0.8 g at 2 years. These differences correspond to a difference in dietary protein 
of 10 g per day and 5 g per day, respectively. 
Endpoint/ Biomarker Tested The primary outcome of the study was the change in body weight over a period of 2 years, and the secondary outcome was the 
change in waist circumference 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b 
Are the endpoints relevant to actual 
practice 
Yes 
Dietary Intake and Adherence 
Results 
 
 
 
 
 
 
 
Mean reported intakes at 6 months and 2 years did not reach the target levels for macronutrients. The reported intakes represented 
differences from target levels of fat, protein, and carbohydrate intake of 8.0, 4.2, and 14.4 percentage points, respectively, at 6 
months and 6.7, 1.4, and 10.2 percentage points, respectively, at 2 years. 
 
Reported energy intakes and physical activity were similar among the diet groups. 
 
The participants who completed the study had a mean weight loss of 6.5 kg at 6 months, which corresponds to a reduction in daily 
energy intake of approximately 225 kcal. 
The respiratory quotient was 0.84 at baseline in both the high-fat and low-fat groups, and the between-group difference in the 
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Dietary Intake and Adherence 
Results contd. 
change at 2 years (the value in the high-fat group minus the value in the low-fat group) was −0.02 (P = 0.002).  
 
Thus, changes in biomarkers confirmed that differences among the groups in macronutrient intake were consistent with those 
recorded in the dietary reports and that participants modified their intake of macronutrients in the direction of the goals, although 
the targets were not fully achieved. 
 
Adherence to the goal for protein intake was associated with more weight loss only in the high protein groups, and adherence to 
the goal for fat intake was associated with more weight loss only in the low-fat groups (P<0.001). 
 
Weight loss and cardio-protective 
and other mechanisms identified,  
Craving, fullness, and hunger and diet-satisfaction scores were similar at 6 months and at 2 years among the diets. 
 
Attendance at group sessions strongly predicted weight loss at 2 years (0.2 kg for every session attended) and was similar among 
the diet groups 
 
Weight Loss / Body Composition 
results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weight Loss 
At 6 months, participants assigned to each diet had lost an average of 6 kg, which represented 7% of their initial weight; they began 
to regain weight after 12 months. 
 
By 2 years, weight loss remained similar in those who were assigned to a diet with 15% protein and those assigned to a diet with 
25% protein (3.0 and 3.6 kg, respectively); in those assigned to a diet with 20% fat and those assigned to a diet with 40% fat (3.3 kg 
for both groups); and in those assigned to a diet with 65% carbohydrates and those assigned to a diet with 35% carbohydrates (2.9 
and 3.4 kg, respectively) (P>0.20 for all comparisons). Among the 80% of participants who completed the trial, the average weight 
loss was 4 kg; 14 to 15% of the participants had a reduction of at least 10% of their initial body weight.  
 
Satiety, hunger, satisfaction with the diet, and attendance at group sessions were similar for all diets; attendance was strongly 
associated with weight loss (0.2 kg per session attended).  
 
The change in waist circumference did not differ significantly among the diet groups. 
 
Most of the weight loss occurred in the first 6 months. Changes from baseline differed among the diet groups by less than 0.5 kg of 
body weight and 0.5 cm of waist circumference. 
 
 
After 12 months, all groups, on average, slowly regained body weight. A total of 185 of the participants (23%) continued to lose 
weight from 6 months to 2 years. The mean (±SD) additional weight loss was 3.6±3.5 kg, for a mean total loss from baseline of 
9.3±8.2 kg, with no significant differences among the diet groups. 
At 2 years, 31 to 37% of the participants had lost at least 5% of their initial body weight, 14 to 15% of the participants in each diet 
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Weight Loss / Body Composition 
results – Contd. 
group had lost at least 10% of their initial weight, and 2 to 4% had lost 20 kg or more (P>0.20 for the comparisons between diets). 
 
Cardiac Risk Factor Results All the diets reduced risk factors for cardiovascular disease and diabetes at 6 months and 2 years. 
At 2 years, the two low-fat diets and the highest-carbohydrate diet decreased low-density lipoprotein cholesterol levels more than 
did the high-fat diets or the lowest-carbohydrate diet (low-fat vs. high-fat, 5% vs. 1% [P = 0.001]; highest carbohydrate vs. lowest-
carbohydrate, 6% vs. 1% [P = 0.01]). 
 
The lowest-carbohydrate diet increased HDL cholesterol levels more than the highest-carbohydrate diet (9% vs. 6%, P = 0.02). 
There was a larger increase from baseline in the HDL cholesterol level, a biomarker for dietary carbohydrate, in the lowest-
carbohydrate group than in the highest-carbohydrate group (a difference in the change of 2 mg per deciliter at 2 years). This 
difference corresponds to a predicted difference in carbohydrate intake of 6%. 
 
All the diets decreased triglyceride levels similarly, by 12 to 17%. 
 
Blood pressure decreased from baseline by 1 to 2 mm Hg, with no significant differences among the groups (P>0.59 for all 
comparisons). 
 
These changes in risk factors in the intention-to-treat population were about 30 to 40% smaller than the changes seen among 
participants who provided data at 2 years, reflecting the effect of the imputation of missing values 
 
Endocrine markers and Hormonal 
Effects 
All the diets except the one with the highest carbohydrate content decreased fasting serum insulin levels by 6 to 12%; the decrease 
was larger with the high-protein diet than with the average-protein diet (10% vs. 4%, P = 0.07). 
 
The metabolic syndrome was present in 32% of the participants at baseline, and the percentage was lower at 2 years, ranging from 
19 to 22% in the four diet groups (P = 0.81 for the four-way comparison). 
 
Exercise and Medication use Physical Activity goals were established for sedentary participants gradually increasing from 30 minutes of moderate intensity per 
week to 90 minutes per week during first 6 months Participants were encouraged to do more if they could. Minutes of exercise were 
monitored using self-monitoring forms.  
 
 Reported physical activity was similar among the diet groups. 
 
What effect may bias have on the 
result? 
None evident 
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The Author's conclusions - are 
these justified? 
Diets that are successful in causing weight loss can emphasize a range of fat, protein, and carbohydrate compositions that have 
beneficial effects on risk factors for cardiovascular disease and diabetes. Such diets can also be tailored to individual patients on 
the basis of their personal and cultural preferences and may therefore have the best chance for long-term success. 
  
Generalizability- the extent to 
which the results might apply 
outside the study 
The four different dietary strategies representing differing percentages of various macronutrients provide clinical options to 
consider when making dietary recommendations. 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The principal finding is that the diets were equally successful in promoting clinically meaningful weight loss and the maintenance 
of weight loss over the course of 2 years. 
 
Satiety, hunger, satisfaction with the diet, and attendance at group sessions were similar for all diets. 
 
The diets improved lipid risk factors and fasting insulin levels in the directions that would be expected on the basis of 
macronutrient content. 
 
The study had a large sample, a high rate of retention, and the sensitivity to detect small changes in weight. 
 
The findings should be directly applicable to both clinicians’ recommendations for weight loss in individual patients and the 
development of population-wide recommendations by public health officials. 
 
Despite the intensive behavioural counselling in the study, participants had difficulty achieving the goals for macronutrient intake 
of their assigned group. The mean differences among the groups in fat, carbohydrate, or protein intake at 6 months were 
nevertheless often greater than those in several previous trials comparing diets for weight loss. 
 
Substantially diminished adherence after the first few months is typical in weight loss trials and occurred between 6 months and 2 
years in our trial. 
Only two trials have reported dietary intake beyond 1 year and one of them provided foods to the participants. 
 
In addition, trials of low-carbohydrate diets have reported a very low incidence of urinary ketosis after 6 months suggesting that in 
most overweight people, it is futile to sustain a low intake of carbohydrates. 
 
Overall, these findings with respect to adherence to macronutrient goals suggest that participants in weight-loss programs revert 
to their customary macronutrient intakes over time but may nonetheless be able to maintain weight loss. 
 
Attendance had a strong association with weight loss, and the association was similar across diet groups. The Authors view 
attendance at counselling sessions as a proxy for commitment to achieving weight loss. 
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Discussion points – contd. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Study participants who attended two thirds of the sessions over the course of 2 years lost about 9 kg of weight. 
 
Regain after 6 to 12 months was about 20% of the regain reported in earlier trials. Several recent trials have also shown that 
continued contact with participants after weight loss is associated with less regain. These findings together point to behavioural 
factors rather than macronutrient metabolism as the main influences on weight loss. 
 
The authors used a generic approach to developing each diet and the instructions for following it, in order to minimize Influences 
media attention, cultural norms or scientific novelty. 
 
No diet was considered to be a control diet, and the dietary counselling and the attention that we provided were the same for all diet 
groups throughout the study period. 
 
The authors  did not confirm previous findings that low-carbohydrate or high protein diets caused increased weight loss at 6 
months and that the advantage of these diets usually eroded by 12 months, with weight loss that was nearly or fully equivalent to 
that with low-fat diets. 
 
Other studies showed increased weight loss at 1 to 2 years with diets that were high in unsaturated fat or with low-fat, high-
carbohydrate vegetarian diets. 
 
When non nutritional influences are minimized, as they were in this study, the specific macronutrient content is of minor 
importance as was suggested many years ago. 
Were study limitations discussed? Association of achieved nutrition with weight loss explored. These post hoc analyses do not have the strong validity of the main 
analysis which compared randomized groups. Protein and fat intakes overlapped hence confounding the results.  
 
Future Implications discussed Any type of diet when taught for the purpose of weight loss with enthusiasm and persistence can be effective. 
Tailoring of diets to suit individual patients on the basis of their personal and cultural preferences may enable more long term 
success.  
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Why was study done? What was 
perceived general importance? 
To evaluate the effects of a high-protein intake on insulin sensitivity and body composition in the context of T2D patients  
Is there a clear hypothesis and 
objectives? 
The hypothesis is that a HP diet will improve insulin resistance in T2D after weight loss and reduce fasting and postprandial 
glucose and insulin concentrations.  
Also proposed was that the preservation of lean mass in the HP diet leads to an improvement in insulin mediated glucose uptake 
as compared with the LP diet. 
 
What specific question is being 
addressed? 
Is there an improvement in insulin-mediated glucose uptake and preservation of lean mass with a high-protein diet as compared 
with a low-protein diet? 
 
The study setting- where did study 
take place? 
The 12 week study was conducted on an outpatient basis and consisted of an 8 week energy restriction component (1600 kcal) 
followed by a 4 week period of the same macronutrient composition but in energy balance. 
 
Group actually studied  A total of 66 subjects with type 2 diabetes and no proteinuria were recruited by public advertisement. Subjects attended detailed 
information sessions, and all gave written informed consent. No payment was provided for participation in the study. 
 
Of the 54 subjects (19 men, 35 women), 25 managed their diabetes by diet alone, 26 required oral hypoglycemic medications (19 on 
metformin, 15 sulfonylureas alone or combination), and 4 required insulin. Four subjects with fasting plasma glucose (FPG) of 4–6 
mmol/l were asked to cease medications before commencement of the diet to allay possible hypoglycemic episodes with weight 
loss. 
Decreases in dosage occurred in eight subjects at weeks 4 and 8 (five from the HP diet and three from the LP diet). Subjects on 
antihypertensive or lipid-lowering medication were asked to maintain the same dose throughout the study. 
All subjects were asked to maintain exercise programs at levels established before the study. 
 
The social, cultural, economic, 
ethnic background 
Subjects with T2D recruited by public advertisement.   
Study Approval Study design approved by the Human Ethics Committee of the Commonwealth Scientific and Industrial Research Organisation 
(CSIRO). All subjects gave written informed consent. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Of the subjects, 54 completed the study. Two subjects withdrew before commencement. A further 10 subjects (5 from each diet 
group) withdrew throughout the study. 
 
Is there a power calculation to 
determine sample size? 
None evident.  
Was there selection bias? None evident 
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Was there funding bias? None evident.  Financial contribution from Meadow lea foods. 
 
Confounding Factors Medications used.  
 
How does the study group relate to 
researchers interest groups / 
patients? 
Potentially diabetics would be clients of the researcher.  The target endpoints of insulin resistance, glucose uptake and 
preservation of lean tissue and the effects on these by manipulating diet are of relevance to this researcher. 
 
 
What was the intervention and how 
was it carried out? 
Subjects were matched on the basis of Fasting Plasma Glucose, BMI, age, sex, and medication and were randomly assigned to 
either the HP diet (30% protein, 40% CHO) or LP diet (15% protein, 60% CHO). The 12-week study was conducted on an outpatient 
basis and consisted of an 8-week energy restriction component (1,600 kcal) followed by a 4-week period of the same macronutrient 
composition but in energy balance. 
 
Body composition was determined by dual-energy X-ray absorptiometry at weeks 0 and 12. 
 
The HP diet consisted of 30% energy from protein and 40% energy from CHO, and the LP diet consisted of 15% energy from 
protein and 60% energy from CHO. Diets were matched for fatty acid profile (8% saturated fatty acids, 12% monounsaturated fatty 
acids, 5% polyunsaturated fatty acids). 
 
The diets were prescriptive fixed menu plans, and subjects were supplied with key foods, which amounted to 60% of energy intake, 
to assist with dietary compliance. 
 
These included pre-weighed portions of beef and chicken suitable for six meals per week and shortbread biscuits plus low-fat 
cheese (3% fat), diet yogurt, and skim milk powder for the HP diet and rice for the LP diet. The other differences between the diets 
lay in the amount of meat and chicken (200 vs. 100 g), fruit (200 vs. 300 g), and whole-meal bread (3 vs. 4 slices). Alcohol was not 
permitted, and a list of free choice vegetables and salad (maximum 2.5 cups) was provided. During the stable weight phase, caloric 
intake was increased by 3̴0%, with a further 7 g protein in the LP diet and 21 g in the HP diet. 
 
What was measured and how was it 
measured? 
Subjects attended the clinic for venous blood samples on 2 consecutive days at weeks 0, 4, 8, and 12 after a 12-h fast.  
Weight was recorded in light clothing at each visit. At weeks 0, 8, and 12, all subjects underwent a 75-g 3-h oral glucose 
tolerance test (OGTT) with venous blood samples taken fasting and at 1, 2, and 3 h. Subjects collected 24 h urine 
samples for assessment of urea/ creatinine ratio at weeks 0, 8 and 12. 
 
Were baseline measures used? Subjects were matched for BMI, age, sex, FPG, and medication. There were no significant differences between two groups for 
weight or blood pressure. 
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Were process measures used? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Each subject completed weighed daily diet checklists of all foods and was assessed by the same dietitian at 2-week intervals. 
Group training was provided in the use of scales and keeping food records. Three consecutive days (1 weekend and 2 weekdays) 
of the checklist from each 2-week period were analyzed by Diet/1 Nutrient Calculation software (Xyris Software 1998, Highgate Hill, 
Australia). This program had no missing values for the nutrients of interest, and because the diet was very prescriptive, unusual 
foods were rarely encountered. Recipes were entered as proportions of the original ingredients. The database had been 
extensively modified by our group to add new foods and recipes. 
 
Body composition - For assessment of body fat amount and distribution, all subjects underwent a dual-energy X-ray 
absorptiometry (DEXA; Norland, Fort Atkinson, WI) scan at weeks 0 and 12.  
 
Abdominal fat mass was measured from the area demarcated by the ribs at the upper portion and the ileac crests at the lower 
portion. DEXA calculates the percentage of lean and fat mass based on measured tissue density and the known density of the two 
tissue types. The CV of these measures was 3– 4%.  
 
Insulin sensitivity - At weeks 0 and 12, 25 subjects (8 men, 17 women), not on diabetes medication, underwent a continuous low-
dose glucose and insulin infusion test (LDIGIT) for determination of steady-state plasma glucose (SSPG) and steady-state plasma 
insulin (SSPI) concentrations. The method, a refinement of the modified Harano test previously described (18), involved the 
insertion of a cannula into a forearm vein for infusion of a combination of insulin and glucose. From a cannula inserted into the 
opposite forearm, blood samples (under a warmed blanket) were taken at baseline and at 120, 130, 140, 145, and 150 min after 
commencement of the infusion. SSPG and SSPI concentrations were determined from the average of the samples taken between 
120 and 150 min. Subjects were required to lie quietly in a supine position for the duration of the test. 
 
Biochemical analysis - Fasting blood samples were collected in tubes containing either no additives for lipids and insulin or 
sodium fluoride/ EDTA for glucose measurements. Plasma or serum was isolated by centrifugation at 600g for 10 min at 5°C 
(Beckman GS-6R centrifuge; Beckman, Fullerton, CA) and frozen at _20°C. Biochemical assays were performed in a single assay at 
the completion of the study, except LDIGIT glucose samples, which were analyzed after each test. 
 
Plasma glucose and serum total cholesterol and triacylglycerol concentrations were measured on a Cobas-Bio centrifugal 
analyzer (Roche, Basel) by using enzymatic kits (Roche) and control sera. 
 
Plasma HDL cholesterol concentrations were measured using a Cobas-Bio analyzer after precipitation of LDL and 
VLDL cholesterol with polyethylene glycol 6000 solution. A modified Friedewald equation was used to calculate LDL cholesterol 
(19).  Insulin was determined in duplicate using a radioimmunoassay kit (Pharmacia & Upjohn Diagnostics, Uppsala, Sweden). 
HbA1c samples were frozen at -20°C and analyzed by high-performance liquid chromatography at the end of the study. Urine 
samples to assess compliance to the diet and albumin excretion were frozen, and urea and creatinine were measured in one run on 
a Hitachi autoanalyzer (Roche, Indianapolis, IN) at the end of the study. 
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Were process measures used? – 
Contd.  
Statistical analysis- Analysis was performed by repeated measures ANOVA (with covariates of baseline weight and total fat mass 
in some analyses) with variables measured at weeks 0, 4, 8, and 12 using SPSS for Windows 10.0 statistical software (SPSS, 
Chicago). Diet and sex were between-subject factors. One-way ANOVA was used to exclude significant differences at baseline 
between diets and men and women. Inclusion of data from subjects with medication changes significantly affected the results for 
the OGTT; therefore, these eight subjects were excluded from analysis in this test. Significance was set at P < 0.05. 
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Primary Outcome Measures: Body composition including weight, body fat levels, abdominal fat mass, Insulin sensitivity; Plasma 
glucose, serum cholesterol and triacylglycerol concentrations, HDL and LDL cholesterol; HbA1c; Compliance to diet and albumin 
excretion via urine samples ; urea and creatinine  
 
Are the methods quantitative or 
qualitative? 
Both 
Safety Results None reported 
Are there end points other than 
those reported that might be 
relevant and important 
Renal function and bone health maybe relevant due to high-protein arm of study. Apo lipoprotein a and b. 
Are the endpoints relevant to actual 
practice 
Yes and consistent with other studies 
Dietary Intake and Adherence 
Results 
Energy intake in the 8-week energy restriction phase and the 4-week energy balance phase was not different between the two diets 
(Table 2). As planned, protein intake was higher and CHO intake lower in the HP diet than in the LP diet both in energy restriction 
and energy balance (P < 0.001), with no differences between phases. Saturated fat intake was not different between the diets or the 
phases, but dietary fiber and dietary cholesterol were significantly different between diets in both phases. 
 
Weight loss and cardio-protective 
mechanisms identified,  
None highlighted. 
Weight Loss / Body Composition 
results 
Overall weight loss of 5.2±1.8 kg achieved independently of diet composition.  Women on the HP diet lost significantly more total  
fat (5.3 vs. 2.8 kg, P=0.009) and abdominal fat (1.3 vs. 0.7 kg P=0.006) compared with women on the LP diet.  
In men there was no difference in fat loss between diets 3.9 vs. 5.1kg.  
Total lean mass decreased in all subjects independent of diet composition. 
Both men and women lost weight on both diets; however, there was a weak sex by diet interaction (P=0.04), such that men lost 
more weight on the LP diet (5.8 vs. 4.7 kg), whereas women lost more weight on the HP diet (6 vs. 4.2 kg). Similarly for total fat 
mass, men lost more on the LP diet (5.1 vs. 3.8 kg), whereas women lost more on the HP diet (5.3 vs. 2.8 kg), as reflected by a 
significant sex by diet interaction (P=0.01). A significant sex by diet effect was also observed in the change in abdominal fat mass 
(P< 0.02), such that men lost more fat on the LP diet (1.7 vs. 1.4 kg), whereas women lost more on the HP diet (1.3 vs. 0.7 kg). Total 
lean mass was reduced significantly with both diets (1.35 kg on the LP diet and 0.52 kg on the HP diet) with no significant 
difference between them. 
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Ketonuria Results None noted 
 
Cardiac Risk Factor Results 
 
 
 
 
 
 
 
 
 
 
 
Both dietary patterns resulted in improvements in the CVD risk profile as a consequence of weight loss.  
 
Greater reduction in LDL cholesterol in both sexes. LDL cholesterol reduction was significantly greater on the HP diet (5.7%) than 
on the LP diet (2.7%) (P<0.01). 
 
Total cholesterol concentrations decreased more on the HP diet than on the LP diet, as reflected by a diet by time interaction of P= 
0.009.  
 
For all subjects, triacylglycerol concentrations decreased at week 12 (P<.001), and there was no diet or sex effect.  
There was no effect of time or diet for HDL cholesterol concentrations. 
 
Blood pressure -  Systolic blood pressure fell significantly by 8 mmHg and diastolic blood pressure by 4 mmHg at week 8 (P < 
0.001) with no differential effect of diet. During the weight stabilization period between weeks 8 and 12, systolic blood pressure 
rose by 3 mmHg and diastolic blood pressure by 1 mmHg (P < 0.001). This was also not affected by diet composition. 
 
Hormonal and Endocrine Results Glycemic control 
Fasting and 1-, 2-, and 3-h plasma glucose concentrations were reduced by both dietary interventions (P < 0.001); however, no 
significant effects of diet or sex were observed. 
Fasting and 2-h insulin concentrations were reduced at weeks 8 and 12 (both P< 0.001). The insulin.glucose product was reduced 
by 42% at 3 h at week 12. HbA1c decreased by 9.4% between baseline and week 12 (P < 0.001). There were no significant 
differences observed for diet or sex. 
 
Exercise and Medication use Subjects asked to maintain exercise programmes at levels established before the study.  
 
What effect may bias have on the 
result? 
None evident. 
The Author's conclusions - are 
these justified? 
 
 
 
 
 
 
HP is a valid diet choice for reducing CVD risk in T2D. 
Both dietary patterns resulted in improvements in the cardiovascular disease (CVD) risk profile as a consequence of weight loss. 
However, the greater reductions in total and abdominal fat mass in women and greater LDL cholesterol reduction observed in both 
sexes on the HP diet suggest that it is a valid diet choice for reducing CVD risk in type 2 diabetes. 
 
  
In this study, both HP and LP diets decreased weight, fasting glucose, and insulin concentrations as well as total and abdominal 
fat. However, in women, the HP diet was able to decrease total and abdominal fat differentially compared with the LP diet. 
 
 
 
 
 
APPENDIX A10:  Data Collection Sheets- Parker et al. 2002          
(Some sections of text and/or data extracted verbatim from the reference paper. Figure, Table and Numerical references 
included in brackets refer to the original article).   
 
176 
 
The Author's conclusions - are 
these justified? contd. 
In addition, the HP diet significantly decreased LDL cholesterol concentrations in both men and women compared with the LP 
diet. 
 
In our study, subjects lost an absolute 2.1% lean mass overall with no significant difference between the two diets. 
 
Generalizability- the extent to which 
the results might apply outside the 
study 
Weight loss and CVD marker improvement with energy restriction may be generalized. The specific sex-specific effect of the HP 
diet on total and abdominal fat in women but not men needs to be explored further.  
Discussion points 
 
 
 
 
 
 
 
Steady state plasma glucose (SSPG) concentrations were significantly decreased at week 12, indicating that subjects became 
more insulin sensitive. SSPI concentrations were also significantly reduced at week 12, but this may reflect the decrease in infused 
insulin (due to a lower body weight) or an enhanced clearance and not necessarily a decrease in insulin secretion. 
 
Greater energy restriction, (800 vs. 1,600 kcal), higher protein levels, and the inclusion of only glucose-tolerant women may have 
affected the disparity in outcomes between the study of Piatti et al. (13), who found that HP weight loss diets spared lean body 
mass, and our study. This study used DEXA for estimating body composition in obese subjects with type 2 diabetes, whereas 
Piatti et al. (13) used anthropometry. DEXA is a more accurate method of determination of body fat distribution when compared 
with traditional anthropometric methods, such as skinfold thickness measurements and waist-to-hip ratio. 
 
Despite greater fat loss, the women on the HP diet were apparently not more insulin sensitive than the men or women who lost less 
fat. A possible explanation for this may be the small differential fat loss (2.5 kg), which may not have been large enough to produce 
a significant change in insulin sensitivity, as assessed by the low-dose glucose and insulin infusion test (LDIGIT) or the oral 
glucose tolerance test (OGTT). Longer-term studies with greater weight loss might reveal such differences.  
 
Both diets were low in saturated fat and cholesterol.  In contrast to the findings of this study, Wolfe and Giovanetti (23) found 
significant decreases in triglyceride concentrations as well as increases in HDL cholesterol concentrations on the HP diet. 
Although triglyceride concentrations were improved, in this study, there was no difference between the diets. 
 
This study found a significant decrease in LDL cholesterol at all time points from baseline in both men and women on the HP diet 
compared with the LP diet. There was no impact of body composition changes on this result. Because saturated fat intake was not 
different between the diets, this was not the cause of the differential LDL cholesterol reduction. The mechanism for the 
hypolipidemic effect of an HP intake on LDL cholesterol concentrations is unclear. 
 
 
Were study limitations discussed? C-Peptide concentrations were not measured which could indicate whether endogenous insulin secretion had reduced.  
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Future Implications discussed The novel observation of a possible sex-specific effect of the HP diet on total and abdominal fat loss in women but not men 
requires confirmation. Although this result may reflect the small number of male subjects in both dietary interventions, there was 
no suggestion that the HP diet was advantageous in men.  
 
The observed decrease in LDL cholesterol concentrations of 5.7% on the HP diet may lead to a 10% decrease in the risk of 
CVD in these subjects. This result is relevant because in people with type 2 diabetes, the risk of CVD is increased two to four times 
that of the normal population (1). However, because this effect on LDL has not been observed before with HP weight loss diets, 
further confirmatory work is required. 
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Author Sacks et al. (2009) 
 
Title  Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates 
 
Journal  The New England Journal of Medicine  
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. 17 Authors listed – 5 of whom are MDs and 6 are PhDs. 
FM Sacks is a member of the Department of Nutrition. Harvard School of Public Health  
 
General Aim Clear To assess the significance of the macronutrients on weight loss over one year. The crucial question is whether overweight people 
have a better response in the long term to diets that emphasize a specific macronutrient composition. 
 
Specific Study objectives stated To compare the effects of three principal dietary macronutrients over two years, recognizing that weight loss typically is greatest 6-
12 months after initiation of the diet with steady regain of weight subsequently.  
 
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and cardiovascular disease (CVD) risk management. 
 
Two lower-carbohydrate diet plans where carbohydrate was 35% and 45 % of energy similar to the Zone type diet compared with 2 
diets with a low-fat/higher carbohydrate design.  
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized , comparative intervention 
Study described as randomised Yes 811 overweight adults randomly assigned to one of 4 diets. The targeted percentages of energy from fat, protein and 
carbohydrates (CHO) in the four diets.  
 
Study described as double blind No 
 
Description of withdrawals and 
dropouts present 
 
 
 
 
 
Of 1638 participants who were screened, 811 (50%) were randomly assigned to a diet, and 645 (80% of those assigned) completed 
the study (i.e., provided a body-weight measurement at 2 years) 
 
Detailed description of dropouts and participants are available in the supplementary index.  Of 201 allocated to HF/HP 
(40%F:25%P:35%Carb),  168 completed; 6 withdrew, 27 lost to follow up of which 19 did not respond to repeated contact, 2 missed 
scheduled appointment, 1 moved away. 
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Description of withdrawals and 
dropouts present contd. 
Of 204 allocated to HF/AP (40% Fat, 15% Protein, 45% Carb), 151 completed, 12 withdrew, 41 lost to follow up. 
 
Of 202 allocated to LF/HP (20%F:25%P:55% C), 157 completed, 11 withdrew and 34 lost to follow up 
 
Of 204 allocated to LF/AP (20%Fat:15%P:65%C) 169 completed, 7 withdrew and 28 were lost to follow up of which 2 moved away, 20 
did not respond and 6 did not meet scheduled appointment. 
 
Randomisation / blinding 
appropriate 
Blinding was maintained by use of similar foods for each diet.  
 
Staff and participants were advised that each diet adhered to principles of a healthful diet and recommended for long term weight 
loss thereby establishing equipoise. Staff who measured outcomes were unaware of the diet assignment of the participants.  
 
Target Population Overweight and obese 30-70 year old Adult Subjects 
 
Why was study done? What was 
perceived general importance? 
To conduct a large trial designed to overcome limitations of previous trials comparing the effects of the three macronutrients. 
Limitations noted were small samples, underrepresentation of men, limited generalizability, a lack of blinded ascertainment of the 
outcome, a lack of data on adherence to assigned diets and a large loss to follow up.   
Weight loss studied over course of 2 years to evaluate the weight loss, weight regain and plateaux phases. 
 
Is there a clear hypothesis and 
objectives? 
Not clearly stated but implied hypothesis relates to the importance of macronutrient levels for weight management.  
What specific question is being 
addressed? 
Whether macronutrient composition affects weight management. 
The study setting- where did study 
take place? 
Trial conducted at 2 sites: The Harvard School of Public Health and Brigham and Women’s Hospital Boston; and the Pennington 
Biomedical Research Centre of the Louisiana State University  
 
Group actually studied Overweight and obese generally healthy adults ensuring the inclusion of adequate number of male subjects 
 
The social, cultural, economic, 
ethnic background 
Overweight and obese subjects of which 40% would be men.  
 
Study Approval The study was approved by the National Heart Lung and Blood Institute.  
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Inclusion criteria: Participants had to be 30-70 years of age and have a body mass index of 25-40. 
Exclusion Criteria: presence of Diabetes treated with oral medications or insulin or unstable CVD; use of medication that affects 
body weight and insufficient motivation as assessed by interview and questionnaire. 
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Is there a power calculation to 
determine sample size? 
The study was powered to detect a 1.67-kg weight loss as an effect of the level of protein or fat in the diet over the 2-year period, 
assuming a withdrawal rate of 40%. 
 
Was there selection bias? Not evident.  
 
Was there funding bias? None evident. The study was supported by grants from the National, Heart, Lung and Blood Institute. 
 
Confounding Factors None noted. 
 
How does the study group relate to 
researchers interest groups / 
patients? 
The researcher’s interest groups would potentially include overweight and/or obese adults 
What was the intervention and how 
was it carried out? 
The nutrient goals for the 4 diet groups. 20% fat, 15% protein and 65% carbohydrates (CHO) the low-fat average-protein plan(LFAP); 
20% fat, 25% protein and 55% CHO  the low fat, high protein plan (LFHP); 40% fat, 15% protein and 45% CHO- the high fat, average 
protein plan (HFAP); and the 40% fat, 25% protein and 35% CHO- the high fat, high-protein plan (HFHP).  
Design: 2 by 2 factorial design and allowed a dose response test of CHO intake that ranged from 35 to 65% of energy. 
 
Other goals for all groups were that diets should include 8% or less of saturated fat, at least 20g of dietary fibre and 150mg or less 
of cholesterol per 1000kcal.  Carbohydrate rich foods with a low glycemic index were recommended in each diet.  
 
Each person had a caloric prescription of a 750 kcal deficit per day from baseline as calculated from the participant’s resting 
energy expenditure and activity level. No initial diet had less than 1200kcal/d. 
 
Group sessions were held once a week, 3 of every 4 weeks during the first six months and 2 of every 4 weeks from 6 months to 2 
years. Individual sessions were held every 8 weeks for entire two years.  
 
Daily meal plans in 2-week blocks were provided. 
 
Participants were instructed to record their food and beverage intake in a daily food diary in a web based self-monitoring tool 
Behavioural counselling was integrated to promote adherence to the assigned diets. 
 
Contact among the groups was avoided.  
 
The goal for physical activity was 90 minutes per week. 
 
Participation in exercise was monitored by questionnaire and by an online self-monitoring tool.  
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What was measured and how was it 
measured? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Body weight and waist circumference were measured in the morning before breakfast on 2 days at baseline, 6 months, and 2 years, 
and on a single day at 12 and 18 months. 
 
Dietary intake was assessed in a random sample of 50% of the participants, by a review of the 5-day diet record at baseline and by 
24-hour recall during a telephone interview on 3 non-consecutive days at 6 months and at 2 years. 
 
Questionnaires that asked for information on satiety, food craving, eating behaviour, and satisfaction with the diet were 
administered at baseline (except for diet satisfaction) and at 6 months and 2 years. 
Fasting blood samples, 24-hour urine samples, and measurement of resting metabolic rate were obtained on 1 day, and blood-
pressure measurement on 2 days, at baseline, 6 months, and 2 years. 
Levels of serum lipids, glucose, insulin, and glycated haemoglobin were measured at the clinical laboratory at the Pennington 
Biomedical Research Centre. 
 
Blood pressure was measured with the use of an automated device (HEM-907XL, Omron). The participants were evaluated for the 
presence of the metabolic syndrome, which was defined by the presence of at least three of the following five criteria: waist 
circumference of more than 102 cm in men or more than 88 cm in women, a triglyceride level of 150 mg per decilitre (1.69 mmol per 
litre) or more, a high density lipoprotein (HDL) cholesterol level of less than 40 mg per deciliter (1.03 mmol per litre) in men or less 
than 50 mg per deciliter (1.29 mmol per litre) in women, a blood pressure of 130/85 mm Hg or more, and a fasting glucose level of 
110 mg per deciliter (6.1 mmol per litre) or more. 
 
Were baseline measures used? Baseline characteristics were similar among participants assigned to the four diets and between those who were assigned to a diet 
and those who completed the study. 
 
Were process measures used? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical Analysis 
Data were pooled from the diets for the two factorial comparisons: low fat versus high fat and average protein versus high protein. 
The analysis also included a comparison of two of the four diets, the diet with the lowest carbohydrate content and the diet with the 
highest carbohydrate content, and included a test for trend across the four levels of carbohydrates. 
 
The effects of protein, fat, and carbohydrate levels were evaluated independently with the use of two-sample t-tests at a two-sided 
significance level of 0.05. 
 
Exploratory post hoc analyses were performed with threshold amounts of weight loss as outcomes, with Bonferroni’s adjustment 
for multiple comparisons. 
 
Associations between adherence to the fat and protein goals and weight loss were also explored in post hoc analyses. 
 
An intention-to-treat analysis was performed in which long-term weight loss for persons who withdrew from the study early (after at 
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Were process measures used? 
contd. 
least 6 months of participation) was imputed on the basis of a rate of 0.3 kg per month of regained weight and a rate of 0.3 cm per 
month of regained waist circumference after withdrawal. 
 
Risk factors for cardiovascular disease and diabetes were also analyzed according to the intention-to-treat principle, with zero 
change from baseline imputed for missing data. 
 
Were outcome measures 
identified? Are there clear validated 
outcomes? 
Yes 
Are the methods quantitative or 
qualitative? 
Both quantitative and qualitative 
Safety Results 
 
 
 
 
 
 
Adverse events were reported by 57 participants (7%); there were no significant differences in the rates among diets.  
 
The ratio of urinary microalbumin to creatinine was more than 30 in five participants in the average-protein group and in five 
participants in the high-protein group at 6 months and in seven participants, all in the average protein groups, at 2 years. 
 
There was a larger decrease in urinary nitrogen excretion from baseline in the average-protein group than in the high protein group 
(a difference in the change of 1.6 g at 6 months and 0.8 g at 2 years. These differences correspond to a difference in dietary protein 
of 10 g per day and 5 g per day, respectively. 
Endpoint/ Biomarker Tested The primary outcome of the study was the change in body weight over a period of 2 years, and the secondary outcome was the 
change in waist circumference 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b 
Are the endpoints relevant to actual 
practice 
Yes 
Dietary Intake and Adherence 
Results 
 
 
 
 
 
 
 
Mean reported intakes at 6 months and 2 years did not reach the target levels for macronutrients. The reported intakes represented 
differences from target levels of fat, protein, and carbohydrate intake of 8.0, 4.2, and 14.4 percentage points, respectively, at 6 
months and 6.7, 1.4, and 10.2 percentage points, respectively, at 2 years. 
 
Reported energy intakes and physical activity were similar among the diet groups. 
 
The participants who completed the study had a mean weight loss of 6.5 kg at 6 months, which corresponds to a reduction in daily 
energy intake of approximately 225 kcal. 
The respiratory quotient was 0.84 at baseline in both the high-fat and low-fat groups, and the between-group difference in the 
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Dietary Intake and Adherence 
Results contd. 
change at 2 years (the value in the high-fat group minus the value in the low-fat group) was −0.02 (P = 0.002).  
 
Thus, changes in biomarkers confirmed that differences among the groups in macronutrient intake were consistent with those 
recorded in the dietary reports and that participants modified their intake of macronutrients in the direction of the goals, although 
the targets were not fully achieved. 
 
Adherence to the goal for protein intake was associated with more weight loss only in the high protein groups, and adherence to 
the goal for fat intake was associated with more weight loss only in the low-fat groups (P<0.001). 
 
Weight loss and cardio-protective 
and other mechanisms identified,  
Craving, fullness, and hunger and diet-satisfaction scores were similar at 6 months and at 2 years among the diets. 
 
Attendance at group sessions strongly predicted weight loss at 2 years (0.2 kg for every session attended) and was similar among 
the diet groups 
 
Weight Loss / Body Composition 
results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weight Loss 
At 6 months, participants assigned to each diet had lost an average of 6 kg, which represented 7% of their initial weight; they began 
to regain weight after 12 months. 
 
By 2 years, weight loss remained similar in those who were assigned to a diet with 15% protein and those assigned to a diet with 
25% protein (3.0 and 3.6 kg, respectively); in those assigned to a diet with 20% fat and those assigned to a diet with 40% fat (3.3 kg 
for both groups); and in those assigned to a diet with 65% carbohydrates and those assigned to a diet with 35% carbohydrates (2.9 
and 3.4 kg, respectively) (P>0.20 for all comparisons). Among the 80% of participants who completed the trial, the average weight 
loss was 4 kg; 14 to 15% of the participants had a reduction of at least 10% of their initial body weight.  
 
Satiety, hunger, satisfaction with the diet, and attendance at group sessions were similar for all diets; attendance was strongly 
associated with weight loss (0.2 kg per session attended).  
 
The change in waist circumference did not differ significantly among the diet groups. 
 
Most of the weight loss occurred in the first 6 months. Changes from baseline differed among the diet groups by less than 0.5 kg of 
body weight and 0.5 cm of waist circumference. 
 
 
After 12 months, all groups, on average, slowly regained body weight. A total of 185 of the participants (23%) continued to lose 
weight from 6 months to 2 years. The mean (±SD) additional weight loss was 3.6±3.5 kg, for a mean total loss from baseline of 
9.3±8.2 kg, with no significant differences among the diet groups. 
At 2 years, 31 to 37% of the participants had lost at least 5% of their initial body weight, 14 to 15% of the participants in each diet 
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Weight Loss / Body Composition 
results – Contd. 
group had lost at least 10% of their initial weight, and 2 to 4% had lost 20 kg or more (P>0.20 for the comparisons between diets). 
 
Cardiac Risk Factor Results All the diets reduced risk factors for cardiovascular disease and diabetes at 6 months and 2 years. 
At 2 years, the two low-fat diets and the highest-carbohydrate diet decreased low-density lipoprotein cholesterol levels more than 
did the high-fat diets or the lowest-carbohydrate diet (low-fat vs. high-fat, 5% vs. 1% [P = 0.001]; highest carbohydrate vs. lowest-
carbohydrate, 6% vs. 1% [P = 0.01]). 
 
The lowest-carbohydrate diet increased HDL cholesterol levels more than the highest-carbohydrate diet (9% vs. 6%, P = 0.02). 
There was a larger increase from baseline in the HDL cholesterol level, a biomarker for dietary carbohydrate, in the lowest-
carbohydrate group than in the highest-carbohydrate group (a difference in the change of 2 mg per deciliter at 2 years). This 
difference corresponds to a predicted difference in carbohydrate intake of 6%. 
 
All the diets decreased triglyceride levels similarly, by 12 to 17%. 
 
Blood pressure decreased from baseline by 1 to 2 mm Hg, with no significant differences among the groups (P>0.59 for all 
comparisons). 
 
These changes in risk factors in the intention-to-treat population were about 30 to 40% smaller than the changes seen among 
participants who provided data at 2 years, reflecting the effect of the imputation of missing values 
 
Endocrine markers and Hormonal 
Effects 
All the diets except the one with the highest carbohydrate content decreased fasting serum insulin levels by 6 to 12%; the decrease 
was larger with the high-protein diet than with the average-protein diet (10% vs. 4%, P = 0.07). 
 
The metabolic syndrome was present in 32% of the participants at baseline, and the percentage was lower at 2 years, ranging from 
19 to 22% in the four diet groups (P = 0.81 for the four-way comparison). 
 
Exercise and Medication use Physical Activity goals were established for sedentary participants gradually increasing from 30 minutes of moderate intensity per 
week to 90 minutes per week during first 6 months Participants were encouraged to do more if they could. Minutes of exercise were 
monitored using self-monitoring forms.  
 
 Reported physical activity was similar among the diet groups. 
 
What effect may bias have on the 
result? 
None evident 
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The Author's conclusions - are 
these justified? 
Diets that are successful in causing weight loss can emphasize a range of fat, protein, and carbohydrate compositions that have 
beneficial effects on risk factors for cardiovascular disease and diabetes. Such diets can also be tailored to individual patients on 
the basis of their personal and cultural preferences and may therefore have the best chance for long-term success. 
  
Generalizability- the extent to 
which the results might apply 
outside the study 
The four different dietary strategies representing differing percentages of various macronutrients provide clinical options to 
consider when making dietary recommendations. 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The principal finding is that the diets were equally successful in promoting clinically meaningful weight loss and the maintenance 
of weight loss over the course of 2 years. 
 
Satiety, hunger, satisfaction with the diet, and attendance at group sessions were similar for all diets. 
 
The diets improved lipid risk factors and fasting insulin levels in the directions that would be expected on the basis of 
macronutrient content. 
 
The study had a large sample, a high rate of retention, and the sensitivity to detect small changes in weight. 
 
The findings should be directly applicable to both clinicians’ recommendations for weight loss in individual patients and the 
development of population-wide recommendations by public health officials. 
 
Despite the intensive behavioural counselling in the study, participants had difficulty achieving the goals for macronutrient intake 
of their assigned group. The mean differences among the groups in fat, carbohydrate, or protein intake at 6 months were 
nevertheless often greater than those in several previous trials comparing diets for weight loss. 
 
Substantially diminished adherence after the first few months is typical in weight loss trials and occurred between 6 months and 2 
years in our trial. 
Only two trials have reported dietary intake beyond 1 year and one of them provided foods to the participants. 
 
In addition, trials of low-carbohydrate diets have reported a very low incidence of urinary ketosis after 6 months suggesting that in 
most overweight people, it is futile to sustain a low intake of carbohydrates. 
 
Overall, these findings with respect to adherence to macronutrient goals suggest that participants in weight-loss programs revert 
to their customary macronutrient intakes over time but may nonetheless be able to maintain weight loss. 
 
Attendance had a strong association with weight loss, and the association was similar across diet groups. The Authors view 
attendance at counselling sessions as a proxy for commitment to achieving weight loss. 
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Discussion points – contd. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Study participants who attended two thirds of the sessions over the course of 2 years lost about 9 kg of weight. 
 
Regain after 6 to 12 months was about 20% of the regain reported in earlier trials. Several recent trials have also shown that 
continued contact with participants after weight loss is associated with less regain. These findings together point to behavioural 
factors rather than macronutrient metabolism as the main influences on weight loss. 
 
The authors used a generic approach to developing each diet and the instructions for following it, in order to minimize Influences 
media attention, cultural norms or scientific novelty. 
 
No diet was considered to be a control diet, and the dietary counselling and the attention that we provided were the same for all diet 
groups throughout the study period. 
 
The authors  did not confirm previous findings that low-carbohydrate or high protein diets caused increased weight loss at 6 
months and that the advantage of these diets usually eroded by 12 months, with weight loss that was nearly or fully equivalent to 
that with low-fat diets. 
 
Other studies showed increased weight loss at 1 to 2 years with diets that were high in unsaturated fat or with low-fat, high-
carbohydrate vegetarian diets. 
 
When non nutritional influences are minimized, as they were in this study, the specific macronutrient content is of minor 
importance as was suggested many years ago. 
Were study limitations discussed? Association of achieved nutrition with weight loss explored. These post hoc analyses do not have the strong validity of the main 
analysis which compared randomized groups. Protein and fat intakes overlapped hence confounding the results.  
 
Future Implications discussed Any type of diet when taught for the purpose of weight loss with enthusiasm and persistence can be effective. 
Tailoring of diets to suit individual patients on the basis of their personal and cultural preferences may enable more long term 
success.  
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Author Samaha et al. (2003) 
 
Title  A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity 
 
Journal  The New England Journal of Medicine 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. 4 out of 10 authors are MDs.  
General Aim Clear To assess how restricting carbohydrates affects weight loss and serum lipid concentrations.  
 
Specific Study objectives stated To test the hypothesis that severely obese subjects with diabetes or metabolic syndrome would have greater weight loss without 
detrimental effects on risk factors for atherosclerosis while on a carbohydrate (CHO) reduced diet than on a calorie and fat 
restricted low- fat diet. 
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet and particularly CHO restriction is 
significant to weight management and CVD risk management. 
 
Low-Carbohydrate Atkins type diet compared to a low-fat conventional diet over 6 months.  
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized comparative intervention. 
Study described as randomised Random assignation of subjects to one of two diets  
 
Study described as double blind No  
 
Description of withdrawals and 
dropouts present 
Between May 2001 and November 2001, 132 persons were randomly assigned to either a low-carbohydrate diet (n= 64) or a 
conventional diet (n = 68). By six months 79 subjects remained – 36 in the LF group and 43 in the low CHO group. The primary 
analysis included all 132 subjects – 79 who completed study; 29 who dropped out but had six-month data from routine visits and 
24 for whom weight recorded at the last follow up was carried forward. 
A second analysis included all subjects for all 53 subjects who dropped out. 
 
Randomisation / blinding 
appropriate 
Randomisation appropriate ; Blinding not relevant 
Target Population Severely obese Adults 
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Why was study done? What was 
perceived general importance? 
The Authors felt that the effects of a carbohydrate-restricted diet on weight loss and risk factors for atherosclerosis have been 
incompletely assessed 
 
Is there a clear hypothesis and 
objectives? 
Yes.  That severely  obese subjects with a high prevalence of diabetes or the metabolic syndrome would have greater weight loss 
without detrimental effects on risk factors for atherosclerosis while on a carbohydrate-restricted diet than on a calorie and fat- 
restricted low-fat diet. 
 
What specific question is being 
addressed? 
For severely obese individuals, do low-carbohydrate diets work better that conventional low-fat, low-calorie diets?  
The study setting- where did study 
take place? 
The Philadelphia Veterans Medical Centre. Department of Medicine – Division of Cardiology. 
The study population - Intended 
group to whom results should apply  
vs. group actually studied 
Severely obese individuals with metabolic disease 
Group actually studied  132 subjects were randomly assigned to either low-carbohydrate or low fat diet using random numbers.  
 
The social, cultural, economic, 
ethnic background 
Veterans. A high proportion of black subjects. 
Study Approval Study approved by review board at the Philadelphia Veterans Affairs Medical Centre. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Yes. Inclusion criteria of age at least 18 years and BMI of at least 35. 
 
Exclusion criteria : serum creatinine level of >1.5mg per decilitre; hepatic disease, life-limiting medical illness; inability of diabetic 
subjects to monitor own glucose; active participation in a dietary programme or use of weight loss medications  
 
Is there a power calculation to 
determine sample size? 
Assuming a two-sided type 1 error of 5% the authors estimated a need for 100 subjects for the study to have 80% power to 
demonstrate a mean ± SD weight loss that was 5±12v kg greater in the low CHO group than the low fat group.  
A dropout rate of 25 was anticipated so the enrolment target was 135.  
 
Was there selection bias? None evident. 
 
Was there funding bias? None evident. 
 
Confounding Factors Many of the subjects were taking lipid lowering medication and hypoglycaemic agents. 
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How does the study group relate to 
researchers interest groups / 
patients? 
Obese and severely obese subjects with evidence of metabolic disease fall in the scope of the researchers interests.  
What was the intervention and how 
was it carried out? 
2 diet groups attended separate 2 hour group teaching for 4 weeks followed by one hour sessions for 5 additional months. 
Subjects received a diet overview handout, instructional nutrition labels, sample menus and recipes and a book on counting 
calories and carbohydrates. No specific exercise was recommended.  
Subjects on Low CHO instructed to restrict CHO intake to 30g per day or less. No restriction on total fat intake. Vegetables and 
fruits with a high ratio of fibre to CHO recommended.  
Subjects on low-fat diet were recommended the guidelines of the National, Heart, Lung and Blood Institute including caloric 
restriction sufficient to create a deficit of 500 calories with 30% or less of total calories derived from fat.  
 
What was measured and how was it, 
measured? 
Weight measured monthly on a single calibrated scale; Other data at enrolment and at six months collected included waist size, 
self reported medical history, blood pressure, glucose and serum lipid levels measured in blood samples obtained after an 
overnight fast.  
 
LDL cholesterol calculated according to the Friedwald formula. 
 
Serum insulin measured by radioimmunoassay; Insulin sensitivity estimated with use of the quantitative insulin –sensitivity check 
index.  
 
Dietary compliance estimated by a previously validated instrument to obtain a 24hr recall of dietary consumption. Data analysed 
with Nutribase Management software (Cybersoft)  
 
Were baseline measures used? Baseline characteristics shown in Table 1 in the paper. 
 
Were process measures used? 
 
 
 
 
 
 
 
 
 
 
For comparison of continuous variables between the two groups, the change from baseline to six months in each subject was 
calculated and mean changes were compared using an unpaired t test. Normality of the distribution was assessed before using the 
t-test.  
 
Triglyceride, insulin and glucose levels were skewed and were log-transformed for analysis. 
 
Dichotomous variables by chi-square analysis. 
 
Linear regression and two way analysis of covariance models were used to correct for potentially confounding variables and to 
identify interactions between variables and diet group assignment.  
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Were process measures used? 
Contd. 
Missing waist sizes were imputed by linear extrapolation on the basis of height and weight.  
 
P values were two-sided and a P value of 0.05 indicated statistical significance 
 
SPSS version 10 software used for statistical analysis.   
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Primary end point was weight loss at six months.  
 
For analyses of changes in dietary intake, serum lipid levels, glycemic control and insulin sensitivity – all subjects were included 
with baseline values carried forward for subjects who dropped out of the study.  
 
Are the methods quantitative or 
qualitative? 
Quantitative and qualitative. 
Safety Results  No clinically significant change in uric acid levels in either group.  
 
One death and hospitalisation in the low CHO group not deemed to be diet related.  
 
Endpoint/ Biomarker Tested Weight loss, serum lipids, glycemic control and insulin sensitivity, BP, adverse reactions, attrition, assessment of dietary intake. 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apolipoprotein a and b, renal and bone health as one arm was a ketogenic diet. 
Are the endpoints relevant to actual 
practice 
Yes and consistent with other studies. 
Dietary Intake and Adherence 
Results 
After 6 months, subjects on the low-fat diet reported a decrease in caloric consumption while the macronutrient composition was 
close to the guidelines on the NHLBI.  
 
Subjects on the low-carbohydrate diet reported a non-significantly greater reduction in caloric intake (P=0.33), a significantly 
greater decrease in % of calories from CHO (P<0.001) and a significantly greater increase in calories from protein (P<0.001) and fat 
(P=0.004).  
 
ADHERENCE: Cumulative % of drop-outs by months 1, 3 & 6 were 38, 44, and 47 in the low fat group and 25, 27 and 33 % in the low 
CHO group. 
Differences in attrition was statistically significant by the 3
rd
 month (P=0.03) but not at six months (P=0.10). 
No significant differences between the groups in the characteristics of the subjects who dropped out 
Subjects in the low-carbohydrate group attended more dietary counselling sessions than the low fat group. 
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Weight loss and cardio-protective 
mechanisms identified  
Greater weight loss in the low-carbohydrate group suggests a greater reduction in overall caloric intake rather than a direct effect 
of macronutrient composition. The explanation for this difference is not clear – potentially higher satiety on a diet with liberal 
portions of protein and fat; simplicity of the diet; improved compliance related to the novelty of the diet. 
 
Amount of weight loss had a significant effect on the degree of improvement in metabolic factors including insulin resistance and 
triglyceride levels. Subjects who lost more than 5% of their baseline weight on a carbohydrate-restricted diet had greater 
decreases in triglyceride levels than those who lost a similar amount of weight while following a calorie and fat restricted diet. 
 
Other uncontrolled variables such as types of carbohydrates selected e.g. proportion of complex carbohydrates or ratio of 
carbohydrate to fibre may have contributed to effects on improved insulin sensitivity and triglycerides.   
 
Weight Loss / Body Composition 
results 
Subjects on the low CHO diet lost more weight during the six month study than those on the low-fat diet – mean -5.8±8.6 kg vs. -
1.9±4.2kg.  
 
95% Confidence Interval for the difference in weight loss between groups -1.6 to -6.3 (P=0.002).  
The difference remained significant after adjustment for baseline variables and for baseline variables plus the number of 
counselling sessions. 
 
The second analysis for dropouts also showed greater weight loss in the low-carb group than in the LF group: -5.7±8.6 kg vs. 
1.8±3.9kg. 
 
Weight loss of at least 10% of baseline occurred in 9 of 64 subjects (14%) as compared with 2 of 68 subjects on the low fat diet 
(3%). White subjects lost more weight than black subjects (mean -13±19kg vs. -5±12kg (P=0.009). 
  
Ketonuria Results None reported. 
 
Cardiac Risk Factor Results 
 
 
 
 
 
 
 
 
 
 
Greater decrease in the mean triglyceride level in the low CHO group than in the low fat group (-20±31 %, P=0.001). 
 
LCHO subjects had a greater decrease in triglyceride levels irrespective of whether they were on lipid lowering drugs (-25±38% vs.  
8±35% with lipid lowering drugs – P=0.01) and -16±46 % vs. -1±25% without lipid lowering drugs.  
 
In a separate analysis of subjects who were not taking medications – 28 on the low fat diet and 24 on the low CHO diet, the mean 
reduction in the triglyceride level was greater in the low CHO group : -20±42 % vs. 2±28%- P=0.001) 
 
Assignment to the low CHO diet (P=0.01) and the amount of weight lost (P<0.001) were each independent predictors of a decrease 
in the triglyceride level however this was limited to subjects who lost more than 5% of base-line weight.  
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Cardiac Risk Factor Results contd. Total cholesterol, HDL and LDL did not change significantly during the six months or between groups. 
 
BP: Systolic and diastolic BP decreased by 2mm Hg and 1mm Hg respectively in the low CHO group. In the low fat group both 
measures decreased by 2mm Hg but there was no significant difference between the groups. 
Hormonal & Endocrine Results Glycemic control: Fasting glucose decreased more in the Low CHO group than the low fat group at six month agents or s -9±19 % 
vs. -2±17% (P=0.02) though this change was more significant for diabetic subjects with no significant change in the levels in 
nondiabetic subjects on either diet.  Similarly diabetic subjects showed a greater decrease in glycosylated haemoglobin compared 
with those on low-fat diets.  
 
By six months seven subjects in the low CHO group had dose reductions in oral hypoglycaemic or insulin as compared to 1 in the 
low- fat group. 
Insulin sensitivity increased more in the low CHO subjects than on the low fat diet. Here again assignment to low CHO diet and 
weight loss were independent predictors of an improvement in insulin sensitivity. 
 
Exercise and Medication use Many subjects were taking lipid-lowering medications and hypoglycaemic agents. No comment on exercise. 
  
What effect may bias have on the 
result? 
None noted. 
The Author's conclusions - are 
these justified? 
Severely obese subjects with higher prevalence of diabetes and metabolic syndrome lost more weight during six months on a CHO 
restricted diet than on a calorie and fat restricted diet.  
 
Results must be interpreted with caution as magnitude of weight loss in relation to subjects’ obesity levels was small. 
 
Unclear if the benefits of a low CHO extend beyond six months.  
 
High dropout rate and small overall weight loss show that adherence was relatively low in both groups. 
 
This study proves a principle and does not provide clinical guidance given the known benefits of fat restriction. 
 
As compared with white subjects, black subjects had smaller overall weight loss.  
 
Generalizability- the extent to which 
the results might apply outside the 
study 
Results may be used to devise weight loss plans for obese individuals. 
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Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Severely obese subjects with prevalence of diabetes and metabolic syndrome lost more weight in a six month period on a CHO 
restricted diet than on a fat and calorie restricted diet.  
 
The greater weight loss in the low CHO group suggests a greater reduction in overall caloric intake rather than a direct effect of 
macronutrient composition.  
 
Possible explanations:   
Subjects may have experienced greater satiety with liberal portions of protein and fat. 
Simplicity of the diet  
Improved compliance due to novelty of the diet.  
 
The low CHO diets improved triglycerides for all; insulin sensitivity for non diabetics; glycemic control for diabetics. 
 
Amount of weight loss had a significant effect on the degree of improvement in metabolic factors. 5% weight loss on a CHO 
restricted diet had better metabolic results than those who lost a similar amount of weight while on a fat and calorie restricted diet.  
 
Cannot definitely conclude that CHO restriction alone accounted for metabolic improvements in triglycerides and insulin 
sensitivity. Other uncontrolled variables such as types of CHO – proportion of complex CHO or ratio of CHO to fibre or other 
unknown variables may have contributed to this effect.  
Subjects on hypoglycaemic and lipid lowering medication may have confounded results but also allowed inclusion of subjects 
with obesity related medical disorders typically encountered in clinical practice.  
 
High drop-out rate reflected the baseline motivation to lose weight rather than a response to dietary intervention.  
Were study limitations discussed? High level of dropouts early in the study. Attrition rates may reflect the base-line motivation to lose weight rather than response to 
dietary intervention.  
 
Overall weight loss relative to the subjects’ severe obesity was small and it was unclear if benefits of carbohydrate-restricted diets 
extend beyond six months. 
 
High dropout rate and small overall weight loss demonstrate that dietary adherence was relatively low in both diet groups. 
 
Future Implications discussed As compared with white subjects, black subjects had smaller overall weight loss. Future studies should explore if results could be 
affected by culturally sensitive dietary counselling. 
 
This study proves a principle and does not provide clinical guidance given the known benefits of fat-restriction. Future studies 
evaluating long-term cardiovascular outcomes are needed before a carbohydrate-restricted diet can be endorsed.    
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Author Shai et al. (2008) 
 
Title  Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-fat Diet  
 
Journal  The New England Journal of Medicine 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. Majority of Authors MDs and PhDs.  
General Aim Clear To test the longer term effectiveness and safety of weight-loss diets.   
 
Specific Study objectives stated To compare the effectiveness and safety of three nutritional protocols: a low fat restricted-calorie diet; a Mediterranean restricted 
calorie diet and a low-carbohydrate, non-restricted-calorie diet.   
  
Aim and study objectives relevant 
to research question being 
explored 
External Validity - relevance of this 
particular piece of work to the 
issue under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet, particularly carbohydrate (CHO) 
manipulation is significant to weight management and cardiovascular disease (CVD) risk management. The inclusion of a restricted 
low-carbohydrate diet is of particular interest due to potential ease of application.  
 
A low-carbohydrate Atkins type diet with no calorie restriction to a low-fat diet and Mediterranean diet plan where calories were 
restricted to 1500kcal for women and 1800 kcal for men.  
 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized Controlled Trial, Comparative Intervention.   
Study described as randomised Yes. 322 moderately obese subjects were randomly assigned to one of three diets: low-fat, restricted calorie (LF); Mediterranean 
restricted calorie diet (MED) or low-carbohydrate non-restricted-calorie diet (LC).  The participants were randomly assigned within 
strata of sex, age (below or above the median), BMI (below or above the median), history of coronary heart disease (yes or no), 
history of type 2 diabetes (yes or no), and current use of statins (none, <1 year, or ≥1 year) with the use of Monte Carlo simulations. 
 
Study described as double blind No  
 
Description of withdrawals and 
dropouts present 
Detailed table available to explain withdrawals and dropouts 
Low- carb diet: 109 assigned, 105 completed 6months (4 withdrew because of disappointment with diet, 102 completed 12m of 
intervention, 3 left because of lack of motivation and personal reasons, 89 completed 18m of intervention, 13 withdrew of which 6 
lacked motivation and 7 had personal reasons; 85 completed 24m of intervention 4 left of which 3 lacked motivation and 1 had 
personal reasons.  93 of 109 assigned to Mediterranean diet completed the intervention and 94 of those assigned to low-fat diet 
completed the intervention  
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Randomisation / blinding 
appropriate 
Randomisation considered appropriate. Blinding was not appropriate. In order to maintain equal intensity of treatment, the 
workshop format and the quality of materials were similar across the groups except for instructions and materials specific to each 
diet strategy  
Target Population Overweight and Obese 40-65 year old Adults with the risk or presence of CVD.   
 
Why was study done? What was 
perceived general importance? 
To conduct a longer term study to study adherence to and effectiveness of 3 nutritional protocols a low fat restricted calorie diet, a 
Mediterranean restricted calorie diet and a low-carbohydrate Atkins type, non-restricted calorie diet.  
 
Is there a clear hypothesis and 
objectives? 
Not clearly stated but implied  
What specific question is being 
addressed? 
Whether low-carbohydrate Atkins type diets and /or Mediterranean diets are as effective and safe as low-fat diets.  
 
The study setting- where did study 
take place? 
Study conducted between July 2005 and June 2007 in Dimona, Israel, in a workplace at a research centre with an on-site medical 
clinic. 
 
Group actually studied Mostly Men. (86%). Study conducted in a workplace in Israel at a research centre with an on-site medical clinic.  
 
The social, cultural, economic, 
ethnic background 
Overweight and obese Israeli Men in a workplace setting with food sources available readily in the right form via a workplace 
cafeteria working closely with dieticians.  
 
Study Approval The study was approved and monitored by the human subjects committee of Soroka Medical Centre and Ben-Gurion University. 
Each participant provided written informed consent. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
The criteria for eligibility were an age of 40 to 65 years and a body-mass index (BMI, the weight in kilograms divided by the square 
of the height in meters) of at least 27, or the presence of type 2 diabetes (according to the American Diabetes Association criteria) 
or coronary heart disease, regardless of age and BMI. 
Persons were excluded if they were pregnant or lactating, had a serum creatinine level of 2 mg per decilitre (177 μmol per litter) or 
more, had liver dysfunction, had active cancer, or were participating in another diet trial. 
 
Is there a power calculation to 
determine sample size? 
The researchers calculated for a mean (±SD) difference between groups of at least 2±10 kg of weight loss, with 100 participants per 
group and a type I error of 5%; the study had the power to detect significant differences in weight loss of greater than 90%.  
 
Was there selection bias? Selection bias possible but unlikely.  Limited information about application and recruitment process.  More detailed exclusion 
criteria available. Participants received no financial compensation or gifts.   
 
 
 
 
 
 
 
APPENDIX A 13: Data Collection Sheets- Shai et al. (2008)           
(Some text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and 
Numerical references included in brackets refer to the original article).   
 
196 
 
Was there funding bias? Study partly supported by the Dr Robert C and Veronika Atkins Research Foundation so there is potentially a funding bias, however 
no conflict of interest relevant to article was reported.  
 
Confounding Factors Potentially the significant increase in activity levels over the duration of the intervention.  
 
 
How does the study group relate to 
researchers interest groups / 
patients? 
The researcher’s interest groups would potentially include overweight and/or obese adults.  
What was the intervention and how 
was it carried out? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The members of each of the three diet groups were assigned to subgroups of 17 to 19 participants, with six subgroups for each 
group. 
 
Each diet group was assigned a registered dietician who led all six subgroups of that group. The dieticians met with their groups in 
weeks 1, 3, 5, and 7 and thereafter at 6-week intervals, for a total of 18 sessions of 90 minutes each. 
 
In order to maintain equal intensity of treatment, the workshop format and the quality of the materials were similar among the three 
diet groups, except for instructions and materials specific to each diet strategy. 
 
Six times during the 2-year intervention, another dietician conducted 10-to-15-minute motivational telephone calls with participants 
who were having difficulty adhering to the diets and gave a summary of each call to the group dietician. 
 
In addition, a group of spouses received education to strengthen their support of the participants 
 
Low-Fat Diet- The low-fat, restricted-calorie diet was based on American Heart Association 20 guidelines. The target energy intake 
was 1500 kcal per day for women and 1800 kcal per day for men, with 30% of calories from fat, 10% of calories from saturated fat, 
and an intake of 300 mg of cholesterol per day. The participants were counselled to consume low-fat grains, vegetables, fruits, and 
legumes and to limit their consumption of additional fats, sweets, and high-fat snacks. 
 
Mediterranean Diet- The moderate-fat, restricted-calorie, Mediterranean diet was rich in vegetables and low in red meat, with poultry 
and fish replacing beef and lamb. The target energy intake was 1500 kcal per day for women and 1800 kcal per day for men, with a 
goal of no more than 35% of calories from fat; the main sources of added fat were 30 to 45 g of olive oil and a handful of nuts (five 
to seven nuts, <20 g) per day. 
 
Low-Carbohydrate Diet- The low-carbohydrate, non–restricted-calorie diet aimed to provide 20 g of carbohydrates per day for the 2-
month induction phase and immediately after religious holidays, with a gradual increase to a maximum of 120 g per day to maintain 
the weight loss. The intakes of total calories, protein, and fat were not limited. However, the participants were counselled to choose 
vegetarian sources of fat and protein and to avoid trans fat. The diet was based on the Atkins diet. 
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What was the intervention and how 
was it carried out? contd. 
A dietician worked closely with the kitchen staff to adjust specific food items to specific diet groups. Each food item was provided 
with a label showing the number of calories and the number of grams of carbohydrates, fat, and saturated fat, according to an 
analysis based on the Israeli nutritional database. 
 
Each food item was also labelled with a full circle (indicating “feel free to consume”) or a half circle (indicating “consume in 
moderation”). The labels were colour-coded according to diet group and were updated daily 
 
What was measured and how was it 
measured? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adherence to the diets was evaluated by a validated food-frequency questionnaire 24 that included 127 food items and three 
portion-size pictures for 17 items. 
 
A subgroup of participants completed two repeated 24-hour dietary recalls to verify absolute intake. 
 
A validated questionnaire was used to assess physical activity. 
 
At baseline and at 6, 12, and 24 months of follow-up, the questionnaires were self-administered electronically through the 
workplace intranet. 
 
The electronic questionnaire helped to ensure completeness of the data by prompting the participant when a question was not 
answered and it permitted rapid automated reporting by the group dieticians. 
 
The participants were weighed without shoes to the nearest 0.1 kg every month. With the use of a wall-mounted stadiometer, height 
was measured to the nearest millimetre at baseline for determination of BMI. 
 
Waist circumference was measured halfway between the last rib and the iliac crest. 
 
Blood pressure was measured every 3 months with the use of an automated system (Datascop Acutor 4) after 5 minutes of rest. 
 
Blood samples were obtained by venipuncture at 8 a.m. after a 12-hour fast at baseline and at 6, 12, and 24 months and were stored 
at –80°C until an assay for lipids, inflammatory biomarkers, and insulin could be performed. 
Levels of fasting plasma glucose, glycated haemoglobin, and liver enzymes were measured in fresh samples. Serum levels of total 
cholesterol, high-density-lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides were 
determined enzymatically with a Wako R-30 automatic analyzer. 
 
Plasma insulin levels were measured with the use of an enzyme immunometric assay. 
 
Plasma levels of high-molecular-weight adiponectin were measured by an enzyme-linked immunosorbent assay (ELISA).  
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What was measured and how was it 
measured? contd. 
Plasma leptin levels were assessed by ELISA. 
 
Plasma levels of high-sensitivity C-reactive protein were measured by ELISA. 
 
For weight loss, the pre-specified primary aim was the change in weight from baseline to 24 months. 
 
The study analyzed the dietary-composition data and biomarkers with the use of raw unadjusted means, without imputation of 
missing data. 
 
Were baseline measures used? The mean age was 52 years and the mean BMI was 31. Most participants (86%) were men. 
 
At baseline, there were no significant differences in the composition of the diets consumed by participants assigned to the low-fat, 
Mediterranean, and low-carbohydrate diets. 
 
Were process measures used? The clinic and laboratory staff members were unaware of the treatment assignments, and the study coordinators were unaware of 
all outcome data until the end of the intervention. 
 
Statistics: Dietary-intake values were compared between groups at each time point with the use of an analysis of variance in which 
all pairwise comparisons among the three diet groups were performed with the use of Tukey’s Studentized range test. 
 
For intention-to-treat analyses, all 322 participants were included and the most recent values for weight and blood pressure were 
used. 
 
To evaluate the repeated measurements over time, generalized estimating equations for panel data analysis were used also known 
as cross-sectional time-series analysis. 
 
The within person changes from baseline in each diet group was determined with the use of pairwise comparisons. 
 
The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated according to the following equation: insulin 
(U/ml) × fasting glucose (mmol/litre) ÷ 22.5. 
 
SPSS software, version 15, and Stata software, version 9, was used for the statistical analysis. 
 
Were outcome measures 
identified? Are there clear validated 
outcomes? 
Yes.   
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Are the methods quantitative or 
qualitative? 
Both qualitative and quantitative. 
Safety Results  
The proportion of participants with detectable urinary ketones at 24 months was higher in the low-carbohydrate group (8.3%) than 
in the low-fat group (4.8%) or the Mediterranean-diet group (2.8%) (P = 0.04). 
 
 
Endpoint/ Biomarker Tested Adherence, dietary intake, energy expenditure, weight loss, lipid profiles, CRP, adiponectin, leptin, blood sugar and insulin 
markers, liver function 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apo lipoprotein a and b; bone and kidney health as one study arm was the Atkins diet. 
Are the endpoints relevant to actual 
practice 
Yes.  
Dietary Intake and Adherence 
Results 
The overall rate of adherence was 95.4% at 12 months and 84.6% at 24 months.  
 
The 24-month adherence rates were 90.4% in the low-fat group, 85.3% in the Mediterranean diet group, and 78.0% in the low-
carbohydrate group (P = 0.04 for the comparison among diet groups). 
 
Daily energy intake as assessed by the food-frequency questionnaire, decreased significantly at 6, 12, and 24 months in all diet 
groups as compared with baseline (P<0.001); there were no significant differences among the groups in the amount of decrease. 
 
The low-carbohydrate group had a lower intake of carbohydrates (P<0.001) and higher intakes of protein (P<0.001), total fat 
(P<0.001), saturated fat (P<0.001), and total cholesterol (P = 0.04) than the other groups. 
 
The Mediterranean- diet group had a higher ratio of monounsaturated to saturated fat than the other groups (P<0.001) and a higher 
intake of dietary fibre than the low-carbohydrate group (P = 0.002).  
The low-fat group had a lower intake of saturated fat than the low-carbohydrate group (P = 0.02). 
 
Weight loss and cardio-protective 
and other mechanisms identified,  
Adherence to diet and calorie deficit. 
Individualisation of diets to personal preferences and metabolic needs. 
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Weight Loss / Body Composition 
results 
The mean weight changes among the 272 participants who completed 24 months of intervention were −3.3±4.1 kg in the low-fat 
group, −4.6±6.0 kg in the Mediterranean-diet group, and −5.5±7.0 kg in the low-carbohydrate group (P = 0.03 for the comparison 
between the low-fat and the low-carbohydrate groups at 24 months).  
 
The mean (±SD) changes in BMI were −1.0±1.4 in the low-fat group, −1.5±2.2 in the Mediterranean-diet group, and −1.5±2.1 in the 
low-carbohydrate group (P = 0.05 for the comparison among groups). 
 
All groups had significant decreases in waist circumference and blood pressure, but the differences among the groups were not 
significant. The waist circumference decreased by a mean of 2.8±4.3 cm in the low-fat group, 3.5±5.1 cm in the Mediterranean-diet 
group, and 3.8±5.2 cm in the low-carbohydrate group (P = 0.33 for the comparison among groups). 
 
 
 
Cardiac Risk Factor Results Systolic blood pressure fell by 4.3±11.8 mm Hg in the low-fat group, 5.5±14.3 mm Hg in the Mediterranean-diet group, and 3.9±12.8 
mm Hg in the low-carbohydrate group (P = 0.64 for the comparison among groups). The corresponding decreases in diastolic 
pressure were 0.9±8.1, 2.2±9.5, and 0.8±8.7 mm Hg (P = 0.43 for the comparison among groups). 
 
HDL cholesterol increased during the weight-loss and maintenance phases in all groups, with the greatest increase in the low-
carbohydrate group (8.4 mg per decilitre [0.22 mmol per litre], P<0.01 for the interaction between diet group and time), as compared 
with the low-fat group (6.3 mg per decilitre [0.16 mmol per litre]). 
 
Triglyceride levels decreased significantly in the low-carbohydrate group (23.7 mg per decilitre [0.27 mmol per litre], P = 0.03 for the 
interaction between diet group and time), as compared with the low-fat group (2.7 mg per decilitre [0.03 mmol per litre]). 
 
LDL cholesterol levels did not change significantly within groups, and there were no significant differences between the groups in 
the amount of change. 
 
Overall, the ratio of total cholesterol to HDL cholesterol decreased during both the weight-loss and the maintenance phases. The 
low-carbohydrate group had the greatest improvement, with a relative decrease of 20% (P = 0.01 for the interaction between diet 
group and time), as compared with a decrease of 12% in the low-fat group. 
 
The level of high-sensitivity C-reactive protein decreased significantly (P<0.05) only in the Mediterranean- diet group (21%) and the 
low-carbohydrate group (29%), during both the weight-loss and the maintenance phases, with no significant differences among the 
groups in the amount of decrease. 
 
 
 
 
 
 
 
 
APPENDIX A 13: Data Collection Sheets- Shai et al. (2008)           
(Some text and/or data extracted verbatim from study article for many of the descriptive sections. Figure, Table and 
Numerical references included in brackets refer to the original article).   
 
201 
 
Endocrine markers and Hormonal 
Effects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
During both the weight-loss and the maintenance phases, the level of high molecular-weight adiponectin increased significantly 
(P<0.05) in all diet groups, with no significant differences among the groups in the amount of increase. 
 
Circulating leptin, which reflects body-fat mass, decreased significantly (P<0.05) in all diet groups, with no significant differences 
among the groups in the amount of decrease. The decrease in leptin paralleled the decrease in body weight during the two phases.  
The interaction between the effects of low- carbohydrate diet and sex on the reduction of leptin (P = 0.04), as compared with the 
low-fat diet, reflects the greater effect of the low-carbohydrate diet among men. 
 
Among the 36 participants with diabetes,  only those in the Mediterranean-diet group had a decrease in fasting plasma glucose 
levels (32.8 mg per decilitre); this change was significantly different from the increase in plasma glucose levels among participants 
with diabetes in the low-fat group (P<0.001 for the interaction between diet group and time). 
There was no significant change in plasma glucose level among the participants without diabetes (P<0.001 for the interaction 
among diabetes and Mediterranean diet and time). 
 
In contrast, insulin levels decreased significantly in participants with diabetes and in those without diabetes in all diet groups, with 
no significant differences among groups in the amount of decrease. 
 
Among the participants with diabetes, the proportion of glycated haemoglobin at 24 months decreased by 0.4±1.3% in the low-fat 
group, 0.5±1.1% in the Mediterranean-diet group, and 0.9±0.8% in the low-carbohydrate group. The changes were significant 
(P<0.05) only in the low-carbohydrate group (P = 0.45 for the comparison among groups). 
 
Liver-Function Tests 
Changes in bilirubin, alkaline phosphatase, and alanine aminotransferase levels were similar among the diet groups. Alanine 
aminotransferase levels were significantly reduced from baseline to 24 months in the Mediterranean-diet and the low-carbohydrate 
groups (reductions of 3.4±11.0 and 2.6±8.6 units per litre, respectively; P<0.05 for the comparison with baseline in both groups). 
 
Exercise and Medication use The amount of physical activity increased significantly from baseline in all groups with no significant difference among the groups 
in the amount of increase.  The energy expenditure increase may be a potential confounding factor in assessing weight loss and or 
CVD marker results over the period of the intervention.  
 
During the study, there was little change in usage of medications, and there were no significant differences among groups in the 
amount of change. Four participants initiated and three stopped cholesterol-lowering therapy. Twenty participants initiated blood-
pressure treatment, five initiated medications for glycemic control, and one reduced the dosage of medications for glycemic 
control. 
 
What effect may bias have on the 
result? 
Atkins Foundation support may have influenced aiming for a favourable result for the low-carbohydrate diet.  
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The Author's conclusions - are 
these justified? 
This 2-year dietary-intervention study, found that the Mediterranean and low-carbohydrate diets are effective alternatives to the 
low-fat diet for weight loss and appear to be just as safe as the low-fat diet. 
In addition to producing weight loss in this moderately obese group of participants, the low-carbohydrate and Mediterranean diets 
had some beneficial metabolic effects, a result suggesting that these dietary strategies might be considered in clinical practice and 
that diets might be individualized according to personal preferences and metabolic needs. 
 
Generalizability- the extent to 
which the results might apply 
outside the study 
The unique nature of the workplace in this study, which permitted a closely monitored dietary intervention for a period of 2 years, 
makes it difficult to generalize the results to other free living populations. However, the researchers recognize that similar 
strategies to maintain adherence could be applied elsewhere and that this intervention model may be useful to apply in a corporate 
sponsored workplace initiative. 
 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The similar caloric deficit achieved in all diet groups suggests that a low-carbohydrate, non–restricted-calorie diet may be optimal 
for those who will not follow a restricted-calorie dietary regimen. 
 
The increasing improvement in levels of some biomarkers over time up to the 24-month point, despite the achievement of 
maximum weight loss by 6 months, suggests that a diet with a healthful composition has benefits beyond weight reduction. 
 
The strengths of the study include the one phase design, in which all participants started simultaneously; the relatively long 
duration of the study; the large study-group size; and the high rate of adherence. 
 
The monthly measurements of weight permitted a better understanding of the weight-loss trajectory than was the case in previous 
studies. 
 
Two phases of weight change were observed - initial weight loss and weight maintenance. The maximum weight reduction was 
achieved during the first 6 months; this period was followed by the maintenance phase of partial rebound and a plateau. Among all 
diet groups, weight loss was greater for those who completed the 24-month study than for those who did not. 
 
Hence even moderate weight loss has health benefits, and this study suggests benefits of behavioural approaches that yield weight 
losses similar to those obtained with pharmacotherapy. 
 
The changes observed in levels of adiponectin and leptin, which were consistent in all groups, reflect loss of weight. 
 
Changes in levels of various biomarkers were noted (leptin, adiponectin, and high-sensitivity C-reactive protein) that are apparently 
related to loss of adipose tissue and changes in biomarkers (triglycerides, HDL cholesterol, glucose, and insulin) that apparently 
reflect, in part, the effects of specific diet composition.  
 
Consumption of monounsaturated fats is thought to improve insulin sensitivity, an effect that may explain the favourable effect of 
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Discussion points- Contd. the Mediterranean diet on glucose and insulin levels. 
 
The results imply that dietary composition modifies metabolic biomarkers in addition to leading to weight loss. 
 
The results suggest that health care professionals might consider more than one dietary approach, according to individual 
preferences and metabolic needs, as long as the effort is sustained. 
 
This trial also suggests a model that might be applied more broadly in the workplace, using the employer as a health coach could 
be a cost-effective way to improve health. 
 
The use of dietary group sessions, spousal support, food labels, and monthly weighing in the workplace within the framework of a 
health promotion campaign might yield weight reduction and long-term health benefits. 
 
Were study limitations discussed? Few women were enrolled however the researchers  we observed a significant interaction between the effects of diet group and sex 
on weight loss (women tended to lose more weight on the Mediterranean diet), and this difference between men and women was 
also reflected in the changes in leptin levels. This possible sex-specific difference should be explored in further studies. 
 
The researchers recognize that measurement of HOMA-IR is not an optimal method to assess insulin resistance among persons 
with diabetes.  
 
Future Implications discussed This study highlights a model that might be applied more broadly in the workplace and the concept of the Employer as a health 
coach as suggested by Okie (2007). Also using dietary group sessions, spousal support, food labels and monthly weighing in the 
workplace might be pragmatic suggestions for weight reduction and long term health benefits. 
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Author Stern et al. (2004)  
 
Title  The Effects of Low-Carbohydrate versus Conventional weight Loss Diets in Severely Obese Adults: One year follow-up of a 
randomized trial 
 
Journal  Annals of Internal Medicine  
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. 4 out of 9 authors are MDs. 
General Aim Clear To follow up on a previously conducted 6 month trial to assess the long term effects of a low carbohydrate diet LC versus a 
conventional fat and calorie reduced diet. 
 
Specific Study objectives stated To review the one year outcomes between the 2 diets as a follow up to the trial conducted by Samaha et al. (2003). 
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet and particularly CHO restriction is 
significant to weight management and CVD risk management. 
 
A longer-term view of a low-carbohydrate Atkins type diet compared with a low-fat conventional diet for severely obese group of 
subjects.  Follow-up to Samaha et al. (2003).  
 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Randomized trial. Comparative intervention 
 
Study described as randomised As for Samaha et al. (2003). Random assignation of subjects to one of two diets. 
 
Study described as double blind No  
 
Description of withdrawals and 
dropouts present 
Of the 132 enrolled persons, follow-up was done at 6 months for 79 persons and at 1 year for 87 persons. For measurements at 6 
months, we retrieved weights on an additional 16 persons on the low-carbohydrate diet and 23 persons on the conventional diet 
(total, 39 persons at a mean [[±SD] of 6.6 ± 1.2 months). For measurements at 1 year, we retrieved weights on 18 persons on the 
low-carbohydrate diet and 21 persons on the conventional diet (total, 39 persons at a mean [±SD] of 13.5 ± 3.2 months). Thus, we 
had 6-month weights on 118 of 132 persons (89%) and 1-year weights on 126 of 132 persons (96%). Of the 18 persons who missed 
the 6-month visit but returned for the 1-year visit (6 in the low-carbohydrate group and 12 in the conventional diet group), all but 2 
had 6-month weights retrieved from medical records. Of the 6 persons for whom no 1-year weights were available, 2 were in the 
low-carbohydrate group and 4 in the conventional diet group. 
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Randomisation / blinding 
appropriate 
Randomisation appropriate ; Blinding not relevant 
 
 
Target Population Severely obese Adults 
 
Why was study done? What was 
perceived general importance? 
To assess the sustainability of results attained during a previous study –Samaha et al. 2003. 
Is there a clear hypothesis and 
objectives? 
Yes. That severely obese subjects with a high prevalence of diabetes or the metabolic syndrome would have greater weight loss 
without detrimental effects on risk factors for atherosclerosis while on a carbohydrate-restricted diet than on a calorie and fat- 
restricted low-fat diet 
 
What specific question is being 
addressed? 
For severely obese individuals, do low-carbohydrate diets work better that conventional low-fat, low-calorie diets and is the weight 
loss sustainable over the longer term of one year. 
 
The study setting- where did study 
take place? 
Philadelphia Veterans Affairs Medical Center 
The study population - Intended 
group to whom results should apply  
vs. group actually studied 
Participants were recruited from the outpatient practices of the Philadelphia Veterans Affairs Medical Center and included persons 
18 years of age and older with a body mass index (BMI) of 35 kg/m2 or greater. 
Group actually studied  Between May 2001 and November 2001, 132 persons were randomly assigned to either a low-carbohydrate diet (n= 64) or a 
conventional diet (n = 68). 
 
The social, cultural, economic, 
ethnic background 
Veterans. A high proportion of black subjects 
Study Approval The Institutional Re-view Committee at the Philadelphia Veterans Affairs Medical Center approved the study, and all participants 
provided written informed consent. 
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Study included persons 18 years of age and older with a body mass index (BMI) of 35 kg/m2 or greater. The exclusion criteria were 
a serum creatinine level greater than 133 _mol/L (>1.5 mg/dL), hepatic disease, severe life-limiting medical illness, inability to self-
monitor glucose levels, or active use of a weight loss program or weight loss medication. 
 
20 persons on the low CHO diet and 25 on the conventional diet dropped out by 1 year 
 
Is there a power calculation to 
determine sample size? 
Assuming a two-sided type 1 error of 5% the authors estimated a need for 100 subjects for the study to have 80% power to 
demonstrate a mean ± SD weight loss that was 5±12v kg greater in the low CHO group than the low fat group.  A dropout rate of 25 
was anticipated so the enrolment target was 135. 
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Was there selection bias? None evident. 
 
Was there funding bias? None evident. The funding source had no role in the design, conduct, or reporting of the study or in the decision to submit the 
manuscript for publication. 
 
Confounding Factors Many of the subjects were taking lipid lowering medication and hypoglycaemic agents. 
 
How does the study group relate to 
researchers interest groups / 
patients? 
Obese and severely obese subjects with evidence of metabolic disease fall in the scope of the researchers interests. 
What was the intervention and how 
was it carried out? 
Counselling sessions continued for 11 months – 5 months after the end of 6 month trial. 
What was measured and how was it, 
measured? 
Changes in weight, lipid levels, glycemic control and insulin sensitivity. 
Were baseline measures used? Participants were well matched between diet groups regarding baseline characteristics, although the low-carbohydrate group had 
more hypertensive and white persons (Table 1). Both groups had a high prevalence of diabetes or the metabolic syndrome (Table 
1). Twenty persons on the low-carbohydrate diet and 25 on the conventional diet dropped out by 1 year. These persons were 
younger and had a lower prevalence of sleep apnea but were not otherwise significantly different from those who completed the 
study (Table 1). 
Differences in baseline lipid values (P> 0.2 for all comparisons), diet composition (P≥ 0.149 for all comparisons), glycemic control 
indices (P ≥ 0.158 for all comparisons), and insulin sensitivity (P> 0.2) between those who dropped out of the study and those who 
completed the study were not significant. 
 
Were process measures used? 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in weight, dietary intake and metabolic data were compared between the 2 diets by random-coefficient analysis to allow 
for a variable number of observations for participants and to take account that the repeated observations of the outcome variables 
over time for individuals were correlated.  
  
A restricted maximum likelihood analysis was used which assumed that changes were distributed according a bivariate normal 
distribution and that data were missing at random.   
 
Missing data : Of the 132 enrolled persons, follow up was done at 6months for 79 persons and at 1 year for 87 persons.  
Of the 18 persons who missed the 6 month visit (6 in the low CHO group and 12 in the low fat group, 6 month weights were 
retrieved for all but 2 subjects in the low CHO group from medical records. 
 
Of the 4 subjects in the low fat group and 2 in the low CHO group for whom 1 year weights were not available, these were retrieved 
from medical records though these may be subject to error as the scales used and clothing protocol would have differed from the 
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Were process measures used? 
contd. 
study. 
 
We used several approaches to handle the 45 participants with missing data for diet recall and metabolic measurements. 
For the primary analysis by random-coefficient analysis, we assumed data were missing at random. To verify this assumption, we 
performed sensitivity analyses based on comparisons of baseline characteristics and weight loss differences between those who 
dropped out and those who completed the study. We also performed 2 additional sensitivity analyses: The first analysis included 
only persons who completed the study, and the second analysis included all persons, with the baseline data carried forward for 
those persons who dropped out. 
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Weight, self reported medical history and blood pressure at baseline, 6 months and 1 year. Blood glucose, glycosylated 
haemoglobin, serum lipids, blood pressure.  
 
Primary end point was total weight loss at 1 year. 
  
Secondary analyses included changes from baseline of serum lipids, insulin sensitivity and glycemic control and dietary intake.  
 
Are the methods quantitative or 
qualitative? 
Quantitative and qualitative. 
Safety Results 2 persons on the low-CHO diet and 4 on the conventional diet developed diabetes at 1 year.  
 
Blood urea nitrogen levels increased more in the low CHO group but changes in uric acid levels were not clinically significant. 
3 individuals on the low CHO group died during the study but these were not regarded as diet related.  
 
Endpoint/ Biomarker Tested Weight loss, serum lipids, glycemic control and insulin sensitivity, BP, adverse reactions, attrition, assessment of dietary intake. 
 
Are there end points other than 
those reported that might be 
relevant and important 
Apolipoprotein a and b, renal and bone health as one arm was a ketogenic diet. 
Are the endpoints relevant to actual 
practice 
Yes and consistent with other studies. 
Dietary Intake and Adherence 
Results 
Caloric intake decreased more by year 1 in the low CHO group than in the LF group. The low CHO group reduced CHO by 52%, 
reduced fibre intake BY 42 %, increased total fat intake by 31%; increased dietary cholesterol intake by 21%, reduced sodium 
intake by 21% relative to baseline.  
 
20 persons on the low CHO diet and 25 on the conventional diet dropped out by 1 year  
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Weight loss and cardio-protective 
mechanisms identified  
 
 
 
 
 
 
 
 
 
 
 
Although it has been speculated that a low-carbohydrate diet would facilitate weight loss by promoting the metabolism of adipose 
tissue (13), our data suggest that weight loss differences may be explained by lower caloric intake on a low-carbohydrate diet. 
 
If true, this may be attributable to the simplicity of a low-carbohydrate diet or to greater effects on satiety. Of note, persons on the 
low-carbohydrate diet who dropped out of the study were less likely to lose weight, whereas those assigned to the conventional 
diet lost a similar amount of weight whether or not they remained in the study. 
 
This observation, together with the difference between diets in weight loss beyond 6 months, raises the possibility that a low-
carbohydrate diet is less sustainable than a conventional diet. 
 
Despite modest and comparable overall weight loss, the responses of triglycerides and HDL cholesterol to the low-carbohydrate 
diet were more favorable than to the conventional diet. These findings are consistent with previous studies (7, 14–17) and may be 
related to diminished very-low-density lipoprotein triglyceride production by the liver in response to decreased carbohydrate 
substrate delivery, as well as to improvements in insulin sensitivity. The greater preservation of HDL cholesterol on the low-
carbohydrate diet may be a secondary effect of the greater decrease in triglycerides via cholesterol ester transferase or through 
down regulation of hepatic scavenger receptor B1 levels (18). The expression of these receptors, which bind HDL cholesterol and 
facilitate reverse cholesterol transport to the liver, may be modulated by dietary fats (18). 
 
Weight Loss / Body Composition 
results 
Participants on the low CHO diet maintained most of their 6 month weight loss whereas those on the conventional diet continued 
to lose weight throughout the year. The final 1 year weight change was -5±8.7kg in the low CHO group and -3.1 ±8.4kg in the 
conventional diet group. The difference between the two diet groups was not significant. 
  
Persons on the low-CHO diet who dropped out lost less weight than those who completed the study. In contrast weight loss was 
not significantly different for those on the conventional diet.  
 
Ketonuria Results None reported. 
 
Cardiac Risk Factor Results Changes in total and LDL cholesterol were not significantly different between groups. 
 
Triglyceride levels decreased more in the low CHO group than in the conventional diet group (P=0.044 before and P=0.041 after 
adjustment for baseline variables. A separate sensitivity analysis that included only the 87 persons who completed the study 
confirmed this finding.  Assignment to the low CHO group and greater weight loss were each independent predictors of a decrease 
in triglyceride concentration suggesting a direct effect of the low CHO diet on triglyceride reduction.  
 
The HDL cholesterol concentration decreased more in the conventional diet group than in the low-CHO group (P=0.025 before and 
P=0.014 after adjusting for baseline variables. The results indicated a direct diet-related effect on HDL cholesterol.                                                              
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Hormonal & Endocrine Results Glycemic Control and Insulin Sensitivity 
The difference between the 2 diet groups was not significant. 
Glycosylated haemoglobin in the small group with diabetes (n=54) decreased more in the low-CHO group after adjusting for 
baseline differences. The results show a direct effect of the low CHO diet on glycemic control   
                                                                                   
Exercise and Medication use Many subjects were taking lipid-lowering medications and hypoglycaemic agents. No comment on exercise. 
 
What effect may bias have on the 
result? 
None noted. 
The Author's conclusions - are 
these justified? 
 
 
 
 
Similar weight loss in persons randomly assigned to a low CHO diet or a conventional diet by 1 year.  
Modest overall weight loss on both diet groups. 
Assignment to the low CHO group had a direct and more favourable effect on triglyceride level, HDL cholesterol level and glycemic 
control in the smaller diabetic subset.  
 
Findings give further evidence that restriction of CHO in obese persons who may be overconsuming CHO at baseline may have 
favourable metabolic effects. 
 
Caution is still needed in recommending a low-CHO diet as important concerns remain.   
 
Generalizability- the extent to which 
the results might apply outside the 
study 
Results may be used to devise weight loss plans for obese individuals. 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
A larger study might have shown a statistically significant difference in weight loss. 
 
The enrolment targets were based on a maximum anticipated weight loss by 6 months and assumed weight stabilization thereafter. 
As weight loss continued beyond 6 months in the conventional diet group a sample size of 284 persons per group may have been 
more appropriate to show a difference between the groups at 1 year.  
 
In contrast to Foster et al. (2003) persons on the low-CHO maintained most of their initial weight loss where as those on the 
conventional diet continued to lose weight. The difference may be due to more intensive counselling.  
 
Data suggests that weight loss differences may be explained by lower caloric intake on a low-CHO diet rather than metabolism of 
adipose tissue.  
 
Possible points in favour of low-CHO diet could be the simplicity and greater effects on satiety.  
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Discussion points contd. Persons on the low-CHO diet who dropped out were less likely to lose weight whereas those on the conventional diet continued to 
lose weight whether or not they remained in the study. This observation together with the difference between diets in weight loss 
beyond six months suggests that a low CHO diet is less sustainable than a conventional diet.  
 
The low-CHO diet followed in the study had a healthy lower sodium intake and unhealthy higher fat and cholesterol and lower fibre 
levels. The difference in sodium intake could represent less consumption of pre-packaged, low-fat but high salt foods in the low- 
CHO group.  
 
The low-CHO diet had more favourable responses of triglycerides and HDL cholesterol consistent with previous studies. This may 
be related to diminished very-low density lipoprotein (VLDL) triglyceride production by the liver in response to decreased CHO 
intake and improved insulin sensitivity.  
 
The higher HDL cholesterol on the low CHO diet may be a secondary effect of the greater decrease in triglycerides via cholesterol 
ester transferase or through down regulation of hepatic scavenger receptor B1 levels. The expression of these receptors which 
bind HD cholesterol and facilitate reverse cholesterol transport to the liver may be modulated by dietary fats.  
 
Glycosylated haemoglobin in the small diabetic group improved in the low CHO group. This is regarded as clinically significant to 
micro and macro vascular complications of diabetes.  
 
Were study limitations discussed? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The weights retrieved from medical records were obtained on scales that were different from those used for the study and were 
probably obtained in a non-uniform manner with regard to clothing. 
 
Overall weight loss was modest. 
 
Overall dropout rate was high. 
 
The authors tried to minimize biasing effects by extracting 1 year weights for persons who dropped out however these weights 
were not measured in a standardized manner. Any random measurement errors would bias results towards the null. 
 
Most persons did not meet their dietary targets (< 30g of CHO daily in the low CHO group and a reduction of 500kcal per day in the 
conventional diet.  Meeting these targets would have yielded different results. 
 
There were differences between persons who completed the study and those who dropped out such as greater weight loss in the 
former.  However observed differences in responses of triglyceride, HDL cholesterol and glycosylated haemoglobin were 
independent of differences in weight loss.  
 
We cannot exclude that a larger study might have demonstrated a statistically significant difference in weight loss between diets. 
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Were study limitations discussed? Our enrollment targets were based on a maximum anticipated weight loss by 6 months and assumed weight stabilization 
thereafter. Given that weight loss continued beyond 6 months in the conventional diet group, we would have needed a sample 
size of approximately 284 persons per group to show a difference between groups at 1 year, assuming preservation of the 
observed changes. 
 
Future Implications discussed Future studies will need to evaluate whether a low CHO has more favourable effects on the development of diabetes and on 
cardiovascular outcomes.  
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Author Yancy, Olsen, Guyton, Bakst & Westman (2004) 
 
Title  A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet to Treat Obesity and Hyperlipidemia 
 
Journal  Annals of Internal Medicine 
 
Quality of Journal and competence 
of Researchers 
Peer Reviewed Journal. 3 out of 5 of the Authors are MDs. The lead author is an associate professor at Duke University, USA.  
General Aim Clear To ascertain the effectiveness of a low CHO diet in treating obesity and hyperlipidemia. 
 
Specific Study objectives stated To compare the effects of a low-carbohydrate, ketogenic diet program with those of a low-fat, low cholesterol, reduced – calorie 
diet  
 
Aim and study objectives relevant 
to research question being explored 
External Validity - relevance of this 
particular piece of work to the issue 
under scrutiny 
Relevant to primary research question as to whether the macronutrient composition of a diet is significant to weight management 
and CVD risk management. 
 
A low-carbohydrate Atkins Diet compared with a low-fat conventional diet. 
Internal Validity - methods and 
actual results in the light of study 
objectives 
Comparative Intervention. Not controlled.  
Study described as randomised Yes. Community dwelling hyperlipidemic persons were randomly assigned to either a low CHO, ketogenic diet or a low-fat , low-
cholesterol, reduced calorie diet for 24 weeks  
 
Study described as double blind No 
 
Description of withdrawals and 
dropouts present 
Yes. One withdrawal in the Low–CHO group who discontinued the study before receiving dietary instruction.  
In the low-CHO group, 4 (7%) could not keep meeting schedule, 5 (8%) could not adhere to the diet, 1 (2%) was unsatisfied with 
weight loss, 1 was lost to follow-up, 3 (5%) dropped out due to adverse effects of which 2 had increases in LDL cholesterol and 1 
had shakiness and uneasiness.  Of 59 – 45 (76%) completed in the low CHO group and of 60 in the low-fat group, 34 (57%) 
completed. In the low-fat group, 15 participants (25%) could not adhere to meeting schedule, 3(5%) could not adhere to diet, 6(10%) 
were unsatisfied with weight loss and 2(3%) were lost to follow up  
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Randomisation / blinding 
appropriate 
Randomisation was relevant. Blinding for participants would not be possible as these are popular diets that participants would 
most likely be aware of. 
 
Target Population Overweight, , hyperlipidemic individuals  
 
Why was study done? What was 
perceived general importance? 
To address the scarcity of data on the long-term effects of low-CHO diets on body weight, body composition and serum lipid levels  
Is there a clear hypothesis and 
objectives? 
The objective is to compare the effects of a low-carbohydrate ketogenic diet with a low-fat, low cholesterol reduced-calorie diet on 
obesity and lipid control. 
 
What specific question is being 
addressed? 
Long-term efficacy and adverse effects of low-CHO weight reduction diets  
The study setting- where did study 
take place? 
Group Meetings took place at an out-patient research clinic 
Group actually studied  Generally healthy persons recruited from the community. Of 1051 volunteers screened for eligibility, 120 underwent randomization.  
  
The social, cultural, economic, 
ethnic background 
Generally healthy individuals from the local community (Durham, North Carolina) 
Study Approval All participants provided written informed consent. Study approved by the institutional review board of Duke University Health 
System.  
 
Was there clear inclusion and 
exclusion criteria and explanations 
of patient drop out?  
Inclusion criteria: Generally healthy persons were recruited from the community. Inclusion criteria Included: age 18-65 years; BMI – 
30-60kg/m2; desire to lose weight; elevated lipid levels (total cholesterol level >5.17 mmol/L [>200mg/dL], LDL cholesterol > 
3.36mmol/L [> 130mg/dL] or triglycerides level >2.26 mmol/L [>200mg/dL]) and no serious medical condition. 
Exclusion criteria : use of any prescription medication in the previous 2 months (except for oral contraceptives, estrogen therapy, 
stable thyroid medication); pregnancy or breastfeeding; use of weight loss or diet pills in previous 6 months; baseline ketonuria.  
 
Is there a power calculation to 
determine sample size? 
None evident.  
Was there selection bias? None evident.  
 
Was there funding bias? 
 
 
The Study had grant support from the Robert C Atkins Foundation. However the grants received or pending receipt by Westman 
and Yancy have been declared as potential conflicts of interest - leaving the review process to evaluate if such a conflict is evident.  
Investigators at Duke University conducted the study and maintained exclusive control of all data and analyses. The funding 
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Was there funding bias? contd. source had no involvement in the recruitment of participants; study interventions; collection, analysis, or interpretation of the data; 
or preparation or review of the manuscript. 
 
Confounding Factors Nutritional supplementation to one group but not the other 
 
How does the study group relate to 
researchers interest groups / 
patients? 
Potentially obese individuals with impaired lipid control would be clients of the researcher and the impact of dietary therapy on the 
endpoints identified would be relevant to the researcher. 
What was the intervention and how 
was it carried out? 
 
 
 
 
 
 
 
 
 
 
 
 
Randomized, controlled trial. 
Low-carbohydrate diet (initially, <20 g of carbohydrate daily) plus nutritional supplementation, exercise recommendation, and 
group meetings, or low-fat diet (<30% energy from fat, <300 mg of cholesterol daily, and deficit of 500 to 1000 kcal/d) plus exercise 
recommendation and group meetings. 
 
Using computer generated simple randomization lists, participants were allocated to receive the low-CHO diet or the low-fat diet. 
The intervention included group meetings, diet instruction and an exercise recommendation. Group meetings took place twice 
monthly for 3 months then monthly for 3 months. Meetings typically lasted one hour and consisted of diet instruction, supportive 
counselling, questionnaires and biomedical measurements. During the study, the participants selected their own menus and 
prepared or bought meals according to the guidelines presented to them. Participants encouraged to exercise for 30 minutes at 
least 3 times weekly but no formal exercise program or incentives were provided. 
 
For the Low-CHO Diet Group – using a popular diet book published by a lay press and additional handouts, trained research staff 
instructed participants to restrict intake of CHO to less than 20g/d. Participants permitted unlimited amounts of animal foods 
(meat, fowl, fish and shellfish), unlimited eggs, 4 oz of hard cheese, 2 cups of salad vegetables (lettuce, spinach or celery) and 1 
cup of low-CHO vegetables (broccoli, cauliflower or squash) daily. Participants encouraged to drink 6-8 glasses of water daily. 
When participants were halfway to their goal body weight at week 10 visit, they were advised to add approximately 5g of CHO to 
their daily intake each week till body weight was maintained. To simulate the practice of the study sponsor the low-CHO group 
received daily nutritional supplements including a multivitamin, essential oils, diet formulation and chromium picolinate.  
For the Low-fat diet group, a commonly available booklet and additional handouts, a registered dietician instructed participants in 
a diet consisting of less than 30% of daily energy from fat, less than 10% of daily energy from saturated fat and less than 300mg of 
cholesterol daily. The recommended energy intake was 500 to 1000 kcal less than the participant’s calculated energy intake for 
weight maintenance (body weight in pounds X 10) 
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What was measured and how was it 
measured? 
Body weight, body composition, fasting serum lipid levels, and tolerability of diet. 
 
Primary Outcome Measure: Body weight and BMI 
 
Secondary Outcome Measures: Adherence, Diet Composition, Ketonuria, Body Composition, Vital Signs- BP and pulse rate, serum 
lipids and lipoproteins, other metabolic effects- serum tests for sodium, potassium, chloride, urea nitrogen, creatinine, calcium, 
phosphorus, total protein, albumin, uric acid.  
Were baseline measures used? Yes. Baseline characteristics collected were age, sex, ethnic group, mean body weight ± SD in kg; mean BMI ± SD in kg/m2; total 
cholesterol; triglycerides; LDL cholesterol; HDL cholesterol, ratio of total cholesterol to HDL and ratio of triglycerides to HDL 
cholesterol. 
 
Were process measures used? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diet Composition -  All participants completed a 24-hour recall of food intake at baseline and take-home food records  
(5 consecutive days, including a weekend) that were collected at each meeting during the study. 
A sample of participants (13 in the low-carbohydrate diet group and 7 in the low-fat diet group) who completed the study were  
selected for food record analysis by the research staff on the basis of adequacy of detail in their records. 
A registered dietitian analyzed the food records by using a nutrition software program (Nutritionist Five, version 1.6 [First 
DataBank, Inc., San Bruno, California]). 
 
Ketonuria- Restriction of dietary intake of carbohydrates to less than 40 g/d typically results in ketonuria that is detectable by 
dipstick analysis, which can be used to monitor adherence to the low-carbohydrate diet (14, 15). At each return visit, participants 
provided a fresh urine specimen for analysis. The following semi-quantitative scale was used to categorize ketone content: none, 
trace (up to 0.9 mmol/L [5 mg/dL]), small (0.9 to 6.9 mmol/L [5 to 40 mg/dL]), moderate (6.9 to 13.8 mmol/L [40 to 80 mg/dL]), large80 
(13.8 to 27.5 mmol/L [80 to 160 mg/dL]), and large160 (>27.5 mmol/L [>160 mg/dL]). 
 
Body Composition - Body composition was estimated by using bioelectric impedance (model TBF-300A [Tanita Corp., Arlington 
Heights, Illinois]) at approximately the same time of day (afternoon or evening) at each return visit. In a subset of 33 participants, 
the percentage of body fat as measured by bioelectric impedance had excellent correlation with the percentage as measured by 
dual-energy x-ray absorptiometry (r = 0.93 [95% CI, 0.87 to 0.97]). 
Blood pressure and pulse rate were measured in the non-dominant arm by using an automated digital cuff (model HEM-725C 
[Omron Corp., Vernon Hills, Illinois]) after the participant had been sitting for 3 minutes. 
 
Serum Lipids and Lipoproteins-  Serum specimens for lipid measurement were obtained in the morning after at least 8 hours of 
fasting at the screening visit and at 8, 16, and 24 weeks. 
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Were process measures used? – 
contd. 
Other Metabolic Effects 
Serum tests for sodium, potassium, chloride, urea nitrogen, creatinine, calcium, phosphorus, total protein, albumin, uric acid, total 
bilirubin, alanine aminotransferase, aspartate  aminotransferase, alkaline phosphatase, thyroid stimulating hormone, iron, 
hemoglobin, leukocyte count, and platelet count were obtained at the screening visit and at 8, 16, and 24 weeks. 
 
The glomerular filtration rate was estimated by using an equation that included age; sex; race; and serum levels of albumin, 
creatinine, and urea nitrogen (Modification of Diet in Renal Disease Study equation) (16). 
 
Adverse Effects 
At all return visits, participants completed an open ended questionnaire on side effects. At the 20- and 24- week visits, participants 
completed a checklist of the side effects that were most often mentioned during the study. 
 
Statistical Analysis 
Analyses were performed by using S-PLUS software, version 6.1 (Insightful Corp., Seattle, Washington), or SAS software, version 
8.02 In most body weight and body composition models, time and group assignment were included as fixed effects with linear and 
quadratic time-by-group interaction terms. 
 
In the fat-free mass, total body water, and vital sign models, the time-by-group interaction was treated as a categorical variable. In 
all body weight and body composition models, random effects included intercept and linear slope terms. For the serum outcome 
measure models, the time-by- group interaction was treated as a categorical variable, and an unstructured covariance was used to 
account for within-patient correlation over time. 
 
All available data, including those from participants who subsequently discontinued the study, were used for the longitudinal 
analyses. Mixed-effects models assume non-informative dropout, meaning that the probability of dropout may depend on 
covariates or a participant’s previous responses but not on current or future responses (17). A P value of 0.05 or less was 
considered statistically significant. 
 
Were outcome measures identified? 
Are there clear validated outcomes? 
Primary Outcome Measure: Body Weight. BMI calculated as body weight in kg divided by height in m2. 
Secondary Outcome Measure: Adherence to the diet measured by self – report, food records and for the low CHO group, urinary 
ketone assessment 
 
Are the methods quantitative or 
qualitative? 
Both. 
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Safety Results Minor adverse effects were more frequent in the low CHO group. 
Adverse effects in the low-CHO vs. the low-fat group. Constipation 68% vs. 35% (P<0.001); headache 60% vs. 40% (P=0, 03); 
halitosis (38% vs. 8%, P<0.001), muscle cramps (35% vs. 7% (P<0.001), diarrhoea 23% vs. 7%, (P=0.02); general weakness 25% vs. 
8% (P=0.01) and rash 13% vs. 0% (P=0.006). One 53 year old man in the low CHO group with a family history of early heart disease 
was diagnosed with CHD. During this study he lost 16 kg, his serum LDL had decreased by 0.75 mmol/L (29 mg/dL) and HDL 
increased by 0.21 mmol/L (8mg/dL).   
 
Are there end points other than 
those reported that might be 
relevant and important 
Renal function and bone health maybe relevant due to ketogenic arm of study. Apo lipoprotein a and b. 
Are the endpoints relevant to actual 
practice 
Yes and consistent with other studies 
Dietary Intake and Adherence 
Results 
Diet composition measured on the basis of food records collected at each visit from a subsample of participants (13 from the Low 
CHO group and 7 from the low-fat group. The Low-CHO group consumed a mean (± SD) of 29.5 ± 11.1g of CHO (8% of daily energy 
intake), 97.9± 24.3 of protein (26% of daily energy intake), and 110.6 ± 27.3 g of fat (68% of daily intake) daily. The low-fat group 
consumed 197.6 ± 34.2 of CHO (52% of daily energy intake), 70.5± 9.7g of protein (19% of daily energy intake) and 48.9 ±12g of fat 
(29% of daily intake). Estimated daily energy intake was 1461.0±325.7 kcal in the Low-CHO group and 1502.0 ± 162.1 kcal in the low 
fat group. 
 
Weight loss and cardio-protective 
mechanisms identified,  
Weight loss resulted predominantly from reduced energy intake in both groups. The method of reducing energy intake differed 
greatly. The low-fat diet group received counseling to restrict intake of fat, cholesterol, and energy, whereas the low-carbohydrate 
diet group received counseling to restrict intake of carbohydrates but not energy. The voluntary reduction in energy intake among 
recipients of the low-carbohydrate diet merits future research. These participants may have restricted intake because of limited 
food choices, or the low-carbohydrate diet may have appetite suppressant properties (21, 22). 
 
Other possible explanations for the discrepancy in weight loss between groups include loss of energy through ketonuria and the 
increased thermic effect of a high-protein diet (23). With regard to the composition of weight loss, both groups lost predominantly 
fat mass over 24 weeks, and the percentage of total weight loss that was fat was similar in both groups. The low-carbohydrate 
group lost a greater amount of water in the first 2 weeks than did the low-fat diet group; this finding confirms anecdotal reports of 
dieresis with the low-carbohydrate diet. 
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Weight Loss / Body Composition 
results 
61% (n=36) of the low-CHO group and 23% (n=14) of the low far group lost greater than 10% of their initial body weight. (P<0.001). 
Over 24 weeks, participants in each group lost more fat mass than fat-free mass. 
 
Percentage of total weight loss that was fat loss was similar in the two groups (78% in the low-CHO group and 74% in the low-fat 
group) 
 
The low-CHO group lost a greater amount of total body water in the first two weeks than the low-fat group.  
 
Ketonuria Results Of the low-CHO Group 86% (47 of 55) had urinary ketones of as trace or greater at 2 weeks and 42% (19 of 45) at 24 weeks. 
Proportion with urinary ketones as moderate or greater was 64% (35 of 55 ) at 2 weeks and decreased to 18% (8 of 45 ) at 24 weeks  
 
Cardiac Risk Factor Results Vital Signs - Over 24 weeks systolic BP in the low CHO group decreased by 9.6mm Hg, diastolic BP decreased by 6.0mm Hg. In the 
low-fat group, systolic BP decreased by 7.5mm Hg and diastolic BP decreased by 5.2mm Hg The low CHO group had statistically 
greater changes in the triglyceride level, HDL cholesterol level and ratio of triglycerides to HDL Cholesterol (P=0.004, P<0.001 and 
P=0.02)respectively.  LDL Cholesterol increased by more than 10% in 13 (30%) of 44 recipients of the low-CHO group and 5 (16%) 
of 31 recipients of the low-fat diet ((P>0.2)  
 
Perhaps the biggest concern about the low-carbohydrate diet is that the increase in fat intake will have detrimental effects on 
serum lipid levels (24). We found that the LDL cholesterol level did not change on average but did increase by more than 10% from 
baseline to week 24 in 30% of recipients of the low-carbohydrate diet who completed the study. 
 
Hormonal and Endocrine Results Serum glucose, insulin levels and insulin sensitivity were not measured. 
 
Exercise and Medication use The researchers could not distinguish the effects of the nutritional supplements given only to the low CHO group. Could be a 
confounding factor. Supplements may have acted as an incentive for participants but may also have increased weight loss in 
participants. 
 
What effect may bias have on the 
result? 
Simulating the practice of the study sponsor- Atkins Foundation, the administration of nutritional supplements to the Low-CHO 
group, potentially creates a bias in favour of this group and potentially confounds the results.  
 
The Author's conclusions - are 
these justified? 
Compared with a low-fat diet, a low CHO diet had better participant retention and greater weight loss. During active weight loss 
serum triglycerides decreased more and HDL increased more with the low CHO diet than the low fat diet.  
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Generalizability- the extent to which 
the results might apply outside the 
study 
Weight loss and CVD marker improvement with energy restriction may be generalized. 
Discussion points 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over 24 weeks the low CHO group led to greater weight loss, reduction in serum triglyceride and increase in HDL cholesterol 
compared with a low-fat diet. Results for weight loss and serum triglycerides similar to 4 randomized controlled trials of the low –
CHO diet. Rise in HDL cholesterol occurred in 1 of the 4 studies. Magnitude of weight loss comparable with that achieved by use of 
orlistat (9% at 6 months) and sibutramine (8% at 6months).  
 
Weight loss in both groups resulted from reduced energy intake however the method of reduction differed – one with advice to 
reduce CHO not energy and the other to restrict fat, cholesterol and energy. 
Voluntary reduction of energy reduction by the low-CHO group merits future research. 
 
Restricted intake explanations include limited food choices or the low CHO diet may have appetite suppressant properties. Loss of 
energy through ketonuria and increased thermic effect of a high protein diet.  
 
A study in which food is controlled will better determine what factors contribute to weight loss from a low-CHO diet. 
 
Both groups lost fat mass over 24 weeks and the percentage of total weight loss comprising fat was similar in both g 
roups. Whilst loss of water was greater with the low-CHO group for the first 2 weeks, after this total body water levels were similar 
for both groups. Changes in fat-free mass in both groups were explained by loss of water not lean tissue mass.  
Because the low CHO may lead to an increase in LDL cholesterol it is prudent to monitor serum lipid profiles of followers of this 
plan.  
 
Decrease in serum triglycerides observed in people with normal / moderately elevated baseline levels. For people with fat induced 
lipemia, the low-fat option may be the preferred option for decreasing triglycerides and preventing pancreatitis.  
 
HDL cholesterol increased for the low-CHO group in line with other studies that found that HDL cholesterol increases when dietary 
CHO is replaced by saturated, monounsaturated or polyunsaturated fat.  
 
With low fat diets HDL decreases during active weight loss and then increases during the weight stabilization phase when the diet 
is maintained. LDL cholesterol and triglycerides decrease during weight loss and then increase during stabilization phase. As 
participants were not followed beyond the phase of active weight loss, it was not possible to state how HDL cholesterol or other 
lipids may change during a weight maintenance phase.  
 
Research may be warranted on the effects of a low-CHO diet for patients with metabolic syndrome.  
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Discussion points contd. 
 
 
 
 
 
 
Authors express view that the underlying reason for greater drop-out rate in the low-fat group was likely to be participant 
dissatisfaction with weight loss as compared with their peers on the low-CHO diet. 
 
Symptomatic adverse effects that occur at the initiation of low-CHO diets (weakness, orthostasis, headaches, constipation and 
muscle cramps) are short-lived and may be reduced by copious fluid intake, consumption of allowed vegetables, bouillon and a 
daily multivitamin and mineral supplement.    
Were study limitations discussed? The researchers could not distinguish the effects of the nutritional supplements given only to the low CHO group. Could be a 
confounding factor.  
 
Supplements may have acted as an incentive for participants but may also have increased weight loss in participants. The 
researchers have considered a systematic review to confirm that the ingredients in the supplement used in this study were not 
shown to induce weight loss. The essential oil supplement with fish oil potentially reduce triglycerides and increase HDL 
cholesterol however the authors comment that the dose of fish oil was very low compared with doses used to treat 
hypertriglyceridemia but they may have contributed to the changes that occurred.  Supplements may also have reduced potential 
adverse effects of the low-CHO diet e.g. citric acid may have helped to prevent kidney stones. 
 
Participants were generally healthy followed only for 24 weeks limiting the generalization of the results.  
Future Implications discussed Further research is needed in other groups and for longer periods to determine the safety of this dietary approach. 
 
The low-CHO diet has not been studied with patients with chronic illness- close medical supervision would be needed. The low-
CHO diet has not been studied with patients with chronic illness- close medical supervision would be needed.  
Weight loss may be difficult to maintain after 24 weeks 
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Studies Selected – Key Features of Dietary Design, Protocols & Weight Management Results  
  
Dansinger et al. (2005); 1 yr ; Atkins (A) : Z (Zone) : Low-Fat (L)  (Ornish) : Weight Watchers (W) 
 
Dansinger et al. (2005) studied four diets. The Atkins group consumed less than 20 grams (g) of 
carbohydrates daily increased gradually to 50 g. The Zone diet group restricted carbohydrate to 
40% of daily energy intake.  
 
The Weight Watchers Group restricted calories to 1200-1600 kcal.  
 
The Ornish diet group restricted fat intake to 10% of energy intake with higher levels of 
carbohydrate intake.  
 
The study noted that the mean caloric reduction from baseline  were 138 kcal for Atkins, 251 kcal 
for Zone, 244 for Weight watchers and 192 for Ornish groups and all the diets resulted in modest 
weight loss at one year that was statistically significant with no statistically significant differences 
between the diets (P=0.4).  
 
The weight loss at one year was 2.1±4.8 kg (2.1%) for the Atkins group (21 (53%) of 40 completed 
participants), 3.2± 6.0 kg for 26 of 40 participants who completed the Zone diet, 3.0 ± 4.9 kg (3.4%) 
for 26 of the 40 participants who completed the Weight Watchers diet plan; and 3.3 ± 7.3 kg (3.2%) 
for 20 of 40 participants who undertook the Ornish diet.  
 
Dansinger et al. (2005) noted that there were poor sustainability and adherence rates for all the 
diets and that adherence level rather than diet type was the key determinant of clinical benefits.  
 
The theory generated from this paper is that adherence may be increased if participants can freely 
choose their dietary approach. Additionally, more research is needed to identify practical 
techniques to increase adherence and match individual preferences, lifestyle and medical 
conditions. 
 
Foster et al. (2003); 3m, 6m &12m; A : L 
 
Foster et al. (2003) compared a low-carbohydrate Atkins diet with a conventional low- fat higher 
carbohydrate diet over three, six and twelve months and purported to be the first randomized 
controlled study that tested the Atkins diet.  
 
The Atkins diet group were asked to follow a copy Dr Atkins New Diet Revolution whilst the low fat 
– high carbohydrate diet prescribed 1500-1800 kcal per day for women and 1800 kcal per day for 
men with 60% of calories from carbohydrates, 25% of calories from fat and 15% from protein.  
 
Baseline weight for Atkins group was 98.7± 19.5 kg and for the low-fat group was 98.3±16.4 kg. At 
three months, subjects on the Atkins diet lost 6.8 ± 5.0 %. (6.7 kg ± 0.5 kg) of body weight as 
compared with 2.7 ±3.7% (2.65 ±0.5 kg) by the low-fat /high-carbohydrate group (P=0.001).  
 
At six months the difference remained significant as weight loss for the Atkins group was 7 ± 6.5 % 
( 6.9 ±6.4 kg)as compared with a weight loss of 3.2± 5.6% (3.14 ±5.5 kg) of body weight (P=0.02) for 
the low fat – high carbohydrate group. At twelve months the weight loss for the Atkins group was 
4.4 ± 6.7 % (4.3±6.6 kg) whilst that for the low-fat group was 2.5 ± 6.3% (2.5±6.2 kg) of body weight 
which was not considered significant (P=0.26).  
 
The weight loss data is based on an analysis in which base-line values were carried forward in case 
of missing data. If an alternative analysis is used that included data on  
 
Subjects who completed the study and data obtained at the time of the last follow-up visit for those 
who did not complete the study the percentage change in weight is higher (-8.1 ±4.4% for the Low-
Carbohydrate (LC)  group vs. -3.8±3.9% for the LF group at 3m (P=0.002); -9.7±5.7% vs. -5.3±6.4% at 
6m (P=0.03) and -7.3 ±7.3 % vs. -4.5± 7.9% at 12m (P=0.27).  
 
This study shows that that over the short to medium term of three to six months, a low-
carbohydrate Atkins type approach is likely to result in a significantly greater weight loss than a 
conventional low-fat approach. The low- carbohydrate group was able to achieve greater weight  
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Foster et al. (2003); 3m, 6m &12m; A : L contd.  
 
loss despite unrestricted intake of protein and fat or a caloric restriction as compared with the 
reduced calorie, low-fat conventional dietary approach with calorie restriction to 1500-1800 
calories.  
 
It was noted that ketosis was not a likely explanation for the increased weight loss with the low 
carbohydrate diet as ketones were not present for most subjects after the first six months. 
However the reduced energy intake with the Atkins type diet may be linked to the simplicity or 
monotony of the food plans or other aspects of the diet that affect appetite and dietary adherence. 
 
Frisch et al. (2009); 6m & 1yr; Z : L 
 
Frisch et al. (2009) compared a low carbohydrate Zone type diet with a low fat conventional diet.  
 
The target macronutrient composition in the low carbohydrate group was less than 40% of total 
energy intake from carbohydrates, more than 35% energy from fat, and 25% energy from protein. 
The target macronutrient composition in the low fat group was more than 55% energy from 
carbohydrates, less than 30% energy from fat, and 15% energy from protein.  
 
All participants were advised to reduce their daily energy intake by at least 500 kcal. During the first 
six months energy intake decreased by approximately 400 kcal/d compared to baseline in both 
groups. At month 12, the mean energy intake had slightly increased again in both groups but 
remained below baseline values.  
 
During the study period, the low carbohydrate group had a 2-3% higher protein intake, a 4-8% 
higher fat intake and a 7-11% higher carbohydrate intake than the low fat group.  
 
At month 6, both diets resulted in similar weight loss. Weight loss was 7.2 ± 5.4 kg in the low 
carbohydrate group and 6.2 ± 4.8 kg in the low fat group.   
 
In the second half-year, mean weight regain was 1.6 kg in the low carbohydrate group and 1.9 kg in 
low fat group. Thus, at the end of the study at month 12, the weight loss was 5.8 ± 6.1 kg in the low 
carbohydrate group and 4.3 ± 5.1 kg in the low fat group, the difference considered borderline 
significance (p = 0.065).   
 
Furthermore, in both groups, approximately 76% of weight reduction was due to a loss of fat mass 
(Frisch et al. 2009). 
 
Johnston et al. 2006 , 6weeks, Atkins Diet (A) : Zone Diet (Z) 
 
Johnston et al. (2006) compared two low-carbohydrate diets over six weeks, one of which was a 
ketogenic Atkins type diet while the other was a low-carbohydrate non-ketogenic diet.  
 
The diets aimed to be isocaloric restricting daily caloric intake to 1500 kilocalories (kcal). In 
Johnston et al. (2006), the weight loss results did not differ significantly. Baseline weight was 
95.8±5.7 kg for the Atkins group and 99.4±6.1 kg for the Zone group.  
 
The Atkins type group lost 6.3± 0.6 kg (6.6% of baseline weight) whilst the Zone type group lost 7.2 
± 0.8 kg (7.2% of baseline weight). Fat losses of 3.4 kg in the Atkins group and 5.5kg in the Zone 
type group also did not differ significantly between the groups by week 6 (P=0.111). 
 
Layman et al. 16 w; (2005); Z : Z+ Exercise : L : L+ Exercise  
 
Layman et al. (2004) compared Zone type diets with and without the inclusion of exercise to a 
higher-carbohydrate conventional diet protocol with and without exercise.  
 
The lower-carbohydrate Zone type diet allowed protein intake of 1.6g per kilogram per day 
(approximately 30% of energy intake), a carbohydrate: protein ratio <1.5 and dietary fats at 30% of 
energy intake. The higher-carbohydrate conventional protocol allowed dietary protein at 0.8g per 
kilogram per day (15% of energy intake), a carbohydrate to protein ratio > 3.5 and fats at 30% of 
energy intake.  
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Layman et al. 16 w; (2005); Z : Z+ Exercise : L : L+ Exercise contd. 
 
The study and menus were designed to provide the diet groups with 1700kcal per day but subjects 
were free-living and determined their own daily intake. The actual caloric intake was 1300-1400 kcal 
for the groups representing approximately 33 % energy reduction from baseline.  
 
Actual protein intake in the lower-carbohydrate group was 107g/day (30% of energy intake) with 
carbohydrate: protein ratio of 1.24 ( ̴ 30% of energy) and fat intake of 32% of energy.  
 
The high carbohydrate group’s intake of carbohydrates was 198g/d (61%), protein intake was 57g/d 
(18%) and reduced fat intake to 37g/day (25.5% of energy intake).   
 
Exercise in the control groups averaged <100min per week against the recommendation of 30 
minutes of walking 5 days a week. The Exercise groups were also recommended 30 minutes of 
walking 5 days a week plus 30 minutes of resistance training and stretching 2 days/week. The 
higher exercise group’s compliance was supervised and averaged more than 200 minutes per 
week.  
 
Baseline weight in the Zone group was 91.1 ± 5.1 kg and 86.1± 4.6 kg for the Zone + exercise group 
and 93.7 ± 3.5 kg for the LC group and 79.8 ± 2.7 kg for the LC + exercise group.  
 
The low-carbohydrate diets achieved an average weight loss of 9.3 ± 0.8 kg after sixteen weeks 
while the conventional diet  subjects had a lower average weight loss of 7.3 ± 0.5 kg (P<0.05).  The 
low-carbohydrate group with exercise achieved the largest relative weight loss at 11.2%, the lower-
carbohydrate control group with less exercise had 9.5%, and the higher-carbohydrate group with 
exercise had weight loss 8.4% whilst the higher-carbohydrate control group with less exercise 
achieved weight loss of 8.3%.   
 
Subjects in the lower-carbohydrate groups together reduced fat mass by 7.3± 0.8 kg whilst the 
higher-carbohydrate groups had average fat mass reduction of 5.3±0.3 kg. Taking the two higher 
exercise groups together the average reduction in fat mass was 7.2±0.7kg whereas the non-
supervised lower exercise groups reduced body fat by 5.5±0.5 kg (P<0.05).   
 
Higher protein intake, lower carbohydrate intake and supervised exercise produced a 21.4% 
reduction in absolute body fat whilst the higher carbohydrate group without supervised exercise 
had a 12.8% reduction in body fat. A similar pattern was evident for changes in abdominal or trunk 
fat.   
 
This study highlights the additive effects of the low carbohydrate-high protein diet and exercise on 
body composition with significant main effects of diet (P<0.01) and Exercise (P<0.001). This study 
reiterates the importance of caloric restriction by 20-30% per day for weight loss and that both 
weight loss and fat loss can be enhanced by consuming higher protein (1.6g per kilogram of body 
weight per day ; reduced carbohydrate and the inclusion of exercise (both cardiovascular and 
resistance).  
 
 
Luscombe-Marsh et al. (2005); 12 w energy restriction & 4 w energy balance ; N: N  
 
Luscombe-Marsh et al. (2005) considered two diets over sixteen weeks that restricted to 
carbohydrates to 30% of energy or approximately 110 grams (g) per day with variations in levels of 
fat and protein intake.   
 
For the purposes of this review these diets were classified as low-carbohydrate non-ketogenic 
though the macronutrient composition resembles the Zone type composition more than the Atkins 
except after about two months of the Atkins programme when carbohydrate levels may be raised to 
120g per day.  
 
The diets undertaken implied calorie restriction to 1500kcal per day. Saturated fat was restricted to 
10% of energy and fibre for both diets was 21 and 27 grams per day respectively. After twelve 
weeks of energy restriction there were no significant differences in weight loss, fat loss and lean 
mass loss between the diets. 
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Luscombe-Marsh et al. (2005); 12 w energy restriction & 4 w energy balance ; N: N  
 
Weight loss after 16 weeks was 9.7± 1.1 kg (10.2%) for the LF-HP (40% Protein, 30% Fat) group and 
10.2±1.4 kg (10.3%) in the HF-SP (20% Protein, 50% fat) group (P=0.78).  
 
Baseline weight for the LF-HP group was 94.86 kg and for the HF-SP group was 99.36 kg. From 
week 0 to week 16, the reduction in fat mass was 13.9±1.5% and the decrease in abdominal fat 
mass was 17± 2%, (P<0.001).  
 
Lean mass was reduced by 6.0± 0.6% (P<0.001). Effects of energy restriction may be confounded as 
weight loss and fat loss data provided after 16 weeks not 12 weeks.  
 
McAuley et al. (2004),  8weeks weight loss, 8 w supervised maintenance , 8 w unsupervised 
maintenance, A v Z v Low-fat (L) 
 
McAuley et al. (2004) included in their study, two low-carbohydrate diets following the Atkins 
approach and the Zone diet approach and one low-fat/high-carbohydrate diet. All three diets 
produced weight loss expected to reduce the risk of type 2 diabetes (T2D) and CVD.  
 
Baseline weight for Atkins group was 96.0±10.8 kg, for the Zone group was 93.2±14.5 and for the 
low-fat group was 98.0±15.1 kg. The weight loss range was assumed to be mean weight loss ± 0.5 
as the range information was not available. The range for weight loss is assumed to be ±0.5 kg as 
data to calculate the range was not available.  Consequently the weight loss in the Atkins group 
was 6.6 kg ± 0.5 kg (6.9%) whilst the Zone group lost 5.4 ± 0.5 kg (5.8%).  
 
Both the Atkins and Zone groups lost more weight than the high- carbohydrate group who lost 4.3± 
0.5kg (4.4%).   
 
The results from the Atkins and Zone diet approaches may be more favourable than a higher 
carbohydrate/ higher fibre diet though this could result from the reduction of mean daily caloric 
intake for the low-fat /high-carbohydrate group (439kcal/day) being less than that for the Atkins 
group (519 kcal/day) and the Zone group (522kcal/day).  
 
Mean fat mass reduction at 8 weeks in the Atkins group was 4.4kg, Zone group was 3.1kg and in 
the low-fat group was 3.4kg. After 8 weeks mean waist circumference had reduced by 8.3cm in the 
Atkins group, 7.7cm in the Zone group and 4.8cm in the low-fat group.  
 
Mean fat-free mass at 8 weeks reduced by 2kg in the Atkins group, 3.1kg in the Zone group and 1.8 
kg in the low-fat group.  
 
Meckling et al. (2004); 10w; Non-ketogenic low-fat diet (N) : L 
 
Meckling et al. (2004) compared a non-ketogenic low carbohydrate diet with a low-fat, high-
carbohydrate conventional diet over 10 weeks.  
The low-carbohydrate diet design entailed reducing carbohydrate intake from 100g per day to 50-70 
g by day 5 resulting in energy intake reduction to 1205-1605 kcal per day for women and 1406-2207 
kcal per day for men.  
Subjects on the low-fat diet were instructed to achieve a similar energy deficit to the low-
carbohydrate group. The average energy reduction over the ten week intervention for the low-
carbohydrate group was 763kcal and that for the low- fat group was 607kcals representing 33% and 
29% reduction of energy intake from baseline.  
The dietary protocols caused a substantial decrease in carbohydrate intake by approximately 228g 
per day for the low-carbohydrate group and an increase in carbohydrate intake by approximately 
13g per day for the low-fat group.  
Similar weight loss was achieved in both diet groups. Baseline weight for the low-carbohydrate 
group was 91.0±4.5 kg and for the low-fat group was 92.3±3.0 kg. Assumed range was Mean ± 0.5 
SD.  
Appendix B1- Dietary Design, Protocols & Weight Management Results  
(Alphabetical Order) – Extracted from Appendices A2-A15 and Summarized Further. 
KEY:  A=Atkins Diet; N= Non-Ketogenic low-carbohydrate diet; Z =Zone Diet;                                               
L=Low-fat conventional diet; W=Weight Watchers; O= Ornish  
225 
 
Meckling et al. (2004); 10w; Non-ketogenic low-fat diet (N) : L 
 
Over the ten week trial period, the low-carbohydrate group decreased body weight by 7 kg (7.7%) 
whilst the low-fat group experienced a reduction of 6.8kg (7.4%).  
Fat loss was significant in both groups. The low-carbohydrate recorded fat loss of 4.1kg whilst the 
low-fat group had fat loss of 5.4 kg. 
 
Parker et al. (2002) ; 8w energy restriction & 4 week energy balance ; Z:L 
 
Parker et al. (2002) compared a Zone type diet (28% protein, 42% carbohydrate and 28% fat) with a  
higher carbohydrate diet approach (16% protein, 55% carbohydrates and 26% fat.  
 
Both diets were matched for fatty acid profile of which 8% was saturated fat and 12 % 
monounsaturated fatty acids and 5% polyunsaturates and aimed for an eight week restriction of 
calories to 1600 kcal per day for both diet plans.  
 
Baseline weight for Zone group was 97.7±17.4 kg and 91.4±18.2 kg for the low-fat group. At 8 weeks 
the mean weight loss in the Zone group and the low-fat group was 4.5kg and 4.6% and 4.9% 
respectively (computed from data provided). The range was calculated assuming a spread of ±0.5 
kg.  
 
Overall after 12 weeks, weight loss of 5.2± 1.8 kg was achieved for both diet groups however this 
study showed a significant sex by diet effect as women lost more weight on the Zone type diet as 
compared with the higher carbohydrate diet (6.0 kg vs. 4.2kg) as well as fat mass (5.3 vs. 2.8 kg) 
and abdominal fat (1.3 vs. 0.7kg)  whilst men lost more weight (5.8kg vs. 4.7kg) , fat mass (5.1kg vs. 
3.8kg)  and abdominal fat (1.7 vs. 1.4 kg) on the higher carbohydrate plan (Parker et al. 2002).   
 
This study finds that a higher-protein Zone type diet compares well with a higher carbohydrate diet 
for weight loss over eight weeks of energy restriction (1600kcals) and may suit women dieters in 
preference to men (Parker et al. 2002). Energy restriction could not be adequately assessed as a 
driver for weight loss as results are combined for the energy restriction and energy balance 
phases.  
 
Sacks et al. (2008); 6m & 2yrs; Z v L. 
 
Sacks et al. (2008) studied a dose response test of carbohydrate intake ranging from 35% to 65% of 
energy. T 
 
his study included two low-carbohydrate options of 35% and 45% of energy intake. These two diets 
were similar to Zone type low – carbohydrate diets whilst the other two diets had a low fat-higher 
carbohydrate design.  
 
The participants in this study were prescribed a caloric deficit of 750kcal per day from baseline and 
the goal for physical activity was 90 minutes per day.  
 
At six months the participants had lost an average of 6kg (7% of initial weight). After 12 months 
participants began to regain weight and by 24 months the weight loss recorded in all the four diet 
groups was similar. A total of 185 (23%) of the participants continued to lose weight from 6m to 2 
yrs the mean additional weight loss was 3.6 ±3.5 kg for a mean total weight loss from baseline of 
9.3 ±8.2 kg with no significant differences among the diet groups.  
 
At 2 years 31-37% had lost at least 5% of initial weight, 14-15% of participants had lost at least 10% 
of initial weight and 2-4% had lost 20kg or more(P>0.2 for comparisons between the diets).   
 
The average weight loss among the 80% of the participants who completed the trial was 4kg.  
 
Furthermore 14-15% of the participants had a reduction of at least 10% of their initial weight.  
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Sacks et al. (2008) contd.  
 
Most of the weight loss occurred in the first six months and changes from the baseline between the 
diets differed by less than 0.5kg of body weight and 0.5 cm of waist circumference. 
 
 Changes in waist circumference, satiety, hunger, satisfaction with the diet and attendance at group 
sessions was similar for all the diets and attendance at counselling and monitoring sessions was 
strongly associated with weight loss (0.2 kg per session attended) (Sacks et al. 2008).  
 
The theory that may be generated from this study is that a reduction of 750 kcal per day may be 
more significant in generating weight loss than the macronutrient composition of the diet.  
 
In addition prescribing a minimum intake of dietary fibre and a limit to the intake of saturated fat 
and cholesterol may support the weight loss process. Similarly this study re-iterated that 
recommending inclusion of foods with a low- glycaemic index may influence weight loss (Sacks et 
al. 2008).  
 
Samaha et al. (2003); 6m; A v L 
 
Samaha et al. (2003) compared a low carbohydrate Atkins type diet with a low fat diet.  
 
Subjects on the low carbohydrate design were required to restrict carbohydrate intake to 30g per 
day or less with no restriction on total fat intake. Vegetables and fruits with a high ratio of fibre to 
carbohydrate were recommended.  
 
Subjects on the low fat diet were recommended the guidelines of the National, Heart, Lung and 
Blood Institute including a caloric restriction sufficient to create a deficit of 500 kcal with 30% or 
less of total calories derived from fat.  
 
Subjects on the low-carbohydrate Atkins diet reported a non-significantly greater reduction in 
caloric intake (P=0.33), a significantly greater decrease in percentage of calories from 
carbohydrates (P<0.001) and a significantly greater increase in calories from protein (P<0.001) and 
fat (P=0.004).   
 
Subjects on the low carbohydrate diet lost more weight during the six month study (-5.8±8.6 kg or 
4.4%) as compared with the low fat group (-1.9± 4.2 kg or 1.4%). Weight loss of at least 10% of 
baseline weight occurred in 9 of 64 subjects (14%) as compared with 2 of 68 subjects on the low fat 
diet (3%).  
 
White subjects lost more weight than black subjects (mean -13±19kg vs. -5±12kg (P=0.009) 
suggesting that weight loss strategy both in terms of adherence and appropriateness may have a 
cultural and / or genetic influences.  
 
Furthermore the amount of weight loss had a significant effect on the degree of improvement in 
metabolic factors. 5% weight loss on a carbohydrate restricted diet had better metabolic results 
than those who lost a similar amount of weight while on a fat and calorie restricted diet.  
 
The theory generated from this study is that statistically significant weight loss may be achieved 
using a low carbohydrate Atkins type diet.  
 
The greater weight loss in the low CHO group however could result from the greater reduction in 
overall caloric intake resulting from such a diet rather than a direct effect of macronutrient 
composition.  
 
Possible explanations for the lower caloric intake could suggest that subjects may have 
experienced greater satiety with liberal portions of protein and fat, the relative simplicity of the diet; 
improved compliance due to novelty of the diet (Samaha et al. (2003). 
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Shai et al. (2008); 2yrs; A v L v Mediterranean diet (M) 
 
Shai et al. (2008) compared a low-carbohydrate Atkins type diet with no calorie restriction to low fat 
and Mediterranean diet plans where a caloric intake was restricted to 1500 kcal per day for women 
and 1800 kcal per day for men.  
 
The mean weight changes among the 272 participants who completed the 24 month study were – 
5.5± 7.0 kg in the low carbohydrate Atkins group, -4.6 ±6.0 kg in the Mediterranean diet group and   -
3.3 ±4.1kg in the low fat group (P=0.03) for the comparison between the low- carbohydrate and low-
fat groups at 24 months).   
 
All the three groups had significant decreases in waist circumference but the differences among 
the groups were not significant (Shai et al. 2008).  
 
The theory emanating from these results is that weight loss and body composition over two years 
by following a diet restricted to 1500-1800 kcal per day can be matched and exceeded by a low-
carbohydrate Atkins style diet that is not restricted for calories.  
 
Shai et al. (2008) show that the Mediterranean and low-carbohydrate Atkins type diets may be 
effective alternatives to the low-fat diet for weight loss and appear to be safe alternatives to the 
low-fat diet.  
 
Further theory emanating from Shai et al. (2008) is that for moderately obese subjects, the Atkins 
type low-carbohydrate and the Mediterranean diets may have beneficial metabolic effects and 
further reinforced the idea that weight loss dietary advice can be individualized according to 
personal preferences and metabolic needs.  
 
In Shai et al. (2008), despite the lack of caloric restriction for the low-carbohydrate diet, a similar 
caloric deficit was achieved in all the diet groups suggesting that a low-carbohydrate diet not 
restricted for calories may be optimal for subjects who prefer not to or are unable to follow a 
restricted calorie regimen.  
 
Stern et al. (2004); 12m; A v L  
 
Stern et al. (2004) undertook a one year follow-up study to Samaha et al. (2003) comparing a low 
carbohydrate Atkins diet with a low fat diet.  
 
Subjects on the low carbohydrate regime were instructed to restrict carbohydrate intake to 30g per 
day or less. There was no restriction on total fat intake. Vegetables and fruits with a high ratio of 
fibre to carbohydrate recommended.  
 
Subjects on low-fat diet were recommended the guidelines of the National, Heart, Lung and Blood 
Institute including caloric restriction sufficient to create a deficit of 500 calories with 30% or less of 
total calories derived from fat.  
 
Caloric intake decreased more by year 1 in the low carbohydrate group than in the low fat/low 
calorie group. The low carbohydrate group reduced carbohydrate by 52%, reduced fibre intake by 
42 %, increased total fat intake by 31%; increased dietary cholesterol intake by 21%, reduced 
sodium intake by 21% relative to baseline.  
 
Participants on the low carbohydrate diet maintained most of their 6 month weight loss whereas 
those on the conventional diet continued to lose weight throughout the year.  
 
The final 1 year weight change was -5±8.7kg in the low CHO group and -3.1 ±8.4kg in the 
conventional diet group. The difference between the two diet groups was not significant.   
 
Persons on the low CHO diet who dropped out lost less weight than those who completed the 
study. In contrast weight loss was not significantly different for those on the conventional diet.  
 
The theory emanating from this study that weight loss differentials between a low-carbohydrate 
approach or a conventional diet evident at six months may diminish over a period of one year. In 
contrast to Foster et al. (2003) persons on the low CHO maintained most of their initial weight loss  
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Stern et al. (2004); 12m; A v L  
 
where as those on the conventional diet continued to lose weight. The difference may be due to 
more intensive counselling.  
 
Persons on the low CHO diet who dropped out were less likely to lose weight whereas those on the 
conventional diet continued to lose weight whether or not they remained in the study. This 
observation together with the difference between diets in weight loss beyond six months suggests 
that a low CHO diet may be less sustainable than a conventional diet. 
 
Yancy et al. (2004); 24 w; A v L 
 
Yancy et al. (2004) compared a low-carbohydrate Atkins type diet with average daily energy intake 
of 1461 ±325.7 kcal and a low-fat diet with average daily energy intake of 1502 ± 162.1 kcal over 24 
weeks. 
 
 Baseline weight for the Atkins group completers was 98.1±15.2 and for the low-fat group 
completers was 95.7±18.0. They noted that the low-carbohydrate group lost an average of 12.0 kg 
(12.9%) as compared with 6.5 kg (6.7%) in the low fat group.  
 
61 % (n=36) of the low carbohydrate group and 23% (n=14) of the low fat group completed the study 
and lost more than 10% of their initial body weight (P<0.001).  
 
The expected mean change in fat mass was 9.4 kg in the low carbohydrate group and 4.8 kg for the 
low-fat group however the percentage of total weight loss that was fat mass was similar in the two 
groups (78% in the low carbohydrate group compared with 74% in the low fat group.  
 
As compared with the other studies that included an Atkins type protocol in the design, the higher 
absolute and percentage weight loss shown in this study cannot be explained by the reported 
energy intake figures of 1461 ±325.7 kcal.  
 
The expected mean change in total body water was -2.4 kg in the low carbohydrate group and -
1.8kg in the low carbohydrate group. Hence a change in total body water accounted in the main for 
the changes in fat-free mass with the low-carbohydrate group experiencing greater levels of water 
loss in the first two weeks as compared with the low-fat group.  
 
The theory suggested by this study is that a low-carbohydrate diet causes a greater loss of body 
water initially. Additionally if an ad libitum diet is appropriate to the preferences and health state of 
an individual and the risks of using such a diet plan can be mitigated, the Atkins type weight loss 
plan may lead to significantly higher levels of weight loss and may provide a useful method of 
starting a weight loss programme.  
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Rationale for Notional Calorie intake level of 2000 kcal/day 
UK DOH Estimated average requirement (EAR) are a daily calorie intake of 1940 for women and 
2550 for men.  Average : 2245 
USDA (2010) dietary guidelines use a 2000 calorie level as a reference with the Nutrition facts 
panel.   
For several studies data on caloric deficit achieved per day was provided. For several studies 
the data on calories intake was provided with no information on the calorie deficit achieved. 
Hence the notional average baseline calorie intake was assumed to be 2000 per day to 
estimate the daily caloric deficit for these interventions. The estimate aims to be prudent, 
hence was set at 2000 kcal/day.  
 
Appendix C:  Fat Loss and Waist Circumference Data from Studies Selected 
(Arranged Alphabetically) – Extracted from Appendices A2- A15 and Summarized 
Further 
230 
 
Study/ Study Arms A: Atkins; Z: Zone; L: low-fat; W: Weight Watchers; O:Ornish; M: Mediterranean; 
N: low-carbohydrate non ketogenic / DURATION 
 
Dansinger et al. (2005) A:Z:W:O; 1 year 
 
Noted that weight loss was highly associated with waist size reductions for all the diets with no 
significant difference between the diets (r=0.86; P<0.001). 
 
Foster et al. (2003); A:L; 3m; 6m; 12m. 
 
No measure of fat loss or waist circumference. 
 
Frisch et al. (2009) Z: L; 6m & 1 year 
 
For both groups 76% of weight loss was due to loss of fat mass and though the reduction in waist 
circumference did not differ significantly at six months. At 12 months, the decrease in waist 
circumference was more pronounced for the low-carbohydrate group. 
 
Johnston et al. (2006) A:Z; 6 weeks 
 
Of the weight loss of 7.2±0.8 Kg and 6.3±0.6 Kg for the Zone and Atkins diets, the reduction in fat 
mass was 5.5 Kg and 3.4 Kg respectively over the six week trial and was not significantly affected 
by the type of diet (P=0.111). 
 
Layman et al. (2005) Z:Z+EX:L:L+EX; 16 weeks 
 
Compared a Zone type diet with a low-fat diet with and without higher levels of exercise.  Noted that 
weight loss was predominantly fat mass and increased fat loss was associated with a higher-
protein/ lower carbohydrate diet and exercise.  
 
Subjects in the low-fat group without increased exercise had 12.8% decrease in body fat whist 
those in the Zone diet group with increased exercise had a 21.4% decrease in body fat (Layman et 
al. 2005). 
 
Luscombe-Marsh et al. (2005) N:N; 12 weeks energy restriction (ER); 4 weeks energy balance (EB).  
 
Both diets led to a reduction in total fat mass- 13.9±1.5%; decrease in abdominal fat mass was 
17.1±2% main effects of time, P<0.001). Difference between groups not significant. 
 
McAuley et al. (2004) A:Z:L; 8 weeks 
 
Greater reductions noted in waist circumference with the low-carbohydrate Atkins and Zone groups 
than the low-fat higher carbohydrate group. 
 
Meckling et al. (2004) N:L; 10 weeks. 
 
Did not measure waist circumference but found that significant losses in fat weight occurred in 
both groups. Additionally the decrease in lean mass was significant only in the low-carbohydrate 
group suggesting that a low-fat diet with sufficient protein may better preserve lean mass.  
 
Parker et al.  (2002) Z:L; 8 weeks ER 4 weeks EB 
 
For total fat mass, men lost more on the low-fat diet (5.1 vs. 3.8 kg), whereas women lost more on 
the Zone type diet (5.3 vs. 2.8 kg), as reflected by a significant sex by diet interaction (P=0.01).  
A significant sex by diet effect was also observed in the change in abdominal fat mass (P< 0.02), 
such that men lost more fat on the low-fat diet (1.7 vs. 1.4 kg), whereas women lost more on the 
Zone type diet (1.3 vs. 0.7 kg). Total lean mass was reduced significantly with both diets (1.35 kg on 
the Low-fat diet and 0.52 kg on the Zone type diet) with no significant difference between them. 
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Sacks et al. (2008); Z:L; 2 Year 
 
Changes in waist circumference did not differ significantly between the low-carbohydrate zone type 
diets and the low-fat alternatives. 
 
Samaha et al. (2003); A:L; 6m. 
 
No measure of fat loss or waist circumference. 
 
 
Shai et al. (2008)A:L:M; 2Year. 
 
Noted that all the groups had significant decreases in waist circumference but the differences were 
not significant (P=0.33).  
Waist circumference in the low-carbohydrate group decreased by 3.8±5.2 cm, by 3.5± 5.1cm for the 
Mediterranean diet group and by 2.8±4.3cm in the low-fat group. 
 
Stern et al. (2004);A:L; 12 months 
 
No measure of fat loss or waist circumference. 
 
Yancy et al. (2004) A: L; 24 weeks. 
Both groups lost predominantly fat mass over 24 weeks and percentage of fat loss was similar for 
the two groups. 
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Dansinger et al. (2005) A: Z: W: O; 1 year 
 
No evidence of clinically significant renal impairment in any diet group. This would be a concern for the 
low CHO groups. 
Study limited in ability to exclude long-term safety risks or occasional dangerous adverse effects 
resulting from diets though no short-term safety risks were found 
 
Foster et al. (2003) A:L; 3months (m) ; 6m; 12m 
 
Urinary Ketones- The % of patients who tested positive for urinary ketones was significantly greater in the 
low CHO group in relation to the conventional diet group but there were no significant differences after 3 
months. No significant relation between weight loss and ketosis at any time during the study 
The study was focused on weight and specific risk factors for CHD. It did not evaluate effects on other 
important clinical end points such as renal function, bone health and exercise tolerance 
 
Health concern of consuming unrestricted saturated fat with potential to increase LDL cholesterol – 
established risk factor for coronary heart disease (CHD).  At 3 months LDL cholesterol increased for low-
CHO group but decreased in subjects on conventional diet group so difference significant. Over the 
longer term LDL levels closer to baseline values and not significantly different between groups 
 
Frisch et al.  (2009) Z:L; 6m & 1 year 
 
 
No safety results reported 
 
Johnston et al. ( 2006) A:Z; 6 weeks (w) 
 
Creatinine Clearance Values- These did not exceed baseline values at week 6 but at 2 weeks for the KLC 
they were 20% above baseline. A higher creatinine clearance rate may be a normal physiologic response 
but in persons with a compromised renal function complications may occur. Hence persons at risk of 
kidney disease should carefully consider KLC diets.  
AA: EPA was 90% higher after week 6 on the KLC. As inflammation is associated with faster rates of 
kidney function loss and elevated ratios of fatty acids is associated with increased inflammation and 
tumouregenesis in rat models.  
Plasma uric acid and urinary calcium typically higher with high-protein diets were not significantly higher 
at trial week 6 than at baseline.  
Layman et al.  (2005) Z:Z+EX:L:L+EX; 16w. 
 
 No safety results discussed. Apo lipoprotein a and b as a significant risk factor for CVD disease along 
with HDL and triglycerides would have been relevant and important. BP was not measured or reported. 
 
Luscombe – Marsh et al. (2005) N(LF-HP): N(HF-SP); 12 weeks Energy Restriction (ER) 4 w Energy Balance 
(EB) 
Urinary calcium and sodium excretion remained unchanged from week 0 to week 16 (3.5 ± 0.4 and 4.1± 0.4 
mmol/24 h for week 0 and week 16 calcium values, respectively, and 181 ± 31 and 158 ± 11 mmol/24 h for 
week 0 and week 16 sodium values), as did concentrations of the bone-turnover markers (94 ± 5.1 and 102 
± 5.2 mmol/l  for week 0 and week 16 pyridinoline: creatinine values, respectively, and 26±1.3 and 28±1.4 
nmol/ mmol for deoxypyridinoline: creatinine values) 
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McAuley  et al. (2004) A:Z:L; 8 w  
 
Observed increases in LDL cholesterol with the Atkins high- fat diet were less than expected. The LDL 
levels with the Atkins diet were significantly higher in the HF Atkins group than in the HP Zone group. The 
HF Atkins group produced a marked increase in LDL cholesterol in a small number of participants 
suggesting that some individuals may be particularly sensitive to substantial increases in fat intake.  
Apo lipoprotein a and b, renal and bone health should have been studied as one arm of the study was 
following the HF Atkins Diet. 
 
Meckling  et al. ( 2004)  N:L; 10w 
 
There was an increase is circulating β hydroxybutyrate at the 2- and 4-wk time points in the LC group that 
remained numerically higher for the remainder of the study but not statistically different from the high at 
2–4 wk or baseline. There were no statistical differences between the LC and LF subjects after wk 4. 
There was no change in β-hydroxybutyrate concentration over time in the LF group.  
Parker et al. (2002) Z:L; 8 w ER 4 w EB 
 
No side effects reported.  
Renal function and bone health review maybe relevant due to high-protein Zone arm of study. Apo 
lipoprotein a and b not measured. 
 
Sacks et al.  (2008) Z:Z:L:L; 2 yr 
 
Adverse events were reported by 57 participants (7%); there were no significant differences in the rates 
among diets.  
The ratio of urinary microalbumin to creatinine was more than 30 in five participants in the average-
protein group and in five participants in the high-protein group at 6 months and in seven participants, all 
in the average protein groups, at 2 years. 
There was a larger decrease in urinary nitrogen excretion from baseline in the average-protein group than 
in the high protein group (a difference in the change of 1.6 g at 6 months and 0.8 g at 2 years. These 
differences correspond to a difference in dietary protein of 10 g per day and 5 g per day, respectively. 
 
Samaha et al. (2003) A:L; 6m 
 
No clinically significant change in uric acid levels in either group.  
One death and hospitalisation in the low CHO group not deemed to be diet related.  
Shai et al. (2008) A:L:M; 2 yr 
 
The proportion of participants with detectable urinary ketones at 24 months was higher in the low-
carbohydrate group (8.3%) than in the low-fat group (4.8%) or the Mediterranean-diet group (2.8%) (P = 
0.04). 
Stern et al. (2004) A:L; 12m. 
 
Blood urea nitrogen levels increased more in the low CHO group but changes in uric acid levels were not 
clinically significant. 
3 individuals on the low CHO group died during the study but these were not regarded as diet related.  
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Yancy et al. (2004) A:L; 24w. 
Minor adverse effects were more frequent in the low CHO group. 
Adverse effects in the low-CHO vs. the low-fat group.  
Constipation 68% vs. 35% (P<0.001);  
headache 60% vs. 40% (P=0, 03);  
halitosis (38% vs. 8%, P<0.001),  
muscle cramps (35% vs. 7% (P<0.001),  
diarrhoea 23% vs. 7%, (P=0.02);  
general weakness 25% vs. 8% (P=0.01) and  
rash 13% vs. 0% (P=0.006).  
 
One 53 year old man in the low CHO group with a family history of early heart disease was diagnosed with 
CHD. During this study he lost 16 kg, his serum LDL had decreased by 0.75 mmol/L (29 mg/dL) and HDL 
increased by 0.21 mmol/L (8mg/dL).  
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Study/Study 
Arms 
Lipid Control Results 
Dansinger 
2005- 1 yr 
A:Z:W:O 
All diets reduced mean LDL cholesterol levels at 1 year though for the Atkins Group the 
reduction was not statistically significant (P=0.07).  
All diets significantly increased mean HDL cholesterol except for Ornish Group (P=0.6). 
The LDL/HDL ratio decreased approximately 10% for each group (P<0.05). 
No diet programme significantly altered triglycerides at 1 year. 
Foster 2003-
3m,6m,12m 
A:L 
No significant differences between the groups in the total or LDL cholesterol 
concentration except at month 3 when values were lower in the conventional diet group. 
The relative increase in HDL cholesterol and relative decrease in triglyceride 
concentrations was greater in the group on the low CHO diet than in the conventional 
diet throughout the study. 
Frisch 2009- 
6m & 1 yr 
Z:L 
Triglyceride levels did not change from baseline to month 6 and month 12 in the low-fat 
(DGE) group, but declined in the Zone type (LOGI) group  by 14% at month 6, and 7% at 
month 12 compared to baseline values. 
HDL-cholesterol decreased in the DGE group until month 6, but rose again in the second 
half year, whereas this parameter remained unchanged in the LOGI group. 
Changes from baseline in triglyceride and HDL-cholesterol levels differed significantly 
between the LOGI and DGE groups at month 6. However, these differences disappeared 
later on in the study. 
Total-cholesterol was not affected in the LOGI-group but increased in the DGE group 
between month 6 and 12. Nevertheless, total cholesterol did not differ significantly 
between groups at any time point. 
Johnston 
2006 – 6 w 
A:Z 
Compared with baseline, the 6 week LDL concentrations increased for 5 Atkins dieters 
and decreased in the remaining 4 Atkins dieters. In comparison LDL cholesterol was 
raised in 2 Zone type dieters and decreased in the remaining 8 Zone type dieters. 
HDL cholesterol concentrations fell 9% during the 6 week trial in both diet groups. 
Layman 
2005-16w 
Z:Z+EX:L:L+EX 
 
 
 
 
 
 
 
 
 
Initial serum lipid concentrations did not differ among all groups. After 16 wk of weight 
loss, changes in TC, LDL were greater in the Low-fat (CHO)  and the low-fat +EX 
(CHO+EX)  than in the Zone (PRO) Groups 
Serum TC in the CHO and CHO+EX groups decreased by 0.51 ±0.09mmol/L (9.2%) and 
LDL-C decreased by 0.38±0.08mmol/L (10.4%) from baseline values. In the Zone (PRO) 
and PRO+EX groups these decreased by 0.21 ±0.12mmol/L (3.7%) and 0.08±0.11 mmol/L 
(1.7%). Changes in TAG were highest in the PRO groups by 0.32 ±0.06 mmol/L (20.2%).  
In the CHO and CHO+EX groups TAG concentration decreased by 0.1±0.07 mmol/L 
(5.2%). 
HDL-C concentrations changed in opposite directions for the 2 diet treatments. The PRO 
groups had a net increase of 0.01±0.03mmol/L in HDL-C and the CHO groups decreased 
by 0.08±0.03mmol/L. Ratios of TAG/HDL were more responsive to the PRO diet than the 
CHO diet No significant effects of EX were apparent for any lipid outcomes. 
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Study/Study 
Arms 
Lipid Control Results 
Luscombe – 
Marsh 
(2005)-  
 8w ER,  
4w EB 
 
N(LF-HP): 
N(HF-SP) 
Improvements in fasting serum lipid concentrations did not differ significantly between 
the LF-HP and HF-SP groups, and there were no time-by-diet or time-by-diet- by-sex 
interactions for any of these variables. 
Total cholesterol was reduced by 6.6 ± 1.4% at week 12 compared with week 0, and it 
remained reduced by 2.9± 1.4% at week 16 (main effect of time, P < 0.001). 
LDL cholesterol was reduced by 3.4±1.9% at week 12 and by 0.7±2.3% at week 16 (P = 
0.005). 
HDL cholesterol was increased by 6.8± 2.0% at week 12, and at the end of week 16 it 
remained 10.1 ± 2.1% above baseline (P < 0.001). 
The serum triacylglycerol concentration was reduced by 23.1 ± 3.6% by week 12 and by 
15.9 ± 4.3% at week 16 (main effect of time, P< 0.001). 
McAuley 
2004 -8w 
A:Z:L 
When compared with the Low-fat -HC diet, the Atkins-HF and Zone- HP diets were shown 
to produce significantly greater reductions in several parameters, including triglycerides 
(HF −0.30 mmol/l, HF −0.22 mmol/l).  
LDL cholesterol decreased in individuals on the HC and HP diets, but tended to fluctuate 
in those on the HF diet to the extent that overall levels were significantly lower in the HP 
group than in the HF group (−0.28 mmol/l, 95% CI 0.04–0.52, p=0.02). Of those on the HF 
diet, 25% showed a >10% increase in LDL cholesterol, whereas this occurred in only 13% 
of subjects on the HC diet and 3% of those on the HP diet. 
Observed increases in LDL cholesterol with the Atkins high- fat diet were less than 
expected. The LDL levels with the Atkins diet were significantly higher in the HF Atkins 
group than in the HP Zone group. The HF Atkins group produced a marked increase in 
LDL cholesterol in a small number of participants suggesting that some individuals may 
be particularly sensitive to substantial increases in fat intake.  
Fasting triglycerides, although reduced by all three diets, fell to a significantly greater 
extent with the HP and HF diets than with the HC diet. 
In accordance with a previous Study (Foster et al. 2003), the HF Atkins diet produced a 
small increase in HDL cholesterol which was similar to that observed for the HP Zone 
diet, but greater than that produced by the HC conventional diet. 
Overall, LDL cholesterol was lower in the HP group than in the HC group. Levels of LDL 
cholesterol were increased by >10% in eight individuals (25%) in the HF Atkins group, 
four (13%) in the HC group and one (3%) in the HP Zone group. 
Meckling  
2004 -10w  
N :L 
 
 
 
 
 
 
Total cholesterol values at baseline indicated that six subjects in each diet category had 
hypercholesterolemia (>6.2 mm) and six more had borderline hypercholesterolemia (5.2–
6.2 mm). After 10 wk, significant improvements in total cholesterol values were only 
observed in the LF group.  Group results indicated that total and LDL cholesterol levels 
were unchanged from baseline in LC subjects, whereas total cholesterol decreased by 
1.6 mm. LDL cholesterol decreased by 1.3 mm in LF subjects.  LF subjects also showed 
a significant decrease (-0.3 mm) in HDL cholesterol. LC subjects showed a significant 
increase (+0.14) in HDL cholesterol. Group results indicated that both LC and LF groups 
saw a decrease of 0.4 mm in total triglyceride values over the intervention period 
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Study/Study 
Arms 
Lipid Control Results 
Parker  2002-
8w ER; 4w EB 
Z (HP):L(LP) 
 
LDL cholesterol reduction was significantly greater on the HP diet (5.7%) than on the LP 
diet (2.7%) (P<0.01). 
Total cholesterol concentrations decreased more on the HP diet than on the LP diet, as 
reflected by a diet by time interaction of P= 0.009.  
For all subjects, triacylglycerol concentrations decreased at week 12 (P<.001), and there 
was no diet or sex effect.  
There was no effect of time or diet for HDL cholesterol concentrations. 
Sacks 2008- 
 2 yrs 
Z:Z:L:L 
At 2 years, the two low-fat diets and the highest-carbohydrate diet decreased low-density 
lipoprotein cholesterol levels more than did the high-fat diets or the lowest-carbohydrate 
diet (low-fat vs. high-fat, 5% vs. 1% [P = 0.001]; highest carbohydrate vs. lowest-
carbohydrate, 6% vs. 1% [P = 0.01]). 
The lowest-carbohydrate diet increased HDL cholesterol levels more than the highest-
carbohydrate diet (9% vs. 6%, P = 0.02). 
There was a larger increase from baseline in the HDL cholesterol level, a biomarker for 
dietary carbohydrate, in the lowest-carbohydrate group than in the highest-carbohydrate 
group (a difference in the change of 2 mg per decilitre at 2 years). This difference 
corresponds to a predicted difference in carbohydrate intake of 6%. 
All the diets decreased triglyceride levels similarly, by 12 to 17%. 
Samaha 
2003-6m 
A:L 
 
Greater decrease in the mean triglyceride level in the low CHO-Atkins group than in the 
low fat group (-20±31 %, P=0.001). 
Atkins subjects had a greater decrease in triglyceride levels irrespective of whether they 
were on lipid lowering drugs (-25±38% vs.  8±35% with lipid lowering drugs – P=0.01) and 
-16±46 % vs. -1±25% without lipid lowering drugs.  
In a separate analysis of subjects who were not taking medications – 28 on the low fat 
diet and 24 on the low CHO diet, the mean reduction in the triglyceride level was greater 
in the low CHO group : -20±42 % vs. 2±28%- P=0.001) 
Assignment to the low CHO diet (P=0.01) and the amount of weight lost (P<0.001) were 
each independent predictors of a decrease in the triglyceride level however this was 
limited to subjects who lost more than 5% of base-line weight.  
Total cholesterol, HDL and LDL did not change significantly during the six months or 
between groups. 
Shai  2008-
2yrs 
A:L:M 
 
 
 
 
 
HDL cholesterol increased during the weight-loss and maintenance phases in all groups, 
with the greatest increase in the low-carbohydrate group (8.4 mg per decilitre [0.22 mmol 
per litre], P<0.01 for the interaction between diet group and time), as compared with the 
low-fat group (6.3 mg per decilitre [0.16 mmol per litre]). 
Triglyceride levels decreased significantly in the low-carbohydrate group (23.7 mg per 
decilitre [0.27 mmol per litre], P = 0.03 for the interaction between diet group and time), 
as compared with the low-fat group (2.7 mg per decilitre [0.03 mmol per litre]). 
LDL cholesterol levels did not change significantly within groups, and there were no 
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Shai  2008-
2yrs 
A:L:M 
Contd. 
 
 
significant differences between the groups in the amount of change. 
Overall, the ratio of total cholesterol to HDL cholesterol decreased during both the 
weight-loss and the maintenance phases. The low-carbohydrate group had the greatest 
improvement, with a relative decrease of 20% (P = 0.01 for the interaction between diet 
group and time), as compared with a decrease of 12% in the low-fat group. 
Stern 2004-
12m 
A:L 
Changes in total and LDL cholesterol were not significantly different between groups. 
Triglyceride levels decreased more in the low CHO group than in the conventional diet 
group (P=0.044 before and P=0.041 after adjustment for baseline variables. A separate 
sensitivity analysis that included only the 87 persons who completed the study 
confirmed this finding.  Assignment to the low CHO group and greater weight loss were 
each independent predictors of a decrease in triglyceride concentration suggesting a 
direct effect of the low CHO diet on triglyceride reduction.  
The HDL cholesterol concentration decreased more in the conventional diet group than 
in the low-CHO group (P=0.025 before and P=0.014 after adjusting for baseline variables. 
The results indicated a direct diet-related effect on HDL cholesterol.                                                              
Yancy  2004 – 
24w 
A:L 
The low CHO group had statistically greater changes in the triglyceride level, HDL 
cholesterol level and ratio of triglycerides to HDL Cholesterol (P=0.004, P<0.001 and 
P=0.02) respectively.  LDL Cholesterol increased by more than 10% in 13 (30%) of 44 
recipients of the low-CHO group and 5 (16%) of 31 recipients of the low-fat diet ((P>0.2)  
Perhaps the biggest concern about the low-carbohydrate diet is that the increase in fat 
intake will have detrimental effects on serum lipid levels (24). We found that the LDL 
cholesterol level did not change on average but did increase by more than 10% from 
baseline to week 24 in 30% of recipients of the low-carbohydrate diet who completed the 
study. 
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 Blood Glucose, Glycosylated 
Hemoglobin 
 
Insulin Resistance, Insulin sensitivity 
Dansinger 
2005- 1 Yr 
A:Z:W:O 
Improvements in blood Glucose and 
Insulin levels noted for all four diets at 
2m, 6m and 12m.  The lower 
carbohydrate diets 
The lower carbohydrate diets Atkins 
and Zone more likely to reduce insulin 
in the short term (2m) though Atkins 
failed to significantly reduce mean 
fasting insulin levels at one year. 
 
Foster 2003- 
3m,6m,12m 
A:L 
Oral glucose-tolerance test- The area 
under the glucose curve did not change 
significantly in either group throughout 
the study. 
The area under the insulin curve 
decreased in both groups, but there 
were no significant differences 
between groups. 
There were no significant differences 
between groups in insulin sensitivity 
(assessed by the quantitative insulin-
sensitivity check index). Both groups 
had significant increases in insulin 
sensitivity at six months, but the 
values were not significantly different 
from base line at one year 
 
Frisch 2009 
6m & 1 Yr 
Z:L 
HbA1c reduced by 0.2 % ± 0.2 for both 
groups at 6m and 12m. 
For the low carb group Glucose 
reduced by -0.26± 0.76  mmol/l at 6 
months and by 0.25 ± 0.75 at 12months 
and for the high carb group by -0.28± 
0.14 at 6 m and 0.14 ± 0.46 at 12months. 
No Comment 
Johnston 
2006 – 6w 
A:Z 
No Comment Insulin sensitivity was significantly 
improved by both LC diets 
Layman 2005 
– 16 w  
Z:Z+EX:L:L+EX 
No comment  No Comment  
Luscombe – 
Marsh 
(2005)- 
12 w – ER 
4w - EB  
N(LF-HP): 
N(HF-SP) 
At week 16, the increase in plasma 
glucose in response to the test meals 
was less than that at week 0. There was 
no significant effect of diet or any time-
by-diet or time-by-diet-by sex 
interactions on plasma glucose 
responses. 
 
Improvements in fasting serum insulin, 
the HOMA index of insulin resistance, 
and in fasting serum free fatty acids 
were also not significantly different in 
the LF-HP and HF-SP groups. 
After 16 wk, the decrease in fasting 
serum insulin was 25 ± 4.2% (main 
effect of time, P < 0.001) and the HOMA 
insulin resistance index was reduced 
by 34±8.8% (P<0.001). 
McAuley 
2004- 8w  
A:Z:L 
No significant differences were 
observed between the dietary groups 
with respect to fasting and 2-h glucose 
and fasting insulin. 
Insulin levels decreased with all three 
diets. This study suggests that the 
popular diets reduced insulin 
resistance to a greater extent than the 
standard dietary advice did. 
Meckling  
2004- 10w  
N :L 
Although individual results suggested 
some improvements in glucose control, 
group results indicated that there was 
no significant decrease in fasting serum 
glucose or either LF or LC 
interventions. 
This resulted in a significant decrease 
in the insulin to glucose ratio for the LC 
group after diet intervention. 
 
However, fasting insulin levels were 
significantly lower after 10 wk of the LC 
diet, but not the LF diet. 
There was no change in fasting 
glucose or insulin to glucose ratio for 
the LF subjects. 
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 Blood Glucose, Glycosylated 
Hemoglobin 
Insulin Resistance, Insulin sensitivity 
 
Parker  2002-
8w ER, 4w EB 
Z:L 
 
Glycemic control - Fasting and 1-, 2-, 
and 3-h plasma glucose concentrations 
were reduced by both dietary 
interventions (P < 0.001); however, no 
significant effects of diet or sex were 
observed. 
HbA1c decreased by 9.4% between 
baseline and week 12 (P < 0.001). There 
were no significant differences 
observed for diet or sex. 
 
Fasting and 2-h insulin concentrations 
were reduced at weeks 8 and 12 (both 
P < 0.001). The insulin, glucose product 
was reduced by 42% at 3 h at week 12.   
 
Sacks 2008- 2 
Yr 
Z:Z:L:L 
All the diets except the one with the 
highest carbohydrate content 
decreased fasting serum insulin levels 
by 6 to 12%; the decrease was larger 
with the high-protein diet than with the 
average-protein diet (10% vs. 4%, P = 
0.07). 
 
The metabolic syndrome was present 
in 32% of the participants at baseline, 
and the percentage was lower at 2 
years, ranging from 19 to 22% in the 
four diet groups (P = 0.81 for the four-
way comparison). 
Samaha 
2003- 6m 
A:L 
 
Glycemic control: Fasting glucose 
decreased more in the Low CHO group 
than the low fat group at six month (-
9±19 % vs. -2±17% (P=0.02)) though this 
change was more significant for 
diabetic subjects with no significant 
change in the levels in non-diabetic 
subjects on either diet.  Similarly 
diabetic subjects showed a greater 
decrease in glycosylated haemoglobin 
compared with those on low-fat diets.  
 
By six months seven subjects in the 
low CHO group had dose reductions in 
oral hypoglycaemic or insulin as 
compared to 1 in the low fat group. 
Insulin sensitivity increased more in 
the low CHO subjects than on the low 
fat diet. Here again assignment to low 
CHO diet and weight loss were 
independent predictors of an 
improvement in insulin sensitivity. 
Shai  2008- 2 
Yr 
A:L:M 
 
Among the 36 participants with 
diabetes,  only those in the 
Mediterranean-diet group had a 
decrease in fasting plasma glucose 
levels (32.8 mg per deciliter); this 
change was significantly different from 
the increase in plasma glucose levels 
among participants with diabetes in the 
low-fat group (P<0.001 for the 
interaction between diet group and 
time). 
There was no significant change in 
plasma glucose level among the 
participants without diabetes (P<0.001 
for the interaction among diabetes and 
Mediterranean diet and time). 
Among the participants with diabetes, 
the proportion of glycated hemoglobin 
at 24 months decreased by 0.4±1.3% in 
the low-fat group, 0.5±1.1% in the 
Mediterranean-diet group, and 0.9±0.8% 
in the low-carbohydrate group. The 
changes were significant (P<0.05) only 
in the low-carbohydrate group (P = 0.45 
for the comparison among groups). 
 
 
 
In contrast, insulin levels decreased 
significantly in participants with 
diabetes and in those without diabetes 
in all diet groups, with no significant 
differences among groups in the 
amount of decrease. 
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 Blood Glucose, Glycosylated 
Hemoglobin 
Insulin Resistance, Insulin sensitivity 
 
Stern 2004- 
12m 
A:L 
Glycosylated haemoglobin in the small 
group with diabetes (n=54) decreased 
more in the low-CHO group after 
adjusting for baseline differences. The 
results show a direct effect of the low 
CHO diet on glycemic control                                                                                     
Insulin Sensitivity: The difference 
between the 2 diet groups was not 
significant. 
 
Yancy  2004-
24w A:L 
Not Measured Not measured 
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Dansinger et al. (2005) A: Z: W: O; 1 Year 
The lower CHO diets (Atkins and Zone) reduced diastolic BP in the short term. 
 
Foster et al. (2003) A:L; 6m; 12m 
Systolic BP did not change significantly in either group. Diastolic BP decreased in both groups but 
there were no significant differences between the groups. 
 
Frisch et al.  (2009) Z:L; 6m , 1 Yr 
Diastolic blood pressure decreased in both groups, whereas systolic blood pressure was 
significantly higher at month 12 in the low-fat group compared with the low-carbohydrate group. 
The differences in systolic blood pressure at month 12 remained significant after adjustments were 
made for fat free mass and sex distribution. 
 
Johnston et al. ( 2006) A:Z; 6w 
Layman et al.  (2005) Z:Z+EX:L:L+EX 16w 
 BP was not measured or reported. 
 
Luscombe – Marsh et al. (2005) N(LF-HP): N(HF-SP) 12 w ER; 8w EB 
Systolic blood pressure decreased from 130±1.89 mm Hg at week 0 to 123±1.5 mm Hg at week 16 
(main effect of time, P<0.001), but diastolic blood pressure remained unchanged (72 ± 1.3 mm Hg at 
week 0 and 71 ± 1.0 mm Hg at week 16).  
 
McAuley  et al. (2004) A:Z:L;8w 
Systolic and diastolic blood pressures were modestly reduced. Diastolic blood pressure was 
significantly lower in the Atkins group than in the Low-fat group (−3 mm Hg, 95% CI −6 to 0, p=0.03). 
No significant differences were observed between the dietary groups with respect to systolic blood 
pressure.  
 
Meckling  et al. ( 2004)  N :L; 10w 
Twelve of 31 subjects completing all 10 wks of the study had some form of abnormal blood pressure 
at baseline. The group results indicated that both diets were equally effective in reducing systolic 
blood pressure by about 10 mm Hg and diastolic blood pressure by 5 mm Hg. 
 
Parker et al. (2002) Z:L; 8w ER, 4 w EB 
Systolic blood pressure fell significantly by 8 mmHg and diastolic blood pressure by 4 mmHg at 
week 8 (P < 0.001) with no differential effect of diet. During the weight stabilization period between 
weeks 8 and 12, systolic blood pressure rose by 3 mmHg and diastolic blood pressure by 1 mmHg (P 
< 0.001). This was also not affected by diet composition. 
 
Sacks et al.  (2008) Z:Z:L:L; 2 Yr 
Blood pressure decreased from baseline by 1 to 2 mm Hg, with no significant differences among the 
groups (P>0.59 for all comparisons). 
Samaha et al. (2003) A:L; 6m 
BP: Systolic and diastolic BP decreased by 2mm Hg and 1mm Hg respectively in the low CHO group. 
In the low fat group both measures decreased by 2mm Hg but there was no significant difference 
between the groups. 
Shai et al. (2008) A:L:M; 2 Yr 
Systolic blood pressure fell by 4.3±11.8 mm Hg in the low-fat group, 5.5±14.3 mm Hg in the 
Mediterranean-diet group, and 3.9±12.8 mm Hg in the low-carbohydrate group (P = 0.64 for the 
comparison among groups). The corresponding decreases in diastolic pressure were 0.9±8.1, 
2.2±9.5, and 0.8±8.7 mm Hg (P = 0.43 for the comparison among groups). 
Stern et al. (2004) A:L; 12m 
Systolic and diastolic BP increased from baseline by 2±15 mm Hg and 1±10mm Hg for the 
conventional diet group and 1±19 and 3±15 for the low-carbohydrate group respectively. The 
differences between the groups were not significant. 
Yancy et al. (2004) A:L; 24 w 
Over 24 weeks systolic BP in the low-carbohydrate group decreased by 9.6mm Hg, diastolic BP 
decreased by 6.0 mm Hg. In the low-fat group, systolic BP decreased by 7.5mm Hg and diastolic BP 
decreased by 5.2 mm Hg. 
 
